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SUMMARY
Psychiatric aspects of migraine 
Literature review
This section provides a survey of the literature on the 
multiple factors implicated in the aetiology of migraine and the 
links between migraine and psychiatric disorder.
The historical development of current concepts of migraine is 
outlined and the main controversies in the present-day classification 
of the condition are critically reviewed.
General characteristics of migraine clinic populations are 
described and contrasted with the results of community surveys.
Studies of the genetics of migraine suggest that genetic 
factors are important in only a subgroup of migraineurs.
No evidence is found for a specific personality type in 
migraine although patients may be rather obsessional and more 
sensitive to minor stresses. Recurrent headaches are associated 
with mild depressive illness, somatisation and anxiety, the extent 
of which is directly related to the frequency and severity of the 
pain.
Mind-body interaction is a difficult philosophical issue. A
variety of models are briefly reviewed and the dualist- 
interactionist model is suggested as the most relevant to migraine.
It is suggested that a neural event, the Spreading Depression 
of Leao (S.D.), initiates classical migraine attacks, possibly due 
to light-induced changes in potassium ion concentration in the 
visual cortex. This underlies the prodrome and aura. Cerebral 
blood flow changes may be secondary to this. The headache could be 
a direct consequence of SD or may be vascular in origin.
Kindling may provide a mechanism for the periodicity in 
migraine, affective disorder and epilepsy. Limbic system 
involvement could explain the emotional symptoms common to the 
three conditions.
Migraine can be associated with persistent neurological 
dysfunction and is a risk factor in cerebral infarction.
The relationship between epilepsy and migraine is reviewed. 
Olfactory auras in epilepsy are associated with depression.
Cocaine abuse is suggested as a model for migraine 
hallucinations and the precipitation of psychiatric illness by 
stress. Endorphins are released along with stress hormones and are 
likely to play an, as yet, unspecified role in the production of 
stress-related psychiatric and physical illness. They are clearly 
involved in the experience of pain in migraine and possibly also in 
mood changes.
Menstrual migraine is accepted as a subgroup of migraine 
although it can be defined objectively much less frequently 
than it is subjectively complained of.
Finally cerebral asymmetry in physiology and cognition is discussed 
as it applies to migraine.
Research conducted
A consecutive series of 46 new, female referrals to a Migraine 
Clinic was obtained for a three part study of the association of 
affective changes and migraine.
The initial psychiatric interview was used to obtain details of 
the family history of migraine and psychiatric illness, the 
patient's own migraine history and the factors involved in 
precipitating migraine attacks. A specific enquiry was made about 
presence or absence of mood changes in association with migraine and 
their frequency. The Structured Clinical Interview for DSM-III was 
used to provide DSM-III diagnoses of psychiatric disorder. The
a
Clinical Anxiety Scale, the Montgomery and Asberg Depression Rating 
Scale and the Manic Rating Scale were also completed to provide 
estimates of the severity of anxiety, depression and hypomania 
respectively.
Thirty-seven patients then completed Irritability-Depression- 
Anxiety rating scales and visual analogue scales over a six week
prospective period.
Finally 27 patients attended for regional cerebral blood flow 
monitoring while migraine was absent and five also had scans when 
migraine was present.
Results
Complaints of mood change and DSM-III diagnoses of affective 
disorder were present in just under half the sample. The initial 
self report of mood changes, the presence or absence of DSM-III 
diagnoses of affective disorder and the data from the prospective 
rating scales were all used to define 'affective' and 'non- 
affective' groups. Differences between the groups were then 
examined. The main factor related to complaints of mood change was 
the presence of a DSM-III diagnosis of affective disorder. Self 
reports of mood change at the initial interview did not correlate 
with the changes in mood components rated in the six week 
prospective period. Twelve of the 37 patients had significant 
associations between changes in mood components and days when 
migraine was present. There was no evidence of a change in any mood 
component in the period just before or just after a migraine attack 
in the group as a whole although this was seen ocasionally in 
individual patients. Olfactory hallucinations as part of migraine 
attacks were significantly associated with complaints of mood 
change. Classical and common migraine patients had differences in 
symptoms and anxiety levels which were likely to be a secondary 
consequence of their condition.
The regional cerebral blood flow data did not discriminate 
between affective and non-affective groups in the absence of 
migraine. There were too few scans in the presence of migraine to
permit analysis. However when scans were performed in the presence
and absence of migraine they did show a trend towards differences 
between common and classical migraine and this would merit further 
examination. No evidence for an excess of weekend headaches was 
found in this sample. Weekend headaches were unrelated to 
employment status or type of migraine. An association between
migraine, mood change and menstruation was found in only one of a
subgroup of six patients.
Conclusions
Patients' initial self reports of the association of migraine 
and mood change did not agree with the prospective data. These 
complaints and diagnoses of affective disorder were probably more 
common than expected in this sample, although in the absence of a 
control population this can only be a tentative conclusion.
There was no evidence of an affective prodrome to migraine or 
of affective change subsequent to migraine attacks. Changes in 
mood components were related to the presence of migraine in a third 
of subjects.
There was no evidence in this sample that migraine attacks 
clustered at weekends or that the day of the week that attacks
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occurred was related to employment status or type of migraine.
A statistically significant association between migraine, 
menstruation and changes in mood components was found in only one 
patient of a small subgroup of six.’ This could be due to chance 
alone. Further investigation of the association of migraine, 
menstruation and changes in mood components is required to explore 
this area properly.
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Psychiatric Aspects of Migraine
Introduction
Approximately,JO$ of patients who consult a doctor because of 
migraine complain of mood changes which they associate with the migraine 
attack. These may occur before, during or after the migraine. This 
figure for the incidence of mood disturbance is quoted in both specialist 
texts on migraine and reference works on organic psychiatry. It is based 
on clinical observation as although mood changes were recognised as a 
feature of migraine as early as the 1860s there have been few studies of 
this aspect of the condition. This may be due to the fact that 
physicans, rather than psychiatrists, are primarily involved in the 
treatment of migraine. By contrast the visual, sensory and motor 
prodromal symptoms have been extensively described.
* >
Migraine is particularly interesting because it is a physical 
condition which has a close association with many psychiatric disorders. 
As such it can be used to examine the interplay of psychological and 
physical factors in the production of illness e.g. personality 
variables interact with genetic constitution to determine predisposition 
to migraine. Social status and intelligence also play a major part in 
deciding which patients with migraine present themselves to the medical 
services.
Prom a philosophical point of view migraine provides a model for the 
study of mind-body and brain-mind relationships. The patient and the 
lay population generally have difficulty conceptualising migraine as it
does not fit neatly into either a psychiatric or physical illness model 
hut lies somewhere between the two.
Migraine has the advantage of being a cerebral disorder with clear 
diagnostic criteria which is generally benign and recurrent. It has 
parallels with recurrent affective disorder, for which it can provide a 
medical model. Vascular and neural components are intertwined in the 
pathogenesis of migraine. A better understanding of this type of 
interaction is relevant to both psychiatry and medicine. Changes in 
cerebral blood flow are found in both classical migraine and affective 
illness. The spreading oligaemia seen in migraine has been compared to 
Leao's spreading depression of cortical electrical activity.
The neural component to migraine has similarities with epilepsy. 
Disturbances in the electroencephalogram are found in both conditions. 
Temporal lobe epilepsy is closely connected anatomically.with the limbic 
system and through this with emotional disorder. Paroxysmal disorders 
such as temporal lobe epilepsy, affective disorder and migraine may all 
be linked pathogenetically by a kindling mechanism similar to that found 
in limbic epilepsy.
Migrainous visual hallucinations are similar to those found with 
cocaine abuse. Consequently cocaine effects can help in understanding 
both the visual hallucinations in migraine and the aetiology of visual 
hallucinations generally.
Stress can lead to both physical and psychiatric illness and is also
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an important factor in the production of endogenous analgesia. Migraine 
provides an opportunity to examine these relationships. As pain and 
depression are also closely linked the episodic pain in migraine can be 
used to study the interaction between depression and endorphin 
concentrations.
Ovarian hormones have a major influence on migraine in a subgroup of 
patients. This may be related to their effects on central opiate 
receptors. The mood changes found in the premenstrual syndrome can be 
used as a model for the association of migraine with affective disorder.
Migraine is unusual in its tendency to be unilateral. Not only that 
but the pain can vaiy from one side of the head to the other between one 
attack and the next. This is associated with cerebral asymmetry and 
possibly with difficulties in cognitive processing.
In summary migraine provides a medical model which can help in 
understanding the interaction of psychological and physical factors in 




The psychiatric aspects of migraine have largely been ignored. 
Instead the main debate over the last 200 years has been over whether 
neurogenic or vascular factors are more important in the aetiology of the 
condition.
The prodromata, especially the visual ones, have lent a particular 
status to classical migraine since they were first described in the 5th 
Century A.D. by Caelius Aurelianus. The fact that it was a common 
condition with a repetitive pattern presumably contributed to the ease 
with which it could be studied and to the extensive clinical descriptions 
which were published in the medical literature.
Galen ascribed migraine'-to an excessive upward thrust of corrupted 
vapours, humors or both from the body to the brain. These substances 
were then driven out into the scalp causing pain and tenderness.
The Swiss physicians Johann Jakob Wepfer (1620-95) and Johann Caspar
Anhalt (1720s) both thought that migraine and epilepsy were due to
vascular congestion. Anhalt believed in humoral involvement but differed 
from Galen in suggesting that the deteriorated chyle affected not the 
brain itself but also the blood vessels. It caused vasoconstriction or 
vasodilatation which in turn led to pain. He explained the unilateral
pain on the basis of congenital weakness of one side of the head.
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The neural hypothesis originated with Robert Whytt (1767) who 
considered migraine as a nervous disorder because it depended on 
"sympathy" between various parts of the body - in this case the head and 
the stomach (1).
By contrast John Fothergill (1778) had very definite views that the 
headache proceeded from the stomach rather than the reverse and that 
migraine generally arose from inattention to diet. He believed that 
only self control and strict adherence to a dietary regime with laxatives 
and stomach bitters over an extended period could relieve the condition. 
He recognised that the medical profession had been unsuccessful in 
treating the disorder - (the patients) "who are yet, sometimes, not much 
less sufferers by the means frequently made use of to remove it, than by 
the disease itself". However he blamed this on the patients' errors in 
diet and conduct. He neatly avoided alienating his customers totally by 
absolving them on the grounds that eventually their behaviour weakened 
the powers of digestion, the secretions of the digestive juices, and the 
organs themselves. The 'morbid piquancy' of the juices inevitably led the 
patient to overeat and defeated the best efforts of the physician. The 
main foods implicated were butter, fat meats and spices, especially black 
pepper. Wine, beer and spirits, together with tea and coffee were all 
acceptable in moderation. Bile was seen as the causal agent echoing 
Galen's earlier humoral theory (2).
Du Bois Reymond (1859) waa first to suggest that migraine was caused 
by the vasomotor effect of the cervical sympathetic nerves. He drew an 
analogy between pain emanating from the blood vessels and pain produced 
by stimulating striated or smooth muscle. He attributed the pain of
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migraine to 'increased lateral blood pressure against the blood vessel 
wall' and illustrated this with examples of increased headache when blood 
pressure increased within the head.
The visual phenomena associated with migraine attracted considerable 
interest in the 19th Century because of their inter-relationship with 
optics and perception. Astronomers and physicists who suffered from the 
condition themselves contributed their self- observations to the medical 
literature. William Hyde Wollaston reported his own two single attacks of 
hemianopic scotoma in 1824 and extrapolated from them to the first 
description of the 'semi-decussation' of optic fibres in the optic 
chiasm. George Airy (1865) was the first to put forward the view that 
'the seat of the disease in in the brain; that the disease is a species 
of paralysis; and that the ocular affection is only a secondary 
symptom'. Sir Hubert Airy (1870) thought the condition originated in 
either the optic tract or the corresponding optic thalamus. He combined 
vascular and neural theories to postulate a temporary suspension of 
function, propagated by contiguity, among the nerve cells of the visual 
sensorium which was due to vascular congestion. He later suggested that 
the headache might be due to propagation of this nervous disturbance into 
other parts of the brain where it could cause pain. This propagation 
could also explain the aphasias seen in the prodrome (1).
Edward Liveing (1875) wrote a carefully researched volume 'On 
megrim, sick-headache and some allied disorders', illustrated with case 
histories and observations of groups patients. His insight into the 
condition was so penetrating that more recent studies have served only 
to confirm his original work.
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His work is worth studying in detail because he went beyond simple 
description of the symptoms of migraine and into an examination of the 
interplay of external and internal factors in the production of the 
illness. He also took the major step of attempting to integrate 
migraine into a general theory of aetiology of neurotic illness (neurotic 
in the sense of having its basis in neural tissue). He noted that if the 
onset of the condition occurred in childhood there was generally a 
hereditary predisposition to it. If there was no family history of 
migraine the onset tended to be later. The attacks generally decreased 
when the patient was approximately 50 and ceased completely before old 
age. They often increased perimenopausally in women and decreased after 
the menopause. He described 'hereditary transformations' in which a child 
might suffer not from the same 'neurosis' as the parent but a 'kindred 
affection'. Epilepsy, insanity and neuralgia were all found in relatives 
of migraineurs. He quoted Sir Henry Holland's observation of a 
periodicity in attacks of migraine even when the intervals between them 
extended to 2-5 weeks. This seemed to denote 'a cause specific in nature 
and uniform in operation'. A kind of compensation was sometimes observed 
between the severity of a seizure and the degree of immunity which 
preceded or followed it (i.e. the more severe the seizure the longer the 
interval till the next one). He clearly appreciated that external and 
internal events influenced the disorder and differentiated exciting and 
accessory causes on the basis of the time period involved. (Exciting 
causes were much briefer than accessory ones.)
'Where the constitutional predisposition is present in a fully- 
developed form and of a well-marked hereditary type these accidental
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circumstances are not at all essential to its manifestation and the 
seizures will occur whether they are present or not; but when this is not 
the case, when the predisposition is originally feeble or latent, and 
when it is waning or declining in force, the influence of these secondary 
agencies becomes much more apparent and important and may make all the 
difference to the patient between frequent suffering and comparative 
immunity.'
Gastric disorder, menstruation and emotional disturbance were the 
main exciting causes. There was no particular relationship between the 
migraine and the phase of menstruation. ’Mental emotion' was recognised 
not only by Liveing but also by Romberg & Tissot as 'among the more 
influential of the occasional causes of migraine'. The passions, 
especially anger and vexation, were particularly linked with the 
condition. The character of the emotion did not seem to matter provided 
it was strongly felt.
Sleep and waking were associated with migraine attacks as well as 
other neurosal affections. Dr Marshall Hall, as quoted by Liveing, 
indicated that 'the transitions from sleeping to waking, and from waking 
to sleeping are peculiarly apt to determine the accession of nervous 
disorders.'
Sensory impressions could also trigger attacks e.g. glaring lights, 
loud noise and strong odours. Liveing cited M. Labarraque as saying that 
'The sense of smell, so highly developed in some persons, often becomes 
an occasion of migraines. Nothing is more common than to see the odours 
of spirits of turpentine, of lilies, of the essence of roses, of anise,
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or musk, of valerian and so forth, determine violent attacks of this 
malady; flowers, especially those which exhale a strong odour, sweet or 
not, often produce the same effect'. Where there was a marked visual 
prodrome to the attack anything which strained vision could produce the 
migraine. Interestingly, Sir John Herschel remarked that his own, purely 
visual, migraines could he induced by allowing his mind to dwell on his 
visual symptoms. This supported the idea that 'the same kind of 
impression on the sensorium, whether arriving through channels of sense 
of idea, may be followed by the same result.'
Accessory causes had 'a more prolonged operation in consequence of 
which the nervous system's latent morbid tendencies are developed or 
those already in action are intensified'. The main factors identified 
were:-
(1) exhausting circumstances of any kind - both physical and mental 
exertion if too close or continuous and especially if accompanied by 
anxiety,
(2) puberty and the climacteric.
The clinical symptoms of attacks were meticulously described and the 
'natural succession' of symptoms documented. 'The affection of sight 
when it occurs is always or almost always first, next come disorders of 
touch and of the muscular sense in the extremities which are quickly 
followed by impairment of speech and disordered ideation; the headache 
then sets in, and as it increases nausea is gradually developed; actual 
vomiting is always later and may terminate the attack, but more 
frequently the paroxysm ends in sleep'. Liveing noted that, in most 
cases, if the headache was unilateral so were the other symptoms and if
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bilateral then both sides were affected. Disturbances of touch and sight 
when unilateral were almost as likely to occur on the opposite as on the 
same side of the body. In most well differentiated unilateral cases one 
side of the body suffered far more than the other. This unilateral, 
bilateral or intermediate character was seen as analogous with other 
functional disorders of the nervous system,particularly epilepsy where 
the convulsions frequently exhibited a more or less one-sided character. 
The tingling and centripetal progress of sensory phenomena were similar 
to the 'aura epileptica'. Disorders of speech were found in 
approximately 25$ of a series of Liveing1s patients. These could be 
persistent - 'It is certain that transient disorders of ideational 
consciousness, a sense of intellectual confusion and inability to attend 
or recollect, occur in many severe attacks of migraine, and that 
frequently repeated and severe seizures occasion a less temporary form of 
the same mental impairment'.
Liveing recognised close links between migraine and epilepsy. 
Migraineurs often had a family history of epilepsy and some patients who 
developed migraine during their teens went on to have epilepsy in adult 
life. The prodrome and aura of classical migraine had much in common 
with minor epilepsy.
'Psychical disorder' was frequently a part of severe attacks. In 
exceptional cases the whole migraine attack could be replaced by 
temporary mental derangement. The psychical disturbance could be either 
intellectual or emotional:
(l) intellectual - loss or impairment of memory; confused, incoherent or 
tumultuous ideation; very rarely hallucination.
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(2) emotional - this affected approximately 25$ of Liveing's patients and 
usually preceded the headache although in a few cases it could continue 
into, or not start until, the later stages of the attack. The emotional 
symptoms were depression or vague subjective feelings of anxiety or 
dread. Irritability could occur before attacks.
Liveing emphasised the importance of self report in this aspect of 
the condition: 'Autograph accounts of which the value can hardly be 
overestimated where the phenomena under consideration are those of the 
patient's own consciousness and do not come within the range of ordinary 
observation'.
Liveing believed in neurosal equivalency and transformations. He 
was convinced that neuroses frequently changed in character when they 
were inherited. Occasionally one form of seizure could be replaced 
temporarily or permanently by another. This happened in a range of 
disorders including epilepsy and mania. He thought that there was a 
continuum of nervous disorders - epilepsy, mania, vertigo, chorea, 
transient amaurosis and somnambulism were all regarded as closely allied 
and interchangeable conditions. These were all the result of 'a 
determination of blood' in different degrees in different parts of the 
brain. Brown-Sequard (as cited by Liveing) thought that many conditions 
resembled epilepsy in being 'due to an irritation starting from a 
centripetal nerve' that is, peripheral irritation with vaso-motor 
reflection. The explanation for the close connection and conversion of 
disorders was embedded in the constitution of the central nervous system. 
Tissot (also as cited by Liveing) proposed that metamorphosis in migraine 
was due to the transfer of morbid activity from one set of nerves to.
- 11 -
another. Epilepsy was the neurosis most closely connected to migraine - 
occasionally one disease replaced the other and intermediate forms also 
occurred.
The fundamental cause of all neuroses was a primary and often 
hereditary morhid disposition of the nervous system itself. The nerve 
centres irregularly accumulated and discharged 'nerve-force' causing 
disruptive and uncoordinated action. The particular regions affected 
determined the type of neurosis. The illness was preceded by a condition 
of unstable equilibrium and gradually accumulating tension. The paroxysm 
was like a storm which dispersed the condition and temporarily restored 
equilibrium. The seizures were complicated by disruption of the function 
of the affected parts which caused various degrees of anaesthesia and 
paralysis. The positive features were direct expressions of the neural 
areas involved.
Liveing described * nerve-storms’ which were (i) paroxysmal and 
explosive, e.g. epilepsy and (ii) intermittent with healthy intervals.
The mechanism was an accumulation and discharge of morbid material which 
was thought to be the 'nerve-force' itself. This also occurred in 
paroxysms of pain and delirium and explained the exhausting effects of 
pain or any strong sensation. Sir Henry Holland felt this was the 
explanation for the periodicity of migraine and epilepsy as it correlated 
with the increased irritability prior to the attack and the immunity 
afterwards.
Over a period exciting causes gradually led to increasing disability 
in the nervous system.
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Liveing acknowledged that others thought that a disorder of cerebral 
circulation was the principal cause of migraine but felt that even they 
must assume a minor degree of morbid irritability or explosive tendency 
in the nervous system.
He thought that migraine could be triggered or exacerbated by 
'excessive brainwork*. This could be intellectual or could be due to 
'strain of the affective or emotional part of our nature, which is the 
result of prolonged mental anxiety, vexation and disappointment, whether 
associated with the former or independently and which is far more 
rapidly exhaustive of nervous power than any intellectual efforts which 
are free from such emotional complications.' (3 )
Gowers (1888) included a chapter on migraine in his 'Manual of 
Diseases of the Nervous System'. He commented particularly on the 
resemblance between epilepsy and migraine with respect to sex 
distribution and age of onset. In order of frequency the common 
'symptoms were
Headache Most








He noted that occasionally a visual impression such as watching
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moving objects or seeing a peculiar kind of motion could induce migraine 
as could over-use of the eyes or a sudden change of light. This could 
also happen with loud noise or peculiar odours. 'A peculiar habit may 
become established by which a sensory impression will always induce a 
paroxysm'.
Emotional changes (depression, restlessness or confusion) could 
occur either as the earliest symptoms of the attack or after the 
development of sensory symptoms. Occasionally there was transient 
loss of memory, double-consciousness (a vivid recollection of things 
past) or brief stupor.
Movement, light and noise all increased pain during the migraine.
The most common vasomotor disturbance was pallor of the face at the 
onset of the migraine and often throughout its course. This could be 
followed by flushing. Rarely flushing was present from the beginning. 
The extremities were usually cold.
Gowers quoted two theories of aetiology:
(1) Vascular
(a) Spasm of the cerebral arteries as proposed by Whyte.
(b) Vascular dilatation as suggested by Mollendorf.
(c) Two varieties of migraine - (i) sympathetico-tonic
(ii) sympathetico-paralytic.
(d) The early symptoms of migraine were due to spasm and the headache 
to dilatation of the vessels (Latham).
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The sympathetic nervous system was implicated in the production of all 
the vascular changes.
(2) Primary derangement of nerve cells
The vasomotor disturbance was secondary to the 'nerve-storm' which was 
a combination of inhibition and discharge of sensory centres. The 
vascular system was influenced by the cerebral centres, e.g. the blush 
of emotion and the pallor of fear. Therefore the vascular changes in 
migraine could be the result of disturbance in the sensory centres.
The sensory symptoms were linked to functional disturbance in the 
nerve cells of the cerebral cortex whereas the headache was more closely 
affiliated with vascular changes.
The prognosis for the condition given by Gowers could be repeated 
today - that the prospect of recovery was never considerable but there 
was a fair chance that attacks could be reduced in frequency and severity 
by continued treatment. Stress was laid on absolute rest and avoidance 
of all strong sensory impressions during the acute attack. (4 )
John Hughlings Jackson initially (1876) described migraine as a 
sensory epilepsy. (1) In a footnote to a lecture on convulsive seizures 
given later (1890) he explained that he had used the term epilepsy to 
describe conditions in which any part of the cerebral cortex might become 
highly unstable and discharge excessively but henceforward he wished to 
restrict the term to convulsive seizures. (5)
Ergotamine was first isolated in 1925 and its benefits in the
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treatment of migraine supported the vasomotor theory of causation.
The major treatise on migraine in this century has been Harold 
Wolff's 'Migraine and Other Head Pain' (1948). Wolff experimentally 
confirmed the classical hypothesis that a dilated temporal artery gave 
rise to a throbbing headache. He also postulated, but did not prove, a 
transient spasm of the occipital artery which preceded this 
vasodilatation and was responsible for the visual aura. In the most 
recent edition (1972) migraine was described 'as a form of relatively 
benign vasospasm, an episodic disorder of an integrative nature produced 
by the interaction of the cerebral vasomotor centres, the extracranial 
and intracranial blood vessels and the microcirculation. It involves 
both central and peripheral vasomotor mechanisms, as well as a sterile 
inflammatory reaction, evoked by the activity of the nervous system.'
(6)
Sacks (1970) portrayed the primary disturbance in migraine as 
neurophysiological disturbance of brainstem activity. Local vascular 
disturbances and systemic upsets were variable in occurrence, 
intermediaxy in role and secondary to this. Migraine was seen as 'both 
eloquent and effective in providing an oblique expression of feelings 
which are denied direct or adequate expression in other ways.' (7 )
1 .1 Summary
The characteristic visual, sensory and motor symptoms prior to the 
migraine headache and the unilateral pain have always differentiated 
migraine from other types of headache. They distress the patient and
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concern their physician. As a consequence they have been extensively 
described. This led to the delineation of the anatomical pathway of the 
optic fibres. The unilateral pain has suggested cerebral asymmetry in 
the production of symptoms. The prominence of nausea and vomiting caused 
initial confusion about the site of origin of migraine and interest in 
dietary factors as part of aetiology and treatment.
There has been longstanding controversy over whether the 
pathogenesis is neural or vascular. The convention has been to assume 
that the sensory and motor symptoms have a neurological origin whereas 
the headache has a vascular basis. The orderly progression of migraine
symptoms is also seen in epilepsy. Different types of neurogenic illness
may be inter-related.
Migraine has a multifactorial aetiology. This was recognised early 
and there has been interest in the interplay of internal and external 
factors for a long time. The main external factors implicated have been 
emotional and intellectual stress. The main internal ones have been the
condition of the stomach, the phase of the menstrual cycle and emotional
disturbance. The fact that so many factors are involved makes an 
explanation of the pathogenesis of the condition both challenging and 
difficult. On one hand migraine provides an opportunity to use multiple 
models to develop understanding of the condition and to look at the 
relative contributions of the variables concerned but on the other hand 
it makes it difficult to concisely summarise the roles of these factors 
in a simple way.
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CHAPTER 2
Syndromes included under the general heading of migraine
2.1 Problems in the definitions of illnesses
The two main problems are achieving a diagnosis which is both 
reliable and useful.
The reliability of a diagnosis can be determined by:
(i) observer agreement i.e. the frequency with which two independent 
raters make the same diagnosis on the same patient,
(ii) frequency agreement i.e. a comparison of the range of diagnoses 
given to -two comparable series of patients,
(iii) consistency or stability of the diagnosis over a period of time. (8 )
A consensus of opinion may only reflect conformity to traditional 
ideas about a condition.
The concordance of diagnosis using two separate classification 
systems does not necessarily imply that either or both is valid.
Different systems may be based on standard symptoms or signs elicited on 
examination of the patient.
The longitudinal development of an illness can produce changes in 
diagnosis which can only be avoided by introducing an arbitrary 
hierarchy. The prognosis of a condition can circularly justify its 
original diagnosis. (9 )
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The most satisfactory criteria are operational definitions 
particularly if these are based on aetiological factors e.g. inheritance.
The usefulness of a diagnostic system will depend partly on its 
purpose e.g. clinically useful systems may not be stringent enough for 
certain kinds of research. Clinical utility depends on:
(i) the relative homogeneity of groups - this is achieved best if the 
classification is based on differences in symptoms,
(ii) prediction of response to treatment - new, effective treatment can 
lead to the revision of diagnosis,
(iii) good separation between the groups - unfortunately overlap of 
symptoms between categories is very common
(iv) prediction of prognosis. (10) '
2.2 Classifications of migraine
X.
The two classification systems most commonly referred to in the 
literature on migraine are (1) that of the World Federation of 
Neurologists' Research Group on Migraine and Headache, and (2) that of 
the Ad Hoc Committee on the Classification of Headache.
The two systems have similar criteria. The World Federation of 
Neurologists consider migraine to be a familial disorder characterised by 
recurrent attacks of headache widely variable in intensity, frequency and 
duration. Attacks are commonly unilateral and are usually associated 
with anorexia, nausea and vomiting. In some cases they are preceded by, 
or associated with, neurologic and mood disturbances. Not all of these
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characteristics are necessarily present in each attack or in each 
patient.
Conditions which are generally accepted as falling within this 
definition are classic migraine and non classic (common) migraine.
Conditions which may or may not fall within the category of migraine 
are 'cluster' headache, 'facial' migraine, 'opthalmoplegic' migraine and 
'hemiplegic' migraine. (11)
The classification proposed by the Ad Hoc Committee on the 
Classification of Headache is mainly descriptive but is also based on 
pain mechanisms as these were conceptualised when the classification was 
introduced in 1962. It is made up of fifteen categories with definitions 
for each one.
Categories




(d) 'Hemiplegic' and 'opthalmoplegic' migraine
(e) 'Lower-half' headache.
(II) Muscle-contraction headache
(ill) Combined headache: vascular and muscle-contraction 
(IV) Headache of vasomotor reaction
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(V) Headache of delusional, conversion or hypochondriacal states
(VI) Non migrainous vascular headaches
(VII) Traction headache
(VIII)Headache due to overt cranial inflammation
(IX)-(XIII) Headache due to disease of ocular, aural, nasal and sinus, 




For the purposes of this review of the literature the following key 
definitions will he adhered to throughout:
(l) Vascular headaches of the migraine type
Recurrent attacks of headache, widely varied in intensity, frequency 
and duration. The attacks are commonly unilateral in onset; are usually 
associated with anorexia and sometimes with nausea and vomiting; in some 
cases are preceded by or associated with conspicuous sensory, motor and 
mood disturbances; and are often familial. Cranial arterial distention 
and dilatation are importantly implicated in the pain phase but cause no 
permanent changes in the vessel involved.
(A) Classic' migraine
Vascular headache with sharply defined, transient visual and other 
sensory or motor prodromes, or both.
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(B) ’Common1 migraine
Vascular headache without striking prodromes and less often unilateral 
than (A) and (C). Synonyms are 'atypical' migraine or 'sick' headache. 
Attention is called to the relationships of this type of headache to 
environmental, occupational, menstrual or other variables by such terms 
as 'summer', 'Monday', 'weekend', 'relaxation', 'premenstrual' and 
'menstrual' headache.
(C) 'Cluster' headache
Vascular headache, predominantly unilateral on the same side, usually 
associated with flushing, sweating, rhinorrhea, and increased 
lacrimation, brief in duration, and usually occurring in closely packed 
groups separated by long remissions.
(il) Muscle-contraction headache
Ache or sensations of tightness, pressure or constriction, widely 
varied in intensity, frequency and duration, sometimes long-lasting and 
commonly sub-occipital. It is associated with sustained contraction of 
skeletal muscles in the absence of permanent structural change, usually 
as part of the individual's reaction to life stress. The terms 
'tension', 'psychogenic' and 'nervous' headache refer largely to this 
group. (12)
Diamond & Medina (1976) have suggested a simpler nosology 
categorising headache under three major headings including psychogenic.
(13)
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(Diamond and Medina 1976)
More recently chronic daily headache has been defined as a daily 
vascular headache without concomitant neurological symptoms. (14) The 
majority of these daily headaches are on a continuum with episodic 
migraine (15) and subsume migraine with inter-paroxysmal headache. This 
last form starts as a common migraine, but there is a progressive 
increase in the frequency of attacks and a reduction in pain-free 
intervals until the latter disappear altogether. (16)
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2.4 Controversial issues in classification
(i) Migraine versus muscle-contraction headache
The main issue is whether migraine and muscle-contraction headache 
are separate categories or points on a continuum of headache severity.
FIG 1 - The headache spectrum Nappi et al, 1985 (14)
CLUSTER
Chronic












According to the severity continuum model the headaches experienced 
most frequently would cluster at a point which would give the diagnosis 
of migraine, tension or mixed (migraine and tension) headache. However 
patients could also experience other headaches which were more or less 
severe. The accessory symptoms and the type of pain would correlate 
with the severity of the headache. (17)
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FIG 2 - The continuum of benign recurrent headache 
Raskin & Appenzeller 1980 (17)
CLASSIC
MIGRAINE









Reproduced from Raskin N H, Appenzellor 0, 
Headache. W.B. Saunders, Philadelphia 
1980, p.182 with permission of the 
publishers.
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Although there is variation within each type of headache and an 
individual can have both migraine and muscle-contraction headache (MCH) 
they differ on a number of variables:
(a) family history of the disorder - this is more frequent in migraine 
than MCH,
(b) age of onset - the majority of MCH cases developed after age 30, 
migraine begins earlier,
(c) prodomata - more frequent in migraine,
(d) frequency - 50$ MCH versus 3$ of migraine cases reported daily 
occurrence,
(e) duration - 35$ of the migraine group versus 10$ of the MCff' group 
reported a duration of 1-3 days,
(f) type of pain - 80$ reported throbbing pain in migraine versus 10$ in 
MCH,
(g) location of pain - unilateral: 80$ migraine versus 10$ MCH,
bilateral: 90$ MCH versus 20$ migraine,
(h) associated symptoms - vomiting was present in 50$ of migraine cases 
versus 10$ of MCH.
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These findings come from a very large study of 1,000 migraineurs and 
1 ,000 tension headache sufferers. Although the characteristics of each 
group are described it is not clear what criteria were used to 
differentiate between them. All patients attended a headache clinic but 
beyond that there is no information on how they were selected. Migraine 
patients were not divided into common and classical groups. (18)
(II) Muscle-contraction headache versus daily chronic headache
As was noted in the preceding section increased frequency and 
duration of headache are likely to produce a diagnosis of MCH rather than 
migraine. By definition, migraine has been an episodic disorder.
However 70$ of patients with daily headaches had been found to have a 
previous history of episodic migraine. This was hormone-dependent (eg 
menstrual migraine) in more than half. Several years elapsed before the 
transformation from episodic to daily headache. (Mean age of onset of 
episodic headache was 17 years, mean number of years of episodic migraine 
was 19 years, and the mean age at which transformation occurred was 30*8 
yrs.) Excluding these patients from a diagnosis of migraine might deprive 
them of the advantages of specific treatment. (15)
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(III) Classical versus common migraine - are these the same or different
entities?
Vasospasm and cerebral ischaemia followed by cerebral and 
extracerebral vasodilatation and hyperaemia are generally believed to 
form the common pathophysiology of the various subtypes of migraine.
Common migraine is at the mild end and classical migraine the severe end of 
a continuum of severity. Because of this view virtually all drug trials 
and many pathophysiological studies have included both types of 
migraine. However regional cerebral blood flow studies have shown marked 
pathophysiological differences between the two conditions. Spreading 
oligaemia which originates posteriorly and progresses anteriorly has been 
found in patients with classical migraine, but not in patients with 
common migraine. This closely resembles the Spreading Depression of 
Leao. (19,20)
However, the conclusions from this work on cerebral blood flow have 
been challenged on both clinical and experimental grounds:
(1) Clinical
(a) The differentiation between classical and common migraine is made on 
the basis of the patient's self report. This is a notoriously unreliable 
source of information. It is also common for the same patient to have 
episodes of both classical and common migraine (20,21). However the vast 
majority of migraine patients never experience an aura, i.e. they have 
common migraine. Since the incidence of common migraine is approximately 
20$ one would expect a similar percentage of patients with classical
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migraine to coincidentally have common migraine. However, as the 
percentage actually found is higher than this there is some indication of 
a relationship between the two conditions. (23)
(b) Headaches are the same whether or not they are preceded by an aura.
(21)
(c) Classical and common migraine are both treated with the same types of 
medication. (21) Despite this it has never been shown in controlled trials 
that they respond equally well to them. (23)
(2) Experimental
(a) The topographical relationship between blood flow changes and 
symptoms is poor. However spreading oligaemia is not an all or none 
phenomenon but can differ in intensity and therefore in symptom 
production. (23)
(b) There has been controversy over whether:
(i) spreading depression (S.D.) can be elicited in man,
(ii) S.D. is the same as the spreading oligaemia demonstrated in regional 
CBP studies,
(iii) S.D. is followed by vasodilatation and reactive hyperaemia. (21)
In fact spreading depression has now been well described in humans but 
the short-lasting and very narrow band of hyperperfusion which follows it 
is difficult to see with external flow monitoring. (23)
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(iv) Conclusions
The considerable differences between migraine and muscle-contraction 
headache suggest that they are separate entities. Both conditions are 
common and it is therefore likely that they will often occur together.
Duration alone is insufficient evidence to differentiate muscle 
contraction headache and daily chronic headache. The latter appears to - 
be closely related to migraine and a past history of migraine in these 
patients may be an indication for specific anti-migraine drugs. There is 
a need for clinical trials to ascertain the most suitable type of 
medication for this group.
There is insufficient evidence to definitely say that classical and 
common migraine are different entities. However the differences between 
the conditions are sufficient to indicate a need to study them 
separately.
2«5 Description and definition of the migraine attack 
(1) Prodrome
The prodrome comprises symptoms with an insidious onset, which last 
several hours and involve mood, behaviour, wakefulness, gut motility and 
fluid balance. It has been hypothesised that these symptoms and signs 
indicate dysfunction, either diffusely in the cerebral hemispheres or 
focally in the hypothalamus. The prodrome is not always followed by 
either the aura or the headache.
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(2) Aura
This begins suddenly, lasts minutes and commonly affects vision or, 
less frequently, somatic sensation, motor, speech or brainstem function. 
It arises from stimulation or inhibition of a restricted area of cerebral 
cortex or, in basilar migraine, of the brainstem. It may occur 
independently from the headache.
(3 ) Headache phase
Headache is accompanied by nausea, vomiting, photophobia and 
phonophobia and is thought to arise from extracranial vasodilation or 
from a vasomotor instability of the meningeal circulation. The mechanism 
of photophobia or phonophobia remains uncertain. (24)
(4 ) Sleep resolution
The most efficient relief for the headache in migraine is sleep. 
Normal sleep is thought to have a restorative function and in migraine 
could be a non-specific response to stress, pain, vomiting or lack of 
food. Alternatively somnolence, yawning and sleep may be integral to the 
altered physiology. Supportive evidence for this hypothesis is found in 
the observations that migraine can be precipitated by lack of sleep, 
becoming excessively tired or sleeping too long. Yawning and tiredness 
are prodromal symptoms that may continue during, as well as after, the 
headache phase. The sleep-waking cycle is affected by hypothalamic 
disturbances. Other cyclical changes implicating the hypothalamus are
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mood variations, fluid retention, diuresis, hyperphagia, nausea and 
vomiting followed by restricted food tolerance. (25) Nocturnal migraine 
has been shown to be temporally related to REM sleep. It has been 
hypothesised that daytime migraine may be 'triggered' by a recurrent CNS 
physiological state resembling the REM stage of sleep although the 
subject is awake. There is a relationship between the adrenergic state 
(REM stage) of sleep and the decline of peripheral platelet-bound 
serotonin which places the peripheral level of serotonin in phase with 






Limited foodVomitingFood craving Nausea
tolerance
DiuresisFluid retention
Prodromal Aure Headache Sleep Recovery
Phase (54) (16) Phase (50) Resolution (34) Phase (47)
12 hours 40 mins 21 hours 7 hours 28 hours
Diagram illustrating phases, average duration and symptoms in migraine 
attacks from 50 subjects with uncomplicated migraine. (25)
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CHAPTER 3
Social and Demographic Factors in Migraine
Three independent epidemiological studies in the British Isles 
reported the prevalence of migraine as 24-29# for women and 15-20# for 
men (27-29)* Migraine is more common in women than in men but the exact 
extent of the sex difference is controversial. The figures quoted have 
varied widely between studies. Most of the epidemiological studies have 
been done in England and Australia and cross-cultural differences may 
account for some of the variance in the reported incidence. (30)
However since women with migraine have a greater propensity to deny life 
problems and focus on physical symptoms they may report the condition 
more than men.
Approximately 50# of migraine sufferers do not consult their GP or 
any other doctor about their condition (31). This causes obvious 
. problems in obtaining a representative sample of migraine patients.
The typical age of onset is approximately 20 years although 
migraines become relatively frequent as early as 10 years of age. After 
the age of 30 the probability of developing vascular headaches is greatly 
decreased and continues to decline through to the age of 60 for both men 
and women. (30)
Lennox (1941) thought migraine affected 'brain-using more than 
muscle-using persons’. (32) This view has subsequently been 
reformulated as the hypothesis that migraine sufferers are more
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intelligent than the general population. However a comparison of 
intelligence in migraine sufferers and a matched comparison group without 
migraine failed to support this. Distributions of intelligence scores 
were similar in both groups. (27)
Fothergill (1784) found 'sick headache' mostly in the 'middle and 
upper ranks of life'. Migraine is said to be commoner in the 
professional classes. Again there is no definite evidence to confirm 
this though there is a tendency for more intelligent individuals with 
migraine and those in social classes I and II to consult a doctor because 
of their headaches. Migraine patients consulting their doctors are a 
therefore selected group and may well not be typical of all migraine 
sufferers in the community. (27)
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CHAPTER 4
Genetic Influences on Migraine
Liveing (1873) stressed that migraine was a familial condition.
Most published work confirms that migraine tends to run in families. 
However there are two problems in interpreting this work (1) the lack of 
a consistent definition of migraine (2) possible bias in the selection of 
patients with migraine or in the collection of data from their families. 
Selection is important as only half of migraine sufferers consult a 
doctor. Bias is almost inevitable when migraine patients are asked about 
the family history of the condition and relatives are often not 
questioned directly about their headaches. (27)
There is no diagnostic test for migraine nor is there a biological 
marker. A positive family history is sometimes included in the 
diagnostic criteria for migraine. There are several clinical varieties 
of migraine which may have different pathophysiological mechanisms. 
Different triggering factors for migraine may be genetically influenced, 
e.g. personality type. Questionnaires have been used to reach a diagnosis 
when large numbers of people are surveyed but this is not as accurate as 
the doctor- patient interview. Patients are usually correct in self 
reports of migraine but under report the condition. It may be 
particularly difficult to differentiate common migraine and tension 
headache.
Information on genetic influences in migraine comes from two sources 
- family studies and twin studies.
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4-1 Family studies
In studies of family history the incidence of two or more migraine 
sufferers within a family has varied from 46—91^ - Lance & Anthony 
found that 46$ of parents and siblings of migraineurs also had migraine. 
Positive family histories of tension headache were found in only 18$ of 
parents and relatives of tension headache sufferers. In a monograph by 
Bille 79-5$ of children with severe migraine had parents or siblings with 
similar headaches. In 72.6$ of these cases the mother had migraine; in 
20.5$ the father. Dalsgaard-Nielson found a positive family histoiy in 
75-90$ of adult migraineurs. Again the mother was affected in 50- 70$ of 
cases, the father in 16- 19$. For both sexes there was an inverse 
correlation between the age of onset of classical or common migraine and 
the strength of the family history. Although the mother was the most 
commonly affected parent involvement of the father was associated with 
earlier onset of migraine.
Waters, basing his results on questionnaires, found migraine 
occurred in 6$ of first degree relatives of non-headache probands and in 
10$ of migraine probands. This difference is not statistically 
significant.
Although most studies confirm a strong familial component in 
migraine there is no simple pattern of inheritance. Both recessive 




Joel-Nielsen reported concordance in 3 of 5 pairs of monozygotic 
(MZ) twins reared apart; two of these were concordant for age of onset. 
Lennox reported 100$ concordance in 5 pairs of MZ twins. However the 
results were biased by epilepsy in three of the pairs. A large study by 
Lucas used a strict definition of migraine and determined zygosity and 
personality by questionnaire. The concordance rate for migraine in MZ 
twins was 26$ overall. Dizygotic (DZ) twins of the same sex had 16$ 
concordance for migraine. When both same-sex and different sex DZ twin 
pairs were considered together the concordance rate was 13$. Rates of 
concordance in male and female twins did not differ significantly. No 
particular symptom had a markedly higher genetic loading. The 
personality questionnaire showed no evidence of increased neuroticism in 
the affected twin of a pair discordant for migraine.
Conclusion
Twin studies, like family studies, suggest that there is more than 
one migraine syndrome. In some cases there is a powerful genetic 
component, but in others environmental factors are more important. (33)
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CHAPTER 5
The role of personality factors
5.1 Assessment of personality
Personality has been defined as the characteristic patterns of 
behaviour and thinking which determine a person's adjustment to the 
environment. (34)
Personality can be assessed by:
(i) observation of an individual in ordinary circumstances,
(ii) a clinical interview
(iii) self-report using personality inventories e.g. Minnesota 
Multiphasio Personality Inventory (MMPl) (35)*
Constitution, social and cultural factors all affect the composition 
of personality. As a consequence personality does not lend itself 
readily to objective assessment. Investigator bias can thus be an 
important confounding factor in studies of the role of personality in 
illness.
The major sources of bias in subjective testing are:
(i) overinterpretation of information to derive expected or 
significant conclusions,
(ii) emphasising subject characteristics in accordance with the 
tester's biases,
(iii) simplifying data to fit the hypothesis being tested,
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(iv) drawing conclusions from insufficient data,
(v) failure to externally verify conclusions (36) •
Psychological tests improve objectivity and resist bias compared to 
unstructured interviews. The subject's behaviour can also invalidate the 
test results - the three main problems are:
(i) unwillingness to cooperate,
(ii) inability to cooperate,
(iii) extreme test-taking attitudes or unusual styles of self
presentation. Difficulties can arise because of a tendency to 
conform with what the subject thinks is expected, or a need to 
present him/herself in an excessively favourable or unfavourable 
way or finally because of a wish to confirm or contradict the 
hypothesis being researched. ^
The concept of a personality profile which is specific to migraine 
assumes that:
people with migraine have common traits
these traits are specific, measurable personality characteristics, 
these traits can differentiate between migrainous and non- 
migrainous people.
The main difficulty in studies of personality in headache is the 
lack of a suitable control group. In practice different types of 
headache sufferers are used to control for each other. All findings have 





headache sufferers. Even when differences are found between patients 
with headache and the general population they could be the consequence 
rather than the cause of the illness - either as a direct result of the 
symptoms or indirectly through coping mechanisms developed by the 
individual concerned.
5.2 Personality factors in migraine
There is a specific migraine personality characterised by rigidity 
of thought, ambitiousness, an exaggerated sense of responsibility, 
intellectualism with a tendency to excessive worry, perfectionism, 
meticulousness, obsessional traits and inhibitions. This, at least, was 
the view of early psychoanalytic writers. The major conflict for 
patients was ambivalence about expressing hostility especially towards 
those close to them. Guilt then led to the repression of these feelings 
and their partial resolution through introjection and physical symbolism.
However there is little objective evidence that classical migraine 
is associated with increased hostility or aggression. One study, using 
an administered adjective checklist, found migraine patients were more 
inhibited in the expression of aggression, more likely to experience 
anxiety, guilt or both after anger and felt angry for longer. As children 
these patients were punished for, or prevented from, expressing anger. 
Unfortunately the checklist used was developed for the study and no 
information is available about findings in a normal control group.
Blaszcynski examined the question of increased obsessionality in 
migraine by comparing four groups of patients - classical migraine,
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tension headache, normal controls and non-headache physical pain - using 
the Hysteroid-Obsessional Questionnaire, the Eysenck Personality 
Questionnaire, the Buss-Durkhee Hostility-Guilt Inventory and the 
Hostility and Direction of Hostility Questionnaire. No evidence for 
increased obsessionality in the migraineurs was found on any of these 
measures. The number of patients in each group was small (15) and the 
migraine patients had fairly mild illnesses (in terms of frequency of 
migraine). The patients had all attended general practitioners or 
clinics because of their.complaints but were not directly comparable with 
the population attending a specialised migraine clinic. Only one study 
by Rogardo et al has found objective evidence of an obsessional component 
in migraine and Kudrow & Sutkus were unable to replicate these findings 
using the same measures in a larger sample. They argued that differences 
in diagnostic specificity in the two studies explained the results.
There are two facto-rs which may explain the discrepancies in the 
results of studies of obsessionality.
(1 ) Pollock has argued that the obsessional personality is commonly found 
in Western cultures where it embodies the Protestant work ethic and is 
prevalent in professional and managerial workers. Waters has shown that 
this type of person is more likely to consult doctors with migraine than 
the general population.. These patients will therefore be over­
represented in clinic populations and this will bias clinical studies.
(2) The validity of the categorisation of ’obsessional personality' is 
doubtful and no satisfactory instrument is available to measure it. The 
differences between the studies quoted may therefore be due to the
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inadequacy of existing measurements.'(37)
More recently the MMPI, the Beck Depression Inventory, the State- 
Trait Anxiety Inventory and Eysenck's Personality Inventory have all 
been used to demonstrate abnormalities in migraine patients. It remains 
uncertain whether these are the cause or the effect of the migraine.
Henryk-Gutt and Linford Rees (1973) used a questionnaire to identify 
classic migraine sufferers in the staff of two Government departments. 
Twenty-five men and 25 women were randomly selected and matched for age, 
sex, marital status and civil service grade with controls with common 
migraine, non migrainous headache and no headache. In addition, 18 women 
were matched with patients who had either classical or common migraine 
and were attending a migraine clinic. Subjects with migraine experienced 
significantly greater emotional distress than controls although their 
life stresses did not differ. Migraineurs seem to be constitutionally 
predisposed to a greater than average reaction to a given 
amount of stress. (38)
Crisp et al (1977) also used a questionnaire method to identify 
migraineurs in a general population sample and asked respondents to 
complete the Middlesex Hospital Questionnaire. Female migraine sufferers 
were significantly more anxious and depressed but also more sociable.
They complained more about other functional somatic disturbance. A 
smaller sample of men showed similar tendencies with respect to anxiety 
and somatic complaints. The profile found, especially in women was of 
undefended dysphoria coupled with a definite tendency to be outgoing and 
engaging in the world. (31 )
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Kudrow & Sutkus (1978) reported finding some specificity of MMPI 
patterns among types of headache.
(A) Migraine and cluster headache patients had normal test profiles.
(B) Muscle-contraction headache and mixed migraine-muscle contraction 
headache patients showed moderate somatisation patterns with borderline 
depressions.
(C) Post-traumatic cephalgia and conversion headache patients had mild to 
moderate depressions with somatisation features.
Group (A) differed from groups (B) and (C) in showing less elevation 
on the neuroticism scales.
The diagnostic criteria used in the study are open to criticism - 
one or two year minimal durations were specified for all categories 
except migraine for which no minimal duration was given. Additionally 
the only discriminating factor between chronic muscle contraction 
headache and 'conversion cephalgia' was the severity of pain. This is an 
extremely unreliable index. (39) Sternbach et al (1980) attempted to 
replicate these findings using the three most common diagnostic 
categories: vascular, muscle-contraction and mixed (vascular and muscle- 
contraction). All patients came from a pain treatment centre but it is 
not clear how they were selected. On the MMPI the vascular headache 
patients were less anxious and depressed than the muscle-contraction 
headache and mixed groups. However although statistically significant
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differences were found there were no clinically significant findings - 
all three groups could be described as having mild masked depressions 
with somatisation and anxiety. Women were inclined to deny life 
problems and focus on physical symptoms. This was more marked in the 
muscle contraction headache and mixed groups. It was hypothesised that 
the lower MMPI scores in the vascular group might be due to the greater 
frequency and length of pain-free intervals in these patients. When all 
the groups of headache patients were compared with the MMPI scores of 
50,000 general medical patients the former obtained markedly greater 
scores on most scales than the latter. This may reflect the greater 
duration and severity of subjective distress in the headache patients. 
However the data on which the authors base this last conclusion is not 
well presented and very little information is given about the general 
medical population used. (40)
Cuypers et al (1981) compared personality profiles of 40 patients 
with cluster headache with 49 patients with migraine. No details of 
the selection procedure are given. The diagnostic criteria used were 
those of the Ad Hoc Committee on the Classification of Headache. The 
personality measure employed was the Freiburg Personality Inventory.
This is a multidimensional personality inventory with comparable validity 
to the MMPI.
No differences were found between the cluster headache and migraine 
groups nor was there any indication of neuroticism in the group as a 
whole. The authors comment that male cluster headache patients have 
limited interest in the masculine role and.that this may reflect their 
chronic disease status. However no reasons are given for this view and
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it does not accord with the intermittent nature of the disease and the 
long pain- free intervals.
Migraine patients are noted to have frequent gastric complaints. 
Cluster headache patients do not and yet they have an increased incidence 
of peptic ulcer. As nausea, vomiting and diarrhoea are frequently an 
integral part of migraine this observation is probably not significant.
Both migraine and cluster headache patients have been found to have 
a tendency towards psychosomatic reactions but no important or specific 
neurotic disturbances. (41 )
Andrasik et al (1982) used a sample of 99 consecutive patients with 
chronic severe headache and 30 non-headache controls. Approximately half 
the headache patients were physician-referred. The other half were self­
referrals. Diagnosis was made using a combination of the criteria of-., 
the Ad Hoc Committee on the Classification of Headache and those of 
Diamond <5 Dalessio. Migraine patients were not classified by diagnostic 
category (i.e. classical, common etc.) A continuum of increasing distress 
was found from cluster headache (minimal distress) through migraine and 
combined migraine muscle-contraction headache to muscle contraction 
headache (maximal distress). None of the headache groups could be 
characterised by marked elevations on any of the psychological tests.
Cluster headache patients were not significantly different from 
controls although there was a tendency to somatisation under stress. 
Migraine patients were preoccupied with somatic symptoms and bodily 
concerns of a vague or diffuse nature. The combined migraine muscle-
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contraction group showed mild depression, worry and pessimism although 
there was uncertainty as to whether this was situational or a stable 
trait. The muscle contraction group were overly sensitive, resentful and 
hostile, perfectionistic, rigid and orderly, self-critical and aloof.
The muscle contraction group was the only one which differed 
significantly from Mayo Clinic medical outpatients.
All groups were equivalent on the Holmes & Rahe Social Readjustment 
Rating Scale which the authors felt ruled out differential exposure to 
stressful life events as a cause of the group differences in personality 
characteristics.
The pattern of test findings is directly related to the frequency 
with which the headache groups are subject to pain but is inversely 
related to the severity of pain experienced during the headaches.
The psychological distress is directly related to 'pain density'. 
However this does not imply that all the distress is a consequence of the 
pain. The MMPI has been applied to migraine patients before and after 
successful treatment with minimal changes suggesting that certain 
psychological characteristics are an integral part of the migraine. (42)
In conclusion migraine patients do not appear to have a specific 
type of personality. Likewise there is little evidence that they have 
particular difficulty in expressing anger. There may be a genuine 
increase in obsessionality in migraineurs but this could be artefactual. 
It may only reflect the characteristics of the patient population which
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presents for treatment or be a consequence of inadequacies in the methods 
available to assess obsessionality.
Patients with migraine seem to react excessively to ordinary life 
stresses. Although it has been claimed that specific MMPI profiles are 
associated with different types of headache these results are 
statistically, rather than clinically significant. In fact recurrent 
headaches are associated with mild depressive illness, somatisation and 
anxiety. This profile is not altered by treatment, suggesting it is a 
trait rather than a state phenomenon. The degree of distress is directly 
proportional to the frequency and severity of the pain but is not related 
to external stress in the form of major life events.
5 .3  Emotional specificity and migraine
One explanation for the specificity of -psychophysiologic disorders 
(i.e. they occur in a single organ system) is that specific emotional 
patterns elicit specific types of physiologic response patterns.
Continual emotional stimulation causes over-reaction and eventual 
disruption in the organ system concerned. In migraine unexpressed 
anger results in an overreactive cephalic vasomotor system which 
eventually becomes dysfunctional. However most of the evidence from 
studies of psychophysiology does not support this hypothesis. (30)
Migraineurs have higher ’N' scores on the Eysenck Personality 
Inventory (EP]) together with increased emotional reactivity. 'N' scores 
on the EPI are thought to be directly related to the degree of activation 
of hypothalamic centres and the autonomic nervous system response of the
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individual. The 'N' score is also largely determined by hereditary 
factors. The association of high 'N' scores and increased autonomic 
sensitivity may predispose the individual to develop migraine. (38)
In a study of male students and patients attending the Institute of 
Psychiatry for psychological testing a significant association was found 
between high neuroticism and a family history of migraine and 
hypertension. The autonomic nervous system is labile in both conditions.
(43)
A second study showed that migraineurs have higher levels of trait 
anxiety and also inhibit expression of feelings. Again this pattern is 
not specific and has also been found in hypertension. (44)
5 .4  Pain and personality
Pain lacks a clear definition and there are difficulties in making 
introspective distinctions between sensation and emotion.
Merskey (1964) has given an operational definition of pain as 'an 
unpleasant experience which we primarily associate with tissue damage or 
describe in terms of tissue damage or both.' There is no subjective 
difference between organic and psychogenic pain. Psychogenic pain can be 
defined as either pain which is independent of peripheral stimulation or 
damage to the nervous sytem and due to emotional factors or pain in 
which any peripheral change is a consequence of emotional factors.
Organic pain can then be regarded as pain which is largely dependent upon 
irritation of nerves, or else due to a lesion of the central nervous
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system. The terms 'organic' and 'psychogenic' in this context indicate 
what the principal cause of a pain is likely to be. (4 5)
Sternbach found that both organic and psychogenic pain patients had 
neurotic patterns in which hypochondriasis and depression were 
significant features. Pain may be substituted for anxiety and depression 
with greater use of somatisation, denial and repression as defenses.
Some patients can be described as 'pain-prone' - they suffer from 
excessive guilt and pain, serves them as a punishment. Pain and 
aggression feature prominently in their families of origin. Pain may 
also result from a perception of threat to the integrity of the body.
5 .5  Psychodynamic aspects of pain
Anxiety 4---- ?>kcute pain----^ Depression ^ ---- £>Chronic pain
Chronic pain should hypothetically be associated with increased 
depression. The MMPI indicates that increased scores for depression, 
hysteria and hypochondriasis are associated with pain complaints. Pain 
is not associated more with depression than other psychiatric conditions 
but is present more often than in healthy controls. Pain occurs in 
slightly more than half of general medical and psychiatric populations. 
In psychiatric patients pain is equally likely to accompany a diagnosis
Separation >  Loss
Body harm Anger - in
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of anxiety, hysteria or reactive depression. Pain may 'mask' depression 
and in this sense is associated more with reactive than endogenous 
depression. In psychotic depression somatic disorders are related to 
the underlying neurochemical disturbance. Here the relationship between 
pain and depression may lie in the balance of brain monoamines. 
Norepinephrine decreases the analgesia-mediating properties of serotonin 
and dopamine in the mesencephalic gray matter. This may be the reason 
that antidepressants are not always effective in controlling pain. (46)
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CHAPTER 6
Philosophical issues raised by migraine - mind-body and 
brain-mind relationships in psychiatry and medicine.
Practical problems in developing a hostilic approach to psychosomatic 
illness.
There is a major difference between people and ordinary objects: 
human beings have minds (or souls or selves) whereas things do not;
people have both mental and physical events. (47)
The discovery of the consciousness of self and the knowledge that 
death is inevitable dates back to prehistoric times where it probably 
followed the acquisition of language. The burial customs of Neanderthal 
man indicate both a consciousness of death and a belief in survival.
This entails some concept of dualism of mind and body.
Mind-body dualism was frequently referred to in Homer where mind and 
body were seen as polar opposites which could, however, interact. This 
interaction was seen in terms of animistic causation bordering on divine 
intervention.
In Greek philosophy soul and mind were equivalent. Together they 
were an entity which summed up the conscious experience of the self. 
Alcmaeon of Croton was the first to locate sensation and thought in the 
brain.
The Hippocratic school maintained that the brain was responsible for
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bodily movements and was also the 'interpreter of consciousness'.
Democritus, a materialist, explained all natural and psychological 
processes mechanically by the movement and collision of atoms and their 
composition or dissociation. The atoms of soul were distributed 
throughout the body.
In Pythagorean theory the hidden essences of all things were 
abstract and based on the relations between numbers such as 'ratios' or 
harmonies'. There were two hypotheses concerning the soul - the first 
that it was a harmony or attunement of abstract numbers which preceded 
and survived the body and the second that the soul was a harmony or 
attunement of the body and therefore must perish with the body in death. 
The latter provided a model of mind-body interaction.
For Plato the soul was similar to ideas and was almost the essence 
of the living body. He regarded the body as the prison of the soul and 
accepted interactionism as inevitable. The mind was the pilot of the 
body. Plato believed the soul to be constant whereas for Aristotle it 
was always striving towards perfection. Socrates developed the concept 
of a responsible moral self for which there was no purely physical 
explanation.
Aristotle and the members of his school accepted that the mind was 
incorporeal, and that the relationship between mind and body was a 
non-mechanical interaction.
Descartes was an essentialist and argued for the existence of a
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perfect God who guaranteed the validity of clear and distinct perceptions
which became criteria of truth. He believed that mind and the
/
consciousness of self were non-corporeal. Human beings were 
automatons except for the immaterial human mind which could cause 
movements in the human body and become conscious of mechanical 
impressions made by physical agencies on the body.
By contrast with Aristotle's cosmos which was always striving towards 
an end Descartes' world was filled with mechanical contrivances and only 
man was truly animate or alive. The soul was located mainly within the 
pineal gland, which it could move to act on the animal spirits and 
through them the movement of the body. The great difficulty of Cartesian 
mind-body interaction lies in the theory of physical causality according 
to which all physical actions must be by mechanical push. Descartes' 
critics objected that if soul and body were substances with different 
natures there could be no interaction between them, particularly if that 
interaction was due to physical causation. The latter objection is the 
major problem. Some Cartesians dealt with this by introducing 
'occasionalism' - i.e. all causation is miraculous and God intervenes on 
every occasion of causal action or interaction. Psychophysical 
interactionism was rejected and replaced by psychophysical parallelism. 
There was no interaction between mind and body but a parallelism which 
created an appearance of interaction which was in fact due to the 
intervention of God.
Spinoza maintained that there could be only one substance (i.e.
God) and that the only two attributes of him which the human intellect 
could grasp were mind and body. They ran parallel because they were
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different aspects of one and the same thing.
Leibniz's explanation for mind-body parallelism was the doctrine of 
pre-established harmony. God, at the time of Creation, ensured that 
minds and bodies, though independent, would continue to run together 
without the need for constant readjustment. Minds and bodies were 
sharply distinguished - minds were real substances and bodies 
appearances. All minds were essentially individual because that was the 
way God made them.
In monism there were two systems for ordering things - a physical 
system and a mental one. Elements were neutral because they could become 
parts -of either physical or mental complexes. Elements could be 
impressions, feelings or sensations. Interaction was avoided and the 
relation between the mental and the physical was parallelistic. (4 8)
Identity theory asserts that mental processes and physical processes 
are identical. Concepts of separate minds and bodies have arisen only 
because human beings are consistently looked at from two differing points 
of view. Identity theory forms an integral part of the holistic approach 
and is thus particularly relevant to psychosomatic medicine.
Behaviourism reduces mental events to publicly discernible 
behaviour. In its mildest form (methodological behaviourism) 
introspection is rejected as a valid method of study in favour of the 
investigation of physical phenomena only. Logical behaviourism is more 
stringent and defines mental phenomena only in terms of behaviour and 
physiology while in radical behaviourism the concept of mind and of other
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hypothetical constructs or intervening variables is felt to be 
irrelevant. (47)
Most recently popper & Eccles have together put forward a dualist- 
interactionist philosophy of mind-body relationships. They conceive the 
self-conscious mind as an independent entity which is actively engaged in 
reading out from a multitude of centres in the modules of the liaison 
areas of the dominant cerebral hemisphere. The self-conscious mind 
selects from these centres in accordance with its attention and 
interests and integrates its selection to give conscious experience. It 
also acts back upon the neural centres. Primacy is given to the self- 
conscious mind which during normal life is engaged in searching for brain 
events that are in its present interest and of integrating these into a 
unified conscious experience. (48)
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CHAPTER 7
Neural and Vascular Hypotheses in Migraine
Both neural and vascular components are involved in the production 
of migraine but there is controversy over which is the primary phenomenon.
7.1 Vascular hypothesis
H.G. Wolff concluded from his clinical and laboratory investigation 
of migraine that the pre-headache phenomena were due to cerebral 
vasoconstriction; that the headache was produced by distension of the 
external carotid arteries and that pain was enhanced by vasoactive 
polypeptides in the tissues surrounding the blood vessels - causing a 
sterile inflammation. (49)
The vascular hypothesis agrees with the pulsatile, throbbing nature 
of the pain and explains the correspondence between the localisation of 
the pain and the branches of the external carotid artery in the face and 
scalp. It is consistent with the observation that digital compression of 
the neck arteries decreases the pain while pressure is maintained and 
with the dilation of conjunctival vessels occasionally seen during 
attacks. The relief of pain by adrenergic drugs (e.g. ergot) and 
the worsening with vasodilators (e.g. alcohol), the alleged prolongation 
of the aura by ergot and its resolution with nitrites all support a first 
phase of extracranial vasodilation. Reduced cerebral blood flow has been 
demonstrated in the aura followed by hyperaemia during headache. It has 
been claimed that oligaemia and hypoperfusion are directly related to the
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symptoms of the aura. (50) A recent study measured CBF using an 
intracarotid injection of in 11 patients. All had attacks of
classical migraine which had been induced by the procedure. Focal 
decreases in CBF were found in the occipital, parietal and temporal 
areas and these spead to central and frontal regions within 30 minutes. 
Cerebral blood flow levels known to be insufficient for normal cortical 
function were found in 7 of these patients during the attack. (51)
Objections
Blood vessels are certainly involved in the production of migraine 
headache. The headache itself appears to be mainly a painful dilatation 
of scalp and facial arteries. Arterio-venous shunting has also been 
implicated by Heyck but there is no evidence that these shunts are 
present in fronto-temporal or temporal regions and also uncertainty as to 
whether changes in arterio-venous oxygen content difference are reliable 
indicators of changes in the proportion of blood flow shunting 
through the anastomoses. (52) However the fact that symptoms of the 
disorder are related to the blood vessels does not necessarily imply a 
vascular cause for the condition. Reduced regional cerebral blood flow 
(rCBF) often precedes the aura by hours and there is no evidence that the 
oligaemia is caused by vasoconstriction. Prolonged major arterial 
constriction would result in infarction far more commonly than is 
reported. Regional CBF changes are also often bilateral during the 
attack when the pain is unilateral. Although visual cortical symptoms 
dominate the aura and are commonly bilateral the oligaemic phase seen 
with CBF monitoring is usually found mainly in part of one occipital lobe 
and spreads anteriorly across anatomical arterial territories rather than
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across the midline. Headache and focal symptoms may occur on the same 
side. There are therefore many inconsistencies between the distribution 
of symptoms and the observed changes in rCBF - the symptoms are not 
adequately explained by sequential constriction and dilatation of major 
arterial trunks. (49)
Blau re-examined the vascular hypothesis of migraine by looking in 
turn at each phase of the attack. He concluded that:
(1) prodrome - this was not explicable on a vascular basis.
(2 ) aura - (i) the gradual spread of the visual or other sensory auras
taking 10-30 minutes is not seen in cerebrovascular 
disease.
(ii) the slow progression of sensory symptoms would require
sequential spasm of successive branches on the posterior 
aspect of the middle cerebral artery without altering the 
blood supply anteriorly. This is untenable.
(iii) migrating teichopsiae are not explicable on the basis of 
vasospasm or ischaemia.
(iv) arteriographic evidence obtained during migraine attacks 
is conflicting.
(3 ) headache phase - this has both vascular and neurological symptoms.
(4 ) sleep resolution - this, plus drowsiness and yawning in the 
prodrome and during the headache phase, implies a neurological substratum 
to migraine. (53) ,
7.2 Neural hypothesis
According to the neural hypothesis migraine is caused by a primary
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disturbance of brain function. This is the periodic derangement of 
function called a ' nerve-storm' by Liveing (1873). From then till 
relatively recently, however, the concept of a primary cerebral cause 
for the condition has been neglected.
Evidence for the neural hypothesis:
(1) The clustering of patients attacks suggests a basic rhythmicity of a 
central threshold which falls for a time allowing the attacks to emerge 
and then rises with consequent remission. Both Pearce and Blau have 
suggested the hypothalamus as the initiating site for the condition.
A periodic disturbance of hypothalamic activity could acount for the 
periodicity of migraine attacks, and could also be related to emotional 
disturbances mediated by pathways from the limbic system to the 
hypothalamus. An instability of central control might be inherited in a 
similar way to the low convulsive threshold found in familial idiopathic 
epilepsy. (54)
(2) Altered neuronal metabolism causes changes in calibre in the 
microcirculation rather than the other way round. (49)
(3 ) The oligaemia demonstrated by rCBF studies does not correlate 
temporally with the symptoms seen, nor is it confined to the distribution 
of the major cerebral arteries. (49)
(4 ) An analogy can be drawn between between migraine and epilepsy. The 
sensory symptoms of both can be qualitatively similar as can the psychic 
phenomena of Hughlings Jackson's dreamy state, metamorphopsia, language
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disorders and vegetative symptoms of mood and appetite. The disorders 
co-exist in a greater number of patients than expected by chance. The 
much briefer duration of symptoms in epilepsy and their abrupt onset 
separate the two conditions clinically but epilepsy occurs in 2-11$ of 
migraine patients. In some patients epilepsy ceases ter many years 
and is replaced by migraine; in others the reverse occurs. An excess of 
migraine is also seen in families of epileptics. (49)
(5) Sleep is recognised as an integral part of the attack and a means of 
terminating it. The precipitating role of fatigue, excitement and stress 
suggest a cerebral rather than a vascular basis. (55)
7-3 Conclusion
There is good evidence for a vascular aetiology in the headache 
phase of migraine. The origin of the prodromal symptoms and the aura 
is much more controversial. The correlation between oligaemia and these 
symptoms is poor - both anatomically and temporally. A neural basis 
for these preliminary symptoms and therefore for the initiation of 
migraine attacks could explain:
(i) the periodicity of migraine
(ii) similarities in the prodromal symptoms in migraine and epilepsy
and the higher than expected frequency with which migraine and epilepsy 
are found together in the same patient.




Cerebral blood flow in migraine
The development of a safe biotechnology for the measurement of 
cerebral blood flow and the interest in vascular changes during migraine 
attacks have combined to allow dynamic studies in patient volunteers. 
These have produced interesting information about the link between 
vascular and neural dysfunction in migraine.
8.1 Physiology of cerebral vasoconstriction
Brain arterioles have a tremendous capacity for dilatation as 
illustrated by the autoregulatory response i.e. constancy of cerebral 
blood flow is maintained even when there is reduction of arterial 
pressure. Arterial blood flow can be dropped to about 60% of normal 
values before brain blood flow begins to decrease. The constancy of 
blood flow is maintained by progressive arteriolar dilatation. If blood 
pressure is further decreased blood flow also decreases but oxygen uptake 
and cerebral metabolism continues undisturbed because the brain can 
increase its extraction of oxygen. Finally when the brain can increase 
this no further a continued decrease in blood pressure results in 
impaired cerebral metabolism and function.
Initially only an increase in regional cerebral blood volume can be 
observed. As constriction increases and cerebral blood flow begins to 
fall measurements of rCBF are of value although sometimes difficult to 
interpret. In the final phase when rCBF and metabolism are reduced
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measurements of rCBF are more reliable.
Brain blood flow is closely linked to metabolism which, in turn, is
connected with cerebral function. Reduced function results in decreased
metabolism and decreased CBF. It can be difficult to decide whether 
reduced CBF is due to vasospasm or is a natural adaptation to decreased 
function and reduced metabolic needs.
The criteria used to make this distinction are:-
(1) Reduced cerebral blood flow secondary to vasospasm is likely to be 
located within one or more regions of supplied by the large cerebral arteries.
(2) To elicit clinical symptoms vasospastic CBF reduction must be marked 
whereas a primary metabolic disturbance may cause symptoms with lesser 
CBF reduction.
(3 ) In an ischaemic area autoregulation is usually lost. Only severe 
ischaemia will result in abnormal reactivity to changes in arterial 
carbon dioxide pressure (PC02). Normal regulation or different patterns 
of disturbance suggest non-ischaemic mechanisms.
8.2 Methods used to measure regional cerebral blood flow
(i) Intra-arterial injection of a ^-emitting diffusible tracer has 
been the most commonly used method. The main tracer has been ^^Xenon 
(^■^Xe). A bolus of this inert, radioactive gas is delivered into one 
internal carotid artery. It is distributed to the carotid artery 
territory and immediate diffusion equilibrium is established. Wash-out 
of radioactivity is then followed by external stationary $  detectors.
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The initial slope analysis (where the slope of the first 1-2 mins of the 
clearance curve is used for flow calculation) mainly represents flow in 
gray substance. Using initial slope analysis has the advantage that it 
is easier to maintain a steady state during the short measurement period. 
The spatial resolution of the method is not optimal, however, because it 
is two-dimensional. Only areas which receive tracer from the internal 
carotid artery can be studied and this usually excludes primary visual 
cortex. Compton scatter also smooths out differences between regions.
The advantages are that a high count rate gives good measurement accuracy 
and allows measurements from many channels. Contamination from 
extracerebral tissues is almost non- existent and the input function is a 
true bolus delivery. The method has been more sensitive in exposing 
functional activation and deactivation than any other method except 
positron emission tomography (PET).
(ii) Inhalation or intravenous (iv) bolus injection of and
external stationary detection.
The immediate advantage is the avoidance of carotid puncture. A 
problem with inhalation or IV injection is that most of the tracer is in 
the respiratory air since Xenon has a low affinity for blood. Protracted 
inhalation over a minute or two is necessary and thus tracer arrives 
gradually in the brain. This can be corrected for by computation but at 
the expense of increased uncertainty over the input function. 
Recirculation of ^^Xe is considerable and must be corrected for. 
Extracranial tissues are labelled, as well as brain, causing confusion 
and the count rate is much lower than with intra-arterial injection and 
therefore does not allow the use of a large number of detectors.
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(iii) Inhalation of and single photon emission computerised
tomography (SPECT)
When ^3xe inhalation or IV injection is used, tomographic detection 
can reduce the problem of radiation from extracerebral tissues. It 
provides a three dimensional view and thus gives much better spatial 
resolution than external stationary detectors. It also visualises deep 
structures as well as cortex. However there are still problems with the 
input function, an unsatisfactory count rate and much Compton scatter. 
Overall whilst single photon emission tomography is superior to ^^Xe 
inhalation and stationary detectors, the cerebral cortex is still studied 
more accurately with intracarotid injection.
(iv) Positron emission tomography
This uses detection of very short-lived tracers emitting positrons. 
The technique gives rCBP as well as regional oxygen consumption, the 
oxygen extraction fraction and the determination of regional glucose 
metabolism. (56)
8.3 Studies of regional cerebral blood flow during migraine attacks
Skinh^j used intracarotid ^^Xe with 35 detectors in four patients, 
all of whom had classical migraine using the accepted diagnostic criteria 
(although this was not specified in the paper). All patients had reduced 
perfusion to a level critical for adequate oxygenation in some areas 
during the prodrome. Further studies on six patients during the headache
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phase showed increased blood flow. No distinction was made between 
classical and common migraine and patients were not studied between 
attacks for comparison. (50)
Olesen et al examined rCBF in headache-free intervals and after the 
induction of a migraine attack with red wine. No significant focal or—  
global reduction in cerebral blood flow was found at either time. All 
six patients had common migraine. Three different techniques were used 
in the study. Although induced attacks were clinically identical with 
spontaneous migraines, this does not necessarily imply that the 
underlying physiological changes were the same. (19)
Lauritzen & Olesen used the ^-^Xe inhalation method combined with 
single photon emission tomography. Twelve patients had common and 11 
patients had classical migraine. During migraine attacks all patients 
with common migraine had normal rCBF whereas most patients with classical 
migraine had unilateral hypoperfusion. There was a focal decrease in 
blood flow of 17$ on average compared to the symmetrical contralateral 
region. The low flow regions were always on the side opposite to the 
focal neurological symptoms. They persisted through the headache period 
for 4-6 hours. Regions of relative or absolute hyperaemia were not seen 
and between attacks rCBF was normal for both groups. (57)
In a further study of the regulation of rCBF during and between 
migraine attacks the same group used intracarotid with 254
stationary detectors in 14 patients suffering from classical migraine. 
Nine patients had migraine attacks induced by the procedure and 4 were 
examined without an attack developing. The regulation of rCBF was
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impaired during provoked migraine attacks and the abnormalities were 
confined to the hypoperfused areas. This suggested that a local factor 
underlay the oligaemia and the regulation abnormalities. Blood pressure 
autoregulation was preserved but there was a reduced response to 
hypocapnia and functional activation procedures. There was thus an 
uncoupling of function, metabolism and CBF. No abnormalities of brain 
blood flow or its regulation were found between attacks. Again these 
attacks were not spontaneous and the intracarotid technique can only 
ethically be used in patients for whom carotid arteriography is 
clinically indicated for diagnostic purposes - this was therefore a 
selected group. (58)
The 9 patients who developed a migraine during the procedure were 
examined by a series of rCBF studies at intervals of 5-10 minutes. A 
wave of reduced blood flow originating in the posterior part of the 
brain and spreading anteriorly was observed in eight of the nine 
patients. The oligaemia advanced at a speed of 2mm/min over the 
hemisphere, progressing anteriorly but not crossing the rolandic or 
sylvian sulcus. Typically the spreading oligaemia reached the primary 
sensorimotor area after symptoms from that area had begun and persisted 
there long after the focal symptoms had disappeared. The time course 
suggested that focal symptoms were not secondary to the oligaemia. (59)
Summary of data obtained from rCBF studies
(1 ) rCBF data strongly indicate that common migraine attacks are not 
preceded by or associated with focal or global alterations of CBF.
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(2) There is agreement that CBF is focally or even globally reduced 
during the prodrome in classical migraine.
(3 ) Although older studies described hyperaemia during the headache 
phase of classical migraine more recent studies have found no change in 
blood flow.
(4 ) On balance the CBF studies do not at present support the vasospastic
theory of migraine but rather indicate a gradual spread of disturbed
function located in the cortex. (56)
As yet there are very few studies in migraine which use positron 
emission tomography. However Sachs et al have used this technique in a 
group of five migraine patients (a mixture of classical and common 
migraine) and found that in the preheadache phase induced migraine is 
associated with decreased regional cerebral glucose metabolism. This 
appeared to be the initial event and was compatible with a primary 
derangement of brain function. There was no difference in laterality and 
both classical and common migraine patients were affected. (60)
8 .4  The relationship between regional cerebral blood flow changes and 
Leap’s spreading depression
The results of the rCBF studies outlined have indicated that a 
primaiy disturbance of neuronal function is more likely to be the cause
of cerebral blood flow changes than Wolff’s vasospastic theory. The most
probable source of this disturbance is the spreading depression (SD) of 
Leao - a slow-moving suppression of electrical activity that propagates
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across the cortex at a rate of 2-5mm/min. It is a transient phenomenon 
which is accompanied by severe disruption of ion homeostasis, 
depolarisation of nerve cells and increased energy metabolism. (61)
During the prodromal phase in classical migraine visualt sensory or 
motor symptoms develop in a way which suggests an underlying disturbance 
in the brain moving slowly in the cerebral cortex. The process causes a 
transient 'dysfunction' (scotoma, anaesthesia or paralysis) often 
preceded by enhanced function (fortification spectra, paraesthesiae or 
twitching). Lashley described his own scintillations (zig-zag pattern) 
which began near the centre of vision and propagated to the periphery of 
the field followed by dimming in the zig-zag area (scotoma). He mapped 
the scintillation-scotoma at brief intervals. The disturbances were 
symmetrically placed in the visual fields indicating a cortical origin 
for the symptoms. He calculated that they were caused by a process 
moving at Jmm/nlin in the visual cortex. Leao himself connected spreading 
depression with migraine without knowledge of Lashley's work. (61,62)
There is considerable uncertainty as to whether, and how, spreading 
depression could be initiated spontaneously in man. The three main 
candidates for the role of trigger factor are potassium ions, glutamate 
and neurotransmitters.
8*5 Neurotransmitter changes associated with Spreading Depression
A local increase in potassium ion concentration causes 
depolarisation of pre-synaptic terminals with the release of both 
excitatory and inhibitory transmitters. This leads to the opening of ion
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channels in the post synaptic membrane which in turn causes an increase 
in potassium ions and a decrease in sodium, chloride and calcium ions 
analogous to the situation found in ischaemia. The diffusion of 
potassium ions to adjacent nerve cells leads to a repetition of the 
process. The ensuing recovery is an energy-requiring process which 
involves increased blood flow and local glucose metabolism. The brain 
cortex is refractory for a period after the passage of spreading 
depression possibly due to enhanced clearance of potassium ions. Attacks 
of classical migraine start most frequently in the visual cortex in the 
area corresponding to the macula where there is a very high neuronal 
density. This area is liable to have the greatest increase in potassium 
ion concentration when stimulated. Adequate light stimuli could increase 
the potassium ion concentration to the threshold for elicitation of 
spreading depression. It may be possible to condition the brain by 
exposing it to any agent which will evoke S.D. thereby lowering the 
threshold for it. (62)
8.6 Migraine, rCBF changes and Spreading Depression
Classic migraine attacks are initiated by a cortical spreading 
depression originating in the posterior part of the brain. The blood 
flow changes are not the prime event in migraine but are secondary to 
disturbed neuronal function.
The generation of pain in the head from intracranial sources 
requires activation of pain-sensitive fibres that are located on the 
ventral surface of the brain. SD may activate these fibres through 
changes in the extracellular fluid (high potassium ion concentration, low
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pH) and thus produce pain. If this is so the latent period between the 
onset of the prodrome and headache may reflect the time it takes SD to 
propagate from the initiating site to the region where pain is 
triggered. Migraine headache would therefore be a specific response of 
pain-sensitive fibres to SD. The prodrome and headache could be separate 
effects of SD affecting different brain regions and this might explain the 
occurrence of different forms of migraine in the same patient. (61)
8*7 The hypoxic hypothesis
A patient suffers migraine attacks either because (s)he is more 
susceptible to the development of brain hypoxia for some reason and/or 
because s(he) reacts in an exaggerated or an abnormal manner to the 
presence of brain hypoxia..
There is some evidence that migraineurs may be more susceptible to 
hypoxia than other people. Subjects with a past history of migraine who 
are exposed to high altitudes simulated in a decompression chamber are 
much more susceptible to scotomata and subsequent headache than controls. 
The induction of migraine by cerebral angiography may also be a reaction 
to a transient reduction of oxygen availability to the brain shortly 
after the injection of contrast medium although this is not proven.
Hypoxia in the brain results from an imbalance between oxygen supply 
and oxygen consumption. The latter part of this equation receives little 
attention in the vasospastic theory.
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Factors involved in decreased oxygen supply
(a) Evidence of vasospasm is scarce although it is difficult to exclude 
the role of diffusely decreased cerebral blood flow.
(b) The potential role of biogenic blood-borne constrictors depends on 
disruption of the blood-brain-barrier. The most likely candidates are 
5HT and catecholamines.
(c) Exogenous substances such as tyramine lower CBF via the release of 
norepinephrine.
(d) Autonomic nervous system overactivity, as shown by a persistent 
degree of vasoconstriction in headache-free intervals, indicates 
excessive sympathetic tone. Migraine sufferers may show a 
supersensitivity to adrenoceptor stimulation during attack-free intervals 
or at the time of the attack.
(e) Anterio-venous shunting - there is no evidence that these shunts are 
involved in the initiation of an attack. If shunting is secondary to the 
migraine attack it may be caused by a sudden drop in blood levels of 5HT at 
the beginning of the headache phase.
(f) Reduced CBF without vasospasm. It is unlikely that the prodromal 
decrease in cerebral blood flow is enough to cause neurological symptoms 
due to ischaemia except in a small minority of cases.
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Factors related to increased oxygen consumption
(i) Autonomic nervous system overactivity may not only affect cerebral 
blood flow but may also activate brain metabolism.
(ii) REM sleep increases brain metabolism and cerebral blood flow in 
normal subjects. Migraine on waking often occurs after arousal from a 
REM sleep period.
(iii) Stress is accompanied by a rise in cerebral oxygen consumption.
This correlates with increased activity in cerebral catecholaminergic 
pathways.
(iv) Psychological factors and precipitants. Migraineurs have been 
described as having a continuous undercurrent of emotional activity and 
as being stress-prone, perhaps because they tend to be rather 
perfectionistic and success-orientated. Psychological preludes to the 
migraine attack include changes in mood and behaviour which may originate 
from psychological conflict.
(v) Use of drugs and exogenous substances. Reserpine can trigger 
migraine in susceptible individuals. The mechanism is suspected to be 
release of 5HT.
(vi) Spreading depression may be a consequence rather than a cause of 
brain hypoxia.
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8.8 The relationship between the migraine attack and hypoxia
Biochemistry
(i) According to some studies 5HT is released during migraine attacks.
It is also released into cerebral venous blood by hypoxia.
(ii) Catecholamines are also released during migraine but this has not 
been demonstrated in hypoxia.
(iii) Histamine, if involved at all, has only a local role. It is 
induced and/or released at the site of pain producing discomfort, venous 
engorgement and oedema.
(iv) Kinins - these act as vasodilators and increase permeability. They 
are algesics, release prostaglandins and cause vasodilatation and 
increased peripheral blood flow.
(v) ATP and adenosine. Hypoxia causes a decrease in cortical ATP.
(vi) Prostaglandins - these affect CBF but whether or not they are 
released in migraine and hypoxia is uncertain.
(vii) Substance P - this appears to have a nociceptive function, may 
increase CBF and is a potent histamine liberator.
(viii) Ions - cerebral hypoxia causes increased acidity and brain 
ischaemia releases potassium ions into the extracellular space. Both
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hydrogen and potassium ions increase cerebral blood flow.
(ix) Free fatty acid concentrations increase in plasma during migraine. 
Haemodynamic Changes
(1) The increased cerebral blood flow seen during the headache phase may 
be explained by biochemical changes induced by hypoxia.
(2) There may or may not be opening of arterio-venous anastomoses in 
migraine. This could be indirectly related to hypoxia via the action of 
5HT.
(3 ) Marked changes in platelet behaviour have been observed during the 
migraine attack.
(i) Serotonin uptake is reduced although this is not the case in the 
headache-free interval.
(ii) Platelet adhesiveness and aggregation are increased during the aura 
but aggregation is reported to decrease subsequently whereas increased 
adhesiveness is maintained. Some authors have also found increased 
aggregability in the headache-free interval.
Brain ischaemia induces the aggregation of platelets and in the 
acute stage of stroke there is a decrease in 5HT and adenosine 
triphosphate (ATP) content in platelets. All the platelet changes seen 
in migraine may be due to hypoxia.
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In summary, according to this hypothesis brain hypoxia occurs in 
every attack of migraine. Whether this becomes manifest as neurovisual 
phenomena depends on the severity of the hypoxia and the site at which it 
occurs. It is likely that excess sympathetic drive with simultaneous 
activation of brain metabolism and decreased oxygen supply is the 
underlying mechanism in the majority of patients. This hypothesis does 
not explain the unilateral nature of migraine in many patients, although 
it has been suggested that cerebral asymmetry renders some areas of the 
brain more liable to hypoxia than others. (63)
8-9 Migraine, cerebral ischaemia and infarction
Approximately two thirds of the patients with benign headache 
referred to a neurologist are afraid that they may have some serious 
intracranial disease such as a brain tumour or impending cerebral 
haemorrhage. Those most likely to be worried are women who have more 
than two headaches per week and have had them for less than two years. 
Patients with tension headaches are slightly more concerned about this 
than patients with migraine. The majority of these patients do not have 
psychiatric symptoms although both anxiety and depression, where present,• 
do predispose to worries about serious illness. (64)
Fere (1881) cited Charcot as saying that any of the transient 
neurological disturbances seen in migraine could become permanent. He 
also suggested (1883) that vasospasm in migraine could cause vascular 
occlusion.
- 76 -
Galezowski (1882) reported four patients with permanent visual 
defects associated with migraine. In the next 70 years only another 13 
cases were described. (65)
The rarity of descriptions of persistent neurological dysfunction 
after migraine episodes has contributed to the view generally held by 
physicians that migraine is a benign condition. However there is 
evidence that for a small proportion of patients, this is not the case.
A comparison has been drawn between classical migraine and 
reversible focal cerebral ischaemic events (TIAs) and between complicated 
migraine and stroke. Headache is frequently reported in the history of 
transient ischaemic attack (TIA) and stroke patients. However the 
visual, sensory and motor disturbances are much shorter in TIA (1-5 mins) 
than in classical migraine (l5-60min) and the latter also show an orderly 
build up and 'march'. This pattern, and the rCBF data from studies of 
patients with classical migraine, both suggest that the neurological 
symptoms in migraine are not caused by cerebral ischaemia. It seems 
likely therefore that TIA and classical migraine are pathophysiologically 
different. (66)
However persistent neurological defects do occur although their 
incidence is uncertain.
In the first 2 years of the Oxfordshire Community Stroke Project 
323 cases of first-ever stroke were registered. Of these 244 had 
cerebral infarctions. There was a past history of migraine in 17$ of the 
total group and 18$ of the patients with cerebral infarction. This is
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approximately equivalent to the incidence of migraine in the general 
population. There was a trend towards a past history of classical 
migraine in the cerebral infarction group although this was not 
statistically significant.
The presence of other risk factors makes it very difficult to decide 
how much migraine has contributed to the pathogenesis of stroke in an 
individual. There was a high prevalence of risk factors (e.g. 
hypertension and artheriosclerotic disease) in patients with and without 
a history of migraine (75$ and 70$ respectively). This high prevalence 
was consistent with the results of other studies. The proportion of 
cerebral infarction directly attributable to migraine has been reported 
at between 2$ and 20$. It is often not easy to decide what defines 
'directly attributable'. Possibly only patients with no risk factors 
other than migraine should be described as having migrainous cerebral 
infarctions. In this study 7 patients in total were presumed to have 
migrainous infarctions (an incidence of 3-56 per 100,000 of the 
population per year). Only 3 of these 7 had no risk factors other than 
migraine, (in this case the incidence would be 1 .44 per 100,000 of the 
population per year). However as migraine is a common condition this 
means a substantial number of new cases per year posing a considerable 
burden on health service resources (67)*
Conner (1962) described 18 patients who attended the neurology 
department at Cardiff Royal Infirmary between 1953 and 1961 . In nine 
patients a lesion developed during the migraine attack and in nine 
patients there was preceding temporary loss of function in the parts 
which were eventually permanently damaged. Five patients had retinal
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lesions, ten had lesions of the hemisphere and three had lesions in the 
brainstem. The age incidence of this series was well below the usual 
age of onset for cerebrovascular disease. (No patient was aged over 50 
when first seen and 12 of the 18 were aged under 40.) (65)
An unexpectedly high incidence of CAT scan abnormalities has been 
found in patients with severe migraine and some of these appear to be 
old cerebral infarcts.
Dorfman et al (1979) reported on four patients with classical 
migraine who all developed cerebral infarctions. In two of the patients 
this was preceded by a typical attack. The criteria used to diagnose 
infarction were two or more of the following:
(1) acute onset with previously normal examination in the affected area,
(2) a circumscribed zone of decreased density with or without a defect in 
the blood brain barrier (as shown by contrast enhancement),
(3 ) relatively little mass effect or oedema in the acute phase,
(4 ) resolution of the lesion in weeks or months leaving an area of 
lucency or a normal examination.
The CAT scan abnormality was not always immediately apparent and 
these patients needed to have complete examinations with or without 
contrast enhancement, with a repeat examination after several days (if the 
first examination was normal) in order to detect all abnormalities.
These patients all eventually made good recoveries probably due to their 
youth and general good health. (68)
All patients in Dorfman's series and 12 of the patients in Connor's
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had cerebral angiography to exclude significant vascular malformation.
Featherstone (1986) identified 64 cases of stroke which were related 
to migraine in a literature review which attempted to define a 
characteristic syndrome. His definition of stroke was arbitary, the data 
available was often incomplete and there was no control group. 
Nevertheless the findings were interesting. In 29 out of 40 cases the 
stroke was associated with an increase in the frequency or intensity of 
the migraine. In 4 cases there was no headache prior to the stroke. In 
20 out of 31 cases onset was sudden and of these 20 patients more than 
one third had had recent transient neurological symptoms. Cerebral 
angiography was abnormal in 23 out of 41 cases. Outcome data was 
reported for 44 out of the 64 cases. Three patients died. Almost half 
the remaining patients made complete or almost complete recoveries. An 
age of more than 4 0, gradual onset of the stroke, or onset of the stroke 
on awakening, and occlusion of the posterior cerebral artery decreased 
the chance of complete recovery. Sudden onset increased the risk of 
death but improved the prognosis in survivors.
The typical patient was a young adult who had previously had classic 
or complicated migraine, noted an increase in the severity of headaches 
prior to the stroke and had a homonymous hemianopia with or without a 
hemiplegia after it. This was consistent with a thrombo-embolic 
process. (69)
Several factors may predispose migraine patients to infarction:
(i) There is epidemiologic evidence of an association between migraine, 
hypertension and heart disease. The frequency of hypertension is
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estimated to be 1.7 times greater in people with migraine than in those 
without. The risk of myocardial infarction is also increased for people 
with migraine and this is most evident below the age of 70 years. For 
both sexes people with migraine tend to die at younger ages than people 
without. (70) This study does not show any appreciable increase in the 
risk of stroke although the Collaborative Group for the Study of Stroke 
in Young Women has reported that a history of migraine increases the 
likelihood of both ischaemic and haemorrhagic stroke. (66)
(ii) Prodromal arterial spasm may decrease rCBF below the critical level 
for tissue viability and this could be compounded during the headache 
phase by diversion of blood into dilated extracranial vessels.
(iii) Abnormalities of platelet function may increase the susceptibility 
to vascular occlusion.
8.10 Migraine, mood change and rCBF
There are extensive clinical descriptions of migraine in the 
literature and textbooks frequently quote a figure of approximately 10$ 
for the occurence of affective concomitants. These are generally:
(1) elated and irritable prodromal states,
(2) prostration, dejection, dread and serious depression accompanying the 
heachache,
(3 ) euphoric rebound.
They are usually of short duration, lasting from a few hours to 2-3 
days at most. Less commonly severe migraine auras may be accompanied by 
sudden eruptions of overwhelming 'forced' affect. This rarely occurs 
during every attack but most patients with severe auras experience it 
occasionally. The reaction may vary from mild pleasure to rapture or
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from strangeness to intense terror. The following features are 
characteristic: (1) sudden onset, (2) apparent sourcelessness and 
frequent incongruity of the mood, (3 ) an overwhelming quality, (4 ) a 
sense of passivity and the affect being 'forced' into the mind, (5) brief 
duration (the feelings rarely last more than a few minutes), (6) a sense 
of stillness and timelessness and (7) difficulty or impossibility of 
adequate description.
It is likely that alterations in higher cerebral function occur in 
the majority of migraine auras but go unnoticed because of their subtlety 
or strangeness or because the patient was not involved in any intricate 
intellectual or emotional activity at the time. There are four main 
categories of disturbance:
(1) complex disorders of visual perception,
(2 ) apraxic and agnosic symptoms,
(3 ) states of double or multiple consciousness, often associated with 
feelings of deja vu or jamais vu and other disorders of time-perception,
(4 ) elaborate dreamy, nightmarish, or trance-like states.
In addition patients who have previously suffered from both 
classical and common migraine may later present with affective 'migrainous 
equivalents' which resemble truncated manic-depressive cycles, being 
distinguished from manic depressive illness principally by their brevity.
(6 ,7 ,71)
Surprisingly there is remarkably little literature on this aspect of 
migraine other than textbook statements which are based on extensive 
anecdotal clinical observation. There have only been three studies which
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attempted to correlate self-ratings of mood with migraine.
Dalkvist et al (1983) obtained twice daily ratings on five mood 
dimensions from five patients with migraine and 6 patients with muscle 
contraction headache for a mean period of just over six weeks. All the 
migraine patients had the common form of the condition. The patients were 
given visual analogue scales which covered four bipolar dimensions (calm- 
nervous, drowsy-alert, sad-happy and unconcentrated-concentrated) and 
two unipolar dimensions (anger and headache). A time-dependent 
relationship was found between migraine and alertness. Patients were more 
alert before attacks and less alert during them. No other mood changes 
were found - either because the scales were not sensitive enough to pick 
them up or because alertness was the only emotional state related to the 
migraine. However, it is unsurprising that patients should feel less 
alert during a debilitating and unpleasant experience. This may explain 
why the same finding was encountered in the muscle-contraction headache 
group although there was also a time-dependent relationship with anger 
in these patients. No support was obtained for a positive relationship 
between muscle contraction headache and anxiety. (72)
Harrigan et al (1984) recorded 10 mood indicators three times daily 
in 17 migraine sufferers over periods from 21 to 75 days. Headaches were 
correlated with mood states during the headache and for periods ranging 
from 12-36 hours prior to the headache. The patients were a mixed group 
of classical and common migraine sufferers. The authors found that some 
mood states were more strongly correlated with migraine than others and 
that changes in mood were also correlated with subsequent headaches. 
Feeling of constraint and fatigue were the best predictors of headache.
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The migraine patients had less mood variability than has been found in 
other studies possibly indicating a narrowed range of perceived personal 
affect and a high degree of control over emotion. Migraineurs may have a 
unique mood profile characterised by generally suppressed moods with 
minimal variability. (73)
Heuser (1986) hypothesised, on the basis of previous work by 
Tunis and Wolff, that there might be vascular instability in the 3 day 
period preceeding a migraine attack. He used the Hassles Scale - a 
retrospective questionnaire - to assess the amount of stress each 
migraineur perceived him/herself as experiencing over the previous month 
and a set of rating scales to fill prospectively in over the following 
month three times daily. These scales covered migraine symptoms, 
stressful events, emotional states and physical activity. Thirty-three 
patients were involved - 20 with common migraine, 8 with classical 
migraine and 5 with equivocal neurological symptoms. Twenty- four 
patients also had muscle contraction headache in addition to their 
migraine. The data from the rating scales were then analysed for the 
first day of an attack and the preceding three days and the results 
compared with headache-free periods. Migraineurs as a group reported the 
same level of stress as normals. However they did report more stressful • 
events and less physical activity in the 4 day period leading up to the 
onset of an attack. This could be explained in two ways - either there 
is a critical threshold for stress beyond which a migraine attack is 
precipitated or there is increased sensitivity or reduced tolerance to 
stress just prior to attacks, possibly as an expression of an underlying 
pathogenetic mechanism. (74)
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From a clinical point of view a highly significant association 
(p<0«001) has been found between an increasing number of definite 
neurological symptoms (paresis, sensory loss, speech disturbance and loss 
of consciousness) and increasing depression as measured by the Zung Self 
Rating Depression Scale. The neurological symptoms are part of the aura 
and prodrome of classical migraine and as such are linked to the cerebral 
blood flow changes described above. (75)
Cerebral blood flow abnormalities have also been found in affective 
disorder, although as this is a condition which is episodic, progresses 
rapidly and responds to medication it is difficult to identify consistent 
patterns of metabolic change. (76)
The occurrence of mood changes following brain lesions has suggested 
regional brain abnormalities in patients with disorders of affect.
Results obtained with normal subjects indicates differential hemispheric 
involvement in emotional processing. Damage to the left hemisphere is 
associated with dysphoric mood whereas lesions of the right hemisphere 
are associated with euphoria and indifference. It has been suggested, on 
the basis of studies of patients following hemispherectomy, that 
dysphoric mood is associated with right hemispheric activation or left 
hemispheric inactivation.
Using ^^Xe inhalation with 13 patients meeting Research Diagnostic 
Criteria (RDC) for depression, gray matter flow has been found to be 
lower in more severely depressed patients. In addition negative 
correlations have been reported between regional cerebral blood flow and 
the scores on the Hamilton Rating Scale of depression. The bilateral
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hemispheric reduction in blood flow has been compared to that seen in 
conditions where there is loss of brain tissue such as Alzheimer's 
disease..Symptoms of cognitive dysfunction, such as attention, 
concentration and memory defects suggestive of mild diffuse organic 
dysfunction are frequent accompaniments of depression. As regional 
cerebral blood flow has been shown to reflect levels of neural activity 
and areas of increased neural metabolism have been associated with 
regional cerebral vasodilation, the decreased regional cerebral blood 
flow found in depression suggests neural hypoactivity. (77)
In another study using the same diagnostic criteria in 16 primary, 
major depressives dexamethasone suppression test (DST) results were 
correlated with rCBF changes. Non-suppressors had normal rCBF patterns 
whereas suppressors showed right posterior hypovascularisation and left 
frontal hypervascularisation. (78)
Gur et al (1984) found no differences in rCBF between 14 depressed 
patients (RDC criteria again) and normal subjects at rest although 
differences were seen during cognitive activation. Depressed men had 
lower rCBF which increased to normal during cognitive activation. 
Depressed women had higher resting flows than normal women and their 
flows remained higher during cognitive activation. VThen these results 
were compared with earlier work in schizophrenics the findings were 
consistent with left hemisphere overactivity in schizophrenia but not 
with right hemisphere overactivation in depression. (79) The lack of 
consistency with Mathews work (77) may be due to the fact that the former 
author did not use rCBF values corrected for pCO^.
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There are, as yet, few studies of affective disorder using positron 
emission tomography. However Buchsbaum et al (1984) used this technique 
to investigate the three main regional hypotheses in the major 
psychoses: frontal, temporal and lateralised cerebral dysfunction.
Sixteen patients with schizophrenia and 11 patients with affective 
disorder (Diagnostic Statistical Manual (ill) Criteria) were compared 
with 20 age- and sex-matched controls. All affective disorder patients 
were depressed and, with one exception, were unipolar depressives. Both 
normal subjects and patients showed a significant anteroposterior 
gradient in glucose use with highest values most anteriorly. This 
gradient was less in both groups of psychiatric disorder when in 
controls. It was thought to reflect a greater balance of activity in 
frontal areas responsible for planning of goal-directed behaviour than in 
posterior sensory-processing areas. This may also be associated with 
some diffuse system projecting to the cortex e.g. the noradrenergic 
projections of the locus caeruleus. (80)
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CHAPTER 9
NeUrotransmitter involvement in migraine and affective disorder
9*1 Neurogenic control of cerebral circulation
The cerebral vasculature is complex and originates from both the 
vertebral and carotid systems. There are both intracranial and 
extracranial vessels: the former are composed of the large vessels of the 
Circle of Willis and small pial vessels on the surface of the brain as 
well as a network of intracerebral vessels. The cerebral vascular
i
neuromuscular apparatus consists of a varicose perivascular nerve plexus 
at the adventitial-medial border and smooth muscle cells in the medial 
coat. The nerve plexus and the smooth muscle cells are functionally 
connected. (81)
The initial fall in cerebral blood flow during the migraine 
prodrome may be triggered by a number of factors e.g.






(g) changes in noradrenaline turnover,
(h) inefficiency or failure of non-adrenergic vasodilator mechanisms,
(i) hyperactivity of circulating vasoconstrictor agents or metabolic 
products.
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Multiple factors are probably involved.
The reactive hyperaemia during the headache is thought to involve 
purine nucleotides and nucleosides, release of substance P from sensory 
nerve collaterals and secondaiy release of local agents such as 
prostanoids, histamine and bradykinin. (82)
9*2 Classical neurotransmitters
Noradrenaline
The superior cervical ganglia and the locus coeruleus supply the 
cerebral blood vessels with noradrenergic neurones. The sympathetic 
supply of vessels in the carotid system is more extensive than that in 
the vertebral system. The sympathetic nervous system may influence the 
function of the blood-brain barrier, possibly via direct control of the 
capillary wall. Noradrenaline constricts the cerebral arteries causing a 
reduction in local blood flow throughcC-adrenoceptor stimulation. c£ 
adrenoceptors also mediate vasodilation in isolated brain vessels. In a 
study of 10 classic and 8 common migraine patients plasma noradrenaline 
concentrations were lower in both groups than in a control group. Patients 
with migraine had decreased sympathetic function even during headache- 
free intervals. Biphasic changes in the diameter of cerebral blood 
vessels during a migraine attack may depend on an equilibrium between 
noradrenergic deficiency and denervation hypersensitivity. (83)
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Acetylcholine
Acetylcholine-containing fibres supply the extracerebral arteries 
and the Circle of Willis where they produce vasoconstriction.
Acetylcholine and noradrenaline may reciprocally modulate each 
other's release.
9 .3  Won-adrenergic, non-cholinergic transmitters 
Dopamine
Dopamine acts centrally and peripherally onc>£ and ^ -adrenoceptors 
and specific dopamine receptors. It has a hypotensive effect which is 
due to vasodilation. This vasodilation is caused by a direct effect 
on smooth muscle and an indirect effect on the sympathetic nervous 
system.
Domperidone is a dopamine receptor blocker which does not cross 
the blood-brain barrier. It can prevent most classical migraine attacks 
if taken at the beginning of the prodromal period. This is only 
successful if the medication is taken six hours or more before the 
expected onset of the pain. One possible explanation for this is that 
the dopaminergic system is over-reactive in migraineurs. (84) Dopamine is 
a mediator in the nociceptive system. (85,86) Migraine patients are more 
sensitive than normal subjects to the emetic effects of L-DOPA and 
apomorphine (both dopamine receptor agonists). The nausea and vomiting 
which are part of the migraine syndrome may be due to acute
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hypersensitivity of peripheral postsynaptic dopamine receptors. Chronic 
dopamine deficiency would predispose to this.
Infusion of piribedil, which is a direct dopamine agonist, has been 
used as a diagnostic test for migraine. Piribedil produced more 
neurovegetative disorder and a greater change in pulse and blood pressure 
in headache sufferers than normal controls. The test differentiated best 
between migraine and cluster headache. However the results overlapped 
and did not clearly distinguish between different types of headache.
There was some evidence for dysfunction of the dopaminergic system in 
migraine. (85)
In idiopathic headache haloperidol, a specific dopamine antagonist, 
has been reported to decrease venospasm and improve headache. 
(Unfortunately no definition of idiopathic headache was given in this 
paper.) However chronic use of haloperidol causes depression in 20% of 
patients after 2-4 months. This subsides spontaneously 1-2 months after 
treatment is stopped. This may be related to a pre-existing dopamine 
deficiency. (86)
Serotonin (5-HT)
5-HT has a variety of effects at all levels of the cerebral 
circulation:
(1) vasoconstriction of the major cerebral arteries,
(2) arteriolar vasoconstriction and vasodilation,
(5 ) modification of cerebral capillary transfer leading to changes in the 
blood-brain barrier,
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(4 ) induction of cerebral oligaemia when in direct contact with neural
tissue.
The last of the above is probably secondary to 5-HT induced depression of 
cerebral metabolism. There is an endogenous 5-HT-containing system which 
innervates brain vessels. This could be the anatomical basis of a link 
between brain function and cerebral blood flow. (87)
5-HT uptake, release and storage are all disturbed in classical 
migraine. (87,88) Total plasma 5-HT levels are raised prior to the 
migraine attack at the same time as cerebral blood flow is decreased.
(87) In the headache phase plasma 5-HT concentrations decrease and 
there is increased excretion of 5-hydroxy-indolacetic acid (5-HIAA), a 
major metabolite of 5-HT.
Platelets store all the 5-HT in the blood. Platelets have been used 
as models of monoaminergic function and as such they have been 
extensively studied in migraine. Unfortunately the results of these 
studies have often been conflicting. The contradictions may be due to 
the following: (1) different types of migraine which differ 
physiologically, (2) the unpredictable nature of the attack, (5) the 
effects of treatments, (4) the use of unstandardised methods.
Hanington (1986) has pointed out that there is a considerable amount 
of circumstantial evidence that abnormal platelet behaviour is the 
primary cause of migraine. However she does not differentiate between 
classical and common migraine. (89)
Most of the evidence supports the view that the changes in platelet
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5-HT metabolism in common migraine are due to plasmatic factors and not 
due to a primary platelet defect. (90,91) By contrast, patients with 
classical migraine have significantly increased platelet aggregation and 
adhesion. An increased number of platelet aggregates in the circulation 
could play a primary role in producing the prodromal symptoms of 
migraine. In addition, although platelet 5-HT concentrations are 
rapidly restored to pre-headache levels after an attack of classical 
migraine, in one study the release of 5-HT from the platelets was 
significantly reduced for at least three days after an attack. This may 
correspond with the refractory period after an attack during which 
further attacks do not occur. (92) However other studies have found no 
differences between the binding characteristics of platelet 5-HT
receptors orcC^ adrenoceptors in classical migraine patients compared 
to controls. Therefore increased platelet aggregation with 5-HT and 
adrenaline may not be due to a primary platelet receptor change.
There is a significant reduction in tritiated %-imipramine 
binding sites in classical migraineurs between attacks compared with 
controls. ^H-imipramine binding sites are closely associated with 5- 
HT uptake sites. The uptake of 5-HT by platelets from patients with 
migraine is reduced between, during and after attacks of migraine. The 
reduced platelet 5-HT uptake in migraineurs may thus be partially due to ' 
a reduced number of platelet 5-HT uptake sites. The reduction in ^H- 
imipramine binding capacity is independent of the time interval since the 
last migraine attack and may reflect a predisposition to attacks rather 
than being a consequence of them. The female predominance in migraine may 
be related to the fact that women have lower control values for ^K- 
imipramine binding capacity than men. Classical migraine may be primarily
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a brain disorder with secondary vascular changes.
In depressive illness platelet 5-HT uptake is also reduced and
3
H- imipramine binding sites are reduced in both platelets and brain.
By analogy the decrease in ^H-imipramine binding sites in the 
platelets of classical migraineurs may reflect changes in ^H- 
imipramine binding sites in the brain. (95)
The platelet aggregation and release of endogenous platelet amines 
which occurs early in migraine could lead to altered permeability and 
diameter of blood vessels. This would contribute to the pain and 
neurological deficits. The platelets could, therefore, be the link 
between the systemic circulation and the central nervous system.
There are several small brain sites without a blood-brain barrier 
which receive a fenestrated capillary blood supply. This provides a route 
for the diffusion of substances from the systemic circulation into the 
brain close to the circumventricular organs. The vegetative symptoms 
associated with migraine are:-





These symptoms are very similar to the known functions of the 
circumventricular organs - the median eminence acts as a neuroendocrine 
transducer in hypothalamic/pituitary regulation, the area postrema is the
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most potent CNS vomiting centre and the subfornical organ and the vascular 
organ of the lamina terminalis are involved in thirst and fluid balance. 
These organs would be particularly susceptible to changes in 5-HT and 
catecholamines in the systemic circulation. Changes in 5-HT and 
catecholamine levels and dietary factors could produce the vegetative 
symptoms of migraine through their entry into the central nervous system 
via this fenestrated capillary blood supply and their effect on the 
circumventricular organs. (94)
5-HT containing neurones are located in the raphe nuclei of the 
medulla, pons, midbrain and centromedial reticular formation. They have 
widespread connections with the anterior and posterior horns of the spinal 
cord, the interomediolateral column, the ventral tegmentum, hypothalamus, 
amygdaloid nuclei and cingulate gyrus. Projections from the brain stem 
nuclei on to the neurones of the posterior horns of the spinal cord 
regulate the transmission of pain impulses at that level. Increased 
activi-ty of 5- HT fibres leads to decreased pain perception and vice 
versa. 5-HT D receptors mediate vasoconstriction and are blocked by 5-HT 
antagonists e.g. methysergide, pizotifen, propranolol and amitriptyline. 
5-HT M receptors mediate pain and are blocked by morphine, propranolol 
and metoclopramide. (94) Sicuteri has proposed that, in migraine, a 
deficiency of 5-HT leads to abnormal perception of pain in sensitive 
areas such as the head. Chronic deficiency produces a state of 
supersensitivity. The basic lesion in migraine is thus a genetically 
determined defect in the biochemical mechanisms underlying the experience 
of pain. It is unlikely that this would only affect pain and it would 
probably also involve other appreciative systems such as those involved 
in mood and sleep.
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Ischaemia associated with the migraine prodrome may alter CNS 5-HT 
metabolism. This could lead to increased pain sensitivity. In animal 
studies arterial occlusion of the cerebral hemispheres causes depletion 
of 5-HT which may be maintained for long periods despite cerebral 
reperfusion. This has been attributed to early neuronal release and 
synthesis inhibition. Interestingly, there is also depletion of 5-HT in 
the contralateral non-occluded hemisphere, possibly due to diaschisis (a 
neurogenically-mediated influence on cerebral blood flow and metabolism 
in brain areas remote from the focal lesion.) (96)
Adenosine-5'-triphosphate (ATP)
There is growing evidence that adenosine and/or ATP, perhaps 
released from purinergic nerves, participates in the regulation of 
cerebral blood flow. Purine nucleosides have been collected in brain 
tissue and cerebrospinal fluid during ischaemic hyperaemia and hypoxia. 
Both ATP and adenosine produce dilatation of cerebral vessels. Adenosine 
may also play an indirect role in the control of cerebral vessels since 
it is a potent presynaptic inhibitor of the release of noradrenaline and 
acetyl-choline from adrenergic and cholinergic nerves respectively. 
Purines are released when there is reactive hyperaemia during the 
headache phase of migraine. These purines may be involved in headache 
production. (63,81)
Substance P
Substance P has been linked to the activity of the trigeminovascular
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system in migraine. The trigeminal nerve fibres form part of an 
elaborate defensive network which protects the brain both against the 
entry of noxious substances from the circulation and damage from such 
substances within the CNS. In animals the trigeminal ganglia store 
substance P and 5-HT together. Substance P dilates pial arteries, 
increases vascular permeability and activates the cells which take part 
in the inflammatory response. Noxious substances stimulate the release 
of substance P which leads to the isolation, dilution and clearance of 
toxins before they have a chance to spread. The release of substance P 
and 5-HT together from trigeminal nerve endings may explain both the 
hemicranial pain and the vasodilation characteristic of the headache 
phase of migraine. (97,98)
Other neuropeptides such as Vasoactive Intestinal Polypeptide 
(VIP) and Neuropeptide Y have also been found in cerebral perivascular 
plexuses but, as yet, their function is unknown. (81)
9*4 Locally released agents
Agents which are released locally often as a secondary consequence 
of neurotransmitter activity are also involved in regulation of cerebral 
blood vessels.
P rostaglandins
These play a role in the normal physiological response of the 
circulation to hypercapnia and in the pathogenesis of cerebral spasm 
after haemorrhage. They are powerful presynaptic inhibitors of the
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release of noradrenaline from sympathetic vasomotor nerves. They can 
be released from platelets and damaged blood vessels or due to the 
actions of ATP and bradykinin.
Endothelial derived relaxing factor (EDRF)-mediated responses
Acetyl choline, ATP, 5-HT and substance P can produce potent 
vasodilation via receptors in the endothelial cells lining the lumen 
of vessels. These endothelial cells also release EDRF. It has been 
suggested, but not proven, that the endothelial cells contain 
acetylcholine and ATP and that the release of these substances 
following damage to the endothelial cells during ischaemia contributes 
to a pathophysiological mechanism of vasodilatation which protects that 
segment of the vessel from further damage as well as protecting the brain 
cells from hypoxia. (81)
9 .5 Neurotransmitter dysfunction in anxiety and depression 
Anxiety
Pharmacological models of anxiety are based on drug-induced 
emotional changes which are reduced by anxiolytics. Although the 
chemical structures of anxiolytics such as benzodiazepines, barbiturates 
and ethanol vary considerably, all act at benzodiazepine receptor sites. 
These sites are made up of high affinity, stereospecific receptors for 
benzodiazepines coupled to a recognition site for ^ f-aminobutyric acid 
(GABA) and a chloride ionosphere. (99)
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ft -carboline - 3-carboxylic acid ethyl ester (y!?-CCE) is a high 
affinity benzodiazepine receptor ligand which has powerful behavioural 
and physiological actions which can be reversed by diazepam. This may 
provide a valid model for human anxiety. There are high densities of 
benzodiazepine receptors in the hippocampus and amygdala and anxiety can 
be induced by hippocampal stimulation. The dense telencephalic 
representation of the benzodiazepine system could produce fear and 
conflict on activation. The benzodiazepine receptor model suggests that 
there is an endogenous ligand for the benzodiazepine receptor. The level 
of endogenous ligand would correlate with inter-and intra-individual 
variations in anxiety and level of arousal or rate of habituation.
Diazepam binding inhibitor (DBl) is a neuropeptide found in the 
brain which displaces diazepam and y#-CCE from their specific binding 
sites. The distribution of DBI-containing neurones may vary between 
different brain areas. It may be the precursor for a family of 
neuropeptides. Hormonal factors may be involved in the synthesis or 
degradation of DBI and it may, in turn, affect GABA-ergic regulation 
of pituitary hormone release.
The other main model for anxiety involves the noradrenergic 
system especially the^C^ adrenergic receptor, adrenergic 
receptor antagonists produce alarm and increase levels of MHPG (a 
metabolite of norepinephrine). The noradrenergic activity originates 
in the pons and is probably a different phenomenon from the emotion 
aroused by the benzodiazepine receptor system.
Both the benzodiazepine receptor system and the noradrenergic alarm
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system may be activated together in some clinical states. (100)
There is preclinical evidence that alterations in serotonin function 
may be related to the development of anxiety and the therapeutic benefits 
of anxiolytic drugs.
Serotonin increases prolactin release and intravenous administration 
of tryptophan, a serotonin precursor, reliably increases serum prolactin 
levels. This can be used as a measure of central serotonin function. 
However the results of tryptophan infusion in 21 patients with 
agoraphobia with panic attacks and 2 'patients with panic disorder (DSM- 
III criteria) failed to show any difference from the results in normal 
controls both before and after treatment with alprazolam (an 
anxiolytic). There was thus no support in this study for an involvement 
of serotonin in panic and anxiety disorders. Unfortunately 
interpretation of the results is complicated by the fact that 7 of the 
patients also concurrently met DSM-III criteria for major depression.
Similarities in phenomenology and response to treatment suggest that 
there is a link between panic disorder and major depression. The exact 
nature of this link is unknown. Studies of the mechanism of action of 
antipanic and antidepressant drugs suggest that antipanic effects may be 
primarily related to regulatory actions on noradrenergic function and 
antidepressant effects to an enhancement of serotonin function.
Tricyclics and monoamine oxidase inhibitors, which have both antipanic 
and antidepressant properties, affect both brain serotoninergic and 
noradrenergic function. (101 )
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Depression
Both first and second generation antidepressant drugs enhance the 
availability of 5-HT and noradrenaline at central receptors. Long term 
administration of antidepressants affects monoaminergic systems both pre- 
and postsynaptically. This generally involves down regulation. Down- 
regulation of the postsynaptic receptor is usually associated with 
decreased function while down-regulation of presynaptic receptors is 
associated with increased function. At present it is believed that the 
net effect is /^-adrenergic suppression andc^C-adrenergic and 
serotoninergic activation.
The traditional monoamine hypothesis of depression is of metabolic 
and functional deficiency of monoamines. Antidepressants would therefore 
enhance monoaminergic functions. However down-regulation of receptors 
suggests a second possibility. There may be monoaminergic hyperfunction 
and antidepressants could act by down-regulating postsynaptic amine 
receptors.
Serotonin (5-HT)
Biochemical research has provided evidence which suggests that 
5-HT turnover in the CNS is decreased in a subgroup of about 45$ of 
depressives. A subgroup of patients also have a reduced ratio of plasma 
concentrations of tryptophan to concentrations of competing amino acids. 
This could decrease the amount of tryptophan entering the CNS and 
therefore decrease 5-HT synthesis. It is not known whether these two 
subgroups are in fact one and the same.
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The disturbed 5-HT uptake in platelets in depression is thought to 
correlate with the patient's clinical state. The reduced density of 
H-imipramine receptors may be another index of abnormal cellular 5- 
HT reuptake. Monoamine receptor changes can persist for a considerable 
period after psychotropic drugs are discontinued.
5-HT disturbance is more likely to predispose to than to cause 
depression. It is not entirely specific to depression and is also found 
in 10% of normals, schizoaffective psychoses and chronic alcoholics who 
are abstinent. Nonetheless it is much commoner in severe depression and 
conditions closely related to it. It has been suggested that central 5-HT 
deficiency may contribute to the depressive states seen in alcoholics. 
Evidence of decreased CNS 5-HT turnover persists even after resolution of 
depressive illness. Studies of normal subjects indicate that decreased 5- 
HT turnover predisposes to depression and studies in depressed patients 
suggest that decreased 5-HT turnover is associated with an increased 
incidence of hospital admission and suicide. There is preliminary 
evidence that administration of 5-HT precursors has a prophylactic effect 
in depression especially in the group with lowered 5-HT turnover.
Noradrenaline
There is no conclusive evidence of noradrenaline disturbance in 
studies on the CNS. However peripheral studies of urinary 3-methoxy- 
4-hydroxyphenylglycol (MHPG) concentrations do indicate that these are 
decreased in depressions with endogenous features. MHPG is the principal 
CNS metabolite of noradrenaline. Sixty per cent of urinary MHPG is central
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in origin and 24 hour urinary MHPG excretion can be used as a crude 
measure of noradrenaline degradation in the CNS. Noradrenaline is also 
thought to play a role in the hormonal disturbances found in depression, 
e.g. disorders of cortisol and thyrotropin releasing hormone secretion 
and altered growth hormone responses.
Dopamine
Chronic administration of antidepressants subsensitises presynaptic 
dopamine receptors and thus probably increases dopamine release.
Dopamine metabolism is reduced in depression especially if there is 
marked motor retardation.
If patients differ in the type of catecholamine disturbance they 
experience they may respond preferentially to different types of 
antidepressant medication, e.g. patients with non-suppression in the 
dexamethasone suppression test (DST) are believed to respond best to 
noradrenaline-potentiating antidepressants whereas patients with a normal 
DST respond best to 5-HT-potentiating antidepressants.
Overall there appears to be more evidence in support of the 
traditional monoamine hypothesis that depression is associated with 
decreased CNS monoaminergic function rather than the alternative view 
that there is monoaaminergic hyperactivity. Activators of the 
monoaminergic system have an antidepressant effect and 5-HT synthesis 
inhibitors antagonise the effects of antidepressants. Catecholamine 




As the common central mediators of CNS processes it is likely that 
neurotransmitters play a major role in the production of both migraine 
and affective disorders (e.g. anxiety and depression).
Changes in neuronal metabolism are tied in with changes in cerebral 
blood flow and this, in turn, is partly controlled by noradrenergic and 
serotoninergic systems.
Noradrenaline can influence the permeability of the blood-brain- 
barrier and can certainly constrict and possibly also dilate cerebral 
arteries. adrenoceptors also mediate the alarm response and thus 
participate in the production of anxiety. Plasma noradrenaline 
concentrations are decreased in both classical and common migraine and 
binary MHPG (a noradrenaline metabolite) is also decreased in endogenous 
depression.
It has been suggested that serotoninergic neurones may provide the 
link between brain function and blood flow. Platelet 5HT function is 
disturbed in migraine and depression with diminished numbers of ^H 
imipramine receptors in both conditions. 5HT is also involved in the 
regulation of pain and is thus likely to be implicated in the close 
association between pain and depression.
In the present context it is difficult to do more than describe the 
similarities noted between some of the neurotransmitter disturbances in
- 104 -
migraine and affective disorders as there is insufficient information 
available to produce firm conclusions. Hopefully more sophisticated 




Epilepsy as a model for migraine and recurrent affective disorder
10.1 The relationship between migraine and epilepsy
The extent of the relationship between migraine and epilepsy has 
caused considerable controversy.
Epilepsy affects approximately 0-5% of the general population.
Figures given for the incidence of epilepsy in migraine patients have 
ranged from 1-11$. This is partly a consequence of the overlap between 
the symptomatology of migraine and epilepsy, e.g. both conditions may be 
preceded by auras and both may be associated with loss of consciousness. 
Nonetheless there is a higher incidence of epilepsy in unselected 
migraine sufferers than in the population as a whole. It is also 
significantly greater than the incidence in patients with tension 
headache. (103) There is also a slightly higher incidence of migraine in 
epileptics than in controls. Of the close relatives of epileptics about 
one third will be epileptic and one fifth will suffer from migraine. (104)
Slatter has suggested that there are four possible ways of explaining 
the association between migraine and epilepsy:
(i) the two conditions may occur independently in the same patient,
(ii) migraine can precipitate epilepsy in a predisposed patient,
(iii) a common focal structural lesion may be responsible for both 
conditions,
(iv) irreversible cerebral damage caused by migraine may rarely cause
- 106 -
local epileptic changes. (105)
10.2 EEG abnormalities in migraine
There is no difference between an undifferentiated group of headache 
sufferers and a headache-free population in terms of the extent of 
electroencephalogram (EEG) abnormality. However the incidence of EEG 
abnormality in migraine sufferers is doubled.
There are two categories of EEG disturbance in the migraine group:-
(a) the EEG in the headache-free periods shows a persistent non-focal 
abnormality. There is excessive, paroxysmal, diffusely occurring 4- 
7c.p.s. activity which may be related to epileptic phenomena
(b) focal EEG abnormalities:-
(i) brief alteration of the EEG during migraines with transient focal 
motor or sensory defects,
(ii) EEG abnormalities which develop when migraine is associated with 
deficits of motor, sensory or mental function and which disappear within 
hours or days concurrently with the resolution of the clinical signs,
(iii) EEGs taken during the headache-free period which show persistent 
focal abnormality and which usually occur in patients who have pronounced 
focal symptoms during their migraine attacks. (6)
Basser has hypothesised that 'there is a fundamental and intimate 
relation between migraine and epilepsy based on a process which has the 
characteristics of the spreading depression (SD) of Leao.'
Leao's work was originally done to investigate the
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electrocorticogram in 'experimental epilepsy'. LeacT concluded that S.D. 
and the 'tonic-clonic' activity of experimental cortical epilepsy were 
closely related. The spread of tonic-clonic responses was felt to be 
mediated by the same cortical elements which were involved in the spread 
of the depression. He considered that both processes were mainly cortical, 
their development and characteristics depending on the local conditions 
in the affected regions. In a subsequent paper Leao noted marked 
dilatation and increased blood flow in the pial vessels which was 
concomitant with, and secondary to, the electrical activity whether or 
not convulsive activity developed. He concluded that the increase in 
blood flow probably influenced the activity of cortical neurones.
The propagation of S.D. depends on the release of potassium ions and 
a high incidence of migraine has been noted in the families of patients 
with hypokalaemic periodic paralysis (a disorder of potassium 
metabolism). (103)
10*3 The relationship between epilepsy and affective disorder
Stress disorders (neurotic disorders) are commoner in people with 
epilepsy than in the general population. Reactions to the condition 
itself have to be discriminated from concurrent psychiatric disorder. 
Endogenous depression is also more common in epilepsy and there is a 
relationship, although not necessarily a direct one, between seizures 
and aggressive outbursts as both decrease in parallel.
Brief changes in mood ranging from elation to depression are well 
known in epilepsy and often described as 'dysphoric states'. Landolt
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(1958) described them in association with 'forced normalisation' of the 
EEG or with a decline in attack frequency. They are similar to the 
prodromal affective symptoms occasionally seen in epileptic patients 2-3 
days before the attack. The patient with prodromal affective symptoms is 
likely to have more prolonged affective changes if his attack frequency 
decreases. Likewise endogenous depressive episodes occur when the attack 
frequency is declining. These differ from ordinary depressive illness 
only in the rapidity with which they can come and go - occasionally the 
rapid switching in and out of depression suggests an ictal experience. 
Successful suicide is also more common in epileptics than in the general 
population. A significant correlation between dominant temporal lobe 
lesions and schizophrenia and non-dominant (usually right) temporal lobe 
lesions and depressive symptoms was found by both Flor-Henry and Lishman 
although these findings have not always been replicated in other studies. 
(106)
Reynolds (1861)# Jackson (1879) and Gowers (1881) were all aware of 
ictal affective changes. Reynolds described fear and depression as 
manifestations of the epileptic process, Jackson wrote of 'the symptom 
fear' and Gowers of 'emotional auras'. The incidence of affective auras 
has been estimated at between 5$ and 6*7$.
The pre-ictal phase is unusual in that the psychological disorders 
seen may be partly the cause of the subsequent epileptic attack or partly 
the result of the physiological disturbance which leads to the fit.
Stress is frequently anecdotally implicated in the production of fits and 
increasing irritability and tension are often noted just prior to 
seizures in chronic epilepsy. The irritability and tension may be
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manifestations of an underlying neurophysiological disturbance. (106)
Jackson has commented on the sequential alteration of affect which 
can occasionally occur with an initially pleasurable aura being replaced 
by one of depression after repeated seizures over a period of time.
Changes in affect produced by the epileptic discharge are diffuse 
and undifferentiated. There is a sudden welling-up of emotion 
inappropriate to the circumstances which may become integrated into the 
immediate environment. (107)
Depression is relatively rare as an ictal affect although interictal 
depression is not uncommon especially in temporal lobe epilepsy 
(T.L.E.). A transient episode of depression can be associated with the 
onset of an attack and may persist after it is over - possibly as a 
manifestation of the epileptic discharge.
By contrast pleasure is relatively common in TLE where it is often 
linked with visual hallucinations or perceptual changes. There have 
been several reported instances of ictal laughter. A sensation of 
pleasure can also occur with olfactory hallucinations. Autonomic upset 
(nausea, sweating and pallor) is almost universal.
The post-ictal period is the commonest time for episodic psychiatric 
disturbance. This can occur in both major and minor epilepsy. In the 
latter it is associated with an irregular, slow, often asymmetrical and 
low voltage EEG. This is thought to reflect lowered cortical control.
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In addition to affective changes fits are frequently accompanied by:-
(i) intestinal motor and sensory phenomena,
(ii) vasomotor disturbances,
(iii) sudomotor phenomena.
The autonomic and visceral phenomena are associated with the fronto- 
temporal region and the mesial parasagittal region of the frontal lobes.
It seems likely that the limbic system is involved and Herrick (1930) has 
suggested that the olfactory cortex is a non specific activator for all 
cortical activities. Affective change, vegetative phenomena and 
olfactory and gustatory sensations often occur together. (107»108)
The thalamus was initially thought to be the main site for the 
central mechanism of emotion. This view was criticised as being 
oversimplistic. Although thalamotomy did successfully relieve emotional 
states, relapses following surgery indicated the existence of additional 
mechanisms. (109) The importance of the autonomic nervous system in the 
translation of emotional distress into physical illness was recognised at 
an early stage. The hypothalamus was involved in the expression, whereas 
the cerebral cortex provided the experience, of emotion.
Papez implicated the limbic system and postulated that 'the central • 
emotive process of cortical origin may ... be conceived as being built up 
in the hippocampal formation and as being transferred to the mammillary 
body and thence through the anterior thalamic nuclei to the cortex of the 
gyrus cinguli. The cortex of the cingular gyrus may be looked on as the 
receptive region for the experiencing of emotion .... Radiation of the 
emotive process from the gyrus cinguli to other regions in the cerebral
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cortex would add emotional colouring to psychic processes.' (110)
Epileptic automatisms provide evidence that the hippocampal 
formation and associated structures are concerned in emotional 
experience. The automatism is a state of clouding of consciousness which 
occurs during or immediately after a seizure. Control of posture and 
muscle tone is retained and simple or complex movements can be performed 
without awareness. This is accompanied by continuous disturbance on the 
EEG.
Approximately 80$ of automatisms are preceded by an aura consisting 
of epigastric sensations, confusion, memory difficulty, a feeling of 
strangeness or unreality, dizziness or mastication and salivation.
There is usually total amnesia for the automatism.
The commonest cause is epilepsy involving medial temporal lobe 
structures. During neurosurgery electrical discharges from the medial 
and inferior temporal lobes have been recorded while automatisms are in 
progress. Stimulation of the amygdaloid nucleus and the uncus can 
provoke an automatism. These can also occur when focal pathology 
in the frontal region or cingulate cortex produces secondary activation 
of periamygdaloid hippocampal structures. (71 ) Patients with automatisms 
also commonly have severe emotional and psychological disturbances 
between seizures.
The hippocampal formation integrates olfactory, gustatory and other 
visceral sensation as well as auditory, visual and somaesthetic 
experiences. (111) This could provide a cortical control mechanism
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for autonomic reflexes.
Alternatively there is close liaison between the prefrontal cortex 
and the limbic system. The prefrontal cortex is involved in anticipation 
and planning. The reticular system connects it with the limbic system.
The association of the limbic system with emotion implicates the cortex 
in control of the autonomic nervous system. The hypothalamus - through 
its control over the sympathetic and parasympathetic parts of the 
autonomic nervous system - could be involved in the patterns of behaviour 
produced by emotional states. (112)
The temporal lobe and through it the limbic system are the brain 
regions most often involved when psychiatric disturbance occurs in 
epilepsy.
Weil commented on 'paroxysmal negative affects' associated with 
temporal lobe epilepsy. Depression is particularly related to seizures 
with olfactory auras. (113)
MacRae noted that 75$ of epileptics who experienced anxiety,
usually as part of the aura, had a temporal lobe focus. Ten per cent
/ \
of cases of temporal lobe epilepsy had uncinate fits with deja vu.
The epileptic discharge in TLE may block the function of the limbic 
system resulting in both affective and autonomic changes (111)
An association has also been found between symptoms of psychomotor 
epilepsy and manic-depressive illness. In a small series of 12 
consecutive patients with bipolar mood disorder (DSM-III criteria),
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six had 5-6 symptoms of psychomotor epilepsy and five of these six 
patients had EEG abnormalities. However all patients responded to 
lithium carbonate and had a first degree relative with bipolar disorder. 
Although the selection of patients for this study was open to bias the 
results are interesting and suggest that further investigation of the 
association of TLE and manic-depressive illness would be worthwhile.
(114)
10«4 Migraine and affective disorder
There is a variety of indirect evidence for an association between 
migraine and depression. Abnormalities of serotonin metabolism have been 
implicated in both conditions. Amitriptyline is effective both as an 
antidepressant and as a prophylactic in migraine. Reserpine precipitates 
headaches in migraine patients and depression in 20$ of patients who use 
the drug regularly. Platelet monoamine oxidase is both low in migrainous 
and depressed patients. The symptoms of migraine and depression overlap 
and prevalence rates of 10-20$ have been reported for depression in 
migraine sufferers. However a recent study by Garvey et al (1984) which 
examined the problem by looking at the lifetime migraine histories of 
patients with major depressive disorder found only a trend for depressed 
men, but not depressed women, to experience a higher prevalence of 
migraine. (115)
10.5 Limbic System Kindling
Limbic epilepsy is closely associated with personality changes and 
psychosis. Stimulation of the amygdalar region can trigger episodes of
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rage and a chronic stimulatory lesion of the limbic system could be 
aetiologically related to the periodic dyscontrol syndrome. The 
proportion of psychotic patients with temporal lobe epilepsy is higher 
than that of the general population. The onset of the epilepsy precedes 
the onset of psychosis and the two conditions run parallel courses. The 
frequency of the seizures is the reciprocal of the psychotic episodes. 
(116)
The two halves of the limbic system operate together although the 
right and left sides have different functions. There may be subtle 
emotional distinctions depending on which side is involved in the 
epileptic process. Flor-Henry found that in limbic epilepsy with 
unilateral foci the resultant psychosis was schizophreniform if the 
dominant side was involved and affective if the focus was in the non 
dominant hemisphere.
The association between dominant hemisphere temporal lobe ^ epilepsy 
and schizophrenia is stronger than that between non-dominant temporal 
lobe epilepsy and manic-depressive psychosis. Depression seems to be 
related to non-dominant frontotemporal dysfunction. When a 
neuropsychological test battery is used laterality effects are only 
apparent in severe dysfunction. These effects are stronger in frontal 
than in temporal regions. The strongest associations between diagnosis 
and lateralised disturbance are found in the frontal regions, are still 
evident in the temporal region but disappear in the parietal regions.
Power spectral analysis of the EEG shows bilateral but predominantly 
right temporal abnormalities in affective psychoses and predominantly
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left temporal dysfunction in schizophrenics. There is also some evidence 
for a defect of interhemispheric integration. (117)
However although there is considerable evidence that the neural 
basis of psychiatric syndromes, particularly the functional psychoses, is 
largely in the limbic system whether this is influenced by cerebral 
asymmetry is more dubious. The studies published have been contradictory 
and the statistics used questionable. (118)
Kindling occurs when mild repetitive stimulation to the brain causes 
a progressive change in response which eventually leads to a major 
convulsion. The brain does not return to normal after repeated kindling 
but remains in a state of readiness and in some cases convulsions may 
start to occur spontaneously. The kindling effect results from neuronal 
activation. There are regional differences in responsiveness to it. The 
amygdala is the most receptive area. Kindling causes widespread neuronal 
changes - if stimulation is applied to a second area the kindling process 
is more rapid than it was the first time. Evoked potential studies have 
shown that changes in the brain are not limited to the seizure. Kindling 
can produce a lasting change in how normal activity is transmitted over 
specific neuronal pathways. The mechanism for this may be a selective 
increase in excitatory synapses biasing a particular region or set of 
synapses to become pathologically hyperexcitable. Specific anatomical 
pathways control specific behaviours. Activity within them may increase 
some behaviours and decrease others. If kindling selectively 
strengthened one set of pathways this could in turn cause behavioural 
change. (116)
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There has been considerable interest in the close association 
between temporal lobe epilepsy and paranoid schizophrenia since Slater & 
Beard published a series of papers on it in 1963* They noted that the 
positive symptoms of schizophrenia and the aura of temporal lobe epilepsy 
were very similar. They also felt that the duration of the epilepsy 
played a causative role in the onset of the psychosis. This might be 
related to organic damage. (119)
Betts & Skarrot (1979) found that paranoid symptoms were common in 
institutionalised epileptics and that there was a continuum of severity. 
Only a few patients met strict diagnostic criteria for paranoid 
schizophrenia. Following a similar study in the USA, Stevens suggested a 
biological antagonism between epilepsy and schizophrenia. Differing 
diagnostic criteria may partially account for the different results in 
earlier and later studies.
There is now doubt about the relationship in time between 
schizophrenia and epilepsy. In chronic mental hospital populations as 
many patients develope schizophrenia before epilepsy as the reverse and 
therefore Slater's original finding that the epilepsy predated the 
psychosis may have been an artefact of the population which he studied. 
Whether patients develop epilepsy or schizophrenia first they eventually • 
lose both. The end state is institutionalisation but little evidence of 
organic impairment. The epilepsy and the psychosis often disappear 
approximately simultaneously. Kristensen & Sindrup found recently that 
the fit frequency for complex partial seizures was lower in psychotic 
patients and that there was an interval with a median of 18 years between 
the onset of the epilepsy and the psychosis. There was a significantly
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greater number of patients with automatisms in the psychotic group.
There are two contrasting hypotheses which could explain the 
association of temporal lobe-limbic system mechanisms and psychotic 
experiences :-
(1) schizophrenia-like illnesses are epileptic in origin and should be 
referred to as epileptic psychoses,
(2) they are a manifestation of organic neurological damage and thus not 
specific for epilepsy.
The first view has been extensively criticised by Flor-Henry on the 
basis of the lack of control populations in the. older studies, the 
inverse relationship between the frequency of seizures and the onset of 
psychosis, and the laterality effect. He has suggested that the 
characteristics of the seizures rather than structural damage lead to the 
clinical picture. Symonds has suggested an 'epileptic disorder of 
function' in which loss of balance between synaptic excitation and 
inhibition causes not only paroxysmal epilepsy but interictal symptoms, 
the nature of which are related to the site of focal activity. It is 
possible that chronic subictal activity leads to a kindling process 
within dopaminergic pathways which in turn causes the development of 
abnormal behaviour patterns and psychosis. These behaviour changes are 
enhanced by dopamine agonists and thus it is probable that the kindling 
itself is associated with altered post-synaptic function of dopamine 
receptors. (106)
Interictal changes in behaviour may result from seizure activity in 
the limbic system. (11 6)
- 118 -
Kindling may provide a model for the production of
(1) epileptic seizures,
(2) migraine,
(3 ) manic depressive disorder.
10.6 Psychotropic drugs used in the treatment of migraine
A variety of psychotropic drugs are used in the treatment and 
prophylaxis of hoth manic depressive disorder and migraine:
(i) anticonvulsants,
(ii) antidepressants,
(iii) calcium channel blockers,
(iv) lithium.
(i) Anticonvulsants
Carbamazepine is particularly effective as an anticonvulsant in 
temporal lobe epilepsy. It is also useful in other episodic disorders 
involving pain, e.g. trigeminal neuralgia, and affect e.g. manic 
depressive psychosis. Kindling may explain the pathological behaviour 
which can develop after a time lag in temporal lobe epilepsy. This is 
very similar to the longitudinal development and changing psychopathology 
in affective disorder over time. By analogy, a form of affective 
spontaneity may develop after repeated stress-related episodes of 
affective disorder
Carbamazepine has beneficial effects on mood and behaviour in 50$ of
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patients being treated for seizures. This can occur in the absence of 
adequate seizure control. Carbamazepine's chemical structure resembles 
that of the tricyclic antidepressants. It blocks reuptake of 
norepinephrine. Its action in affective illness may be related to 
mechanisms which stabilise limbic system dysfunction and not directly due 
to its anticonvulsant effect. Clinical trials on non-epileptic manic 
depressives have also shown that it has both antimanic and antidepressant 
effects as well as being a useful prophylactic. (120) It is the treatment 
of choice in trigeminal neuralgia - a recurrent condition involving pain 
in the face in the distribution of the trigeminal nerve. As yet it has 
not been investigated extensively as a treatment for migraine.
(ii) Antidepressants
Both amitriptyline and mianserin have been shown to decrease the 
frequency, duration and intensity of migraine headaches when used as 
prophylactics. (121,122) The response to both appears to be to some 
extent independent of their action on mood. Initial work with 
amitriptyline in open clinical trials suggested that the response of the 
migraine population was bimodal, i.e. that 80$ of patients responded well 
or not at all. These results were consistent with the presence of two 
discrete migraine populations - one susceptible to amitriptyline and the 
other not. (125) This was later confirmed in double blind studies where 
non depressed subjects with severe migraine and depressed subjects with 
less severe migraine responded best to amitriptyline, whilst depressed 
subjects with severe migraine had little headache relief. (121)
The mechanism of action is uncertain but, as far as amitriptyline is
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concerned, may relate to Mocking reuptake of serotonin and 
catecholamines. In addition to being a non-specific calcium channel 
antagonist it also has anticholinergic, antihistaminic and 
antiserotoninergic actions and may interfere with the release of 
norepinephrine at nerve endings. (121) An explanation related to an effect 
on neurotransmitter control of brain circulation or on the 
antinociceptive central systems has been suggested. (122)
(iii) Calcium channel blockers
Calcium channel blockers all share the ability to slow the entry of 
calcium ions into cells through voltage - activated, ion-selective 
channels. They cause both coronary and peripheral vasodilation. They 
have specific high and low affinity binding sites in brain and skeletal 
muscle as well as the cardiovascular system. (124) Given continuously 
by mouth they can provide significant relief in migraine and cluster 
headaches and reduce prodromes. Ten to 14 days of calcium antagonist 
therapy is required before prodromes are reduced and a further 2-6 week 
delay is necessary before headaches are alleviated. This slow time 
course is similar to that seen when antidepressant drugs are used for the 
same purpose. Headache symptoms reappear 1-2 weeks after stopping 
therapy with either type of compound. Most clinically effective 
antidepressants block calcium entry and inhibit calmodulin action in 
isolated blood vessels or cardiac preparations. (125) Some drugs employed 
in treating depression and migraine share common mechanisms of action.
It is possible that the antidepressant and antimigraine actions may 
involve the contractile apparatus of vascular smooth muscle and thereby 
be linked with the rCBF changes found in both depression and migraine.
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(125) Flunarizine, a calcium entry blocker, has also been shown to reduce 
cortical spreading depression and hypoxia - both of which have been 
implicated in the pathogenesis of migraine. (126)
(iv) Lithium
Calcium functions as an intracellular second messenger and activates 
a wide range of enzymes. Lithium can alter many calcium-dependent 
processes. These include enzyme systems, regulation of receptor 
sensitivity, parathyroid hormone release and microtubule structure. All 
neural mechanisms hypothesised to explain successful pharmacological 
treatment of bipolar illness involve calcium - dependent processes. 
Lithium's therapeutic effectiveness could be explained by its effect on 
calcium function. (127),
Lithium is best known for its role in both the acute treatment and 
the prophylaxis of manic-depressive disorder. However it has also been 
used as a prophylactic in cluster headache and migraine. This was based 
on the analogy between conditions which had periodic attacks with 
remissions and recurrent affective disorder. Clinical trials of lithium 
in migraine have been generally discouraging as it has exacerbated 
symptoms. However it has been more beneficial in a subgroup of patients 
with cyclic migraine, i.e. daily attacks for two or more weeks with 
recurrences on average five times a year with headache-free periods in 
between.
Lithium is also effective in hypomanic mood and behaviour disorders 
which occur as a consequence of structural damage to the brain. It has
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been used to treat acute steroid-induced psychoses and as prophylaxis 
against recurrence during further courses of steroids. (128) It has been 
suggested that lithium's ability to increase the threshold for after­
discharges in the limbic system may interfere with a kindling mechanism 
and that this underlies its therapeutic activity. (129)
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CHAPTER 11
Temporal lobe epilepsy, depression and olfactory hallucinations - 
is the same mechanism producing the affective changes in temporal 
lobe epilepsy and migraine
Olfactory hallucinations are produced by irritation of the uncinate 
gyrus or the adjacent temporal lobe. They occur most frequently in 
association with tumour or epilepsy. It is only within the last five 
years that it has been recognised that they can also occur in migraine, 
where they are thought to be a consequence of temporal lobe ischaemia. 
(130,131)
In the 1930s Keschner et al compared two series of patients with 
temporal lobe and frontal tumours• Mental symptoms were found in 94$ of 
patients with temporal lobe tumours, although this was associated with 
evidence of intracranial hypertension in 72$. Similar figures were found 
in frontal lobe tumours. Hallucinations were present in 14$ of patients 
- the right and left lobes were equally likely to be affected. When the 
tumour involved the uncinate gyrus olfactory and gustatory hallucinations 
were common and sometimes also 'dreamy states' with or without 
generalised convulsions. Olfactory and gustatory hallucinations were 
characteristic of the temporal lobe but not particularly frequent. The 
triad of complex hallucinations, uncinate phenomena plus dreamy states 
and expressive aphasia was diagnostic of a lesion in the dominant 
temporal lobe. Disturbances of affect were found in 57$ of patients.
The affective changes were much commoner in tumours of the left
- 124 -
temporal lobe. The incidence for all affective disturbance was 
approximately the same as for frontal lobe tumours. Disturbances of 
memory and orientation were found in 50$ of patients and disordered 
intellectual and higher psychic functions in 56$. (132)
Ictal hallucinations are especially likely in temporal lobe 
epilepsy. These hallucinations are 'paroxysmal, involuntary 
recollections drawn from direct or vicarious experiential records which 
interrupt consciousness as a sequential part of the ictus'. 
Hallucinations derived from the right temporal lobe are usually related 
to space and form whilst those from the left temporal lobe are mainly 
ventral in content. Generally, hallucinations originate mainly from the 
right hemisphere whilst illusions are almost equally distributed across 
the two sides. (133) Olfactory and gustatory hallucinations are 
relatively rare and have been estimated to occur in from 2-5*9$ of 
patients with temporal lobe epilepsy. The olfactory hallucination is 
unchanging in character between attacks (i.e. the odour is the same each 
time), the majority of patients give it an affective quality of being 
pleasant or unpleasant and a crude and unrecognisable smell is the most 
common. Olfactory illusions can also occur when there is an alteration 
in the character of normal olfactory stimuli during the seizure. There 
may be an interictal defect in the sense of smell with hallucinations or 
illusions which are sustained over relatively lengthy periods. (134)
The size of the olfactory cortex and the extent to which surrounding 
areas receive olfactory bulb fibres varies according to the importance of 
the sense of smell in different species. There is a close anatomic 
relationship between the entorhinal area and the hippocampus, between the
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amygdaloid body and the hypothalamus and between the olfactory tubercle 
and the basal ganglia. Olfaction is thus closely connected with areas of 
the brain involved in memory, food and water intake, reproduction and 
emotional reactions. (135)
In 1899 Jackson & Stewart drew attention to the association of ictal 
affective states with uncinate paroxysms. The emotion was usually 
unpleasant. (136) Affective change is not uncommon in temporal lobe 
epilepsy - Williams found 165 patients with complex feelings as part of 
the epileptic attack in a survey of 2,000 epileptics. Of these 100 had 
emotion as part of the epileptic experience. (137) Similarly Weil found 
that 28 out of a total of 132 temporal lobe epileptics had ictal emotion. 
(138) Fear and depression were the two emotions most often encountered by 
both authors. Fear was usually found as part of the aura. Williams 
described fear in association with 40$ of anterior temporal foci and 46$ 
of middle temporal foci whereas depression could not be related to any 
one area of the temporal lobe. (137) Weil has suggested that depression 
is caused by subclinical epilepsy in the whole hippocampal-amygdaloid- 
temporal lobe complex or by after-discharges following overt seizure 
activity. (138) Ictal aggression was uncommon (17$ in Williams' series) 
but was associated with lesions in the anterior half of the temporal lobe 
or the inferior part of the frontal lobe. Fear was experienced either 
immediately before or after visceral sensations or activity, auditoiy 
hallucinations or vertigo in over 70$ of Williams' patients. This 
relationship was dependent on the proximity of the limbic and superior 
temporal cortex to the anterior part of the temporal lobe. Fifty per cent 
of patients with ictal fear experienced either visceral sensoiy or 
visceral motor changes. In order to explain this Williams suggested that
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the integration of visceral activity resulting from sensory change was 
mediated through the fronto-temporal cortex whilst the anterior temporal 
cortex was concerned with the sensory and motor aspects of fear. (137) 
Daly came to very similar conclusions. (134) Both Weil and Daly commented 
on the association between olfactory hallucinations and ictal depression 
although Daly stressed that in his own series this was not a fixed 
relationship. (134 >138)
Pryse-Phillips described the olfactory reference syndrome. Its the 
central feature is an intrinsic hallucination of foul body odour. The 
patients are generally men with premorbid personality traits of 
sensitivity, self criticism and obsessionality. The mean age of onset 
is 25 years. The syndrome is interesting in the present context because 
of its good response to antidepressants. (139>140) A single case has been 
described in association with an arterio-venous malformation in the 
lower medial part of the right frontal lobe. Psychomotor epilepsy can be 
initiated by foci in the frontal and orbitofrontal areas. In this case it 
was suggested that the olfactory symptoms could be due to ischaemia 
caused by local vascular shunting. (141 )
There are close parallels between migraine and temporal lobe 
epilepsy: olfactory hallucinations and affective change are features of 
both conditions. Both may be unilateral or bilateral and this can vary 
between attacks: a temporal lobe focus in one hemisphere can cause 
discharges in its opposite number; the pain in migraine can be felt on 
either one or both sides of the head. Although this has been ascribed 
to ischaemia in migraine the underlying mechanism may be closer to the 
electrical discharge of temporal lobe epilepsy. Both migraine and
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Cocaine abuse as a model for migraine hallucinations
Perceptual disturbance is common with chronic cocaine use,
particularly visual hallucinations. Olfactory and auditory
hallucinations have also been reported. In a survey of 85 recreational
cocaine users 43*5$ experienced perceptual phenomena such as increased
sensitivity to light, halos round bright lights and difficulty in
focussing. All these patients had intermittent attentional dysfunction.
17*6$ of subjects had frank hallucinations. The limited range of
patterns found in the cocaine-related visual hallucinations was very
similar to that found in migraine patients. (142) Several authors have
commented on the presence of form constants in visual hallucinations with
a tendency to geometrisation. These form constants may be a consequence
of entoptic structures such as the choriocapillary circulation and
retroretinal features. Alternatively they could reflect the organisation
of the visual cortex. This is arranged as a mosaic of detectors of
contrast. Excitation of these detectors by a wave of spreading
depression could elicit the range of hallucinatory experiences found in
both cocaine abuse and migraine. (142-145) Sensory inputs are directly
controlled by a subcortical modulating system in the midbrain reticular 
6
formation. This operates in conjunction with the regulation of arousal. 
(144) Cocaine's stimulant effects include seizure-type electrical 
discharges in the temporal lobe and increased activity in the reticular 
activating system with increased function of arousal mechanisms. In 
this context it is interesting that J% of the series of cocaine abusers 
described above had olfactory hallucinations similar to uncinate
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phenomena. (142)
Cocaine abuse and the resultant psychiatric dysfunction provides a 
model for the endogenous psychoses. Cocaine has a continuum of effect 
from initial euphoria through dysphoria to frank psychosis. Increasing 
doses and/or chronicity and parenteral administration all enhance 
cognitive and affective disorganisation. The biological changes 
associated with cocaine mimic those associated with stress i.e. it is 
sympathomimetic, predominantly catecholaminergic. Acute and chronic 
cocaine abuse may therefore affect catecholamine levels in a parallel way 
to acute and chronic stress. Cocaine can also induce seizure activity 
confined to the limbic system which is associated with profound 
behavioural change without convulsions. Drugs which alter the cocaine 
seizure threshold have major psychotropic effects (neuroleptics and 
thymoleptics), while routine anticonvulsants (diphenylhydantoin and 
phenobarbital) do not significantly affect cocaine seizures and are not 
useful antipsychotic agents. Pharmacological or functional disconnection 
of cortical- subcortical integration due to altered limbic system 
activity could profoundly affect cognitive and affective integration in 
the cocaine and functional psychoses. (146)
Cocaine can induce a progressive alteration in behaviour with 
repetitive administration. This is known as reverse tolerance. This 
cannot be explained by conditioning alone. Kindling has similar effects 
and a similar time course. Cocaine may produce a pharmacological 
kindling mechanism - possibly through increasing receptor sensitivity. 
This would cause a progressive increase in the duration and spread of 
discharges. This could result in increasingly pathological behaviour.
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Psychological kindling would involve disruption of critical limbic areas 
involved in emotion and cognition. This could, in turn, be related to 
the onset and maintenance of pathological affective and schizophrenic 
states. Kindling may be the means by which environmental stress leads to 
exacerbation of psychiatric illness.
Temporal lobe epilepsy is also associated with psychosis. The 
longer the duration of the epilepsy and the longer the interval between 
seizures the commoner this psychosis is. This could be caused by a 
kindling mechanism. (129) The similarity between the symptoms of cocaine- 
induced psychoses, temporal lobe epilepsy and migraine suggests that 
kindling and increased arousal may underlie all. three conditions.
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CHAPTER 13
Migraine as a stress-related disorder
13*1 Stress and its association with illness
Migraine is one of several illnesses which are thought to be related 
to emotional stress.
Stress is an inevitable part of life - obstacles must be overcome, 
choices made and delays tolerated. When progress towards a desired 
objective is blocked or delayed there is resulting frustration. However, 
a mild level of emotional arousal is necessaiy to produce alertness and 
interest. Sensory deprivation experiments indicate that the absence of 
normal stimulation has a detrimental effect on functioning. The 
autonomic nervous system prepares the organism for action in emergencies 
- prolonged stress can lead to physical disorders in the organ systems 
involved, e.g. high blood pressure and heart disease.
Three main factors determine individual physiological responses to 
stress:-
(1) individual differences in the reactivity of the autonomic nervous 
system,
(2) vulnerability of a particular body organ or system as a result of 
heredity or prior illness,
(3 ) early learning experiences.
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A wide range of stressful situations can lead to a given type of 
disorder and conversely a wide range of disorders can result from a given 
type of stress.
Life stress is generally measured using rating scales e.g. the 
Holmes & Rahe Social Readjustment Scale. Both pleasant and unpleasant 
life events require some readjustment. Unfortunately individual 
reactions to life events are not easy to predict as they depend upon a 
number of factors e.g. previous experience. The predictability of the 
outcome of the event is also an important determinant of the reaction to 
it. There is no adequate animal model which encompasses this aspect of 
the human response to stress. Uncertainty can be extremely stressful - 
it can prevent anticipatory coping processes and cause confusion. The 
more immediate an event is, the more urgent and intense is its effect. 
Appraisal becomes more complex as imminency decreases - this can either 
increase threat or allow time for cognitive processes to reduce anxiety 
and therefore decrease it. If events go on for long enough they can 
produce the General Adaptation Syndrome - this includes an alarm 
reaction, resistance and exhausion. This is not inevitable - emotional 
habituation can also occur with reduction of the stress response. Not 
knowing when an event will occur also generates coping activity which 
decreases stress reactions. Ambiguity allows more individual 
characteristics to determine reaction to an event. The timing of
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stressful events in relation to the life cycle can also affect the way in 
which they are viewed by the individual affected. Normal life events can 
become stressful if they occur out of phase with the life cycle - they 
are usually unexpected and deprive the individual of the support of 
compatible peer’s, a complete sense of satisfaction and the opportunity to 
prepare for them. The timing of events in relation to other events can 
also alter their personal significance. Situational factors and 
individual factors always interact to produce the final response.
Studies of personal histories suggest that physical and emotional 
disorders tend to cluster around periods of major change in a person's 
life. Parkes found a mortality rate (mostly from cardiovascular disease) 
40$ high than expected for widowers observed for six months following the 
death of their wives. Studies using the Holmes and Rahe Scale have found 
a relationship between the number of stressful events and physical and 
emotional health. When the summed life-change units are between 200 and 
300 points over a period of a year more than 50$ of individuals have 
health problems the following year. If the summed scores exceed 300 this 
percentage goes up to 79$• The assumption is that the more critical the 
changes in individual experiences the greater the effort required to
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adapt. This effort presumably lowers the body's resistance to disease. 
However this explanation is over simplistic and does not 
account for all factors - it is difficult to separate the effects of 
stress from general health habits and to avoid the bias generated by 
individual variation in help-seeking behaviour when assessing the results 
of life-change studies on physical and psychiatric illness. Stress is 
only one factor amongst many others which interact to produce illnesses 
such as migraine. (147,148)
Both tension headache and migraine sufferers report an association 
between life stresses and their illness. Neither group reports an 
increase in major stressful life events compared to controls. Tension 
headache sufferers do report an increase in numerous, everyday minor 
stresses. However this could be a consequence rather than a cause of 
their condition. (17) In some studies up to two-thirds of migraine 
patients have cited emotional upset as a cause of their headaches and it 
has also been suggested that emotional factors become of greater 
aetiological significance as the frequency of attacks increases. (14 9)
The temporal relationship between stress and migraine is often less 
clear than that in tension headache. Stress-induced migraine may occur 
during the relaxation period after stress rather than during the height 
of the stress itself. This may partly explain the periodicity of 
migraine i.e. characteristically sufferers can have several weeks free of 
headaches and then have a number of headaches close together. However 
there may be other explanations for this e.g. the headaches may trigger a 
process which leaves the individual temporarily refractory to further
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episodes. (3 ) In addition migraine frequently reported to occur regularly 
at weekends rather than during the week whilst the patient is at work.
A link between a physical condition and everyday life stress has 
already been demonstrated in myocardial infarction. Massing & Angermeyer 
found that there was an increased mortality from myocardial infarction on 
Saturdays and Mondays in men aged between 25 and 55 years. This 
association was also found for non-fatal myocardial infarctions but was 
not seen in deaths due to cancer. (150)
Stress reduction can also decrease the mortality from ischaemic 
heart disease. In a randomised, controlled trial of a stress monitoring 
and intervention programme the treated group had a reduction in stress 
scores and deaths compared to controls although the rate and length of 
stay in rehospitalisation did not differ. (151 )
13*2 External stress and the hypothalamic-pituitary-adrenal axis
The body responds to increased physical or psychological demands by 
releasing adrenocorticotrophin (ACTH) from the anterior pituitary, 
glucocorticoids from the adrenal cortex, epinephrine from the adrenal 
medulla and norepinephrine from sympathetic nerves. These hormones 
activate the cardiovascular, energy-producing and immune systems and 
adapt the body to deal with stress. Prolonged stress produces 
compensatory changes in the activity of the catecholamine biosynthetic 
enzymes. Catecholamine concentrations in the plasma are generally 
considered to be a more precise measurement of stress-induced activation 
of the sympathetic medullary system than urinary measurements. Generally
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plasma norepinephrine levels indicate activity in the sympathetic nerves 
while epinephrine is a measure of secretion from the adrenal medulla. 
During harassment type A individuals (coronary-prone) have a greater 
elevation of plasma epinephrine than type B subjects (non coronary- 
prone). Depressed subjects also show increased basal levels of plasma 
norepinephrine and epinephrine which correlate with the extent of their 
anxiety symptoms. (1 52)
The release of ACTH is controlled by complex regulatory mechanisms. 
ACTH release is stimulated by the central release of the hypothalamic 
peptides corticotrophin releasing factor (CRF), cholecystokinin (CCK) and 
vasopressin which act directly on the anterior pituitary. Peripheral 
control is mediated by epinephrine and norepinephrine. ACTH stimulates 
the formation of glucocorticoids in the adrenal cortex. These in turn 
operate a negative feedback loop to the anterior pituitary, where they 
inhibit the release and synthesis of ACTH, and to the hypothalamus where 
they inhibit production of CRF, CCK and vasopressin. They simultaneously 
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Multihormonal control of ACTH release publishers.
Different neuronal circuits may be affected more by one type of 
stress than another.
The corticotrophs contain a number of second messenger systems.
They provide extracellular factors with a variety of ways to release 
ACTH. This seems to preserve the corticotroph's ability to produce ACTH 
even when desensitised to individual releasing factors. Chronic stress 
also seems to activate the gene for the ACTH precursor pro-opio- 
melanocortin. This may be a form of cellular memory. This type of 
cellular memory could be related to the physical ill health associated 
with prolonged stress. (153)
- 138 -
13*3 Circadian rhythms and the hypothalamic-pituitary-adrenal axis
In addition to being able to respond to external stress the 
hypothalamic-pituitary-adrenal axis has an internally generated rhythm. 
There is a circadian variation in plasma 17-hydroxycorticosteroid levels 
with an early morning peak followed by a downward trend during the day 
and a nocturnal trough. This is dependent on a circadian pattern in 
corticotrophin secretion rather than adrenal cortical responsiveness. 
Pathways from the rostral brain stem reticular activating system and the 
limbic system together with their hypothalamic projections partly control 
pituitary ACTH secretion. (154)
The human circadian system is controlled by at least two endogenous, 
self-sustained, coupled oscillators: a strong one controlling body 
temperature, REM sleep propensity and cortisol secretion, and a weak one 
controlling the sleep-wake cycle and sleep-related neuroendocrine 
activity. (155)
The circadian rhythm of cortisol release can be affected by:
(i) disease of the central nervous system,
(ii) pain,
(iii) affective disorder.
(i) Disease of the central nervous system
Krieger et al compared 48 patients with focal disease in the central 
nervous system with 47 normal subjects. They divided the former group
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into three subgroups:
(A) disease of the temporal lobe,
(B) disease of the pituitary,
(C) disease of other areas.
The circadian cortisol rhythm of groups (A) and (B) differed from 
(C) and from the normal control group. There was only a significant 
alteration in circadian 17-OHCS if there was central nervous system 
disease affecting the pretectum, the temporal lobe or the hypothalamus. 
Disease in these areas could interfere with the normal function of the 
regulatory pathways which control ACTH release. This alteration in the 
circadian rhythm could occur in the absence of overt clinical or 
laboratory evidence of endocrine dysfunction. Chronic illness, by 
itself, had no influence oh the pattern of circadian variation. It was 
uncertain whether the organism's ability to respond to stress varied with 
the phases of the circadian pattern and whether an abnormal circadian 
rhythm implied an abnormal stress response. (154)
Ziegler et al examined circadian rhythms of cortisol release in 25 
migraine patients (type of migraine unspecified) and eight controls.
They found little variation in plasma cortisol levels in control subjects, 
but a large disparity within the migraine group. Overall there was a 
positive association between pain and elevation of the plasma cortisol 
level. There was also a tendency for the group with abnormal plasma 
cortisol levels to have higher depression scores. Two abnormalities in 
circadian rhythms were found to occur in subgroups of the migraineurs:
(i) consistently high levels of plasma cortisol (ii) one or more aberrant 
high values occurring during the day. There was therefore heterogeneity
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within the patient group although unfortunately it is impossible to tell 
from the data presented whether this was related to the type of 
migraine. The abnormalities seen in migraine could be related either to 
an interaction between pain and depression or to primaiy hypothalamic 
dysfunction. (156)
(ii) Pain
Shenkin examined plasma cortisol levels in 16 healthy, 
unhospitalised controls and compared them with 66 patients who had 
objective evidence accompanying a complaint of pain and 45 patients who 
complained of pain without such evidence. The evaluation of pain and the 
determination of cortisol levels were performed independently. There 
were major differences in the patterns of cortisol secretion between the 
two groups with pain: 9 of the 66 patients (13»6$) with objective 
evidence of pain had normal mean levels of cortisol and normal diurnal 
patterns compared to 38 of the 45 patients (84*4$) without such evidence. 
The average values for the control group were similar to the 'no pain* 
group. The overall conclusion was that the determination of plasma 
cortisol diurnal variation could be used to discriminate between organic 
and non-organic pain with a 15$ range of error. It remains uncertain 
whether systemic and psychic stimuli have different effects on the stress 
response of the pituitary and adrenal glands. However, there is a good 
correlation between increasing levels of emotional stress and elevation of 
cortisol levels. (157)
In a different study Lascelles investigated 25 patients with pain 
complaints who had been referred for psychiatric assessment. This design
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immediately introduced bias into the sample and not surprisingly, when the 
total group was divided into a principally 'organic' and a principally 
'psychogenic' group, emotional problems were seen in both subgroups. All 
patients were taking some form of medication. Plasma cortisol levels 
were increased in both groups and this was greater if an organic lesion 
was present. The differences were most marked in the 9am blood sample. 
Both a painful organic lesion and psychological illness with pain were 
associated with a decrease in the diurnal variation of secretion. The 
patients studied formed a relatively intractable group suffering from 
pain due to chronic, but not progressive, illness. There were no clear 
cases of endogenous depression which could have inflated cortisol values. 
(158)
(iii) Affective disorder
Pour clinical features of depression suggest that circadian rhythm 
disturbances are involved in the disease:
(i) early morning wakening,
(ii) diurnal variation in symptom severity,
(iii) seasonality of the illness,
(iv) cyclicity of the illness.
The shift in the time of awakening suggests an abnormal phase- 
advance in the sleep-wake circadian rhythm. By contrast there is a delay 
in the 1 waking-readiness" rhythm. Together they imply an internal phase- 
displacement of the two rhythms. Depressive hospital admissions, 
electroconvulsive treatments and suicides occur most frequently in the 
spring. There may also be a secondary peak in autumn, although this is
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more controversial. Mania too has a seasonal variation in incidence 
although this is less clear cut.
Seasonal affective disorder is a recently described syndrome in 
which recurrent depressions begin at the same time each year. Generally 
they begin in autumn or winter and have remitted by the following spring 
or summer. Most patients have a bipolar affective disorder and their 
depressive illnesses are characterised by hypersomnia, overeating and 
carbohydrate craving. There is some evidence that extending exposure to 
natural light by using bright artificial light can have an antidepressant 
effect in this group. (159)
Affective illness tends to be recurrent. Halberg has suggested 
that long term cycles of relapse and remission could be the result of an 
abnormal relationship between two circadian rhythms if one of them was 
free running and slipping slowly inland out of phase with the other.
(155)
The circadian pattern of cortisol secretion is phase-advanced in 
depressives. The degree to which this occurs correlates with the 
severity of depression. The diurnal rhythmicity also appears to be 
reduced although this may be due to masking by the effects of sleep. In 
the dexamethasone suppression test (DST) there is hypersecretion of 
cortisol and resistance to negative feedback inhibition after 
administration of the synthetic steroid dexamethasone. Most 
investigators have found that 35-60$ of subjects with endogenous 
depression fail to suppress cortisol production after dexamethasone 
administration compared with 5-20$ of normal subjects or other
- 143 -
psychiatric patients. (160) It is more sensitive in psychotic affective 
disorder and mixed manic-depressive states. (161) This may be connected 
with the phase advance of the circadian rhythm in relation to sleep. DST 
non-suppression has been linked with endogenous-type depression, 
increased severity of depression and enhanced treatment response to ECT 
and antidepressants. The abnormality usually disappears on clinical 
recovery; if it does not do so the risk of relapse is thought to be 
increased. (155>162) The use of the DST in the diagnosis of depression is 
limited by its lack of specifity. No-one knows why half the patients with 
endogenous depression show hypothalamic-pituitary-adrenal (HPA) axis 
dysfunction whilst the other half do not. Cortisol is thought to be 
under stimulatory control by ACTH but ACTH and cortisol concentrations 
are not directly correlated following dexamethasone administration. Thus 
changes in ACTH cannot be the only cause of the non- suppression seen in 
endogenous depression. The pituitary peptides y^-EP and j3-LPH also show a 
circadian rhythm, similar to that of ACTH, which is suppressable by 
dexamethasone. This rhythm can escape suppression in patients with 
endogenous depression but does not necessarily co-vaiy with cortisol 
escape. Using estimation andy^-LPH together with cortisol could
improve the reliability of the DST in major depression. Used together 70$ 
of patients with endogenous depression have evidence of abnormal HPA 
function. (160,162)
Curtis et al examined the relationship between different levels of 
emotional arousal and the circadian rhythm of cortisol secretion. They 
selected two groups of psychiatric inpatients on the basis of the degree 
of affect they displayed - the high affect group had intense emotion 
which was sustained virtually all day every day and the low affect group
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had no overt emotional arousal and no exaggeration of their emotional 
responses to everyday situations. They were matched with hospital 
employees who were felt to he 'well balanced' and without major external 
stresses. All selections were made subjectively but correlated 
positively with psychological test results for anxiety and mood. 
Unfortunately it is uncertain whether or not the psychological ratings 
were made blind to the affective status of the individual. The 
inpatients were mainly schizophrenics. There were only two patients 
with a diagnosis of psychotic depression - one in the high affect and 
one in the low affect group. Both plasma and urinary corticosteroid 
levels were highest in the high affect group and lowest in normal 
subjects. There was a sex difference in both the absolute values and the 
diurnal trend - both of which were higher in men than women. The high 
affect group was most variable and the low affect group least variable 
for plasma and urine steroid values. The overall conclusion was that 
although adrenal cortical function was slightly increased in states of 
emotional stress this effect was overshadowed by the sex difference which 
was stronger and more consistent. (1 63)
13*4 Summary
Stress is inevitable and a certain amount is essential for normal 
functioning. The physiological stress response is mediated by the 
autonomic nervous system. There are considerable problems in assessing 
the emotional response to a stressful event as this is as much determined 
by individual variables as the characteristics of the event itself. Both 
tension headache and migraine sufferers report more minor, everyday 
stresses than controls. The temporal relationships between these
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stresses and the headache is less clear in migraine patients. Reducing 
the amount of stress can affect the outcome of disease processes.
The anterior pituitary, the adrenal cortex and the sympathetic 
nerves are all involved in stress responses. This is a complex system 
which may he involved in the production of stress-related physical and 
psychiatric illnesses. Central nervous system disease affecting the 
pretectum, the temporal lobe or the hypothalamus can influence circadian 
rhythms of 170HCS excretion. Circadian rhythm disturbances are also 
found in migraine, pain and depression. A normal level of emotional 




Endorphins and their relationship with pain and psychiatric disorder
The endorphins are a family of structurally-related peptides which 
are formed in nerve and endocrine tissues and which have an affinity for 
opioid receptors. Their complexity, in terms of structure, function and 
tissue distribution, is such that there is no simple relationship between 
any one physiological variable and 'endorphinergic' activity. (164) 
Endorphins mediate their effects through a Ja. (mu) receptor which can 
produce analgesia and euphoria, receptor sites predominate in regions 
which regulate nociception (such as the spinal cord, midbrain or
thalamus). The k  (kappa) receptor may be involved in the regulation of 
sedation and sleep, different types of analgesia and dependence whereas
(165) There may be cross-reactivity between naturally occurring opioids 
and their multiple receptors. This confounds efforts to determine 
whether any one peptide system is more likely to be involved in pain 
regulation than another. (166)
The two main approaches to the assessment of endorphinergic activity, 
in humans:-
(1) administration of selective agonists and antagonists e.g. naloxone,
investigation of endorphin activity in relation to pain in human subjects.
the cY  (sigma) receptor may be involved in dysphoria and hallucinations
which selectively b l o c k s K  and This can be used in the
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(2) laboratory techniques e.g. peptide and receptor assays and 
investigation of endorphin synthesis and degradation.
Lumbar cerebrospinal fluid is the material most often used for 
assays. Endorphins are also produced by tissues outside of the CHS, e.g. 
adrenal medulla, and therefore the endorphin content of plasma does not 
directly reflect CNS activity. The CSF can be viewed as an expansion of 
the extracellular fluid of the brain. The CSF endorphin content may 
therefore be more closely related to CNS function. Endorphins are also 
stable in CSF for reasonably long periods of time. (164)
Anatomical, physiological and clinical studies have shown that the 
brain has an endogenous pain inhibitory system which operates by 
activating controls which descend from the brain stem to the spinal cord. 
The highest concentrations of opiate receptors in the brain have been 
found in the amygdala and ^periaqueductal gray area, the medial thalamus 
and hypothalamus. The substantia gelatinosa of the spinal cord is also 
rich in opiate receptors. This antinociceptive system is intrinsically 
activated by terror, rage, sexual excitement and violent pain and can 
also be extrinsically activated by direct electrical stimulation and the 
administration of opiate drugs. (1 67)
14.1 Stimulation-produced analgesia
Stimulation of specific sites in the brain may lead to reduced 
responsiveness to pain. The fact that this is reversible by naloxone and 
cross tolerant with morphine suggests that opioid involvement plays a 
critical part in the phenomenon. Non-opioid systems are also involved to
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a lesser extent. Pain relief is accompanied by both an increase in 
enkephalin-like material and increased ^ -endorphin immunoreactivity in 
the CSP. (166)
14»2 Stress-induced analgesia
Analgesia is an adaptive response to acute stress e.g. inescapable 
footshock in rats. This is partially reversible by naloxone. The effect 
is an interaction between the duration and the constancy of the shock. 
(168) Trivial (i.e. acute, localised and mild) stimuli do not activate 
opioid mechanisms. (169) Repeated daily exposure to stress leads to 
further adaption. Eventually further stress no longer produces 
analgesia. This is accompanied by an increase in endogenous opioids. 
Hypothalamic endorphin content is decreased, possibly due to release of 
its stores during stress. (167)
Analgesia can also be produced by psychological stress e.g. learned 
helplessness. This paradigm has also been used as a model for 
depression. Stimuli indirectly associated with an aversive event, e.g. 
the smell of shocked rats, can activate the endogenous opiate system in 
unshocked animals. (168)
Stress-induced analgesia (S.I.A.) activates both opioid and non­
opioid systems. Short durations of stress induce non-opioid analgesia 
whereas longer durations induce opioid analgesia. The type of analgesia 
can be determined by the part of the body being shocked - it is possible 
that pain inhibition induced by shock recruits both local circuits, which 
may not be opioid in nature, as well as more central, partly
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endorphinergic, circuits.
Stress appears to activate the hypothalamic-pituitary-adrenal axis 
of the peripheral sympathetic system leading to the release of endogenous 
opioid peptides from "both the anterior pituitary and the adrenal medulla, 
y^-endorphin and ACTH are secreted together by the anterior pituitary. 
Administration of dexamethasone inhibits the release of both ACTH and 
^-endorphin but does not abolish S.I.A. Elevation of the plasma 
^-endorphin level is not always correlated with analgesia e.g. chronic 
daily stress leads to the loss of S.I.A. but still produces elevated 
plasma endorphin levels. In acute stress endorphin synthesis is 
initially increased but then returns to normal. Analgesia diminishes 
despite high plasma endorphin concentrations. As either no, or total, 
analgesia would be equally inappropriate opioid and non-opioid pain- 
relieving systems probably act to set the level of pain perception in 
situations of potential or actual acute pain. (167)
Psychological factors also influence endogenous opioid production 
e.g. in placebo analgesia. Approximately one in three people given 
placebo medication will obtain significant pain relief. The mechanism 
is similar to narcotic analgesia, at least to the extent that both 
manifest tolerance, a compulsion to continue with, and increase the dose 
of medication and an abstinence syndrome when the medication is suddenly 
withdrawn. A placebo can also partially reverse withdrawal symptoms in 
narcotic addicts. Patients who respond to placebo gain increased relief 
from narcotic analgesics post operatively. In a randomised double blind 
study of dental post operative pain in which patients received morphine, 
naloxone or placebo, patients on naloxone had more pain than those on
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placebo. When naloxone was subsequently given to the placebo group there 
was no change in the status of placebo non-responders but placebo 
responders had more pain. The results suggest that endorphin release 
mediates placebo analgesia. (170) Part of the variation in pain intensity 
in patients with similar lesions could be due to differences in endorphin 
activity. This is consistent with results from studies of on-demand 
post-operative pain relief in which patients themselves control the rate 
of narcotic infusion. There is an inverse relationship between the 
steady state level of analgesic in the CSP and the preoperative CSF 
endorphin level. (171)
14.3 Opioids and control of blood pressure
Morphine and other opiate alkaloids have potent cardiorespiratory 
effects. Opioid peptides and their receptors are present in brain areas 
involved in control of the cardiovascular system as well as the heart 
itself.
There are three main sites where endogenous opioids could influence 
blood pressure control:-
(i) the vagal-solitary complex in the medulla,
(ii) the anterior lobe of the pituitary,
(iii) the sympathetic nervous system.
The sympathetic nervous system seems to be mainly responsible for 
the cardiovascular effects of opioid peptides. The vagus may play a 
subsidiary role but vasopressin does not seem to be important. (172)
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There may be an interaction between blood pressure control and 
nociception. Significant correlations have been found between changes in 
blood pressure and the response to pain. Stress-induced analgesia has 
been linked to respiration and stress-induced hyperglycaemia. (166)
14-4 Endogenous opioids in migraine
The endogenous opioid system controls pain, hedonia and 
neurovegetative systems. The anhedonia, autonomic disturbance and pain 
in migraine closely resemble the symptoms of morphine abstinence (172, 
173). The movement of pain from one side of the head to the other and to 
different regions within the head, the episodic nature of migraine and 
physiological and environmental influences on it are all suggestive of a 
chemical basis which involves neurotransmitter dysfunction. The pain 
has the characteristics of central pain, i.e. it is poorly localised, it 
has affective colouration, it outlasts the stimulus, and anaesthesia or 
paraesthesia are present. (172) Pain which comes from the vascular 
architecture emerges only when the local pain threshold is decreased. 
Centrally mediated hypernociception implies dysfunction within the pain- 
suppressing system. In migraine inhibition of the release of substance P 
from the trigeminal ganglia by enkephalinergic neurones may be involved 
in the production of pain. (174)
Morphine is a surprisingly poor analgesic in migraine. This suggests
that:
(1) there is under sensitivity of opiate receptors,
(2 ) there is a failure of serotoninergic function (since serotonin 
appears necessary for morphine to achieve its analgesic effect),
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(3 ) there may he a deficiency in both systems. (174)
Half of central pain sufferers have a poor or absent response to 
inhibition of 5HT-mediated venospasm with morphine. This supports a 
possible reduction in opiate receptor sensitivity in central pain. (174)
Postreceptoral supersensitivity (PRSS) is a condition of exaggerated 
cellular reaction due to an increase in intrinsic potential. This is 
mainly because of an elevation in the energy of a second messenger. PRSS 
is found in both non-organic central pain and morphine abstinence. In 
non-organic central pain deficiency in the endogenous opiate system may 
produce neuronal leakage of neurotransmitter into the synaptic cleft of 
the endorphin-dependent neurones. The neurone is left empty and this 
leads to an adaptive PRSS. (174)
The results- of studies which look at 'morphine-like factors' in 
migraine conflict although there is general agreement that the 
concentrations of these factors in the CSF return to normal during 
headache-free intervals. Interpretation of results is confounded by:
(i) the use of differing diagnostic criteria,
(ii) small numbers of patients in trials,
(iii) differences in the sensitivity, specificity and reproducibility of 
the techniques employed. (176)
The main endogenous opioid implicated in migraine is y^-EP. Both 
y^-EP and ACTH are synthesised from pro-opio-melano-cortin (POMC). One 
study found no difference between EP and ACTH levels during and between 
migraine attacks in patients with either classical or common migraine.
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However, there was a trend towards increased y^-EP levels during attacks 
and a positive correlation betweeny^-EP and ACTH during attacks but not in 
headache-free periods. On the basis of this study alone it is uncertain 
whether the increase in ^-EP release was involved in antinociception or 
simply part of a general stress response. There were methodological 
problems in the study which should be taken into account when assessing 
the results - the criteria for common migraine were fairly wide and could 
have led to the inclusion of some patients with tension headache, there 
was a higher frequency of headache in the common migraine group and the 
duration of the headache free interval was a minimum of only three days. 
(175)
Other researchers with larger groups of patients and looking at only 
headache-free periods have found that plasma concentrations ofy^-EP in 
chronic daily headache and common migraine were similar to those of 
controls. By contrast the plasma concentrations of y^-EP in classical 
migraine were significantly reduced. (177,178) These results could not 
be replicated in later studies e.g. Genazzani et al found that there 
was a progressive reduction in CSF y^-EP levels from healthy controls 
through common migraine sufferers to patients with continuous migraine 
with interparoxysmal headache who had the lowest levels of all. These 
changes were independent of ACTH levels. (16)
The evolution of migraine throughout life and its improvement in 
pregnancy and impairment at the menopause correlates with changes in 
y^-EP which increases in pregnancy and decreases at the menopause. This 
has led to the hypothesis that the non-organic central pain of migraine 
is due to decreased activity in the neurones responsible for the CSF
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content of ^-EP. (16)
Idiopathic headache sufferers are particularly sensitive to 
hallucinogenic drugs which are chemically related to 5HT. Frank 
hallucinations can he provoked in migraineurs by doses which are not 
hallucinogenic in controls. Pentazocine is especially poorly tolerated 
and patients complain of disagreeable dysphoria, depersonalisation and 
frank hallucinations more often than non-headache controls. Pentazocine 
acts mainly on the opiate receptors. By implication both the 
antinociceptive system and opiate receptors are involved in the 
production of hallucinatory experiences. Migraine may be a genetic 
disorder of the central peptidergic (enkephalinergic and endorphinergic) 
neurones and of serotonergic-dopaminergic neurons. This would result in 
both pain and functional disorder (nausea, vomiting, oliguria, dysphoria 
and hallucinations). (172)
Clonidine, B.-&0L 2 adrenergic stimulant, has been used in the 
treatment of opiate withdrawal and migraine. It acts principally on the 
locus coeruleus. Endorphins inhibit the release of norepinephrine and 
other amines at this site. The link between amines and endorphins in 
migraine could be a sudden loss of endorphin inhibitory tone due to a 
sudden decrease in the CSF endorphin concentration. This would lead to 
an overflow of amines, especially norepinephrine, causing the initial
prodromal phase of vasoconstriction. Clonidine could act at this point by
/
counteracting the norepinephrine overflow. The successive vascular 
phenomena and the pain depend on the release of vascular-activating 
amines and humoral factors (histamine, prostaglandins, bradykinin) which 
produce vascular dilation and perivascular oedema, mainly in the
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extracranial vessels. (179)
Primary headache disorders border on both ischaemic cerebrovascular 
disease and affective disorder. Pro-opio-melanocortin (POMC) peptides 
are involved in pain perception, adaptation to stress and modulation of 
higher brain functions such as learning, drive and mood. Nappi et al 
looked at a variety of different groups of headache sufferers, although 
unfortunately they did not include subjects with uncomplicated classical 
migraine. Using the Hamilton Rating Scale for Depression (HRSD) an 
increased incidence of mild depression was found in patients with 
migraine with interval headache (MIH) and chronic tension headache (CTH) 
(HRSD scores 14-21). Common migraine (CM), cluster headache (CH) and 
psychogenic headache (PH) groups all scored as non-depressed. Using the 
MMPI patients with CM and CH had normal profiles whilst there was a 
progressive increase in hypochondriasis, depression and hysteria in the 
MIH, CTH and PH groups. In a study of patients with neurotic and major 
depression which was carried out at the same time both groups had 
elevated plasma endorphin levels. ACTH levels were increased only in the 
patients with major depression and cortisol levels were elevated in both 
groups. These values were all greater than those in all groups of 
headache sufferers.
Approximately 50$ of patients with acute endogenous depression have 
a diminished ability to suppress cortisol secretion after the 
administration of dexamethasone. Patients with daily chronic headache 
are sometimes considered to have a somatised equivalent of a depressive 
state. However, the rate of dexamethasone non suppression in these 
patients is only slightly greater than that in healthy, and much the same
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as that found in neurotically depressed, individuals. This suggests that 
the underlying pathology for this group is different from that underlying 
acute endogenous depression. The dexamethasone suppression test (DST) is 
also unable to discriminate between different types of daily chronic 
headache. Prolonged dexamethasone administration over four days causes 
suppression of plasma levels of^?-EP,^-LPH and cortisol levels in healthy 
volunteers. Neurotic depression causes diminished/^-EP levels. In DCH,
i
^S-EP, -LPH and cortisol are all suppressed.
5HT and acetylcholine (Ach) both enhance pituitary POMC-related 
peptide secretion. There is also a tonic dopaminergic inhibition ofyjf-EP 
secretion. Adrenergic pathways could also be involved in the control of 
resting levels ofy^-EP and related peptides. y^-EP levels are reciprocally 
related to the frequency of migraine attacks. There is uncertainty as 
to whether this reflects opioid deficiency or increasing pain. Similar 
results are found in patients with continuous tension headache. In 
cluster headache, although plasma concentrations o f A C T H  and 
cortisol are normal the circadian rhythms of their secretion are 
disorganised with a delay in acrophase. Chronic pain seems to be 
accompanied by reduced function of endogenous opioid. There is integrity 
of the hypothalamic-pituitary-adrenal axis in most headache sufferers.
(1 SO) A small additional study by the same author attempted to examine 
the relationship between pain, affective disorder and CSF/?-EP levels. In 
a comparison of patients with migraine with interparoxysmal headache, 
major depression, both conditions simultaneously and normal controls,
^  -EP levels were reduced in migraineurs but not patients with major 
depression or healthy controls. In patients with both migraine with 
interparoxysmal headache and major depression there was a significant
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further reduction in p - W  levels. This suggests that y^-EP is concerned 
with chronic pain independently of affective state - however the numbers 
of patients involved were very small and these results cannot be regarded 
as conclusive. (1 81)
Sicuteri has grouped the relationships between emotion and 
headache under four main headings:
(1) headaches may disappear after unexpected strongly-felt emotions,
(2) headaches often occur after psychic tension e.g. 'weekend' headache,
(3 ) headaches increase concomitantly with increased 'routine' emotion,
(4 ) the headache history may start after long-lasting stress and repeated 
episodes of anxiety, especially if there is repressed aggression.
The antinociceptive system is activated mainly by intense emotion. 
The increase in the pain threshold in emotionally stressed animals 
supports the hypothesis that pain may be reduced or prevented by 
psychogenic activation of the antinociceptive system. The 'weekend' 
headache may be due to stopping daily emotional stimulation of the 
analgesic-providing system. The immediate increase in headache with 
increased routine emotion may be due to increased sensitivity to 
emotionally induced vasomotor reactions. Repetitive life stress should 
enhance the function of the antinociceptive system and this should result 
in adaptation to the stressful situation. However, if the system is 
vulnerable it may fail with hyperalgesia and pain as a consequence. (182)
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14*5 Endorphins, Mood and Pain
All pain syndromes have both a somatic and a psychic component. In 
a study comparing affective disorder (both primary and secondary 
affective disorder as defined by Research Diagnostic Criteria), organic 
pain, non organic central pain and a control group there was increased 
pituitary adrenocortical function and decreased DST suppression in the 
affective disorder group compared to the others. This was shown by 
increased cortisol and ACTH levels in primary affective disorder and a 
gradient ofy6 -EP andy$-LPH levels. These were highest in secondary affective 
disorder, intermediate in primary affective disorder, and least in 
controls. y^-EP and y$-LPH levels were decreased in patients with daily 
chronic headache.
The differing patterns of ACTH and opioid levels in secondary 
affective disorder patients compared to those with primary affective 
disorder implies that the increased levels of ^ -LPH and^-EP are not 
sustained by the same mechanism in the two conditions.
The normal levels ofy$-EP and /?-LPH in organic pain and the impaired 
levels in daily chronic headache suggest that impaired y^-EP secretion 
may be linked to headache production. (182)
Almay et al compared 37 patients who had pain of greater than six
months duration with 19 healthy volunteers. The pain patients were a 
series of consecutive admissions to a neurology inpatient unit and were
separately evaluated by a neurologist and a psychiatrist. The whole
group was then divided into patients with mainly organic pain and
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patients with predominantly psychogenic pain. Unsurprisingly the 
inclusion and exclusion criteria were stronger in the organic than the 
psychogenic group. Endorphins were estimated in CSF samples using a 
standard fractionation procedure.
There was no significant relationship between Fraction 1 and the 
duration of pain for the group as a whole but in the organic group there 
was a significant negative correlation between the two variables. There 
was no significant correlation with the severity of the pain. Depressive 
symptomatology was closely related to Fraction 1 endorphin concentrations 
- there were significant correlations with:-
(i) the total comprehensive psychopathological rating scale (CPRS) score,
(ii) the total score of reported items,
(iii) the total score of observed items,
(iv) the reported item ’depressed mood',
(v) the observed item 'depressed mood'.
These were seen in both 'organic' and 'psychogenic' pain patients. The 
depression scores were slightly higher in the psychogenic than in the 
organic pain group. Patients with organic pain, especially those with 
clear positive signs of peripheral nerve lesions, show lower levels of 
Fraction 1 than patients without lesions. (183)
14.6 Endorphins in Affective Disorder and Schizophrenia
There have been several reports of decreased pain sensitivity in 
psychotic patients. These predate the advent of phenothiazines and 
antidepressants and are inexplicable on the grounds of a drug effect 
alone. There has been speculation that either the meaning of pain is
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lost in these patients or that there are excessive levels of circulating 
endogenous opioid peptides. (184)
Opium was extensively used as a cure for agitated depression at the 
beginning of this century. (185) Exogenous opiates alleviate anxiety and 
produce euphoria suggesting a link between endogenous opioids and. 
affect. Work on psychiatrically normal populations has suggested that 
endogenous opiods may be involved in the modulation of mood and feelings 
of wellbeing. Endorphin deficiency may be involved in the production of 
endogenous depression. (186) Synthetic ft -EP has psychoactive properties 
when administered to depressed patients and results in transient 
improvements in overall performance although not in ratings of individual 
items of behaviour. The response is almost immediate leading to 
speculation thaty3-EP may be involved in the 'on-off switch' mechanism of 
affective disorder. (187»188)» Elevated endorphin levels, particularly 
Fraction 1, have been found in manic-depressive patients. Fraction I 
levels correlate with measures of depression, especially with depressive 
hallucinatory episodes. (168) Naloxone has also been reported to reduce 
manic symptoms. However the numbers of patients in these studies have 
been very small. (188,189) A decreased sensitivity to somatosensory pain 
has been noted in a small proportion of depressed patients. These 
patients may form a subgroup with raised levels of endorphin-like 
compounds. (188,190) Physostigmine infusion can produce depressive 
symptoms in patients with a past history of depression. It also has 
antimanic properties. These depressive mood changes are significantly 
correlated with increased plasma j8-EP levels but not with peak cortisol 
levels. This suggests a cholinergically-mediated y$-EP pathway within 
which increased activity could cause depressive symptoms. (190)
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There is controversy over whether^-EP activity is increased or 
decreased in schizophrenia. This is likely to be a consequence of
(1) diagnostic variation in the patients in different studies,
(2) concomitant medication,
(3 ) the use of single blind and open studies as well as double blind 
designs,
(4 ) small sample sizes,
(5) different subgroups of patients e.g. both acute and chronic illness 
included in an apparently homogeneous sample. (188)
Initial reports of increased levels of leucine-5-y^-endorphin in 
schizophrenia have not been replicated. Increased plasma endorphin 
levels have also not been found consistently. Although some studies of 
the use of naloxone have reported decreases in psychotic symptoms, 
especially auditory hallucinations, not all reports agree. Double-blind 
administration ofy^-EP worsens schizophrenic symptomatology. (188) 
Endorphin levels vary markedly in acute and chronic schizophrenia e.g. 
one study found levels ten times higher than those of controls in acute 
schizophrenia and 30% less than controls in chronic schizophrenia. (191) 
Elevated Fraction 1 levels in 'symptom rich' patients (i.e. those with 
florid illnesses despite several months hospitalisation) returned to 
normal values or slightly above following treatment with neuroleptics or 
propranolol. The Fraction 1 levels decreased in parallel with clinical 
improvement in four out of six patients who responded to medication.
(189) There are two possible hypotheses to explain the involvement of 
brain opioids in schizophrenia:
(i) increased activity of either normally or abnormally functioning
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endorphins,
(ii) certain non-opioid, ^ -endorphin derivatives have neuroleptic 
properties and these may be defective in schizophrenia.
Somatic treatment methods (e.g. electroconvulsive therapy and 
insulin coma treatment) result in the mobilsation of endorphins and this 
may be relevant to their efficacy in both depression and schizophrenia. 
(186)
14*7 Summary
(1) The endorphins are a group of structurally related peptides with an 
affinity for opioid receptors.
(2) Stress activates the hypothalmic-pituitary-adrenal axis causing the 
release ofy5-EP and ACTH together from the anterior pituitary.
(3 ) The sympathetic nervous system is mainly responsible for the 
cardiovascular effects of opioid peptides.
(4 ) The anhedonia, autonomic nervous system disturbance and pain found in 
migraine are very similar to the symptoms of morphine abstinence.
(5) The sensitivity of migraineurs to the hallucinogenic effect of drugs 
which affect both 5HT and ^  opiate receptors suggest that both amine and 
endorphin systems are involved in this condition.
(6) Endogenous opioids are important in the modulation of pain.
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(7) There is no clear relationship between endorphins and schizophrenia 
or major depressive illness.
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^ CHAPTER 15
Pain, depression and migraine
15*1 Psychogenic and somatogenic pain
A dualistic approach to psychogenic and somatogenic pain encounters 
the major problem that both feel that same. This can be resolved by a 
description of the pain in either psychological or physical language or 
both depending upon which option appears most helpful to the individual 
patient. Psychogenic pain thus implies a pain which is better 
understood in psychological than in physical language.
There are no significant differences in psychological test scores 
between psychogenic and somatogenic pain. One study used the MMPI in 
a medical outpatient department and compared patients who complained of 
pain with those who had other physical complaints -
(1) depression was less frequent and hypochondriasis more frequent in 
patients with pain than in those without,
(2) all patients had neurotic patterns in which hypochondriasis and 
depression were significant features. Patients with pain had a 
significantly greater degree of hypochondriasis than those without.
These results have been replicated repeatedly. This has led several 
authors to postulate that pain may be substituted for anxiety and 
depression. Some people appear to find pain less distressing than 
these emotions. This group has a greater use of somatisation, 
denial and repression as defenses.
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Merskey examined 100 psychiatric patients with pain complaints of 
greater than three months duration and compared them with 65 patients 
without pain. He found a greater percentage of neurotic conditions, 
especially hysteria, among the pain patients.
Sternbach compared the MMPI profiles of two groups of patients 
admitted to a low-back pain clinic. One group had physical findings on
examination and the other group did not. He found an equal incidence of
hypochondriasis and depression in both groups.
The overall conclusion is that people with psychogenic pain tend to 
be neurotic and in this respect do not differ much from those with
chronic pain of organic origin. (46)
15.2 The relationship between pain and depression
Pain is frequently found as a symptom in depression and depression 
often occurs secondary to chronic pain. Diamond, in a study of 423 
patients with various types of depression, described complaints of 
headache in 84$« Lesse, in a similarly uncontrolled study of 324 
depressed patients found that 31$ had physical complaints rather than low 
mood as their main presenting symptoms. (46) This is in agreement with 
the incidence of 'masked depression ' described by other authors e.g. 
Kreitman found that only 21 of 120 cases of masked depression were
diagnosed as such despite the fact that 25$ of them had previous overt
psychiatric illness. This is important for two reasons
(1 ) Incorrect diagnosis leads to a delay in psychiatric referral - in one
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series 84$ of patients had been ill for more than 1 year, 69$ for more 
than 2 years and 30$ for more than 5 years. The prognosis worsens 
with increasing delay in receiving antidepressant treatment.
(2) As two-thirds of patients with masked depression have suicidal ideas 
the illness may require urgent treatment by the time the psychiatrist is 
involved. (192)
Cassidy compared 100 severely depressed manic depressive patients 
with several control groups. A complaint of pain indicated illness but 
this was as likely to be physical as psychiatric. Merskey & Spear 
assessed 200 consecutive admissions to a psychiatric clinic and found 
that pain was a symptom in 33% • Depression was the most common diagnosis 
(42*5$) and pain occurred in 56$ of the depressed patients. In general 
medical practice Baker & Merskey described pain in 64$ of a consecutive 
sample of patients. Sixty-six per cent of the patients with 
predominantly physical problems had pain complaints compared with 59$ of 
those with predominantly psychiatric conditions.
The main components of depression which emerge from factor analysis 
of rating scales for depression are:
(1) subjective misery,
(2) overconcern with physical health,
(3 ) a general complaining neurotic or irritability factor.
There seems to be an important hypochondriacal element in 
depression, particularly reactive depression with environmental 




(2) loss of interest,
(3) hypochondriacal complaints,
(4 ) depression which is accentuated in the evening,
(5) a persistent response to environmental precipitants.
These patients manipulate others by expressions of dependency, but 
resist outside influences. They are unwilling to please those around 
them and their behaviour both expresses anger and attempts to get support 
and concern from others without incurring the responsibility for 
reciprocating. (46)
In summary a complaint of pain occurs in slightly more than half the 
general medical and psychiatric populations and in psychiatric 
populations the presence of a pain complaint is equally likely to predict 
anxiety, hysteria or reactive depression.
1 5*3 Antidepressants and pain
In a study of 196 private patients with unipolar depression Lindsay 
& Wyckoff demonstrated that 59$ had chronic benign pain of greater than 
three months duration. When treated with antidepressant medication 83$ 
obtained significant relief of their pain syndromes. (193)
Bradley studied the response to antidepressant treatment in two 
groups of patients - 16 whose pain preceded their depression and 19 whose 
pain and depression occurred together. In the first group only the 
depression responded to treatment but there was increased tolerance for
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the pain. In the second group both the pain and depression were relieved 
together.
Antidepressants are useful in the treatment of chronic pain. There 
is some dispute over whether the length of time taken to relieve pain is 
less than the length of time generally required for antidepressant 
efficacy. Tricyclic antidepressants may have direct antinociceptive 
properties. Their analgesic effect is apparent even when there is no 
evidence of depression. They have been used to treat chronic pain states 
such as migraine, facial pain, trigeminal neuralgia, arthritis and 
metastatic carcinoma amongst others. The response rates for these 
conditions vary between 44-78$ (average 62$). The site of the pain has 
no effect on the likelihood of obtaining a good response to treatment.
The relationship between pain and depression is uncertain.
Depression may be:
(1) a psychological consequence of pain,
(2) part of a reverberating circuit between pain and depression,
(3 ) one aspect of a psychobiologic disorder which underlies both 
conditions.
There is a monoaminergically-mediated pain - inhibitory mechanism 
which is located in the mesencephalic ventral central gray area.
Increased levels of 5-HT increase analgesia whereas increased levels of 
norepinephrine decrease it. Dopamine potentiates analgesia to a greater 
extent than norepinephrine. The relationship between pain and depression 
may lie in the balance of brain monoamines. The enkephalins are also 
important as inhibitory neurotransmitters in pain appreciation. They are
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found in the periaqueductal gray substance, the nucleus raphe magnus, the 
locus coeruleus and the substantia gelantinosa of the spinal cord. This 
distribution closely follows nociceptive pathways. As both the 
periaqueductal gray substance and the nucleus raphe magnus have high 
concentrations of 5-HT and the locus coeruleus has a high concentration 
of norepinephrine it appears that affective and nociceptive pathways 
overlap. This may explain the coincidence of pain and depression and the 
response of chronic pain to antidepressant medication. This presupposes 
that chronic pain and depression are both neurotransmitter deficiency 
disorders and that antidepressants restore 5-HT, norepinephrine and 
enkephalin levels to normal. Interaction between the biogenic amines and 
the enkephalins is thought to take place via mutually interacting 
feedback loops at midbrain, medullary and spinal cord levels. (4 6,193)
15*4 Summary
(1) Both psychogenic and somatogenic pain are associated with increased 
neuroticism.
(2) Anxiety, hysteria and reactive depression are all associated with 
pain complaints.
(3 ) Pain may be a symptom of reactive depression and depression may be
a reaction to chronic pain.
(4 ) Depression masked by somatic complaints is underdiagnosed. Early 
treatment with antidepressant medication improves the prognosis.
(5 ) The response to antidepressant medication is good - especially
if the onset of depression preceded the pain. However even if
the reverse is the case treating the depression can still increase 
the tolerance of the pain.
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(6) Some characteristic behaviours in reactive depression can cause 




The influence of ovarian hormones on migraine
16.1 Migraine - its relationship with menstruation, pregnancy 
and the menopause
Although a variety of hormones have been linked with migraine the 
marked female preponderance in the condition following puberty has 
focussed attention on the role of the reproductive hormones.
Various authors have suggested that approximately two-thirds of women 
associate the periodicity of their migraine with the phases of their 
menstrual cycle. Most have an increased incidence of migraine just prior 
to or during menstruation. Ovulatory migraine is much less common. (194- 
6). However, in a clinical survey of 138 menstruating women with 
migraine, Epstein and Hockaday found that true menstrual migraine 
confined to just before or during menstruation was rare, affecting only 
14$ of the patients. Menstrual migraine was associated with the onset of 
migraine at the menarche, weight gain and breast discomfort around the 
time of menstruation and improvement during pregnancy. (19Y) Although it 
has been claimed that only common migraine is menstrually- related this 
does not accord well with clinical experience.
Nattero performed a chi square analysis on data from 720 female 
migraineurs and defined two populations with menstrual migraine and non- 
menstrual migraine. These populations differed statistically with regard 
to family background, history of headache, premenstrual stress,
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relationship with menstruation and pregnancy, pattern, frequency and 
duration of headaches, topography (unilateral, bilateral and radiation of 
pain), site and accompanying symptoms. (194) However, although Epstein 
and Hockaday found that plasma levels of oestrogen and progesterone were 
significantly increased in migraine patients compared with controls there 
were no significant differences in hormone levels between the menstrually- 
related and non-related groups. There is, therefore, no evidence that 
absolute levels of reproductive hormones are responsible for the 
differences between the two groups of migraine patients. (197)
Nonetheless in a subgroup of migraine patients the reproductive 
hormones are closely associated with the development of migraine. The 
fact that the premenstrual and menstrual phases of the cycle are most 
commonly involved has suggested a relationship with falling levels of 
oestradiol and progesterone. Normally these hormones decrease 
synchronously. Somerville manipulated hormone levels by separately 
administering progesterone and oestradiol to migrainous women and normal 
controls and prospectively observing the relationship between 
progesterone and oestradiol levels and the occurrence of migraine. He 
concluded that withdrawal of oestrogens, rather than progesterone, 
during the premenstrual phase was more likely to precipitate migraine. 
(198,199)
In Epstein and Hockaday's survey 66% of women reported improvement 
during pregnancy. This accords fairly well with the results of two other 
studies which gave rates of 50$ and 77$ respectively. (200,201) In 
the second of these studies Somerville found that the majority of women 
had relief of their migraine during the second and third trimesters but
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could have an exacerbation in early pregnancy. He related this to 
fluctuating progesterone levels. (201) Migraine can arise for the first 
time during pregnancy - usually in the first trimester. Callaghan and 
Somerville differ in their estimates of the frequency with which this 
occurs - probably because of different diagnostic criteria for 
migraine and confusion with non-migrainous vascular headaches. (200,
201).
There is little evidence that migraine decreases in frequency after 
the menopause. (197) Hormone replacement therapy can exacerbate 
migraine. This can be obviated to a great extent by using a low dose of 
oestrogen continuously rather than by cyclical administration. (202) 
Several days exposure to high oestrogen levels appears to be necessary 
before oestrogen withdrawal precipitates migraine.
16«2 Oestrogen and the sympathetic nervous system
Oestrogen may increase the sensitivity of the blood vessels to other 
factors. This is likely to be independent of progesterone. Oestrogen 
could achieve its effects through the sympathetic nervous system. It has 
been suggested by Welch et al that increasing levels of oestrogen lead to 
increased noradrenaline receptor production in vascular smooth muscle and 
also block noradrenaline's action at the neurovascular junction thereby 
activating 2 adrenoceptors and causing a partial sympathectomy. This 
is coupled with concurrent inhibition of catechol-ortho-methyl- 
transferase (COMT) and mono-amine oxidase (MAO) and decreased synaptic 
release of noradrenaline. The latter has the predominant effect. (195)
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16*3 Endogenous opioids, ovarian hormones and migraine
Ovarian steroids are thought to modulate endogenous opioid 
systems. Opiate JA* receptors are found in the arcuate nucleus of the 
hypothalamus where they are known to exert a tonic inhibition on 
luteinising hormone releasing hormone (LHRH) secretion. Naloxone, a 
specific JA, antagonist, causes an increase in peripheral concentrations of 
luteinising hormone (LH). This effect has been used to investigate CNS 
opiate receptor activity. The major drawback is that pituitary 
gonadotrophe function inevitably affects the outcome following naloxone 
administration and a variety of factors can be involved in this.
Genazzani et al used this method to examine three groups of patients:
(i) Group A - 7 healthy post menopausal women treated with a combination 
of sequential oestrogens and progestagens
(ii) Group B - 10 healthy women in the reproductive age group who had had 
a premature menopause due to hysterectomy and ovariectomy for intrauterine 
fibrosis. Half of this group had the same treatment as Group A and the 
other half had progestagen supplementation only
(iii) Group C - 8 post menopausal women suffering from common migraine 
treated in the same way as Group A.
Group A had no LH rise after naloxone initially but went on to do so 
after hormone replacement therapy (HRT). The menopause appears to be 
accompanied by an impairment of opiate receptor function which can be 
modified by HRT. Group B also lost the LH rise after surgery and
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regained it with combined HRT but not with progestagens alone.
Oestrogens seem to play a major role in modifying central opiate 
activity. Group C had no change in LH values after naloxone. An LH rise 
was again apparent after sequential hormone treatment.
Progesterone seems to enhance the action of oestrogens although it 
is ineffective alone. The impairment in central opiate receptor function 
in common migraine can be corrected by HRT suggesting it has a potential 
role in the treatment of common migraine exacerbated by the menopause. 
(203)
16*4 Migraine and the oral contraceptive
There is a well recognised relationship between the oral 
contraceptive and migraine. Headache is the first or second most common 
symptom described with oral contraceptive use. Patients with established 
migraine have an 18-49$ increase in the frequency and severity of attacks 
when taking oral contraceptives. This tends to happen during the drug- 
free interval of the cycle. When migraine begins for the first time 
after starting on the oral contraceptive this is not the case. A small 
number of migraine patients seem to improve whilst taking the oral 
contraceptive but as yet this group has not been systematically 
investigated. A family history is less likely in patients who develop 
migraine after, rather than before, starting to take the oral 
contraceptive. When migraine occurs for the first time after starting on 
oral contraceptives it is most likely to appear in the early cycles. 
However it can also occasionally arise after prolonged administration. 
Stopping the oral contraceptive does not always stop the migraine which
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may continue long term. (195)
An exacerbation of migraine following oral contraceptive use may be 
more likely if:
(i) patients are aged more than 30 years and have menstrual migraine,
(ii) there is an interval of greater than 30 days between menstrual 
periods,
(iii) patients are multiparous,
(iv) there is postpartum onset. (196)
Phillips, a consultant neurologist, reported on 41 patients 
attending his outpatient clinic. He himself acknowledged that they were 
a highly selected group. Half of the patients had pre-existing migraine 
and half had a new onset of migraine subsequent to starting on the oral 
contraceptive. Fifteen patients in the total sample were noted to have 
depressive symptoms. There was no significant difference in the 
frequency of depression in either group of migraine patients. 
Unfortunately no rating scale for depression seems to have been used and 
the assessment of depression was therefore a subjective one. (204)
Mood change and the oral contraceptive
In a small uncontrolled study of 12 volunteers with no previous 
history of mental illness visual analogue scale ratings of depression 
increased from day 11 to day 19 of the menstrual cycle. There was no 
such trend for anxiety scores. (205)
There have also been larger studies of psychological symptoms while
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taking the oral contraceptive, both of which included a control group of 
women who were using physical methods of contraception.
In a study of 168 women taking oral contraceptives and 93 using 
physical methods of contraception the distribution of scores obtained 
using the Beck Self-Rating Depression Inventory were very similar except 
that 6.6$ of the oral contraceptive group scored 25 or more compared to 
none of the control group. The length of time on the oral contraceptive, 
the type of oral contraceptive taken and age were not significantly 
related to depression score. Some oral contraceptives appeared more 
likely to cause depressive symptoms than others but this could have been 
an artefact of the population studied. This effect was not obviously 
related to alterations in the balance of oestrogen and progesterone.
(206)
In a second study the same author combined a questionnaire survey of 
menstrual symptoms with administration of the Maudsley Personality 
Inventory in 152 women about to start on the oral contraceptive and 40 
women about to use the cap or the sheath for contraception. Follow-up 
questionnaires were sent to the oral contraceptive group at 5 weeks, 5 
months and 11 months and slightly less regularly to the control group.
The oral contraceptive significantly decreased premenstrual depression 
and irritability and dysmenorrhoea throughout the period of the 
investigation compared to the retrospective ratings for the period prior 
to starting oral contraceptive. Six per cent of the oral contraceptive 
group compared to 2$ of the controls had moderate to severe depressive 
symptoms at follow-up. Both groups had a 5$ incidence of irritability. 
None of the control group complained of headache but 4$ of the oral
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contraceptive group mentioned this at the 5 week follow-up, 7$ at the 5 
month review and 2% at 11 months. Neither the subject's age nor the 
composition of the pill made any difference to the scores for depression 
or irritability. However complaints of premenstrual moderate or severe 
depression prior to starting on the oral contraceptive were associated 
with an increased incidence of depression. Depression on the oral 
contraceptive was also associated with an increase in dysmenorrhoea.
(207)
16.5 The premenstrual syndrome as a model for the association of
migraine and affective disorder
In retrospective studies 29-97$ of women report cyclical changes of 
some kind related to menstruation. However, although prospective studies 
have found increased reporting of pain and water retention premenstrually 
mood change was randomly distributed throughout the cycle. In 
retrospective studies women may incorrectly attribute mood change to the 
premenstrual phase as a result of their expectations.
Premenstrual changes can be positive or negative, e.g. increased 
energy, sex drive or feelings of affection or the opposite. The most 
common psychological changes are irritability, depression and lack of 
energy; the most common somatic symptoms are bloatedness and breast 
tenderness. There is wide variation in both the types of symptom and 
their timing. This contributes to the difficulty in obtaining a standard 
definition of the premenstrual syndrome. Premenstrual changes have been 
described as a cyclic change in the intensity of the symptom(s) measured 
from the second week of the menstrual cycle compared to the peak
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intensity of the symptom during the late luteal phase (one to seven days 
prior to the onset of the menses).
Premenstrual depression has been used as a model for affective 
disorder on the basis of studies which have shown:-
(i) a positive correlation between premenstrual depression and a 
lifetime diagnosis of affective disorder,
(ii) that premenstrual depression may be severe enough for patients 
to seek treatment for it,
(iii) that suicide attempts and admissions to psychiatric hospitals 
for depression are associated with the paramenstrual period,
(iv) that premenstrual exacerbation of depression is seen in 
patients with depressive disorders.
Typically endogenous depressive symptoms do not occur in 
premenstrual depression. However endogenous depression is itself only 
one subgroup of depressive disorder. Using the Premenstrual Assessment 
Form (PAF) Halbreich et al identified 145 women from a sample of 335 who 
had what they defined as a Full Depressive Syndrome. This Full 
Depressive Syndrome has six non-mutually exclusive subtypes. None of 
the women met the recognised criteria for endogenous depression. However 
63$ bad Atypical Depressive features, 52$ characteristics of Hostile 
Depression, 42$ met criteria for the Anxious-Agitated Depressive Syndrome 
and 42$ had features of. Withdrawn Depression.
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Criteria of the Premenstrual Assessment Form Typological Categories
FULL DEPRESSIVE SYNDROME
A. 1 . Depressed or low mood - 1 of the following 5 items must he
at least mild (3-6): Feel depressed (233) or Feel "empty"
(263) or Feel sad or blue (265) or Feel lonely (271) or 
Pessimistic outlook (359)
OR 2. Loss of interest or pleasure - all of the following 4 items 
must be at least mild (3-6): Less sexual interest (323) and 
Avoid social activities (324) and Want to be alone (328) and 
Less leisure activities (345)
OR 3» Irritable - 1 of the following 2 items must be rated at least
mild (3-6): Outbursts of irritability (264) or Feel "at war"
(269)
B. If Depressed - at least 4 of the following 8 items, or item
sets, must be rated at least mild (3-6). If Irritable or Loss 
of interest or pleasure only, at least 5 of the 8 items must
be rated at least mild (3-6):
1. Appetite change - Loss of appetite (222) or Weight gain (273)
or Increased appetite (331)
2. Sleep change - Hypersomnia (219) or Trouble sleeping (278)
3» Decreased energy (216)
4» Psychomotor change - Physical agitation (228) or Less desire 
to talk or move (237)
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5- Less interest - Less sexual interest (323) or Avoid social 
activities (324) or Want to be alone (328) or Less leisure 
activities (343)
6. Self deprecation - Guilt feelings (262) or Decrease in self 
esteem (316)
7- Concentration difficulties (245)
8. Suicidal ideation (236)
ATYPICAL DEPRESSIVE FEATURES
A. Meets criteria for Full Depressive Syndrome
B. Rapid mood changes (215) or Mood swings (260)
(rating of 3 or more)
C. At least 2 of the following 4 items rated 3 or more:
1. Hypersomnia (219)
2. Feel sleepy (241)
3* Crave specific foods (330)
4 • Increased appetite (331)
ANXIOUS-AGITATED DEPRESSIVE FEATURES
A. Meets criteria for Full Depressive Syndrome
B. At least 2 of the following 4 items rated 4 or more:
1. Feel anxious (218)
2. Feel jitteiy or restless (221)
3 . Physical agitation (228)
4- Pick skin/bite nails (259)
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HOSTILE DEPRESSIVE FEATURES
A. Meets criteria for Full Depressive Syndrome
B. At least 3 of the following 6 items rated 3 or more:
1. Violent (240)
2. Outburst of irritability (264)
3. Feel "at war" (269)
4» Act spiteful (270)
5. Intolerant (274)
6. Blames others (317)
IMPAIRED SOCIAL FUNCTIONING
At least 3 of the following 11 items rated 3 or more:
1. Tend to nag (235)
2. Decreased judgment (247)
3- Family notes mood (268)
4. Stay at home (322)
5- Avoid social activities (324)
6 • Lowered performance/efficiency (326)
7- Miss time at work (327)
8. Lack of inspiration (329)
9. Less attention to appearance (333)
10. Less housework (342)
11 . Less leisure activities (343)
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GENERAL DISCOMFORT SYNDROME
At least 1 of the following 3 items rated 3 or more:
1. Headaches or migraines (224)
2. Backaches/joint/muscle pains (267)
3. Abdominal discomfort/pain (276)
WATER RETENTION SYNDROME
At least 3 of the following 6 items rated 3 or more:
1. Breast pain or swelling (223)
2. Urinate less (272)
3 . Weight gain (273)
4 . Abdominal discomfort/pain (276)
5 . Water retention signs (321)
6 . Feel bloated (325)
AUTONOMIC PHYSICAL SYNDROME
At least 3 of the following 7 items rated 3 or more:
1. Nausea or vomiting (227)
2. Dizziness, faintness, vertigo (234)
3 . Rapid heartbeat (243)
4 . Urinate frequently (253)
5 . Become constipated (254)
6. Urinate less (272)
7 . Feel cold (334)
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Reprinted by permission of Elsevier Science 
Publishing Co. Inc. frcm ’Premenstrual changes 
and affective disorders’ by Endicott J. et al 
Psychoscmatic Medicine, Vol 43, No 6, pp519-29. 
Copyright 1981 by The American Psychosomatic 
Society, Inc.
The authors emphasise the importance of collecting both 
retrospective and daily prospective data when assessing the association 
of mood change and menstruation. Day-to-day swings in mood and 
behaviour are common and are thought to be a reflection of the bipolarity 
in the changes which are ocurring.
In a study of 194 women which used the Schedule for Affective 
Disorders and Schizophrenia (SADS) to obtain current and lifetime 
RDC diagnoses and the PAF assessment 57# of women with a lifetime 
diagnosis of Major Depressive Disorder also had a Premenstrual Full 
Depressive Syndrome while only 14# of women who were 'never mentally 
ill' met the PAF criteria. The PAF Full Depressive Syndrome was 
particularly closely associated with recurrent unipolar depression.
This association of a premenstrual affective syndrome with a lifetime 
diagnosis of affective disorder is consistently reported in several 
studies. Two studies have also reported an association between the 
premenstrual affective syndrome and the later development of affective 
disorder. However the follow-up period was fairly short and the 
magnitude of the association was low. They suggest the possibility that 
dysphoric premenstrual changes may be a predictor for the future 
development of major depressive disorder. (208).
Oestrogen is thought to produce CNS excitation whereas progesterone 
produces inhibition. Women with primary generalised petit mal epilepsy 
have a distribution of attacks which is similar to the pattern of the 
premenstrual syndrome. In focal epilepsy there are two peaks of seizure 
frequency - at menstruation and during the pre-ovulatory oestradiol 
peak.
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Improvement in mood typically occurs in the late follicular phase, 
corelates with the pre-ovulatory oestradiol peak and is consistent with 
the positive excitatory effect of oestradiol. During the luteal phase 
however negative changes in mood continue to increase during "both the 
rise and fall of oestradiol and progesterone. The ratio of oestradiol to
progesterone may be the crucial variable.
Surveys of oral contraceptive users have tended to find a lower
incidence of premenstrual syndrome than those of non pill-users. Although
several studies have reported a decrease in premenstrual symptoms while 
taking the oral contraceptive they have not been placebo-controlled.
Early studies on oral contraceptives implicated the progestagenic 
constituent as a cause of negative psychological symptoms. Pyridoxal 
phosphate is a co-enzyme which is involved in the decarboxylation of 5- 
hydroxy-tryptophan to 5-HT and dopa to dopamine. A subgroup of patients 
-who become depressed on the oral contraceptive are pyridoxine deficient 
and the depression responds to treatment with pyridoxine.
Endogenous opiates have been suggested as the causal agents in the 
premenstrual syndrome. Opiate receptors have been identified on 
dopaminergic neurones. Activation of these receptors at presynaptic 
sites decreases the cell firing rate leading to the gradual development of 
disuse hypersensitivity in the postsynaptic neurone. This could in turn 
account for the tolerance associated with chronic opiate administration 
and withdrawal effects when the opiates are suddenly stopped. A two 
phase model of opiate effect has been postulated in premenstrual 
symptoms. This combined inhibition induced by a mid-luteal rise in
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opiates, followed by a withdrawal effect accompanying the premenstrual 
fall in opiates. (209)
16.6 The inter-relationship between prolactin, ovarian steroids
and migraine
Prolactin has been closely linked with ovarian steroids in its 
effect on migraine. Many of the trigger factors and effective treatments 
for migraine are associated with high prolactin levels. These are, in 
turn, linked to alterations in free fatty acid concentrations. However 
Nader et al, in a small study of migrainous patients, was unable to
if
provoke migraine by artificially raising prolactin concentrations. This 
is in agreement with the finding that migraine is particularly likely 
to remit in the later stages of pregnancy when there is a 5 to 10 fold 
increase in prolactin concentrations. Changes in prolactin concentration 
were also found to be independent of the free fatty acid response to 
glucose. (210) Nevertheless Polleri et al hav-e shown that there is a 
disturbance in the regulation of prolactin secretion in migraine. This 
does not appear to be due to alteration in the rhythm of prolactin 
secretion, although as this part of the study concerned only 6 male 
patients and the type of migraine was not specified, the results are not 
conclusive. Pharmacological studies using drugs which affect 
monaminergic and serotoninergic systems indicate an altered response to 
these compounds in migraine - particularly when the drugs used affect 
dopamine-dependent regulation of prolactin secretion in the pituitary. 
Prolactin does not appear to be responsible for pain in migraine. (210)
The central regulation of prolactin release is very complex but
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involves an interaction of endogenous opioids and neurotransmitters such 
as dopamine and ft-amino butyric acid (GABA). The pathway through which 
they achieve their effects is probably serotoninergic. (212) Murialdo et 
al compared 23 healthy women with 17 women with menstrual and 17 women 
with non-menstrual migraine. All migraineurs had common migraine. 
Prolactin secretion was investigated pharmacologically. The overall 
conclusion was that there was an increased lactotrophe prolactin reserve 
in migraine. This was likely to be due to increased dopamine receptor 
sensitivity. There were no statistically significant differences in 
either prolactin responses or plasma levels of ovarian steroids when the 
menstrual and non-menstrual migraine groups were compared. However 
comparing the total group of migrainous women with the healthy controls 
17-^ -oestradiol levels were higher in both the follicular and luteal 
phases whilst progesterone levels and the progesterone to oestradiol 
ratio were lower in the luteal phase. This suggested a change in the 
oestrogen-dependent modulation of pituitary dopamine receptors. (213)
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CHAPTER 17
The relevance of cerebral asymmetry to migraine and affective disorder
One of the most striking features of the migraine headache is that
the pain is frequently restricted to one side of the head. There is no
satisfactory explanation of how the headache can vary in location in 
different attacks.
A considerable amount of research has been conducted on cerebral 
asymmetiy and its relationship to both migraine and psychiatric disorder.
It has been apparent since Broca’s discovery that the neural basis
of language was located primarily on one side of the brain and that there
were differences in the capacities of the two hemispheres. (214) There 
has been controversy over whether this asymmetry is present from birth or 
whether both hemispheres initially have the capacity for language 
development. The left hemisphere is usually the dominant hemisphere for 
speech. (Dominance in this context refers to the predominant 
lateralisation of any function on one side or the other in the nervous 
system.) Despite the early predisposition of the left hemisphere to 
acquire language, damage can result in a partial or complete shift of 
this function to the opposite hemisphere. There is thus some flexibility 
in the organisation of asymmetric functions, at least initially. (215) 
Cerebral dominance develops concurrently with speech and becomes fully 
established well before maturity. Dominance for language and handedness 
are linked. In most people both are located in the left hemisphere. 
However although this is fairly straightforward in the right-handed
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members of the population, a proportion of left-handers have bilateral 
representation of language. (214) Anatomical asymmetries in the auditory 
regions (temporal planum) and Sylvian fissures have been found in the 
foetus. They are thought to be related to right-left differences in 
function. These asymmetries in the temporal planum could be linked with 
language lateralisation. There are also structural asymmetries in the 
frontal and occipital lobes and the lateral ventricles which correlate 
with hand preference. (216)
17*1 Cerebral asymmetry and migraine
Studies of human brains have provided some evidence for 
developmental malformation in the left posterior superior temporal region 
in dyslexia. All developmental disorders of language, speech, cognition 
and emotion which begin before puberty have a strong male predominance 
and a higher rate of left handedness than that found in the general 
population. Two studies have found that both migraine and immune 
diseases (e.g. ulcerative colitis, coeliac disease, regional ileitis, 
thyroid gland disorders and childhood allergies) have higher frequencies 
in left- than in right-handers. However a questionnaire method was used 
and for the first study this was the only evidence on which a diagnosis 
of immune disease was based. The second part of the investigation, which- 
concerned migraine, used a patient group selected from neurological 
clinics. No diagnostic criteria were quoted for migraine and the type of 
migraine was not specified.
The anatomical asymmetries associated with developmental learning 
disorders appear early in foetal life. Three possible reasons for this
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could be:
(i) a fixed developmental pattern,
(ii) intrauterine influences which accelerate development on the right 
side of the brain,
(iii) intrauterine factors which slow development on the left.
The abnormalities in dyslexic brains suggest a developmental delay 
in the migration of cells. As these disorders are found mainly in males 
this delay could be related to testosterone. It has been suggested that 
testosterone is responsible for the delay in the growth of the left 
hemisphere, especially the areas related to language and handedness. 
Testosterone also suppresses the activity of the thymus. The foetal 
thymus appears to control the development of the lymphocytes which 
prevent autoimmunity. This theory assume a link between autoimmunity and 
migraine which is not widely documented elsewhere in the migraine 
literature. (214» 217)
In addition to structural asymmetries there are also 
interhemispheric differences in neurotransmitters and cerebral blood flow 
patterns.
In an analysis of the concentrations of between 3 and 5 
neurotransmitters in 9 different structures on the right and left sides 
of 14 human brains, brains asymmetric for one substance or region were 
consistently asymmetric for other substances or regions. There was 
evidence for a diffuse mechanism regulating both the nature and extent of 
chemical asymmetry in different brain structures. (218)
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Both interhemispheric and antero-posterior differences in cerebral 
blood flow patterns have been demonstrated. The latter are more marked. 
Complex tasks produce increased activation in multiple areas of the 
hemispheres. Despite this overall flow patterns are very similar in 
both hemispheres even during activities such as speech which are mainly 
located in one hemisphere. (219)
Cerebral asymmetries in migraine have been investigated electro­
physiol ogically by EEG recording of visual evoked potentials (VEPs). VEPs 
are altered by anatomical changes, abnormalities in neurotransmitters and 
ischaemic damage to the central nervous system. For the most part 
changes in VEPs correlate with the severity of the underlying condition. 
In migraine the hemisphere which is thought to be ischaemic has an 
altered VEP. In a comparison of 22 normal controls and 16 migraine 
patients, VEPs were recorded using vertex and temporal lobe placements. 
All subjects were right handed. The type of migraine was not specified. 
VEP abnormalities were found in the, vertex and temporal recordings in the 
migraine patients. When the results were analysed according to the side 
of the headache only the temporal recordings were abnormal in patients 
with right-sided headache. This group had larger VEP amplitudes at the 
left temporal site compared to the group with bilateral headache. (More 
of the patients in the study had left-sided headaches.) There is a 
difference in the responsiveness of the visual system in migraine 
patients which could be due to a failure of sensory input modulation or 
an increased response to such input. The asymmetrical VEP response in 
patients with right-sided headache could reflect a secondary process in 
the left hemisphere set in motion by repeated right hemisphere 
dysfunction. (220)
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Unfortunately not all studies on this aspect of migraine agree. In 
another study of 20 women with classical migraine who were selected from 
a Neurology Clinic and matched for sex and age with clinic staff there 
was little difference in pattern-shift VER between migraine and control 
subjects. There was a slightly longer P100 component latency and 
slightly smaller P100 amplitude implying that there might be minor 
abnormalities in visual sensory processing in some migraine patients. 
When the data were analysed according to the most frequent lateral 
location of the headaches there were slight differences in P100 
amplitudes in left-sided subjects although these did not reach 
statistical significance. Minor differences were found between the 
migraine and control populations when spectral analysis of the background 
EEG was used. However these were not thought to be clinically 
significant. The authors suggest that the differences between their own 
and previous work are probably due to the careful matching of migraine 
and control populations in their study. (221)
Subsequently this work on central regulatory processes in migraine 
has been extended by investigating the effects of sensory stimuli on 
autonomic responses. The Pavlovian orienting response and its 
habituation with repeated stimulation were used to produce autonomic 
responses which were monitored by measuring skin conductance. Initially 
12 normal controls were compared with 11 patients with migraine and 7 
patients with bilateral tension headache. All except one of the 
migraineurs had classical migraine. Anxiety levels were measured using a 
self-report questionnaire and no differences were found between the 3 
groups. Patients with left-sided migraine were less responsive to visual
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stimuli than those with right-sided migraine. The left-sided migraine 
patients were less responsive and the right-sided migraine patients more 
responsive than the normal controls and the patients with tension 
headache. Patients with tension headache were no different from normal 
controls. As some patients were on prophylactic medication a further 
study was conducted on drug-free patients. On this occasion auditory, 
rather than visual, stimuli were used. Thirteen patients, 7 with left­
sided and 6 with right-sided migraine, participated in the study. A 
minority of patients in each group had common migraine, the remainder the 
classical variety. All patients were right-handed. The same pattern of 
results was demonstrated as in the first study for the migraine group. 
There appears to be a dysfunction in the mechanism which regulates 
autonomic responsiveness in migraineurs. This may involve the diffuse 
thalamic projection system which regulates regional patterns of cerebral 
activity. (222)
Cerebral asymmetry has been linked to responsiveness and the rate of 
habituation of electrodermal responses to sensory stimuli. Patients with 
left hemisphere lesions and dysphasia show higher galvanic skin responses 
whereas patients with lesions of the right hemisphere and unilateral 
spatial neglect are under-responsive compared to non brain-damaged 
patients. (223)
Patients with left hemisphere damage often appear depressed. This 
is usually described as a reactive depression due to insight into the 
extent of their loss of function. Patients with left hemispheric lesions 
are, by contrast, often emotionally indifferent to them. Although 
patients with right hemisphere damage are unable to understand or convey
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emotional expression in speech, this is not enough to explain their lack 
of reaction. Indifference is usually coupled with unilateral neglect.
It has been suggested that this is an attention - arousal defect caused 
by dysfunction in a cortico-limbic-reticular loop. The cortex is 
responsible for analysing stimuli and the reticular system mediates 
arousal. Ablation of the areas of cortex which produce arousal results 
in neglect and, possibly, hypoarousal. Disruption of this loop has been 
suggested as the cause of neglect in these right hemisphere damaged 
patients. The reactive depression seen in left hemisphere damage may be 
partly a consequence of disinhibition of sympathetic activity coupled 
with awareness of loss. (223)
In normal subjects fast habituation on electrodermal recordings is 
associated with left hemisphere influence and slow habituation with 
predominantly right hemisphere influence. Migraine therefore "would 
appear to represent a state of extreme hemispheric imbalance and it is 
this which underpins the laterality of pain." (222,224-) Dysregulation of 
regional activation due to a dynamic process could provide an explanation 
for the episodic nature of migraine and the inconsistencies in both the 
laterality of the pain and the laterality of the neurological symptoms 
which may be associated with the condition. (222)
17.2 Laterality of migraine and cognitive processing
Crisp et al have suggested that migraine may be "a fail-safe 
reaction to 'information overload' and furthermore that laterality might 
be determined by the nature of this information i.e. verbal or 
visuospatial." This overload could result from excessive intellectual or
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social effort or from a conflict between current experience and 
previously held values. Migraine patients show high levels of 
sociability and dysphoria combined with an absence of excessive neurotic 
avoidance and ritual mechanisms. In a small study 18 migraine patients 
were grouped according to the laterality of their symptoms and the type 
of migraine (i.e. common or classical). Low levels of anxiety and 
depression were found in the two patients with left-sided classical 
migraine. Both of these patients were right-handed. This contrasted with 
generally increased levels of anxiety and depression in the migraine 
group as a whole when compared to scores obtained in the general 
population. The low levels of dysphoria observed in left-sided classical 
migraine and the high levels seen in right-sided classical migraine agree 
with the hypothesis that euphoria is associated with left hemisphere 
inactivation and dysphoria with, right hemisphere dysfunction. An 
immediate criticism of this hypothesis is that it applies only to 
classical and not to common migraine. (225) However there is some 
indirect support for it in that cerebral blood flow changes are also 
found in classical, but not in common, migraine.
More recently this work has been extended by an examination of two 
further hypotheses:
(1) that subjects with exclusively one-sided migraine would have a 
dysfunction of the same hemisphere. This would leave them susceptible to 
strain when processing combinations of verbal and non-verbal information,
(2) waking activities would produce migraine in the hemisphere 
principally involved.
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The authors highlight the difficulty of obtaining a sufficiently 
large sample of patients with exclusively unilateral migraine. Their 
patients are therefore a highly selected subsample of migraine patients 
and this must raise doubts about the applicability of the results to the 
migraine population as a whole. However 9 migraine patients had their 
verbal and non-verbal abilities measured using the corresponding verbal 
and non-verbal performance scales of the Wechsler Adult Intelligence 
Scale (WAIS). The psychologists administering the WAIS were blind to 
the laterality of the migraine. All patients were right handed. The 
results obtained were inconsistent with the hypotheses. Verbal-non­
verbal discrepancies were small and not always in the expected 
direction. This could have been because the WAIS was too insensitive to 
detect interhemispheric differences, or more probably, it suggested that 
the original hypotheses required revision. (226)
Taken overall, the limited amount of evidence available does not 
suggest that cognitive processing plays a major role in the laterality of 
migraine and that it is, at most, only one of many contributory factors.
Evidence for lateral specialisation in the intact brain is found in 
electroencephalogram and visual evoked potential studies as well as the 
investigation of left-right visual field differences in perception and 
reaction time. Typically, right handed people deal primarily with 
language processes and arithmetic in the left hemisphere and spatial 
relationships and musical functions in the right hemisphere. Following 
commissurotomy operations, in which the fibres connecting the right and 
left hemispheres are cut, the left hemisphere retains the capacity for
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speech, writing and calculation hut is very limited in its ability to 
deal with spatial relationships. The right hemisphere can cope with 
complex spatial and musical patterns but can manage only very simple 
addition and has few words. Each hemisphere has a different cognitive 
style: the left has analytical, logical thinking and the right holistic, 
gestalt processing. It has been suggested that the right hemisphere is 
the anatomical equivalent of the Freudian unconscious and that repression 
and denial of material there is neurophysiologically based in inhibition 
of interhemispheric transfer of information. (227) A breakdown in 
interhemispheric inhibition has also been suggested by studies of 
cerebral laterality using dichotic listening tests in acute psychoses 
e.g. schizophrenia, schizoaffective illness and primary major depressive 
illness. (228)
Studies of patients with brain lesions show that schizophreniform 
symptoms are more likely to occur after left sided lesions and affective 
symptoms arise more often after right sided damage. The thought disorder 
and auditory hallucinations found in schizophrenia are in keeping with 
the specialisation of the left hemisphere for language and logic. The 
mood disorder's in affective illness also correspond with the right 
hemisphere's.capacity for non-verbal functions.
The direction of lateral eye movements (LEMs) is thought to reflect 
differential hemispheric activation. These LEMs are increased to the 
left following emotionally laden questions and this may reflect right 
hemisphere involvement in the processing of these questions. When 
patients with right and left hemispheric damage are compared those with 
right hemisphere damage have more difficulty in assimilating emotional
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cues conveyed in speech. When full face photographs and their mirror 
reversals are split down the mid-line and composite faces made from two 
right halves and two left halves, subjects rate left sided composites as 
expressing more emotion than right sided composites. There is an excess 
of contralateral projections controlling facial muscles and the results 
may imply greater involvement of the right hemisphere in the production 
of emotional expression.
The right hemisphere therefore appears to be more important in the 
processing of emotional information and the production of emotional 
expression than the left hemisphere. This is consistent with right 
hemisphere involvement in affective disorder. (219)
17*3 Summary
The two hemispheres have different capacities. Dominance refers 
to the predominant lateralisation of any function on one side or the 
other in the nervous system. Dominance for language and handedness are 
linked. Hemispheric differences are linked to anatomical asymmetries. 
Migraine and immune disorders are associated with left-handedness.
There are also lateral asymmetries in the distribution of 
neurotransmitters and in cerebral blood flow patterns. Electro- 
physiological investigations in migraine have found lateral differences 
related to the side of the headache. Although the extent of the 
differences found has varied there seem to be alterations in visual 
processing in migraine and possibly also dysfunction in the mechanism 
which regulates autonomic responsiveness. Abnormalities in
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responsiveness and the rate of habituation to sensory stimuli in patients 
with left and right hemisphere damage have been extrapolated to migraine 
to provide an explanation for the unilaterality of the headache.
Laterality of migraine might also be linked to hemispheric defects 
in cognitive processing. However there is little evidence that it makes 
a major contribution to this.
Cognitive processing does appear to differ hemispherically and this 
may be related to the different psychological symptoms elicited following 
right and left hemisphere damage.
- 200 -
CHAPTER 18
Conclusions from the Literature Review
The characteristic prodromal symptoms and the unilateral pain in 
migraine have been extensively described. The prodromal symptoms are 
usually assumed to be neurological in origin whereas the headache is 
assumed to be vascular.
From the 1800s onwards migraine has been described as a 
multifactorial condition. External factors such as emotional and 
intellectual stress interact with internal factors such as the phase of
the menstrual cycle and emotional disturbance.
Although migraine and muscle contraction headache can occur together 
in the same patient both conditions are common the association could be 
coincidental. Clinically there are considerable differences between 
migraine and muscle contraction headache. Daily chronic headache 
appears similar to muscle contraction headache in duration but is 
actually closely related to migraine and antimigraine drugs may be a
better choice of treatment for these patients.
As yet, classical and common migraine cannot definitely be said to 
be different entities, although there are sufficient differences between 
them to justify studying them separately.
The prevalence of migraine in British women is 24-29$ and 15-20$ in 
men. This sex difference may be due to higher reporting of the condition
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by women. Half of migraine sufferers do not seek medical help. The 
typical age of onset is 20 and the probability of developing vascular 
headaches decreases after age 30. More intelligent migraine sufferers in 
upper social classes are more likely to consult a doctor about migraine 
and thus bias studies performed in GPs' surgeries and migraine clinics. 
There is no evidence that migraine is more common in more intelligent or 
upper class subjects in the community.
Twin studies, like family studies, suggest that there may be more 
than one migraine syndrome. In some cases there is a powerful genetic 
component but in others environmental factors are more important.
Migraine patients do not have a specific personality type nor do 
they have particular difficulty in expressing anger. There is an 
increase in obsessionality in migraineurs but this may be an artefact of 
the clinic population.
Patients with migraine appear to react more to minor life stress. 
Recurrent headaches are associated with mild depressive illness, 
somatisation and anxiety. This remains after treatment and seems to be a 
state rather than a trait. The degree of distress is directly related 
to the frequency and severity of the pain.
Philosophically, a condition like migraine exemplifies the 
difficulties in conceptualising the interaction of mind and body. A 
modern view is a dualist-interactionist model in which the self- 
conscious mind is viewed as an independent entity which selects from the 
inputs available and integrates the results to produce conscious
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experience.
There is good evidence for a vascular aetiology in the headache 
phase of migraine. Oligaemia is not closely related in time or in 
anatomical distribution to these symptoms. A neural origin for 
migraine attacks could explain the periodicity of migraine, the 
association of migraine and epilepsy, the relationship between 
tiredness and the precipitation of attacks and the resolution of 
attacks with sleep.
Regional cerebral blood flow data indicate that common migraine 
attacks are not preceded by, or associated with alterations in CBF. 
However rCBF is focally or possibly even globally reduced during the 
prodrome of classical migraine. Although older studies described 
hyperaemia during the headache phase of classical migraine more recent 
studies have found no change in blood flow. The CBF studies indicate 
that there is a gradual spread of disturbed function in the cortex.
Leao's Spreading Depression (S.D.) is likely to be the primary 
disturbance of neuronal function which initiates cerebral blood flow 
changes. Stimulation of the visual cortex by light could raise the 
potassium ion concentration to the threshold required to elicit S.D. The 
effect of S.D. on pain sensitive fibres at the ventral surface of the 
brain could also produce the headache in classical migraine.
According to the hypoxic hypothesis cerebral hypoxia occurs in every 
attack of migraine. Whether or not prodromal symptoms occur is 
determined by the severity of the hypoxia and the site at which it 
occurs. It may be caused by excess sympathetic drive.
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Migraine can be associated with persistent neurological dysfunction 
in a small proportion of cases. It is difficult to give an exact figure 
for the incidence of cerebral infarction in migraine as cerebral 
infarction is itself a multifactorial condition and it is difficult to 
separate out the contribution made by migraine from that of other 
factors.
Textbooks quote a 10$ occurence of affective concomitants with 
migraine. 'Migrainous equivalents' representing brief manic-depressive 
cycles have been reported subsequently in patients who present initially 
with migraine. Previous studies of the correlation between self-report 
of mood changes and migraine have found that subjects with both migraine 
and muscle contraction headache are less alert during attacks and that 
feelings of constraint and fatigue are the best predictors of subsequent 
migraine headaches. It has also been suggested that there is a critical 
threshold for stress beyond which a migraine attack is produced or that 
there is increased sensitivity or reduced tolerance to stress just prior 
to attacks.
Depression has been linked with prodromal neurological symptoms in 
classical migraine and to the rCBP changes already noted in that 
condition. A diffuse decrease in rCBF has also been found in depression.
Multiple biochemical factors are probably involved in the CBF 
changes found in migraine. Noradrenaline and serotonin appear to be the 
two neurotransmitters which are most concerned. It is likely that they 
are both involved in the production of anxiety. Serotonin is also
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thought to play a major role in depression.
There is a higher incidence of epilepsy in migraine than in the 
population as a whole. The incidence of EEG abnormality in migraine 
sufferers is also doubled. Leao's Spreading Depression may underlie both 
conditions. There are similarities between the association of affective 
symptoms and epilepsy and affective symptoms in migraine. The 
prefrontal cortex, the limbic system and the hippocampus appear to be 
the brain regions principally involved in the production of these 
affective symptoms. Depression is particularly linked to seizures with 
olfactory auras. Kindling within the limbic system could provide an 
explanation for the emotional changes seen in limbic epilepsy. Kindling 
can also occur in spreading depression and could, by analogy, be the 
underlying mechanism which links,affective changes with migraine. This 
could provide a rationale for investigating the use of carbamazepine in 
the treatment of migraine.
Calcium channel blockers and antidepressants have some actions in 
common and a similar time course for their effects. This may involve an 
action on the contractile apparatus of vascular smooth muscle.
Olfactory hallucinations are produced by irritation of the uncinate 
gyrus or the adjacent temporal lobe. They are often linked with ictal 
affective states. There are close parallels between migraine and 
temporal lobe epilepsy.
Cocaine abuse can be used as a model for migraine hallucinations. 
Cocaine's stimulant effects include seizure-type discharges in the
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temporal lobe and increased activity in the reticular activating system. 
Olfactory hallucinations have been reported in seven per cent of cocaine 
abusers.
Cocaine abuse has also been used as a model for the endogenous 
psychoses. Biological changes assoicated with cocaine mimic the effects 
of stress. It has been suggested that stress may precipitate psychiatric 
illness by triggering a kindling process in the limbic system.
Both tension headache and migraine sufferers report more minor life 
stress than controls. It has been shown that decreasing the effects of 
stress can affect the outcome of disease processes. The anterior 
pituitary, adrenal cortex and the sympathetic nerves are all involved in 
stress responses and possibly in the production of stress-related 
physical and psychiatric illnesses.
The endorphins affect both the central nervous system and the 
cardiovascular system. Stress activates the hypothalamic-pituitary- 
adrenal axis and this releases0  -EP and ACTH from the anterior 
pituitary. The cardiovascular effects are mainly produced by the 
sympathetic nervous system. Endorphins are more closely implicated in 
the perception of pain than in psychiatric illness. They do not appear' 
to play a major role in the production of affective changes in migraine.
Pain is associated with increased neuroticism - especially anxiety, 
hysteria and reactive depression. It can be a symptom of depression and 
depression can be a reaction to chronic pain.
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True menstrual migraine is uncommon (approximately 14$ of female 
migraineurs). It is associated with onset of migraine at menarche, 
weight gain and breast discomfort around menstruation and improvement 
in migraine during pregnancy. There is no evidence that absolute levels 
of reproductive hormones are responsible for this. However the 
withdrawal of oestrogens appears important. Oestrogens also seem to play 
a major role in modifying central opiate activity.
Many women incorrectly attribute symptoms to the premenstrual phase 
of their cycle as a result of their expectations. Premenstrual 
depression has also been used as a model for affective disorder.
The unilateral pain in migraine suggests that cerebral asymmetry is 
an important component of the condition. The two hemispheres have 
different capacities and there are lateral asymmetries in cerebral blood 
flow patterns and neurotransmitter distribution. There are lateral 
differences on electrophysiological investigation in migraine which are 
related to the side of the headache. Visual processing and autonomic 
responsiveness are also disturbed. Cognitive processing differs between 






This review of the literature has highlighted several important 
areas for future research. Regional cerebral lood flow studies suggest 
that the pathophysiology of classical and common migraine differs. It is 
therefore necessary to examine classical and common migraine separately 
to avoid obscuring differences between the two conditions. This would 
also help to identify other divergent factors which might shed further 
light on the aetiology and pathogenesis of both types of migraine.
The patterns of flow changes found is very reminiscent of Lead's 
spreading depression which has always been linked with migraine. As a 
consequence there has been a revival of interest in the neural hypothesis 
of migraine. Migraine has a recognised association with epilepsy. 
Temporal lobe epilepsy in particular has been linked with affective 
disorder. There is now evidence which also suggests that some patients 
with manic depressive illness have symptoms of temporal lobe epilepsy. A 
better understanding of the kindling phenomenon in temporal lobe epilepsy 
would be relevant to both affective disorder and migraine. In this 
context further assessment of the inter-relationship between olfactory 
hallucinations, temporal lobe epilepsy, depression and migraine would 
also be of assistance.
The amount of information available on neurotransmitter and
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metabolic disturbance in the CNS during migraine is very limited. 
Hopefully the advent of PET with its increased information access will be 
useful in this respect. It is obviously extremely difficult to determine 
and quantify transient biochemical abnormalities but in time the 
information obtained could be linked with other transient 
neurotransmitter abnormalities in conditions such as affective disorder 
and epilepsy as well as acute and chronic pain.
After initial interest in major life events as contributors to the 
onset of physical and psychiatric illness there is now a growing 
appreciation of the role played by everyday, minor stresses in 
precipitating episodic conditions like migraine. Interestingly this does 
not appear to be linked with any specific personality characteristics. 
This is another area in which migraine can offer a model for the 
relationship between social and psychological variables and physical 
illness and, as such, it has yet to be fully explored.
Another important avenue to explore is the relationship between the 
hypothalamic-pituitary-adrenal axis, the endogenous opioid system, pain 
and depression. The HPA axis is involved in the response to stress and 
is closely affiliated with the endorphin system. How this is linked 
with pain and depression is yet to be determined.
The hemispheric asymmetry in migraine has always differentiated it 
from ordinary headache. Advances are now being made in systematically 
exploring these interhemispheric differences using psychophysiological 
methods but as better equipment and facilities become available further 
research opportunities will arise. This type of research could also
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benefit from knowledge derived from other fields e.g. the regional 
cerebral blood flow studies with their implication of pathophysiological 
differences between common and classical migraine.
19*2 Specific questions to be answered in the present study
(1) What is the incidence of transient mood changes in association with 
migraine?
(2) What types of affective change are involved?
(3) What is the prevalence of persistent psychiatric disorder within a 
clinic population of migraine sufferers?
(4 ) Are there any factors which differentiate patients who experience 
transient affective change from those who do not?
(5) Do patients with classical and common migraine differ with respect 
to the incidence of either transient or persistent affective disorder?
(6) Can the affective changes in migraine be linked to regional cerebral 
blood flow abnormalities?
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B. Aims, Design and Hypotheses
Aims
The starting point for this investigation is the clinical 
observation that some patients with migraine complain of mood changes 
which they associate with their attacks. An examination of the published 
literature indicates that, although this is widely recorded anecdotally, 
there have been few systematic attempts to investigate this symptom.
The first aim of this study is to determine the prevalence of these 
complaints and the type of mood change involved. The second objective 
is to define and quantify transient changes in mood and assess their 
relationship with migraine attacks. The third aim is to identify the 
factors in the individual which are related to mood changes. The fourth 
aim is to determine the incidence of psychiatric illness in migraine 
sufferers and to assess its relationship with acute mood changes 
associated with migraine attacks. The fifth and final aim is to attempt 
to determine the relationship between patterns of cerebral blood flow 
and mood changes in migraine.
Design
The design of this study is in three parts:
(1) the initial psychiatric interview,
(2) a six week prospective period during which data is collected on the 
occurrence of migraine and fluctuations in mood,
(3 ) monitoring of regional cerebral blood flow on two occasions - once
while the migraine is absent and once when it is present.
(1) Initial psychiatric interview
The immediate problem of determining the incidence of mood change as 
part of the migraine syndrome is best resolved by interviewing a group of 
migraine sufferers. Mood changes associated with migraine can then be 
identified initially on the basis of self report.
In order to assess the importance of individual factors in the 
predisposition to these changes information is also collected on:
(a) social and demographic factors,
(b) migraine symptoms,
(c) cerebral dominance,
(d) past history of emotional distress,
(e) family history of migraine and psychiatric illness,
(f) the relationship between migraine and menstruation,
(g) the frequency with which migraine is precipitated by emotional 
stress.
The next problem is to differentiate acute, transient mood changes 
from psychiatric illness. This becomes considerably more complex if the 
two co-exist. It then becomes extremely difficult to assess the 
contribution of psychiatric illness to acute mood changes related to the 
migraine attacks.
Concurrent psychiatric illness may influence the reporting of 
migraine-related mood changes. High levels of emotional distress at the
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initial interview might also have the same effect.
A structured clinical interview is administered to obtain current 
and past psychiatric diagnoses. This is combined with rating the levels 
of anxiety, depression, euphoria and irritability. These measures 
provide an opportunity to look at the relationship between self report of 
mood changes, current and past psychiatric illness and current levels of 
emotional distress.
(2) Six week prospective rating period
prospective daily ratings of migraine and mood are used to compare 
retrospective self-reporting of the association of mood change and 
migraine with an objective assessment performed at the time.
(3) Regional cerebral blood flow monitoring
Regional cerebral blood flow monitoring using peripheral injection 
of radioactively labelled technetium provides a safe, reliable and 
inexpensive method for examining cerebral blood flow changes.
Hypotheses
(1) that the mood changes associated with migraine are due to more than 
the coincidental expression of two common conditions, i.e. migraine and 
affective disorder, in the same individual,
(2) that a relationship can be demonstrated between the mood changes and 
abnormalities in cerebral blood flow - specifically that dysphoria is 
associated with flow abnormalities in the left hemisphere and euphoria
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with flow abnormalities in the right,
(3 ) that mood changes are more likely to be associated with classical 
than with common migraine,
(4 ) that unilateral migraine affecting the dominant hemisphere is 
associated with depression and unilateral migraine affecting the non­
dominant hemisphere is associated with euphoria.
Additional hypothesis based on unexpected findings during the 
collection of data from the initial interview:
(5) that olfactory hallucinations which are experienced as part of the 




A consecutive series of new referrals to a migraine clinic were 
recruited to the study if they met the criteria of the Ad Hoc Committee 
on the Classification of Headache for common or classical migraine. All 
patients were women aged between 18 and 65» who did not have other 
serious physical illness. All patients who entered the study had to have 
an average of at least two migraines within a six week period.
All patients had an initial psychiatric interview to obtain social 
and demographic information, details of their migraine symptoms and 
migraine history and an account of the personal and family history of 
psychiatric disorder. The Structured Clinical Interview for DSM-III 
(SCID)(229) was completed to provide a record of both current and past 
psychiatric diagnoses and current levels of anxiety, depression and 
hypomania were evaluated using the Clinical Anxiety Scale (CAS) (230),
o
the,Montgomery and Asberg Depression Rating Scale (MADRS) (231) and the 
Manic Rating Scale (MRS) (232).
The patients were then asked to complete daily visual analogue 
scales (VAS) of anxiety, depression and euphoria and daily Irritability, 
Depression and Anxiety (IDA) (233) questionnaires over the following six 
week period.
Finally patients who consented had regional cerebral blood flow 
measures performed on two occasions - once while the migraine was absent 
and once while it was present. The regional cerebral blood flow 
examinations were obtained using radioactively labelled technetium given
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by peripheral venous injection. The radioactivity was detected using a 
stationary (f camera and linear slope analysis was performed by computer.
Approval for the study was obtained from the Psychiatry and Clinical 
Ethics of Medical Research Sub-Committee of Lothian Health Board and the 
ARSAC prior to initiating the research.
Methodological problems
(i) How to select the population for the survey?
As discussed in Chapter 3 of the literature survey approximately 
half of migraine subjects do not seek medical help for their 
condition. These patients can only be included in studies of migraine 
by using appeals in newspapers or magazines. This involves using 
questionnaires to screen the, hopefully, large number of respondents and 
then possibly obtaining specialist advice on the certainty or otherwise 
of the individual's diagnosis. This is costly and time-consuming and 
obtains only those individuals sufficiently motivated to reply.
Appeals to local general practitioners (GPs) for patients with 
migraine would provide a group of patients in whom the diagnosis was more 
reliable. However, as patients are generally accurate in their replies 
to questionnaires this is not a great advantage. Contacting a large 
number of GPs would probably lead to heterogeneity in referrals and, if 
the GPs were aware of the nature of the study, possibly a bias towards 
patients who they thought would benefit from psychiatric assessment.
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The population selected for this investigation consists of a 
consecutive series of new referrals to a specialist migraine clinic run 
by a general physician with a particular interest in migraine.
The disadvantage of using this group is that it is highly selected 
- firstly because of the patient's own choice over whether to seek 
medical advice and secondly because of the GP's right to select which 
patients to refer on for a specialist’s opinion. It would therefore be 
expected that the patients obtained would be at the more severe end of 
the migraine spectrum with an increased frequency and intensity of 
headaches. The sample might also be biased towards classical rather than 
common migraine on the assumption that both patients and GPs would be 
more concerned about the prodrome to classical attacks.
It is clearly impossible to extrapolate from the results obtained in 
this population to migraineurs as a whole.
However using patients from a migraine clinic has several 
advantages. This type of population has been extensively studied and the 
results of this study can readily be compared with the work of others. 
This group of patients is relatively easy to obtain if there is close 
liaison with the physician in charge of the clinic and bias towards a 
psychiatric type of referral can be avoided by interviewing all new 
patients. The psychiatric interview can be carried out immediately after 
the patient's appointment at the migraine clinic provided the patient is 
agreeable. Most patients find this more convenient than returning for a 
second appointment. Compliance with the research can also be improved by 
allowing the patient to meet the investigator before the psychiatric
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interview. This often helps to allay the patient's fears that the 
physician or the GP secretly thinks that she is mad but does not wish to 
tell her so directly. A migraine clinic population also provides 
patients who have the high frequency of migraine attacks necessary for a 
prospective period of daily ratings of mood and migraine.
The marked female predominance in migraine means that it is 
extremely difficult to obtain a sufficient number of male new referrals 
within the period of time available for data collection to allow 
statistical analysis of the results. This study is therefore restricted 
to women only.
Intercurrent serious physical illness is excluded in order to reduce 
confounding variables which might obscure the relationship between mood 
and migraine.
Uncertainty over whether the pathophysiology of migraine and other 
types of headache, e.g. cluster headache and basilar migraine, is 
identical makes it preferable, within the limitations of the present 
study, to restrict the type of headache studied to the classical and 
common varieties of migraine.
(ii) The selection of appropriate social, demographic and other data
There are no clear guidelines on which questions are most relevant 
in this type of study. As it is, all information obtained from patients 
was based on the areas in the literature survey which seemed most 
appropriate to a psychiatric investigation. General information about
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the population studied was also included to allow this investigation to 
he compared with the work of others.
(iii) Reliability and compliance with self-ratings
Self report is a notoriously unreliable way of collecting 
information particularly when the subject is asked for a retrospective 
account. This was one reason for including prospective daily ratings of 
mood and migraine.
The amount of information patients can be expected to record 
accurately over a six week period is limited. The methods used for data 
collection therefore have to be.simple and quick and yet provide an 
objective measure which is reasonably easy for the investigator to score 
afterwards.
Compliance with this part of the study is difficult to obtain-.
It is improved if a good relationship is formed with the interviewer at 
the initial assessment interview and if the patient is given the 
opportunity to practise completing the scales under the supervision of 
the investigator. Clear written instructions are necessary on how to 
complete the scales at home. In an attempt to reduce bias the patients' 
are advised that the interviewer is just as interested in patients 
without mood changes as in patients who experience them. To improve 
compliance with, and the reliability of, the ratings it is also suggested 
to patients that they complete the scale for the preceding 24 hour period 
just before they go to bed at night. As a 'halo' effect can occur when 
patients are asked to fill in the same rating scale repeatedly patients
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are particularly asked to fill in each scale only for the previous 24 
hour period and not to check back with previous ratings.
Patients are sent a follow-up letter at the end of this phase of the 
study reminding them to return their completed scales to the 
investigator. If no scales are forthcoming patients are contacted again 
by telephone. The more direct the contact the more likely the scales 
are to be returned. (234)
(iv) Choice of rating scales
The aim of the initial interview is to collect a large amount of 
information over a wide spectrum. To avoid overtaxing the patient, and 
thereby jeopardising compliance with further phases of the study, this 
has to be completed within a limited period of time. The overlap between 
symptoms of medical and psychiatric illnesses can cause considerable 
difficulty when attempting to classify psychiatric problems in patients 
who have concurrent physical illness. Where possible scales selected for 
this investigation are designed for use in a medical outpatient 
population and chosen to obtain diverse information quickly.
(v) Choice of method for regional blood flow monitoring
As described in the literature survey regional cerebral blood flow 
can be estimated in several ways. The method used in this survey 
involves a peripheral bolus injection of a measured dose of radioactively 
labelled technetium.
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This technique has several advantages - it is widely available, 
inexpensive and safe. The only discomfort for the patient is the 
venepuncture required for the examination. It is also quick - only flow 
studies are used in the present investigation and these can be obtained 
within 15 minutes.
Numerical values can be obtained for hemispheric transit times and 
fractional flow rates as well as quadratic hemispheric values for areas 
corresponding approximately to frontal, temporal, parietal and occipital 
lobes. Unfortunately contamination from radioactivity in neck 
structures means that the figure for the occipital region is less 
accurate than the others.
(vi) Difficulty in obtaining patient co-operation for repeat cerebral 
blood flow studies
Although the majority of patients'who complete the six week self- 
rating period are agreeable to having cerebral blood flow monitoring 
performed while their migraine is absent it is much more difficult to 
obtain repeat scans when the migraine is present. This is not unexpected 
as it is asking a lot for the patient to come up to hospital for an 
investigation when she is feeling unwell. In an attempt to improve 
compliance patients always have the first scan when headache-free so that 
they can meet the staff and become familiar with the radioisotope 
department when feeling well. They are given a telephone number to ring 
when they next have a migraine and are promised an immediate appointment 
so that they do not have to wait in the department while feeling ill.
When patients are contacted to ascertain the reasons for noncompliance
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with this phase they frequently explain that their headaches arise in the 
evening or at weekends when the radioisotope department is shut. (The 
consultant in charge therefore volunteered to come in out-of-hours if 
patients contacted him and a few more scans were obtained in this way.) 
Patients are also offered taxi fares to assist them in getting safely to 
and from the hospital when feeling unwell. However transport does not 
generally seem to be a problem. Several patients improve considerably 
following their initial interview at the migraine clinic and as a 
consequence have far fewer headaches. As migraine is an episodic disorder 
it is not entirely clear whether this improvement is a result of 
therapeutic intervention or 'spontaneous' remission. I did consider 
attempting to induce migraines with red wine or chocolate but few 
patients had a reliable history of this type of dietary response. It is 
also unclear whether these induced headaches are identical to spontaneous 
migraine.
(vii) Problems encountered in interpretation of the results
The first problem is that the self report of mood change at the 
initial interview frequently disagrees with the data obtained during the 
six week prospective rating period. As a consequence the data are 
assessed in two ways - firstly on the basis of the initial interview and 
then on the basis of the prospective period.
The prospective data are analysed as single cases (using time-series 
analysis) with cross correlation of migraine and mood. (235) This works 
well when there are several attacks of migraine during the six week 
rating period but data are lost if attacks are infrequent. This proved
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to be an insoluble problem. It is also difficult to examine the 
interrelationship of migraine, mood change and menstruation. This has 
been resolved by using time series plots.
(viii) Difficulty in assessment of personality
Personality is one of the most poorly defined concepts in psychiatry 
and measures of personality tend, as a consequence, to be unreliable. (236)
Although I initially intended to include an assessment of 
personality discussion with psychologist colleagues and investigation of 
the tests and literature available convinced me that it would not be 
possible to obtain a quick, reliable assessment of personality which 
would accord with current views on the nature of this concept.
Literature on methods
Questionnaires and scales have three possible uses in psychiatric 
research:
(i) screening to detect the prevalence of a disorder in a community,
(ii) to establish the pattern of symptoms or characteristics in an 
individual or a group,
(iii) to measure the severity of disorders.
Scales are employed for all three purposes in the present 
investigation.
Questionnaires may be completed by the observer or the subject. In
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observer-rated scales the investigator's expectations may bias the 
recording of results e.g. the rating of the severity of illness. The 
rater's personal experiences will also influence the way he or she views 
a disorder e.g. a GP and a psychiatrist might well view the level of 
depression found in a psychiatric in-patient population very differently. 
The major drawback of self-rating scales is that the patient has only 
his/her own experience to draw on in rating the severity of a problem.
It is particularly important to choose the form of words carefully when 
visual analogue scales are used so that they are readily understood by 
a lay population. It has been suggested that the best way of obtaining 
accurate information is to use a combination of observer and self-rated 
scales. However discrepancies can arise between the observer's and the 
subject's views.
There are several general factors which it is important consider 
when selecting a scale for use in an investigation:
(i) the orientation of the scale. There may be an inherent bias in the 
items which make up the scale e.g. the Hamilton Rating Scale for 
Depression (HRSD) emphasises somatic symptoms and psychomotor behaviour 
whereas the Montgomery and Asberg Depression Rating Scale concentrates on 
the patient's report of their mood,
(ii) the scale's ability to distinguish numerically between varying 
degrees of severity across the whole range of a disorder,
(iii) the amount of information which can be derived from the scale 
depends on the type of information it has access to e.g. a self report 
scale cannot assess all somatic symptoms which may or may not be 
concomitants of anxiety,
(iv) the ease with which it can be used,
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(v) how well the scale measures the disorder it was designed to measure - 
this is a particular problem in psychiatry where the symptoms of 
different disorders overlap, e.g. anxiety and depression. (237)
The characteristics of the scale and its suitability for a 
particular study play a major role in determining the validity of the 
results obtained.
Scales selected for the present investigation
Observer-rated scales used in the initial interview.
Structured Clinical Interview for DSM-III (non-patient version) 1983* 
(229)
DSM-III diagnoses have particular advantages. The diagnostic 
criteria are phenomenologically-based and have specific inclusion and 
exclusion criteria. DSM-III thus offers a high, degree of inter-rater 
reliability. Unfortunately it was developed in psychiatric patients who 
did not have serious medical conditions.
There are four possible ways of resolving the problem of diagnosing 
psychiatric illness in patients who have concurrent medical illness:
(i) symptoms can be rated irrespective of whether or not they could be 
attributed to physical disorder. This produces high sensitivity to 
psychiatric disturbance but low specificity and many cases of physical 
illness will be falsely diagnosed as also having psychiatric illness,
(ii) the criteria for psychiatric illness in medically ill patients can 
be altered by specifying those symptoms which are most likely to predict
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psychiatric illness,
(iii) symptoms which are likely to be confused with physical illness can 
be eliminated whereas other, more psychiatric symptoms are retained. 
Which symptoms to include or exclude obviously needs to be clearly 
specified. This method can result in missing patients who are 
psychiatrically ill i.e. although it has high specificity the 
sensitivity is low,
(iv) the investigator can decide, on the basis of clear rules, whether a 
symptom is caused by physical or psychiatric illness and rate it 
accordingly. This is the approach used in the SCID. (238)
The most recent revision of the SCID in the non-patient version was 
obtained for use in the study.
The SCID has two parts - the first takes 5-10 minutes to complete 
and allows the rater to form a relationship with the subject while 
obtaining a brief overview of their current health and circumstances and 
identifying episodes of severe distress in their past history.
The second part of the SCID involves more detailed questioning about 
current and past emotional distress in order to reach DSM-III diagnoses 
if these are applicable. This can take anything from 20-40 minutes 
depending on the amount of psychopathology. The SCID is orientated 
towards affective disorder and neurotic illness but also includes a 
brief psychotic screening section. This is appropriate for use in a 
medical outpatient clinic population. Training in completion of the 
SCID was carried out in accordance with the Instruction Manual. (229)
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A recent study demonstrated that the SCID had high inter-rater 
reliability and could also distinguish between generalised anxiety 
disorder and major depression in an outpatient population. (239)
The Montgomery and Asberg Depression Rating Scale (MADRS). (1979) (231)
This instrument was derived from the Comprehensive 
Psychopathological Rating Scale (CPRS) (Asberg et al 1978)* (240) The 
CPRS is made up of 65 scaled items which cover a wide range of 
psychiatric symptoms. The 17 items which occurred most commonly in 
depressed patients were used as the basis for the MADRS. The ten items 
most sensitive to change were then selected to form the final scale. The 
MADRS has good inter-rater reliability and is valid when compared with a 
global clinical assessment. The MADRS has fewer items to score than the 
Hamilton Rating Scale for depression, a standard instrument, but has 
equally high reliability (241 » 242). There is also less emphasis on 
somatic symptoms than in the HRSD and clear instructions on grading 
scores of individual items and this makes it particularly useful in a 
medical outpatient population. The MADRS has high specificity for 
depression and there is only one item which overlaps with the Clinical 
Anxiety Scale. This reflects the common association of anxiety symptoms 
with depression. (241) Nonetheless the two scales appear to measure 
different dimensions of mood disturbance. Snaith has subsequently 
established score ranges for the MADRS which allow patients to be grouped 
into recovered mild, moderate and severe categories. He has recommended 
that the MADRS be used concurrently with the Clinical Anxiety Scale.
(243)
- 227 -
The Clinical Anxiety Scale (1982) (230)
The CAS was obtained by item analysis of the Hamilton Anxiety Scale 
(HAS). The HAS has 88 symptoms of anxiety included in 15 variables.
Each variable is rated on a five point scale. In a two stage procedure 
correlations of individual items with a severity rating were obtained and 
then a number of scales made up of items with the highest correlations 
were compared in a new patient group. The final CAS consists of six 
items largely confined to psychic anxiety and muscle tension. The HAS 
and the CAS were both developed in clinical populations suffering from 
anxiety neurosis. However where the HAS was standardised on a group of 
35 patients who were taking part in a drug trial, and therefore presumably 
all had moderate to severe anxiety requiring medication, the CAS was 
developed in a group of both out- and in-patients who covered a spectrum 
from recovery to severe anxiety disorder. The authors of the CAS have 
suggested that although it is intended for use in a clinical population 
it may have wider applicability than the HAS and can also be used-in 
patients with anxious personality disorder. The decreased emphasis on 
somatic anxiety compared to the HAS may make the CAS more valid in the 
assessment of anxiety in patients with medical rather than psychiatric 
disorders. (230, 244)* Score ranges which allow the severity of anxiety 
to be graded have subsequently been determined in the same way as for the 
MADRS described earlier. (243)
Manic Rating Scale (MRS) (232)
Euphoria has been reported as part of the migraine prodrome and 
subsequent to attacks. It is therefore as important to document
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elevation of mood at the initial interview as it is to record depression. 
There is no totally satisfactory scale is available to measure elation in 
a non-patient population. All existing scales are for use in 
psychiatrically ill in-patient populations. The MRS is an eleven item, 
clinician-administered scale which is based on the core symptoms of the 
bipolar phase of affective disorder and includes abnormalities which 
cover the range from mild to severe illness. This scale is reliable, 
valid and sensitive and appears to function over the entire range of 
severity of manic illness. It is shorter and more sensitive than other 
available scales. (232,245*246,247)•
Assessment of Handedness and Cerebral Dominance
The assessment of cerebral dominance from handedness is not entirely 
straightforward as the preferred hand is not necessarily constant when a 
variety of manual behaviours are sampled. Handedness can be assessed 
either by presenting the subject with unfamiliar tasks which he is asked 
to complete with minimal practice or by using inventories of everyday 
tasks. In the present context, in conjunction with all the other rating 
scales being used and given that cerebral dominance was not the main 
focus of the study, I felt that a very simple measure of cerebral 
dominance was appropriate. This study therefore defines cerebral 
dominance on the basis of the position of the hand in writing. (248,249)
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Self-Rating Scales used in the 6 week prospective rating period
Visual Analogue Scales and recording of migraine and menstruation
The Visual Analogue Scale is a widely used method of obtaining self- 
ratings of mood rapidly and easily. (250) Three separate 10cm lines are 
used to record daily estimates of anxiety, depression and auphoria. The 
anxiety dimension extends from 'completely relaxed' to 'extremely 
anxious'. Depression is rated on a 10cm line from 'totally miserable' 
to 'my usual self’ and euphoria from 'my usual self’ to 'high as a 
kite'. Care is taken over the language used and the way the lines are 
printed. Subjects are asked to put across against 'my usual self' if 
neither elated nor depressed and to use one or other dimension for a 24 
hour period taken overall rather than using both lines. Subjects 
generally found this concept easy to grasp and had little difficulty with 
the scales. After completing the scales they are asked to check a box 
for the presence or absence of migraine and, in a subsample of patients, 
also the presence or absence of menstruation. In retrospect a measure of 
the intensity of the migraine would have been more useful than a simple 
record of presence or absence but the initial intention was to look more 
intensively at the mood changes themselves rather than the 
characteristics of the migraines. The only measures of migraine severity 
available are therefore frequency and duration. Subjects are asked to 




The use of self-rating scales depends on the patient's literacy and 
ability to concentrate and may be biased by the patient's desire to 
present him/herself in a particular way. However they are economical of 
time and personnel and can be used repeatedly by the same patient. (257)
Self-assessment scales for depression can be classified into those 
which measure the symptoms of depressive illness and those that are 
concerned with measurement of depressed mood. Depressive affect can be 
assessed by asking patients to check lists of adjectives and mark the 
ones they feel best apply to them. The Zung Self Rating Scale (ZRS) for 
Depression is widely used and designed as a simple scale for patients to 
complete without assistance. The patient indicates the frequency with 
which he experiences each symptom and the scale includes affective, 
psychological and somatic features. However by comparison with the 
observer-rated Hamilton Rating Scale for Depression the ZRS is limited in 
its access to relevant information for rating depression. The ZRS does 
not appear to be sensitive over a wide range of clinical depression. 
(252,253). The Leeds self assessment scales for anxiety and depression 
might also have been suitable instruments for the present study but are 
rejected in favour of the Trritability-Depression-Anxiety Scale on the • 
grounds that the IDA gives a measure of irritability in addition to 
depression and anxiety and the fact that it is easier for patients to 
complete one scale covering all aspects of mood than a number of scales 
dealing with each aspect separately. (254)
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Irritability-Depression-Anxiety Scale (IDA) (Snaith et al 1978)
Irritability is often described as a concomitant of migraine attacks. 
Aggression is a difficult concept to define and scales which attempt to 
measure it often vary in whether they are concerned with enduring 
personality characteristics (traits) or temporary psychological 
experiences (states). The concept of irritability used in the IDA is 
a temporaiy psychological state characterised by impatience, intolerance 
and poorly controlled anger. This can be expressed inwardly towards 
oneself or outwardly towards others. The combination of measurement of 
irritability with depression and anxiety provides an opportunity to 
investigate the relationship between the three mood states. The IDA is 
based on items selected from the Hostility and Direction of Hostility 
Questionnaire (1967)* tbe Buss-Durkee Inventory (1957) and the Hamilton 
Rating Scales for anxiety and depression. The IDA consists of 18 items, 
each with 4 possible responses. There are 5 items each for depression 
and anxiety and 4 items each for outwardly directed and inwardly directed 
irritability. The scale has been validated in both inpatient and 
outpatient populations. (237*243*255)• Outwardly expressed irritability 
appears to be an independent mood disorder but the relationship of 
irritability to other psychopathological concepts is poorly defined.
There are no data on whether irritability differs with gender but there 
does seem to be an inverse relationship with age. It is also found in 




Three scales were constructed to measure anxiety, depression and 
euphoria on the basis of information obtained from the pilot study.
These are completed daily immediately after the IDA.
Regional cerebral blood flow monitoring by cerebral scintigraphy
Pertechnetate is the most widely used substance for cerebral 
scintigraphy. The radioactively labelled form is readily avilable and 
decays giving abundant ^ radiation. It has a half-life of 6 hours which 
allows a large amount of activity to be delivered. The ^radiation 
emitted is recorded using a ^camera with on-line acquisition facilities. 
The camera uses a stationary detector which views all parts of the
scintillation crystal which absorbs energy from ionising radiation and 
emits weak flashes of light and an array of photomultipliers which 
convert the light flashes into electrical pulses. A collimator ensures 
that each part of the crystal looks at only a small area of the patient. 
When a scintillation occurs within the crystal the light is divided 
between the photomultipliers and the relative pulse sizes give the 
position of the scintillation. Pulses from individual photomultipliers 
are also summed and passed to a pulse-height analyser to measure the 
total energy loss in the interaction.
Pertechnetate is bound by the thyroid gland and thyroid blocking 
agents are therefore routinely administered before cerebral scintigraphy 
with pertechnetate. The patient is then positioned in front of the
field simultaneously. The
-  233 -
camera and a lead collar not less than 2mm thick is fitted closely round 
the neck to prevent scattered radiation from the neck and trunk reducing 
contrast and obscuring abnormalities in the cerebral circulation. A 
vertex view gives the best visualisation of the greatest part of the 
cerebral cortex. Data collection starts just before the injection of 
pertechnetate. As there are few counts in each frame of the study the 
image quality is correspondingly poor. Visualisation of abnormalities is 
improved if sets of frames are summed. The optimum timing can be found 
by plotting the total count rate in each frame against time. The arrival
of the bolus at the head can then be identified from the graph. The peak
of the curve occurs late in the venous phase when most of the activity is
in the superior sagittal sinus. Frames occurring between the arrival of
the bolus and this peak can be regrouped into four longer frames with 
improved count content and image quality. These frames correspond 
approximately to the angiographic phases referred to as arterial, early 
capillary, late capillary/early venous and late venous.
An activity of between 600-750 mBq (15-20 mCi) of pertechnetate in 
up to 2ml of fluid is given as a rapid intravenous bolus into a large 
vein as centrally as possible. The bolus is flushed into the right 
atrium with 10-20ml of normal saline or 5% dextrose which is injected as 
rapidly as possible immediately after the radioactivity.
Data are available on the net cortical transit time, net fractional 
flow and net large vessel transit time for each hemisphere. In addition 
values can be provided for each of these variables for each quadrant of 
the hemisphere. These correspond roughly to the frontal, temporal, 
parietal and occipital lobes. (256)
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Pilot Study
Prior to initiating the main study the physician in charge of the 
migraine clinic was asked to select, from patients already known to him, 
those who spontaneously complained of mood changes in association with 
their migraines. Five patients then had an unstructured interview during 
which they were asked to describe the mood changes that they and their 
families were aware of and their pattern with respect to the headaches. 
They were particularly invited to supply the adjectives which they felt 
best applied to these mood states. The intention was to obtain an 
assessment of the kind of mood changes experienced, their intensity and 
their timing in relation to the migraines themselves. The adjectives 
suggested by the patients were used as the basis for the wording of the 
Visual Analogue Scales used later in the study. These patients then took 
part in the structured clinical interview and the prospective rating 
period. Their results were^not included in the analysis of initial 
interview data to avoid bias towards an affective change group and to 
allow assessment of a consecutive series of new referrals to the clinic. 
However their prospective ratings were included in the total analysis of 
mood change and migraine.
Modifications
The pilot study highlighted the necessity of allowing subjects to 
practise completion of the visual analogue scales and the IDA in the 
presence of the interviewer. This allowed questions and uncertainties 
about the scales to be dealt with immediately. It also proved necessaary
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to give subjects brief written instructions on how to complete the scales 
at home as they appeared to have difficulty in retaining this information.
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(D) Results
The Initial Psychiatric Interview (Table I)
Table I presents the descriptive statistics obtained in the first 
phase of the study. Data from the pilot study group are not included 
here to avoid generating a bias towards patients with complaints of 
affective change.
The sample consists of a consecutive series of new referrals to a 
specialist migraine clinic. Subjects were collected over the 18 month 
period between November 1985 and March 1987* All patients were referred 
to the clinic by their GPs. All new female patients aged between 18 and 
65 who had a diagnosis of common or classical migraine and no other 
serious intercurrent physical illness were invited to participate in the 
initial interview.
Seven patients did not attend for the research appointment. All had 
had no personal contact with me when they were seen by the physician at 
the clinic. Each patient was sent a full written explanation of the 
purpose of the study and the procedures involved and given the 
opportunity to decline further contact. They then had two offers of 
appointment dates and times. Two of these patients found that their 
migraine improved after they saw the physician and one of them also had a 
fall which resulted in back pain and temporarily reduced her mobility.
Two further patients had addresses outwith the Edinburgh area which could 
have made travel to the hospital for further appointments more difficult. 
There is no information available on the reasons for non-participation
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amongst the remaining three patients.
Social and Demographic variables
The patients were predominantly middle aged, married ladies in the 
upper social classes. This age and class distribution is similar to that 
reported in studies of migraine clinic populations. (11 ,18)
Migraine variables
Over half the patients had classical migraine, a reversal of the 
picture seen in the general population where common migraine is more 
frequent. (28) As expected the majority of patients were having frequent 
attacks of migraine.
Most patients had unilateral headaches. Unilateral pain is 
generally accepted as a diagnostic feature of migraine whereas 
bilaterality is a feature of muscle-contraction headaches.
Migraine symptoms
Symptoms were divided into definite and questionable neurological 
symptoms and general symptoms on the basis of work by Couch, Hassanein & 
Ziegler. (75) Amongst definite neurological symptoms paresis, sensory 
loss and speech disturbance were relatively common whereas loss of 
consciousness was a rare finding.
Visual disturbance and difficulty in thinking were common 
questionably, neurological symptoms. Visual disturbance has a well-known
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association with migraine attacks. The difficulty in thinking was 
described by patients in terms of impaired attention and concentration.
The general symptoms of nausea, vomiting and photophobia were all 
extremely common. In fact, these are often important secondaiy symptoms 
which are used in making the diagnosis of migraine.
Hallucinatory experiences were reported by a small percentage of 
patients on specific questioning. Olfactory hallucinations and 
distortions of body image in the face, head and neck areas were the most 
common symptoms.
Most patients had had a long history of migraine prior to referral. 
The referral was generally made because of a recent increase in the 
frequency or severity of the migraine attacks. The physician's main 
therapeutic intervention at the medical consultation was to change the 
patient's drugs. The results obtained from a comparison of the patient's 
medication before and after this appointment reflect his objectives.
These were:
(1 ) to decrease the number of different preparations to the minimum 
required,
(2) to produce effective symptom relief during the acute attack,
(3) to prescribe prophylactic medication if the attack frequency 
justified regular drug intake.




Few patients entirely discounted emotional factors as precipitants 
of their migraine attacks, but only a small number were convinced that 
this was always the case.
Only a small number of patients were on the oral contraceptive - 
partly because of their age and partly because a history of migraine is 
now considered to be a contraindication to its use. Only a third of 
patients believed that their migraine was always related to 
menstruation.
Psychiatric history
Just over half the patients had a previous.history of psychiatric 
illness and one third had a current DSM-III diagnosis of affective 
disorder. This increased to almost two thirds when past diagnoses of 
affective disorder were also included. However retrospectively-made 
diagnoses are inevitably less certain than current illnesses as they are 
so dependent on the patient's recollection of the symptoms which were 
experienced at that time.
Mood change
The proportion of patients with complaints of mood change in 
association with their migraines was much higher than that expected from 
the literature review. Twenty-six per cent felt this was an inevitable 




Results (initial Interview - total group)
(A) Social and demographic variables (46 subjects)
(i) Age Range 20-61 yrs
Mean 38.8 yrs 
Median 40.5 yrs 
Standard deviation 11.03





(iii) Social class 40 subjects (4 subjects were excluded by the
Registrar General's classification system and 2 subjects did 
not provide sufficient information to allow class allocation).
1 = 8  (20%) II = 13 (32.5$) III = 16 (40$) IV = 1 (2.550 V = 2 (550
(B) Migraine
(i) Type classical = 26 (56*5$)
common = 20 (43*550
(ii) Average number of migraine attacks in a 6 week period 
Range 1-42, mean 10-29, median 3 , standard deviation 13*22.
(iii) Cerebral dominance right = 3 (8.7$)
left = 42 ( 91 *350
(iv) Laterality unilateral right
unilateral left 
bilateral
unilateral right and left 
both bi- and unilateral
(v) Symptoms 








speech disturbance absent 30 (65-2:0
present 16 (34-8%)

















symptoms - dizziness absent 26
present 20
blurred vision absent 23
present 23








psychotic phenomena absent 39
present 7
(v) Length of migraine history
Range 1—44 yrs, mean 12.87, median 10, standard deviation 9.<
(vi) Family history of migraine absent 24
present 22




combination with ergot 1 
combination without ergot 23
(viii) Change of medication after interview with physician no 6
yes 40
(ix) New medication none 6 (13$)
painkiller 2 (4 .3$)
prophylactic 22 (4 7*8$)
antidepressant 3 (6 -5$)
combination with ergot 3 (6 .5$)
combination without ergot 9 (19*6$)
acupuncture 1 (2 -2$)
(C) Predisposing Factors
(i) Emotional trigger to attacks never 12 (26-1$)
sometimes 25 (5 4*3$)
usually 6 (13$)
always 3 (6 .5$)
































(i) Personal psychiatric history none 21 (45*7$
seen by GP for psychiatric illness 18 (39*1$
seen by psychiatrist for psychiatric illness 6 (13$)
other 1 (2.2$)
(ii) Pamily history of psychiatric illness absent 33 (71 *7$)
present 13 (28-3$)
(iii) DSM-III diagnosis of affective disorder absent 22 (4 7 .8?)




Current only absent 51 (67.4?)
present 15 (32.6%)
(E) Mood
(i) Frequency of mood change in association














33 (71 -7?) 
13 (28.3?)
euphoria absent 40 (87?)
Clinical anxiety scales scores
present 6 (13?)
Range =0-19, mean 4*8, median 3, standard deviation 4*7.
Normal range (<5) 26 patients
Mild anxiety (5-10) 13 patients
Moderate anxiety (11—19) 7 patients
(iv) Montgomery and Asberg depression rating scale scores 
Range = 0-31, mean 9.0, median 8, standard deviation 8«
Normal range (>7) 19 patients
Mild depression (7-19) 21 patients
Moderate depression (20-31) 6 patients
(v) Manic rating scale scores
Range = 0-10, mean 2*3, median 1, standard deviation 2-6.
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Results from the Initial Interview - Group Comparisons
The initial intention was to define affective and non-affective 
groups of patients on the basis of the presence or absence of complaints 
of migraine-related mood changes at the initial interview. However, after 
these data had been collected it became apparent that a much higher 
proportion of patients than expected had current and past DSM-III 
diagnoses of affective disorder using the SCID. It therefore seemed 
reasonable to reallocate the patients into affective and non-affective 
groups using this as a criterion and then to re-examine the differences 
between the groups using the descriptive variables. The diary data also 
showed that the patients' initial reports of mood change did not 
correspond well with the mood states which they recorded during the 
prospective rating period. An arbitrary decision was made to allocate 
patients into affective and non-affective categories on the basis of the 
number of significant point biserial correlations found during migraine 
attacks. This was used as a third way of viewing the affective and non- 
affective dimension. Finally, as common and classical migraine may have 
different pathophysiologies and this, in turn, may be related to the 
production of mood changes patients were also grouped on the basis of the 
type of migraine they experienced.
The descriptive data was reorganised on the basis of the type of 
scale used to measure each variable and the appropriate statistical tests 
were applied. The SPSSX computer package of statistical tests was used 
throughout. (257)
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Interval scales with normally distributed data
Affective 17 patients, Non-affective 29 patients
Affective 24 patients, Non-affective 22 patients
Affective 12 patients, Non-affective 7 patients
Classical 26 patients, Common 20 patients
(1) t-test Variable = age
Mean Standard Separate Degrees of 2 Tailed










DSM-III Aff 38.1 10 -0.14 40.34 0.89








Classical/ Cl 37.6 11 .1 -0.5 40.57 0.62









Interval scales where the data were not normally distributed -
Mann Whitney U-tests







Initial interview 181 0.13
DSM-III diagnosis 175 0.001











Initial interview 156.5 0.01
DSM-III diagnosis 117 0.001












Initial interview 107 0.001
DSM-III diagnosis 125 0.002











Initial interview 232 0.87
DSM-III diagnosis 212.5 0.26













Initial interview 243.5 0.95
DSM-III diagnosis 203 0.17











Initial interview 0 0
DSM-III diagnosis 119.5 0.0007












Initial interview 194.5 0.19
DSM-III diagnosis 238.5 0.54











Initial interview 223.5 0-58
DSM-III diagnosis 194.5 0.1






Chi-squared tests were performed for all other variables unless more 
than 20$ of the cells had an expected frequency of less than 5 . In 
this case the Fisher exact test was used instead. The entries in 
each cell were independent. The Yates correction was used for all 
chi-squared tests. These were also always two-tailed.
(1) Type of Migraine









Classical 14 12 26
(56.5)
Migraine
Common 5 15 20
(43-5)
















Chi square = 1.36, 1 degree of freedom (D.F.) Chi square = 0, 1 D.F. 
p < 0*24, minimum expected frequency (EF) 7«4 P < 1, min EF 9*6, 
no cells with EF < 5 . no cells EF < 5*
Diary data - Fisher's exact test p < 1
(2) Cerebral dominance
Initial interview - Fisher's exact test p < 0*53
DSM-III diagnosis - Fisher's exact test p < 0*27
Diary data - Fisher's exact test p < 1
Classical/common - Fisher's exact test p < 0*41
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(3) Unilateral versus bilateral symptoms
The 5 categories which were initially used to describe the laterality 
of the migraine headache produced too few patients in each cell to 
permit either chi square or Fisher exact tests. They were therefore 
condensed into unilateral and bilateral headache and the appropriate 
tests applied.
Initial interview - Fisher's exact test p < 0*77 
Diary data - Fisher’s exact test p < 0-36
DSM-III Diagnosis Classical/Common
Aff NAff Class Common
Unilateral 18 16 34 Unilateral 19 15 34
(17.7) (16.3) (19-2) (14.8)
Bilateral 6 6 12 Bilateral 7 5 12
(6.3) (5.7) (6.8) (5-2)
24 22 26 22
Chi square = 0.03, 1 DF. Chi square = 0.02, 1 DF.
p > 0-5, min EF 5-7, p < 0.9» min EF 5-2,
No cells with EF < 5* No cells with EF < 5 •
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(4) Paresis
Tiie different categories for paresis had to be condensed down 
to the presence or absence of this symptom to make statistical 
tests possible.
Initial interview - Fisher exact test p < 0.15 
Diary data - Fisher exact test p < 0.24
DSM-III Diagnosis Classical/Common
Aff NAff Class Common
Absent 15 20 35 Absent 17 18 35
(18.3) (16.7) (19-8) (1 5-2)
Present 9 2 11 Present 9 2 11
(5-7) (5-3) (6 .2) (4.8)
24 22 46 26 20 46
Chi square = 5«09» DF = 1 Chi square = 3 .76, DF = 1
p < 0.02, min EF = 5.3 , p < 0*06, min EF 4 •8,




The data again had to be condensed down to presence or absence of 
sensory disturbance to allow statistical analysis.
Initial interview - Fisher exact test p
DSM-III diagnosis - Fisher exact test p
Diary data - Fisher exact test p
Classical/common
Classical Common
Absent 18 18 36
(20-3) (15*7)
Present 8 2 10
(5-7) (4-3)
26 20 46
Chi square = 2.87» DF = 
1 cell with EF < 5»






Diary data - Fisher's exact test p < C M 7
Initial Interview DSM-III Diagnosis
Aff NAff Aff NAff
Absent 10 20 30
(65*2)
Absent 15 15 30
(65*2)
Present 7 9 16
(34.8)














Chi square = 0.14, DF = 1 Chi square = 0.009, DF = 1 ,
p < 0*7, min EF = 5*9* p < 0.92, min EF 7 .7 .
Classical/Common
Classical Common
Absent 14 16 30
(6 5.2)




Chi square = 2-35, DF 
Min EF = 6*95
20 46 
(43-5) (100)
= 1 , P < 0.13
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- Fisher's exact test p < 0*7
- Fisher's exact test p < 0*53
- Fisher's exact test p < 0.6
- no patient in either the affective or the 




-Fisher's exact test p < 0*62
DSM-III Diagnosis
Aff NAff Aff NAff
Absent 9 17 26
(56-5)
Absent 9 17 26
(56.5)
Present 8 12 20
(43-5)














Chi square = 0.14, DF = 1 Chi square = 7.39, DF = ..1,
p > 0.5, min EF = 7 .4
Classical/common
Classical Common
Absent 14 12 26
(56.5)








= 1,  P < 0 . 9
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(g) Blurred vision
Diary data - Fisher's exact test p < 0.65
Initial Interview DSM-III Diagnosis
Aff NAff Aff NAff












Present 9 14 25
(50)














Chi square = 0, DF = 1 Chi square = 0.08, DF = 1.
p < 1 , min EF = 8*5 P < 0-77> min EF = 11.
Classical/common
Classical Common
Absent 9 14 23
(50)








Chi square = 
Min EF = 10*
4-3. DF = 1, p < 0.04
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(10) Difficulty thinking
Diary data Fisher's exact test p < 1
Initial interview DSM-III diagnosis
Aff NAff Aff NAff
Absent 3 13 16 Absent 6 11 17
(3 4.8) (37)
Present 14 16 30 Present 18 11 29
(65.2) (63)
17 29 46 24 22 46
(37) (63) . (100) (52.2) (47-8) (100)
Chi square = 2»4» DF = 1 Chi square = 2»1, DF = 1 ,
p < 0.12, min EF = 5*9 p < 0.15t min EF = 8.13
Classical/common
Classical Common
Absent 7 10 17
(37)




Chi square = 1 .69 , DF = 1, P < 0.19
Min EF = 7 .4
(11) Nausea
Initial interview _ Fisher's exact test p < 0«61
Diary data - Fisher's exact test p < 1
Classical/common - Fisher's exact test p < 0.05
DSM-III diagnosis - Fisher's exact test p < 0.62
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(12) Vomiting
Diary data - Fisher's exact test p < 0.66
DSM-III Diagnosis Initial Interview
Aff NAff Aff NAff
Absent 12 7 19 
(41.3)
Absent 10 9
Present 12 15 27
(58.7)
Present 7 20
24 22 - 46 17 29
(52.2) (47.8) (100) (37) (63)
Chi square = 0.9, DF = 1 Chi square = 2*36, DF = 1 ,
p < 0*34> EF = 9*1 P < 0*12, min EF = 7»
Classical/common
Classical Common
Absent 10 9 19 
(41 -3)








Chi square = 0.02, DF = 1, p < 0.89 
Min EF = 8 .3
(13) Photophobia
Initial interview - Fisher's exact test p < 0.18
DSM-III diagnosis - Fisher's exact test p < 0*55
Diary data - Fisher's exact test p < 0.6
Classical/common - Fisher's exact test p < 0.65
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(.14) Psychotic phenomena
Initial interview - Fisher's exact test P < 0.007
DSM-III diagnosis - Fisher's exact test P < 0.28
Diary data - Fisher's exact test P < 0.52
Classical/common - Fisher's exact test P < 0.65
(15) Family history of migraine
Diary data - Fisher's exact test p < 0 .63
Initial interview DSM-III diagnosis
Aff NAff Aff NAff
Absent 13 11 24 Absent 15 9 24
(52.2) (52.2 )
Present 4 18 22 Present 9 13 22
(47-8) (47.8)
17 29 46 24 22 46
(37) (63) (100) (5 2.2) (47.8) (100)
Chi square = 4*93> DF = 1 Chi square = 1.3 7, DF = 1 ,
p < 0*03, min EF = 8.13 p < 0.24» niin EF = 10.5
Classical/common
Classical Common
Absent 13 11 24
(52.2)




Chi square = 0.002, DF = 1 , p < 0«97 
Min EF = 9 .6
(16) Change of medication
Fisher's exact test p <
Fisher's exact test p <
Fisher's exact test p <
Fisher's exact test p <
(17) Oral contraceptive
Initial interview - Fisher's exact test p <
DSM-III diagnosis - Fisher's exact test p <
Diary data - Fisher's exact test p <














(18) Personal psychiatric history
The information available on this variable included data on whether 
the illness had been treated by the GP or a psychiatrist. In order 
to obtain sufficient patients for each cell in a chi square test 
the categories were condensed into (l) absent i.e. no psychiatric 
illness and (2) present i.e. illness treated by GP, psychiatrist or 
other specialist in mental illness. (Full details of illnesses are 
available in the abbreviated case histories in the appendix.)
Diary data - Fisher's exact test p < 0.08
Initial interview DSM-III diagnosis
Aff NAff Aff NAff
Absent 6 15 21 Absent 4 17 21
(7 .8) (13-2) (11) (10)
Present 11 14 25 Present 20 5 25
(9-2) (15.8) (13) (12)
17 29 46 24 22 46
Chi square = 1.17, DF = 1 Chi square = 16.99, DF = 1 ,
P < 0.3, min EF = 7*8 p < 0 .001, min EF = 10
Classical/common
Classical Common
Absent 12 9 21
(11-9) (9.1)
Present 14 11 25
(14.1) (10.9)
26 20 46
Chi square = 0.01, DF = 1, 
Min EF = 9.1
p < 0.8
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(19) Family psychiatric history
This was again condensed to the presence of absence of illness. 
Details of relatives' illnesses and treatment, where available, 
are contained in the abbreviated case histories in the appendix.
Initial interview 
Diary data
- Fisher's exact test p < 0*87
- Fisher's exact test p < 0*6
DSM-III Diagnosis Classical/Common
Aff NAff Class Common
Absent 16 17 33 
(71 .7)
Absent 19 14 33 
(71 .7)
Present 8 5 • 13
(28.3)














Chi square = 0.22, 
p < 0.6, min EF =
DF = 1 
6.2,
Chi square =0, DF = 
p < 1, min EF = 5 .7
1
(20) Self report of mood change - Depression
Initial interview Fisher' s exact test; p < 0.006
Diary data Fisher's exact test p < 1
Classical/Common DSM-III Diagnosis
Class Common Aff NAff
Absent 16 17 33 
(71 -7)
Absent 14 19 33 
(71.7)
Present 10 3 13
(28.3)















Chi square = 2.02, 
p < 0*16, min EF =
DF = 1 
5-7
Chi square = 3 .17, DF 




(21) Self report of mood change - Anxiety
Initial interview _ Fisher's exact test p < 0.14
DSM-III diagnosis - Fisher's exact test p < 0.07
Diary data - Fisher's exact test P < 1
C las s i cal / c omm on - Fisher's exact test P < 0.79
(22) Self report of mood change'- Euphoria
Initial interview Fisher's exact test p < 0.12
DSM-III diagnosis - Fisher's exact test p < 0*38
Diary data - Fisher's exact test p < 0.12
Classical/common - Fisher's exact test p < 0.78
(23) Self report of mood change - Irritability
Initial interview Fisher's exact test p < 0.0008
Diary data - Fisher's exact test p < 0.12
DSM-III Diagnosis C las s i cal/C omm on
Aff NAff Class Common
Absent 13 20 33 Absent 17 16 33
(71.7) (71.7)
Present 11 2 13 Present 9 4 13
(28.3) (28-3)
24 22 46 26 20 46
(52.2) (47.8) (100) (56-5) (43-5) (100)
Chi square = 5 .9 , DF = 1 Chi square = 0-58, DF - 1
p < 0.015, min EF = 6.2 p < 0.45f ^in EF = 5*7
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(24) DSM-III diagnosis of psychiatric illness - affective disorder
Full details of all DSM-III diagnoses made are contained in Tables 
III and IV. This concerns only current and past DSM-III diagnoses 
of affective disorder. (The affective diagnoses available using the 
SCID are the DSM-III categories of Bipolar Disorder, Cyclothymic 
Disorder, Major Depression, Dysthymic Disorder and Affective Disorder 
not otherwise specified.)
Diary data - Fisher's exact test p < 0»45
Initial Interview Classical/Common
NAff Aff
(as defined by self report of 




Aff Diagnosis 18 3
Absent (13.2) (7-8)
SCID
Aff Diagnosis 11 14
Present (15-8) (9-2)
29
Chi square = 8«52, DF = 1 






Aff Diagnosis 10 11 21
Absent (11) (10)
SCID
Aff Diagnosis 14 11 25
Present (13) (12)
24 22 46
Chi square = 0.52, DF = 1
p < 0*5» mia EF = 10
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Nominal scales with too many categories for chi square 
or Fisher exact tests
Some variables proved impossible to condense into suitable categories 
for statistical analysis. The raw data are presented below with the 
observation that no differences between groups are apparent on visual 
inspection of the figures.
(1) Marital Status
Initial Interview DSM-III Diagnosis
Aff NAff Aff NAff
Single 3 5 Single 4 5
Married 12 15 Married 14 13
Widowed 1 2 Widowed 1 1
Divorced 0 6 Divorced 0 6
Separated 1 1 Separated 2 0
17 29 24 22
Diary Data Classical/Common
Aff NAff Aff NAff
Single 1 4 Single 4 5
Married 6 7 Married 18 9
Divorced 0 1 Widowed 1 1




Marital status was condensed for the classical/common groups and 




Married 18 9 27
(15.3) (11-7)
Others 8 11 19
(10.7) (8.3)
26 . 20 46
Chi square = 2*74» DF = 1 , p < 0.1 
Min EF = 8*3
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(2) Current medication (when referred)
Initial Interview DSM-III Diagnosis
Aff NAff Aff NAff
None 3 3 None 3 3
Analgesic 4 7 Analgesic 5 7
Prophylaxis 1 3 Prophylaxis 2 1
Antiemetic 0 0 Antiemetic 0 0
Antidepressant 0 1 . Antidepressant 1 0
Combination Combination
with Ergot 0 1 with Ergot 1 0
Tranquillisers 0 0 Tranquillisers 0 0
Combination Combination
without Ergot 9 14 without Ergot 12 11
Acupuncture 0 0 Acupuncture 0 0
Steroids 0 0 Steroids 0 0










with Ergot 0 0
Tranquillisers 0 0
Combination 




The categories ’no medication' and 










with Ergot 0 1
Tranquillisers 0 0
Combination




'on medication' were compared in 
- the Fisher exact test probability
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(3) New medication (after the interview with the physician)
Initial Interview
Aff NAff
0 None 3 3
1 Analgesic 1 1
2 Prophylaxis 8 14
3 Antiemetic 0 0
4 Antidepressant 2 1 •
Combination
5 with Ergot 1 2
6 Tranquillisers 0 0
7 Combination
without Ergot 1 8
8 Acupuncture 1 0










with Ergot 2 1
Tranquillisers 0 0
Combination







0 None 2 2
1 Analgesic 0 0
2 Prophylaxis 3 5
3 Antiemetic 0 0
4 Antidepressant 0 1
Combination
5 with Ergot 0 1
6 Tranquillisers 0 0
7 Combination
without Ergot 2 3
8 Acupuncture 0 0










with Ergot 1 2
Tranquillisers 0 0
Combination





For the classical/common group prophylactic medication versus all 













Chi square = 2«33> 
Min EF = 9 .6
DF = 1, p < 0.15
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TABLE II
Summary table of significance levels for all variables
Group 1 Affective/Non affective (initial Interview)
Group 2 Affective/Non affective (DSM-III diagnosis based on SCID)
Group 3 Affective/Non affective (Diary data)
Group 4 Classical/Common
VARIABLE (1) Affective/ (2) Affective/ 
Non affective Non affective 
Initial interview (DSM-III)
(3 ) Affective/ 
Non affective 
Diary data
(4 ) Classical/ 
Common
Social & Demographic Variables

















migraine 0.24 (x2) 1 U 2) 1 (FET) Not applicabl
Frequency 
of migraine 0.95 (MW) 0-47 (MW) 0.49 (MW) - ' 0.27 (MW)
Cerebral
dominance 0.53 (PET) 0.27 (PET) 1 (FET) 0.41 (PET)
Uni/bilat
symptoms 0*77 (PET) NS 0-36 (PET) 0.9 (x2)
Paresis (A/P) 0.15 (FET) p<0.02* (x2=5.09) 0.24 (FET) 0.06 (x2)
Sensory dist­
urbance (a /p ) 0.27 (FET) 0.05* (PET) 0.07 (PET) 0.08 (x2)
Speech
disturbance 0.7 (x2) 0-92 (x2) 0.17 (PET) 0.13 (x2)
Loss of con­
sciousness 0.7 (PET) 0.53 (PET) 1 (X2) 0.6 (PET)
Dizziness 0.94 (x2) p<0.02* (x 2=5»86) 0.62 (PET) 0.9 (x2)
Blurred
vision 1 (x2) 0.77 (x2) 0.65 (PET) p<0.03* (x2=4
Difficulty
thinking 0.07 (x2) 0.15 (x2) 1.0 (PET) 0.19 (x2)
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Nausea 0.61 (FET) 0.62 (FET) 1 (FET) 0.05* (FET)
Vomiting 0.13 (x2) 0.34 (x2) 0.66 (FET) 0.9 (x2)
Photophobia 0.18 (FET) 0.55 (FET) 0.6 (FET) 0.65 (FET)
Psychotic
phenomena 0.007** (FET) 0.52 (FET) 0.52 (FET) 0.65 (FET)
Family history
of migraine p<0«03* (x2=4.93) 0.24 (x2) 0.63 (FET) 0.97 (x2)
Length of mig­

































stress 0.19 (MW) 0.54 (MW) 0.25 (MW) 0.8 (MW)
Oral contra­
ceptive 0.48 (FET) 0.45 (FET) 0.23 (FET) 0.098 (FET)









0.87 (FET) 0.64 (x2) 0.6 (FET) 1 (x2)
Mood
Frequency of
mood change p<0.001 **MW(U=0) 0.0007***MW(U=119-5) 0.12 (MW) 0.15 (MW)
Depression 0.006**(FET) 0.08 (x2) 1 (FET) 0.16 (x2)
Anxiety 0.14 (FET) 0.07 (FET) 1 (FET) 0 .7 9 (fet)
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Euphoria 0.12 (FET) 0*38 (FET) 0.12 (FET)
Irritability 0.0008***(FET) p<0.02*(x2=5.94) 0.12 (FET)
CAS score 0.13 (MW) 0.05*MW (U=125) 0.25 (MW)
MADRS score 0.01*MW(U=136) 0.001 **MW(U=117) 0-55 (MW)
MRS score 0.001 **MW(U=107) 0.002**MW(U=125) 0.16 (MW)
DSM-III
diagnosis p<0.01* x2=8*52 Not applicable 0.45 (FET)
TT = t=test * = p<0.05
x2 = chi squared test ** = p<0.001
FET = Fisher's exact test *** = p<0.0001
MW = Mann-Whitney U test
0.78 (FET) 
0.5 (x2) 
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DSM-III diagnosis based on the SCID
Tables III and IV show the DSM-III diagnoses obtained using the 
SCID for all patients. The patients have been subdivided into an 
affective and a non-affective group based on whether or not they 
complained of migraine-related mood change at the initial interview. 
There are 3 possible categories for each diagnosis, i.e.
(i) DSM-III criteria are not met and the diagnosis is absent,
(ii) DSM-III criteria are not quite fulfilled (1 or 2 criteria are not 
fulfilled) and the diagnosis is therefore subthreshold,
(iii) DSM-III criteria are satisfied and diagnosis is therefore 
definitely present.
In the tabTes the DSM-III current and past diagnoses are specified 
separately, together with the length of time each has been present for. 
Past episodes of illness are discrete from present episodes unless 
otherwise stated. The length of the migraine history is also given to 
allow comparison of the length of the migraine history and the length 
of the psychiatric history.
Following the structured clinical interview the dates given for 
each DSM-III diagnosis were compared with those given on initial 
questioning as to whether the patient had ever suffered from psychiatric 
illness and if so whether this had caused them to consult their GP or a 
psychiatrist. Eleven of the 29 patients in the non-affective (initial
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interview) group had a SCID diagnosis of affective disorder. All of 
this group plus two others, i.e. 13 of the 29, had consulted their GP 
and/or a psychiatrist because of psychiatric illness. In the affective 
group (initial interview) 13 out of 17 patients had a SCID diagnosis 
of affective disorder and all had seen their GP or a psychiatrist 
because of this. There was complete agreement between the information 
given on open questioning and information obtained using the SCID with 
regard to when these illnesses had occurred.
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TABLE III
DSM-III Diagnosis based on the SCID 
Affective Group (initial Interview) D = Definite
ST = Sub threshold
= Still present
Patient Length of Current DSM- 






























D) Major depression 1981
104 15 yrs D) Cyclothymic 
disorder
9 yrs D) Major depression 1979-81
105 17 yrs ST) Depression
during migraine
3 yrs D) Major depression 1974 (last* 
three montl
106 35 yrs ST) Mania
during migraine
Unknown None
107 36 yrs D) Simple phobia 36 yrs None
108 14 yrs None D) Bipolar illness 









D) Major depression 1963 - last 
2 years
110 10 yrs D) Hypochondriasis 6 mths 
ST) Major depression 
during migraine 
ST) Simple phobia Childhood



























ST) Major depression Unknown 
during migraine
None
D) Major depression 2-3 mths 
with migraine 




D) Dysthymic disorder Childhood None 




D) Major depression Uncertain 
with melancholia)
D) Simple phobia Childhood
D) Major depression 12 yrs 
with migraine 
D) Dysthymic syndrome 10 yrs 
D) Simple phobia . 10 yrs
D) Major depression months
D) Simple phobia Childhood 
D) Generalised 4-5 yrs
anxiety disorder 
D) Obsessive - 16 yrs
Compulsive disorder
D) Generalised 11 mths None
anxiety disorder
ST) Major depression 18 mths None
with migraine 
D) Dysthymic syndrome 2 yrs











DSM-III Diagnosis based on the SCID 
Non Affective Group (initial Interview) D = Definite
ST = Sub threshold 
-S* = Still present
Patient Length of Current Duration of Past DSM-III
identif- migraine DSM-III psychiatric diagnosis
ication history diagnosis illness
number
201 7 yrs D) Simple phobia 7 yrs None
202 4 yrs D) Simple phobia 6 yrs None
203 26 yrs ST) Major depression Unknown None
204 16 yrs D) Major depression 1976 D) Major depression 1975 ->
205 12 yrs D) Cyclothymic ) 
disorder ) 




206 16 yrs ST) Generalised 6 mths 
anxiety disorder 
ST) Social phobia Unknown
None
207 10 yrs D) Generalised
anxiety disorder 
D) Simple phobia










208 20 yrs None D) Major depression 1978 - 
3 episode
209 7-8 yrs D) Major depression 1979 -t> D) Major depression Since 197
210 30 yrs None None
211 38 yrs D) Simple phobia Childhood - None












214 11 yrs D) Social phobia Since None
childhood
215 26 yrs None None
216 7 mths D) Simple phobia 5 years D) Major depression
217 10 yrs D) Major depression 3 years None
218 17 yrs D) Generalised 5 years 
anxiety disorder
D) Simple phobia Several yrs
None
219 25 yrs None D) Major depression
220 7-8 yrs D) Generalised 4-5 yrs 
anxiety disorder 
ST) Major depression
with migraine 3 years
D) Major depression
221 6 yrs D) Major depression 1984 
D) Alcohol dependencel 984
None
222 2 yrs D) Obsessional 3-4 wks 
ruminations
ST) Major depression
223 9 yrs None None
224 3 yrs None None
225 10 yrs ST) Hypomania with 1 yr 
migraine 
ST) Generalised 1978 
anxiety disorder
None
226 3 yrs None None
227 27 yrs None None
228 2 yrs None None
229 7 yrs D) Panic disorder 1970 
with limited 
phobic avoidance















(2) Six week prospective rating period
The Irritability-Depression-Anxiety questionnaires were scored 
according to the author's instructions. This produced daily ratings 
of anxiety, depression, outward irritability and inward irritability.
The VAS were scored by simple measurement which provided daily ratings 
of 1-10 for anxiety, depression and euphoria.
A separate file was made for each patient containing the mood 
data and the presence or absence of migraine on a daily basis during 
the study period. The relationship between mood components and the days 
when migraine was present was examined using point biserial correlation. 
Mann Whitney U-tests were used to compare:
(i) mood components on the day before a migraine with mood components 
on the first day of the migraine attack,
(ii) mood components on the day before a migraine with mood components 
on days when migraine was absent,
(iii) mood components on the day after a migraine with mood components 
on all days except the first,
(iv) mood components on the day after a migraine with mood components 
on days when migraine was absent.
(Mann Whitney U tests and point biserial correlations were performed 
using the Minitab computer programme (258)).
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Unfortunately the amount of information available was limited 
by the frequency and duration of the migraines experienced. If the 
attacks were infrequent and of short duration there was insufficent 
data for Mann Whitney tests to be used (a minimum of two migraines, 
each lasting for more than one day was required for analysis).
Five patients also misunderstood the instructions for completion 
of the last two VAS scales and there was therefore no data available 
from them for VAS depression and euphoria.
Data from each individual case was then combined and the affective 
group and the non-affective group (as defined by the self report of 
mood change at the initial interview) were compared.
Of the total group of 51 patients (46 new referrals and 5 pilot 
study patients) 37 patients completed and returned their prospective 
rating scales. The pilot study group was amalgamated with the affective 
group for group comparisons. Thus 16 of a possible 22 patients in the 
affective group returned their scales whereas 21 of a possible 29 
the non-affective group did so.
Seven patients in the affective and 9 patients in the non-affective 
group had an insufficient number and duration of migraines for 
examination of mood changes before and after migraines. Thus data on 
these changes is actually available for 9 patients in the affective 
group and 12 patients in the non-affective group.
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Several attempts were made, both by telephone and by letter, to 
obtain forms which had not been returned spontaneously. One patient was 
lost to follow up as she moved to England shortly after her initial 
interview and a second patient became physically ill and was too unwell 
to complete the forms. The remaining patients had either forgotten to 
complete the forms or had done so and then mislaid them.
Few significant associations were found for the 24 hour period 
immediately prior to, or following, migraine attacks (see Tables V - 
VIII).
Data was available for point biserial correlations for all except 1 
of the 37 patients (this lady had no migraines during the study period). 
Significant associations were much more frequent between mood and the 
days when migraine was actually present.
An arbitrary decision was made to reallocate patients into affective 
and non-affective groups on the basis of the prospective data depending 
on whether they had a significant (p<0»05) association between 4 of the 
possible 7 mood indices and the migraine days (see Table IX)•
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TABLE V
Relationship between mood components the day "before a migraine with 
mood components on the first day of the migraine (Mann-Whitney U Test)
Patient IDA IDA IDA IDA VAS VAS VAS




101 NS NS NS NS p<0.04 NS NS
(w=27)
102 ID ID ID ID ID ID ID
103 ID ID ID ID ID ID ID
105 NS NS NS NS NS NS NS
106 NS NS NS NS NS ND ND
107 NS NS NS NS NS AVI NS
108 p<0.0009
(w=37)















111 NS NS NS NS NS NS NS
112 AVI NS AVI AVI AVI AVI AVI
113 NS NS NS NS NS ND ND
117 ND ND ND ND NS NS AVI
118 p<0.05 
(w=11.5)
NS NS NS NS NS AVI
119 ID ID ID ID ID ID ID
121 ID ID ID ID ID ID ID
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Non Affective (initial Interview)
201 NS NS AVI NS AVI AVI AVI
202 NM NM NM NM NM NM NM
203 NS NS AVI AVI NS AVI AVI










208 NS NS AVI AVI NS AVI AVI
209 ID ID ID ID ID ID ID
210 NS NS NS NS NS AVI AVI
211 ID ID ID ID ID ID ID
212 ID ID ID ID ID ID ID
213 ID ID ID ID ID ID ID
214 NS NS NS AVI NS NS AVI
215 p<0.005
(w=57)
NS NS AVI AVI NS AVI





NS AVI NS NS AVI
218 ID ID ID ID ID ID ID
219 NS NS AVI NS NS NS AVI
222 NS NS NS NS NS NS AVI
224 NS NS NS NS NS NS AVI
225 ID ID ID ID ID ID ID
228 NS NS AVI NS NS NS AVI
NS = Non significant AVI = All values identical
ID = Insufficient data NM = No migraine
ND = No data
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TABLE VI
Relationship Between mood components the day before a migraine
with mood components on the days when a migraine was absent
(Mann-Whitney U test)
Patient IDA IDA IDA IDA VAS VAS VAS




101 NS NS NS NS NS NS NS
102 ID ID ID ID ID ID ID
103 ID ID ID ID ID ID ID
105 NS NS NS NS NS NS NS
106 NS NS NS NS NS ND ND
107 p<0.04
(w=134-5)
NS NS NS NS AVI NS
108 NS NS NS NS NS ND ND
109 ID ID ID ID ID ND ND
110 NS NS NS AVI NS ND ND
111 NS NS NS NS NS NS NS
112 AVI NS AVI AVI AVI AVI AVI
113 NS NS NS NS NS ND ND
117 ND ND ND ND NS NS AVI
118 NS NS NS NS NS NS AVI
119 ID ID ID ID ID ID ID
121 ID ID ID ID ID ID ID
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Non Affective (initial Interview)
201 NS NS AVI NS AVI AVI AVI
202 NM NM NM NM NM NM NM
203 NS NS AVI AVI NS AVI AVI







207 NS NS NS NS NS NS NS
208 NS NS AVI AVI NS AVI AVI
209 ID ID ID ID ID ID ID
210 NS p<0.002 
(w=136)
NS NS NS AVI NS
211 ID ID ID ID ID ID ID
212 ID ID ID ID ID ID ID
213 ID ID ID ID . ID ID ID
214 NS NS NS AVI NS NS NS
215 NS NS NS AVI NS NS AVI
216 AVI NS NS NS NS AVI NS
217 NS NS AVI NS NS NS AVI
218 ID ID ID ID . ID ID ID
219 NS NS NS NS NS NS AVI
222 NS NS NS NS NS NS AVI
224 NS NS NS NS NS NS AVI
225 ID ID ID ID ID ID ID
228 NS NS AVI AVI NS NS AVI
NS = Non significant AVI = All values identical
ID = Insufficient data NM = No migraine
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TABLE VII
Relationship between mood components on the day after a migraine
with mood components on all migraine days except the first
(Mann-Whitney U Test)
Patient IDA IDA IDA IDA VAS VAS VAS




101 NS AVI NS NS p<0.05 NS AVI
(w=50.5)
102 ID ID ID ID ID ID ID
103 ID ID ID ID ID ID ID
105 NS NS NS AVI AVI NS AVI
106 NS AVI AVI AVI NS ND ND
107 NS NS NS NS NS NS AVI
108 NS NS NS NS NS ND ND










• 0 ND ND
111 NS NS NS NS NS NS AVI
112 ID ID ID ID ID ID ID
113 ID ID ID ID ID ND ND












119 ID ID ID ID ID ID ID
121 ID ID ID ID ID ID ID
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Non Affective (initial Interview)
201 NS NS NS AVI AVI AVI AVI
202 NM NM NM NM NM NM NM
203 AVI AVI AVI AVI NS NS AVI










208 AVI NS ID AVI NS NS AVI
209 ID ID ID ID ID . ID ID
210 AVI NS NS NS NS AVI AVI
211 ID ID ID ID ID ID ID
212 ID ID ID ID ID ID ID
213 ID ID ID ID ID ID ID
214 NS NS NS AVI NS NS AVI
215 NS NS NS AVI AVI NS AVI





AVI AVI NS NS AVI
218 ID ID ID ID ID ID ID
219 AVI NS NS NS NS NS NS
222 NS NS NS AVI NS NS NS
224 NS NS NS NS NS NS NS
225 ID ID ID ID ID ID ID
228 NS NS AVI NS NS NS AVI
NS = Non significant AVI = All values identical
ID = Insufficient data NM = No migraine
ND = No data
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TABLE VIII
Relationship between mood components on the day after a migraine
with mood components on the days when migraine is absent
(Mann-Whitney U Test)
Patient IDA IDA IDA IDA VAS VAS VAS
Identification Anxiety Depression Outward Inward Anxiety Depression Euphoria 










102 ID ID ID ID ID ID ID





NS AVI AVI NS AVI
106 NS AVI AVI AVI NS ND ND









109 ID ID ID ID ID ND ND
110 NS NS NS AVI NS ND ND
111 NS NS NS NS NS NS AVI
112 NS NS NS AVI AVI AVI AVI
113 NS NS NS NS NS ND ND
117 ND ND ND ND NS NS AVI





119 ID ID ID ID ID ID ID
121 ID ID ID ID ID ID ID
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Non Affective (initial Interview)
201 NS NS AVI AVI AVI AVI AVI
202 NM NM NM NM NM NM NM
203 AVI AVI AVI AVI NS AVI AVI
204 NS NS NS NS NS NS NS
207 NS NS NS NS NS NS AVI
208 NS p<0.05 AVI AVI NS NS AVI
(w=89)
209 ID ID ID ID ID ID ID
210 AVI NS NS NS NS AVI NS
211 ID ID ID ID ID ID ID
212 ID ID ID ID ID ID ID
213 ID ID ID ID ID ID ID
214 NS NS NS AVI NS NS AVI








217 NS NS NS AVI NS NS AVI
218 ID ID ID ID ID ID ID
219 p<0.02 NS AVI AVI NS NS NS
(* -1 4 4 .5 )
222 NS NS NS NS NS NS NS
224 NS NS NS NS NS NS NS
225 ID ID ID ID . ID ID ID
228 NS NS AVI NS NS NS AVI
NS = Non significant AVI = All values :identical
ID = Insufficient data NM = No migraine
ND = No data
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TABLE IX
Point biserial correlations of the presence of migraine with mood
components together with the patients' initial self report of the









IDA IDA IDA IDA 
Anxiety Depression Outward Inward
Irrita- Irrita­
bility bility
VAS VAS VAS 
Anxiety Depression Euphoria
Freq.• Type Affective (initial Interview)


























106 U E NS NS NS NS p<0.001
(-0.16)
ND ND















p<0.001 P<0.001 P<0.001 
(-0.693)(-0.587)(0.754)
ND ND
109 A E NS p<0.01
(0.75)
NS NS NS ND ND









111 A E NS NS NS NS NS NS NS







113 U I NS NS NS NS p<0.02 
(-0.413)(-0.511)
ND ND


























121 U D&E NS NS NS NS NS NS NS
Non Affective (initial Interview)
201 N - NS p<0.01 ) 
<-0 .501)
NS p<0.001 NS 
<-0.587)
NS NS
202 N - NM NM NM NM NM NM NM




NS NS ND p<0.001
(-0.734)
AVI
204 N - NS NS NS NS NS NS NS













208 N - NS NS NS NS NS NS NS
209 N - NS NS NS NS NS NS NS









211 N - NS NS NS NS NS NS NS





213 N - NS p<0.05
(0.331)
NS NS NS NS NS
214 N - NS p<0.05
(-0.369)
NS NS NS NS NS







































219 N - NS NS NS NS NS NS NS
222 N - NS NS NS NS NS NS NS
224 N NS NS NS NS NS NS NS
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225 S E NS
228 N - NS
NS = Non significant 
ID = Insufficient data 
ND = No data
N = Never 
S = Sometimes 
U = Usually 
A = Always
NS NS NS NS NS
p<0.001 p<0.001 NS NS p<0.05
(-0.526) (-0.525) (-0.565)
AVI = All values identical 
NM = No migraine
A = Anxiety 
D = Depression 





Twelve out of the 37 patients who completed the prospective rating 
scales met these criteria for an affective designation. They did not 
differ materially from the study group as a whole with respect to:
(i) age,
(ii) self report of mood changes at the initial interview,
(iii) type of migraine,
(iv) the presence or absence of past and present DSM-III diagnoses of 
affective disorder.
The relationship between affective changes and the severity of migraine
The relationship between the frequency and duration of the 
migraines in the prospective rating period and the presence and absence 
of affective change was examined for:
(1) initial interview,
(2) SCID DSM-III diagnoses,
(3 ) diary data,
(4 ) classical and common migraine.
Chi square tests were used throughout. The median frequency (2 ) 
and duration (1 .5 days) were used to separate patients into high and 
low groups for frequency and duration.
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Initial Interview (Non-affective 19 patients, Affective 17 patients)
Frequency Duration

























17 19 36 17 19 36
min EF = 8 
chi square = 0 
DF = 1 
p = NS
chi square = O' 
DF = 1 
min EF = 8
p > 0.1
•42
DSM-III Diagnosis (Non-affective 18 patients, Affective 18 patients 
including pilot group)
Frequency Duration



























18 18 36 18 18 36
Chi square 
p<0-5, min
= 0.11 , 
EF 8 .5






Diary Data (Non-affective 22 patients, Affective 12 patients)
Frequency Duration
Aff NAff Aff NAff
Low 3 13 16 Low 4 14
Frequency (5 .6) (10.4) Duration (6.4 ) (11.6)
High 9 9 18 High 8 8
Frequency (6.4 ) (11.6) Duration (5 .6) (10.4)
12 22 34 12 22
Chi square =: 3-62, DF = 1 Chi square = 2.86, DF = 1
p<0.06, min EF = 5 • 6 p<0.09> min EF = 5'.6
(2 patients were excluded from this analysis because there were 
insufficient data from the prospective rating scales to allow them 
to be classified as either affective or non-affective.)
Classical/Common (Classical 16 patients, Common 19 patients)
Frequency Duration
Classical Common Classical Common
Low 11 6 17 Low 10 9 19
Frequency (8.0) (9.0) Duration
High 6 13 19 High 7 10 17
Frequency (9.0) (10.0) Duration
17 19 36 17 19 36
Chi square = 3.95, fc
i II t Chi square = 0.47, 11
p<0.05> niin EF = 8 p<0»5, min EF = 8.
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The extent of agreement between the self report measures employed 
during the prospective rating period.
Comparison were made between the IDA anxiety and depression 
scores and the VAS anxiety and depression scores where data was 
available (see Table 10). Both straightforward and differenced 
correlations were calculated between the raw scores.
Data was available for 14 of the affective group (initial 
interview) for anxiety and 10 for depression. The corresponding numbers 
for the non-affective group were 20 for anxiety and 20 for depression.
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TABLE X
Correlations and differenced correlations between IDA and 
VAS Scores for Anxiety and Depression
Patient IDA(A) & VAS Anxiety
Identification Correlation Differenced
No. Correlation
IDA (D) and VAS Depression 
Correlation Differenced 
Correlation
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’Weekend Headache1
As patients had recorded the date on each daily questionnaire it was 
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This was then related to employment status and type of migraine. 
Finally the frequency each day, employment status and type of migraine 
were examined with respect to affective and non- affective groups as 
defined by (1) initial complaints of mood change and (2) the diary 
data. The results were separated into 'mid week', 'weekend' and 'no 
clear pattern' for each patient. Chi square tests were performed on this 
data to see whether employment/unemployment or classical/common migraine 
was associated with weekend headache. There were too few patients in 
each cell for the statistics to be meaningful and therefore mid-week 
headaches and no clear pattern groups were amalgamated for chi square 
testing.
















6 20 10 36















1 cell EF < 5, chi square = 0
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Midweek Weekend NCP
Classical 5 10 3 18
(2.5) (10) (5-5)
Common 0 10 8 18
(2.5) (10) (5-5)
5 20 11 36




Classical 8 10 18
Common 8 10 18
16 20 36
Obviously here chi square would be zero.
There was no significant association between either the type of 
migraine or employment status and weekend headaches.
Log linear modelling of the interaction between cerebral dominance, 
laterality of migraine, the type of migraine and self report of anxiety, 
depression, euphoria and irritability.
In order to test the hypothesis that unilateral migraine affecting 
the dominant hemisphere is associated with depression and unilateral 
migraine affecting the non-dominant hemisphere is associated with 
euphoria the GLIM computer package (259) was used to fit appropriate 
models to the data on the variables named above (see appendix). Laterality
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and type of migraine were found to be important for depression only.
Dominance was not important for any of the mood changes reported.
For complaints of depression the results indicated that this was 
more commonly associated with classical migraine. The relative risk with 
respect to common migraine was 6*7. Unilateral migraine affecting the 
right hemisphere was most closely related to complaints of depression. 
There was a 20 fold decrease in the relative risk of depression in 
patients with unilateral symptoms affecting the left hemisphere, a 10 
fold decrease for bilateral symptoms, a less than 5 fold decrease for 
unilateral symptoms intermittently affecting left and right hemispheres 
and a two fold difference for both bilateral and unilateral symptoms.
Migraine and menstruation
Unfortunately data on this particular aspect of migraine and mood 
change was not collected for all patients initially. Of the total group 
of 51 patients 38 were pre-menopausal (i.e. were regularly menstruating), 
4 had had hysterectomies, 3 were post-menopausal, 4 were perimenopausal 
(i.e. had infrequent, irregular periods) and no information was available 
for the other two patients.
For a subgroup of 6 patients (the last 6 menstruating women to enter 
the study), the relationship between migraine, mood change and 
menstruation was examined using time series plots of mood, migraine and 
menstruation (see graphs in appendix) and Fisher exact tests of the 
presence or absence of migraine and the presence of absence of
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menstruation (see Table XV).
TABLE XV Comparison of subjective estimate of the frequency
with which migraine was associated with menstruation 
with the objective record obtained during the 6 week 
prospective rating period.
Patient No. Self report of frequency 
of migraine vs menstruation
Diary data - 
Fisher's exact test 
probability value 
for the association 
of migraine and 
menstruation
121 Never P < 1
219 Always p < 0-962
222 Never p < 0.184
224 Never P < 0.45
225 Usually p < 0.044
228 Never p < 0-438
(5 ) Regional cerebral blood flow monitoring
Altogether 27 patients had rCBF monitoring performed when their 
migraine was absent (10 in the affective group (il) and 17 in the non- 
affective group (il). Descriptive reports on these scans are available 
for all patients (Tables XVI and XVII). Unfortunately data for two 
patients were not available for numerical analysis but the numerical data 
for the remaining 25 patients are summarised in Appendix „
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Only 5 patients attended for repeat rCBF monitoring during a 
migraine (1 in the affective (il) group and 4 in the non-affective (il) 
group). The descriptive reports on these scans are also available in 
Tables XVI and XVII. The numerical data is summarised in Appendix*




REGIONAL C.B.F. RESULTS - AFFECTIVE GROUP


















Asymmetry of perfusion - 
(L) anterior temporal 




Little difference in 
cortical transit times, 




REGIONAL C.B.F. RESULTS - NON AFFECTIVE GROUP



















Increased perfusion in (R) 
anterior parietal region
Asymmetry of flow times with 
prolonged transit in (R) 

















Cortical transit times 
are longer in the base 
line study than during 
a migraine
Impaired perfusion (L) 
mid temporal region
The large vessel transit 
time is more asymmetrical, 
the cortical transit time 
is unchanged
Transit times shorter but 
regional flow is less 
uniform during migraine. 
The large vessel transit 
times are asymmetrical.
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The numerical data are grouped as follows:
(1) input function - arrival,
transit,
(2 ) net cortical transit time left hemisphere and quadratic values for 
frontal, temporal, parietal and occipital regions,
(3 ) net cortical transit time right hemisphere and quadratic values for 
frontal, temporal, parietal and occipital regions,
(4 ) net fractional flow for the left hemisphere and quadratic fractional 
flow values,
(5 ) net fractional flow values for the right hemisphere and quadratic 
fractional flow values,
(6) net large vessel transit time for the left hemisphere and quadratic 
large vessel transit times,
(7) net large vessel transit times for the right hemisphere and quadratic 
large vessel transit times.
The cerebral blood flow data were grouped according to:
(i) affective/non-affective initial interview
(ii) affective/non-affective SCID DSM-III diagnoses
(iii) affective/non-affective diary data
(iv) classical/common migraine.
Mann Whitney U tests were performed on each of these four groupings
for all baseline data (i.e. for results obtained when migraine was
absent). (See Table XVIII). (The input function data were not included
in the Mann Whitney tests because this is simply an indication that the
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radioactivity was given in a suitable bolus injection and is relevant 
only in ensuring that correct technique was used.)
The left/right ratios for rCBF are presented for each of the 5 
patients for whom results were available for scans performed in both 
the absence and presence of migraine. (See Tables XIX and XX).
The net values for common and classical migraine in the presence and 
absence of migraine are compared in Table XXI. The difference between 
the results is expressed as a percentage increase or decrease from the 
baseline value (i.e. when migraine was absent).
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TABLE XVIII
rCBF - Mann Whitney U tests by group
(2-tailed probability levels corrected for bias are used throughout)
II Aff = 10 NAff = 15
.SS2UIII Aff = 15 NAff = 12
Diary Aff = 7 NAff = 12









U value P U value P U value P U value P
Net CTT(L) 56.5 0.3 77-5 0.98 28-5 0.25 56.5 0.3
CTT L(F) 69 0.74 77 0.97 24 0.13 72 0.9
CTT L(T) 75 1.0 66 0.5 21 0.08 69 0.7
CTT L(P) 73 0-91 62.5 • 0.4 28 0.24 60 0.4
CTT L(0) 66 0.62 70 0.66 34 0.5 61 0.4
Net CTT(R) 67 0.7 72.5 0.76 32.5 0.42 73 0.9
CTT R(F) 69 0.74 77.5 0.97 27 0.2 65 0.58
CTT R(T) 70 0.78 69 0.6 24.5 0.14 63 0.5
CTT R(P) 68 0-70 59 0.3 22 0.09 59 0.4
CTT R(0) 67 0.66 70 0.66 39 0.8 74 0.9
Net FF(L) 69-5 0.76 63-5 0.43 23.5 0.12 54.5 0.3
FF L(F) 70.5 0.8 75 0.9 22.5 0.1 61 0-5
FF L(T) 74 0.96 66 0.5 20 0.06 60.5 0.4
FF L(P) 74 0.96 59 0.3 27.5 0.22 52 0.2
FF L(0) 69 0.74 67-5 0.57 29.5 0.29 50 0.2
Net FF(R) 71 -5 0.85 61 .5 0.37 28 0.2 64-5 0.6
FF R(F) 71 0.82 76 0.9 26 0.18 66 0.6
FF R(T) 70.5 0.8 69 0.6 23.5 0.12 62 0.5
FF R(P) 70.5 0.8 60.5 0.34 24 0.13 58 0.3
FF R(0) 66*5 0.64 70 0.66 35.5 0.58 74 0.9
Net LVTT(L) 51 -5 0.19 46 0.08 25 0.15 48.5 0.1
LVTT L(F) 57 0.32 55 0.2 28 0.24 53 0.2
LVTT L(T) 57 0-32 54 0.19 26 0.18 54 0.2
LVTT L(P) 58 0.35 53 0.17 24 0.13 54 0.2
LVTT L(0) 57 0.32 52 0.16 24 0.13 54 0.2
Net LVTT(R) 50.5 0.17 46 0.08 24.5 0.14 49 0.15
LVTT R(F) 56 0.29 59 0.3 26.5 0.19 55 0.3
LVTT R(T) 56.5 0.31 55 0.2 26 0.18 55-5 0.3
LVTT R(P) 57-6 0*33 53.5 0.18 24 0.13 54 0.2
LVTT R(0) 56 0.29 51 0.14 23 0.1 49 0.15
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Table XIX


































































































































































































































































1.06 1.15 1-05 1.1 1.05 0.9 0.86 0.96 0.9 1.07 0.9 0.91 0.94 0.94 0.8
Migraine Present
Patient No. 220 (repeat examination)
Net
CTT















































- 1.06 1.05 1.13 0.98 - 0.92 0.95 0.88 1.12 - 0.99 0.99 1 .0 1.0

































4.01 3.75 4.29 4.92 



























Net CTT CTT CTT CTT Net FF FF FF FF Net LVTT LVTT LVTT LV1]
CTT F T P O F F F T P O  LVTT F T P 0
Left 6.1 6.3 5-48 6.54 7*25 0.16 0.16 0.18 0.16 0.14 4*9 4-95 4-79 4-76 5*2
Right 6.0 5*69 5*12 5»85 7*22 0.17 0.18 0.2 0.17 0.14 5-0 4-97 4*89 4*87
Left/ : ”









































4.35 4 .17.4,11  
































































































































































































































0.98 1.03 1.01 0.9 0.82 1.1 0.96 1.0 1.13 1.2 1.0 0•97 1.0 1 .0 1.0
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TABLE XXI
Classical vs Common Migraine
Comparison of net rCBF values in the presence and absence of migraine
(The difference between net values in the presence and absence of migraine 














CTT R * 13# t 19# + 45-2# 4 28$ 4 23.7$
P-A L t 21.2# ^ 14 * 6# ■f 53.8# 'J? 26*1$ *  25.8$
FF R i 15-8# 4 5# 1 33# * 50$ * 22.2$
P-A L 4 5-6# 4 8-7# 4 37# *  40$ 4 17.6$
LVTT R t 42.1# 4 5>4# t 25.6# * 25$ 4* 11.1$
P-A L t  38.7# 4 2. 6# ■f 25# * 25$ * 11.1$
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(E) Discussion
This study aimed to determine the prevalence of migraine-related 
mood change and investigate the type of mood change involved. The 
intention was then to identify any factors in the patient's background or 
migraine history which could be related to the occurrence of these mood 
changes. This included both current and past psychiatric diagnoses. 
Finally the study aimed to assess the relationship between cerebral blood 
flow patterns and mood in migraine.
(i) Reliability and validity of the results
The Initial Interview
* ’
The patients were all new referrals to the Migraine Clinic as 
verified by the GP's referral letter and the hospital case record. Age 
was obtained from the hospital case record and checked directly with the 
patient. Marital status was obtained by direct questioning and 
information about the spouse's employment was obtained when 
appropriate. Social class was determined using the Registrar General's 
tables (260). The husband's occupation was used to define social class. 
The patient's own occupation was used when she was in any other category 
except married.
The diagnosis of migraine was made by an experienced physician with 
a special interest in the disorder and was classified into classical or 
common migraine on the basis of the Ad Hoc Committee on the 
Classification of Headache guidelines. The average number of migraine 
attacks was estimated retrospectively for the 6 week period preceding the
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interview. This corresponded well with the actual incidence of migraine 
attacks during the 6 week prospective rating period. Cerebral dominance, 
as assessed by the simple method selected, was checked at interview by 
asking the patients to demonstrate how they held a pen for writing and 
watching them when they signed the consent form. Laterality of the 
headache was obtained directly from the patient and checked against the 
history given to the physician by the patient and the GP's letter.
The neurological symptoms were discussed carefully with the 
patients who were asked to describe their own symptoms in detail before 
the presence or absence of each category was decided. It was always made 
clear to the patient that these symptoms were being enquired about only 
when they were clearly related to migraine attacks. Where unilateral 
symptoms were complained of patients were asked to demonstrate which side 
was affected and to indicate whether this was the same as or opposite to 
the headache. A careful distinction was made between total loss of 
consciousness and dizziness. Difficulty in thinking was only rated as 
present if there was poor concentration and attention. Disinterest 
because of pain was not rated here. Nausea, vomiting and photophobia were 
familiar concomitants of migraine in the majority of patients. The 
symptoms described were all in accordance with a diagnosis of migraine 
and the low incidence of unconsciousness suggested it was unlikely that 
many patients were misdiagnosed epileptics.
The length of migraine history given was subjective. As it was 
generally long patients often had difficulty giving exact dates.
Patients often spontaneously attempted to resolve this problem by linking 
the onset of their migraine with major life events e.g. before leaving
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school or just after marriage etc. However the figure given was 
generally an estimate rather than a precise date.
Hallucinatory experiences were elicited during the psychotic 
screening section of the SCID. Patients were always asked to describe 
the phenomena in their own words and questioned carefully about the 
relationship with migraine and medication.
Patients were asked specifically about a family history of migraine. 
If positive they were asked which relative had been affected. A 
description of the relative's symptoms was obtained and by whom their 
diagnosis had been made. However no relative was questioned 
independently and it is recognised that this generally increases the 
incidence figure for familial illness. (261)
Medication prior to the initial visit was obtained from the GP's 
letter, the physician's notes and questioning the patient. Patients were 
asked particularly about proprietary medications and herbal remedies as 
well as doctor's prescriptions. Any change of medication made at the 
clinic and the new prescription given was always verified with the 
physician.
The information on emotional triggers to attacks and their 
relationship with menstruation was based entirely on the patient's own 
report and was therefore inevitably subjective. However if a menstrual 
relationship was claimed patients were asked to specify whether this was 
prior to, during or after the menstrual bleeding. (One patient arrived 
at her appointment with a calendar for the previous year with both
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migraine and menstruation marked on it - but this was atypical!)
With regard to personal psychiatric history - patients were 
questioned on three occasions; during the collection of social and 
demographic data, in the SCID overview section and in more detail in the 
relevant portion of the SCID interview. This information was cross 
checked with dates given for the onset of illnesses and attendance at 
their GP or psychiatrist for treatment. There were no discrepancies in 
the dates or descriptions of the illnesses given by the patients.
The same sort of problem is encountered in assessing the prevalence 
of a family history of psychiatric illness as in a family history of 
migraine. Where positive patients were asked to describe which relatives 
had had the illness, their symptoms, diagnosis and treatment. However, 
as there is an even greater social stigma attached to psychiatric then 
physical illness it is even more likely that this infonna.tion is 
incomplete.
The DSM-III diagnoses were made using the SCID after training 
according to the SCID manual. The DSM-III handbook (262) was referred to 
in all cases of doubt. Past diagnoses based on retrospective reports of 
symptoms are inevitably less objective than current diagnoses. If in 
doubt the subthreshold rather than the definite category was used. The 
results, in terms of diagnoses, were in close agreement with the 
patient's reports of attendance at their GP/psychiatrist both for dates 
and type of treatment received.
The frequency of mood change was highly subjective although again,
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if a positive response was given, patients were asked to describe the 
change and its relationship in time with the migraine (e.g. before, 
during or after). A report of mood change was only accepted if the 
mood change differed in intensity or quality from a general reaction to 
discomfort and if it was clearly related to the migraine attack. Patients 
were asked if relatives had also noted the change in mood and, if so,
what comments they had made about it.
Rating scale scores were all made by the interviewer at the
conclusion of the interview. All scales were scored according to the
author’s instructions.
Group comparisons
A major difficulty in testing differences between groups on a 
number of variables simultaneously is that it becomes more probable that 
significant associations will be found by chance alone unless the 
multiple hypotheses are compensated for by adjusting the significance 
level to avoid type I errors. One method of doing this is to apply the 
Bonferroni inequality. (263) The overall significance level is chosen and 
then individual significance levels are selected to satisfy the equation:
where = 1 denotes the sum of k terms.
In other words the o C  level is adjusted according to the overall number 
of comparisons made. The tests are then carried out atc*£i and the risk 
of a type I error is reduced to ©Coverall.
For the group comparisons of data from the initial interview the 
variables fell into two subtypes
oC overall ^  . = 1 <pO-
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(i) the social, demographic and migraine variables,
(ii) the predisposing factors, psychiatric history and mood variables.
There were 36 variables in total and as 22 of these were in group
(i) and 14 were in group (ii) the<?C were 0.0023 and 0.0039 respectively 
and q (C overall was 0.05* On this basis the only significant result 
from the group comparisons would have been the frequency of complaints 
of irritability in the affective and non-affective groups at the initial 
interview.
However, the Bonferroni method is a very stringent method of 
assessing significance if the number of tests is large as it was here and 
even dividing the data into two subgroups does not resolve this problem. 
Another way to deal with this difficulty would have been to obtain more 
patients but the constraints on the time available for completion of the 
study did not permit this. The overall significance level can be 
increased to avoid an excessive risk of type II errors while accepting 
that this inevitably implies a greater possibility of a type I error. If 
the significance level forc?Coverall is set at 0«1 thec^L for group (i) 
becomes 0.005 and for group (ii) 0.007- In this way an increased number 
of associations become statistically significant e.g. frequency of mood 
change in the affective/non-affective initial interview group. However- 
as this is the variable which was used to divide these groups and define 
them in the first place it is obviously clinically highly significant 
regardless of the level of statistical significance assigned to it.
When testing a large number of associations in this way the degree 
to which a relationship is clinically relevant may be more meaningful
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than an absolute level of statistical significance. Thus, from a 
clinical viewpoint, the association of psychotic phenomena with the 
affective complaint group may be an indication of temporal lobe 
dysfunction. This may well be linked with complaints of depression and 
irritability which are known to be closely related to limbic system 
function. The increase in MADRS and MRS scores in the affective group 
would reflect this as would the increased incidence of DSM-III affective 
diagnoses. The only association which would remain uncertain clinically 
would be the family history of migraine.
Likewise, in the DSM-III diagnostic groupings personal psychiatric 
history could be expected to correlate with past and present psychiatric 
diagnoses. Complaints of irritability could be linked to current and 
past illness as could elevated CAS, MADRS and MRS scores.
It is interesting that no associations approached statistical 
significance using the diary data to define affective and non-affective 
populations as it implies that the actual presence of mood change during 
migraine is independent of psychiatric history and current levels of 
symptoms.
In the classical/common group it is not unexpected that blurred 
vision should be more common in the classical group as it is a well 
recognised part of the migraine aura, in fact it is slightly surprising 
that it is not more common in this group. The significance of the 
observation that fewer patients with common migraine are on no medication 
probably reflects higher patient and physician concern about the 
classical group as they have both an unpleasant and debilitating
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condition together with an, often frightening, prodrome. This concern 
may make it more likely that the classical group will receive medication. 
The elevated CAS scores in the classical group may he related to 
frightening prodromal symptoms or be a secondary consequence of the 
physiological disturbance engendered by the illness process.
However clinical interpretation can be biased by an investigator's 
own clinical experience and interests and the best test of the 
significance of the associations found in this study would be replication 
of the results in a further sample.
DSM-III diagnoses based on the SCID
Current information is generally more reliable than information 
about past events. (261) The retrospective diagnoses and their dates are 
therefore likely to be less reliable than current diagnoses. Likewise 
the length of migraine history can only be regarded as an approximation.
For both generalised anxiety disorder and affective disorder 
considered together, migraine appears to precede psychiatric illness in 
21 patients, psychiatric illness appears to precede migraine in 6 
patients and in 5 patients the order in which the two conditions arose is 
uncertain because the two problems were almost simultaneous in onset.
However migraine generally has an earlier age of onset than 
generalised anxiety disorder and major depression. It is also difficult 
to assess sequencing of illnesses retrospectively e.g. Slater's work on 
the association of TLE and paranoid schizophrenia could not be replicated
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by Betts and Skarrot and may have been an artefact of the population 
originally studied (see Chapter 10 of literature survey). Migraine, 
anxiety and depression are all common disorders and they are therefore 
likely to occur occasionally in the same individual by chance alone.
The significance of the observation that migraine generally 
preceded affective disorder in this sample is therefore questionable.
(2) Six week prospective rating period
The results of the 6 week prospective rating period were analysed 
separately for each individual patient. Mann Whitney U tests were 
performed on the data to examine the association of mood components with 
the migraine prodrome and the recovery period after an attack. Seven 
Mann Whitney U tests were performed (one for each mood index). There 
were few significant associations for either period using an arbitraryaC 
of 0*05. When the Bonferroni inequality was used to obtain an<?Coverall 
of 0*05 the actual o C level became 0.007*
Using either the original ©C level of 0.05 or the Bonferroni- 
obtained 0.007 to assess significance, no patient had four or more 
significant differences between mood components the day before a migraine 
and days when migraine was absent. Three patients had four or more 
significant differences (i.e. above p<0.05) for mood the day before a 
migraine with mood on the first day of the migraine. Using an oC level of 
0*007 this fell to only one patient. This lady (patient No. 108) 
complained of irritability which she usually experienced as a concomitant 
of a migraine attack. The other two patients were No.110 who complained
-  330 -
of always experiencing anxiety and euphoria and No.207 who sometimes 
experienced euphoria.
Setting an ©C of 0.05 or 0.007 only one patient (No. 108) had 
significant differences between 4 mood indices when the day after a 
migraine was compared with days when migraine was absent. Using an oC 
of 0.05 "two patients had more than four significant differences between 
mood components on the day after a migraine and mood components on all 
migraine days except the first (patients Nos.118 and 207). Using an oC 
of 0*007 only patient 118 meets these criteria. This patient complained 
of always experiencing anxiety, depression and irritability. Patient 
No.207 has already been described.
Of these patients only No.207 was able to estimate when her mood 
changes occurred and she felt that they were prior to the migraine.
The data available suggest that only a small number of patients 
have convincing evidence of mood changes in the period prior to and 
subsequent to migraine attacks. Three of these four patients had 
current diagnoses of generalised anxiety disorder or affective disorder.
By contrast 12 of 37 patients had at least four significant (at 
p<0.05) point biserial correlations between mood indices and migraine. 
This was reduced to 8 of 37 if a significance level of 0.007 was used. 
This did not correspond well with the patient's subjective estimates of 
the frequency and type of mood change they experienced prior to the 
prospective rating period.
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This lack of correspondence may be genuine but it is also possible 
that the rating scales used were not sensitive enough to register the 
transient disturbances in mood which the patients described. However the 
patients' mood changes were often quite severe, as assessed by the 
descriptions given during the SCID. Eleven patients were subthreshold 
for affective disorder during migraine episodes, generally only because 
these were shorter than ordinary affective illnesses, and it seems 
unlikely that patients would have failed to record this degree of 
distress on either the IDA or the VAS.
Chi square tests of the association of affective and non-affective 
groups (as defined by self report, DSM-III diagnoses and diary data) with 
frequency and duration of headaches were not significant. It is 
therefore unlikely that the severity of the migraine, as assessed using 
these indices, played any significant role in the affective/non- 
affective distinction in any of these groups. The only significant 
association (at the 0.05 level) was between a high frequency of migraine 
and the common variety of the condition.
Agreement between the IDA and VAS Scales
There was agreement between the scales measuring anxiety and 
depression in approximately half of the patients. This may reflect the 
different construction of the VAS and the IDA, i.e. the two scales may 
be tapping different areas of experience.
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Migraine and the day of the week
The day of the week was shown on each questionnaire and VAS scale. 
Employment status and migraine diagnosis were recorded at the initial 
interview as described above. There was no evidence of a relationship 
between either employment status or migraine diagnosis and weekend versus 
mid-week headaches.
Log linear analysis of cerebral dominance, laterality, 
type of migraine and self-report of mood change
The type of migraine, laterality of migraine symptoms and cerebral 
dominance were all assessed with regard to their association with self 
report of mood change at the initial interview. Laterality and type of 
migraine were important for depression only. Dominance was not related 
independently or in combination with type and laterality for any mood 
change.
Given that no association was found between classical migraine and 
DSM-III diagnoses of affective disorder or Montgomery and Asberg 
depression scale scores the significance of this finding is uncertain.
The self reports of depression were also associated with right hemi­
sphere dysfunction which was the opposite of the anticipated association. 
These results require replication and further investigation.
Migraine and menstruation
Unfortunately data on the relationship of mood change, migraine and 
menstruation was not collected routinely from all patients throughout the
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study. However, for five of the six patients there was no significant 
association (i.e. p<0«05) between migraine and menstruation. The sixth 
patient menstruated during 30% of migraine episodes in the study period. 
This could be a chance finding but a longer period of observation would 
be required to determine this more definitely. Graphs of the 
relationship of mood components, migraine and menstruation also failed 
to show a relationship between these three parameters for the other five 
patients. It was thus impossible to demonstrate menstrual mood change 
and menstrual migraine in five of these six patients but it has to be 
remembered that four of the six said that their migraine was never 
associated with menstruation. However this type of self report is often 
unreliable.
(3 ) Regional CBF monitoring
Unfortunately it was not possible to obtain rCBF scans on all 
patients during the absence of migraine. Patients gave a variety of 
reasons for their refusal to consent to this - a fear of injections, 
difficulty in obtaining time off work (especially as they often had 
frequent absences because of migraine and medical appointments), 
residence outwith the city or, in only 2-3 cases, a fear of the radiation 
involved in the procedure. Of the 27 patients who attended, 10 had 
complained of affective changes at the initial interview and 17 had 
not. Fourteen of the patients had classical migraine and 13 common 
migraine. The age range was from 20-62 years with a mean of 40.1 years, 
a median of 43 years and a standard deviation of 11.4 . The population 
of patients who had rCBF scans performed was thus comparable with the 
total population of patients within the study.
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Regional cerebral blood flow values do not differ significantly with 
age. In patients who do not have neurological signs there is no 
significant difference in the median values for the left and right 
hemispheres and no evidence of systematic differences between the 
hemispheres. For frontal, temporal and parietal regions there is no 
trend towards lateralisation. The values obtained in the occipital 
region are too heavily influenced by radiation from structures in the 
neck to be valid for analysis (personal communication, Dr M. Merrick,
1988 - see appendix).
The net values represent the following:
(1) cortical transit time - the time such that, at equilibrium, the 
volume of tracer entering or leaving the cortex is equal to the volume of 
blood within the cortex,
(2) fractional flow - at equilibrium the volume of blood entering the 
organ is equal to the fraction already there. Autoregulation causes 
vasodilatation which, in turn, increases the volume of blood within the 
tissue. Measurement of fractional flow therefore corrects for this,
(3 ) the large vessel transit time is the time take for the leading edge 
of the bolus of radioactivity to travel from the aorta to the head. It 
demonstrates asymmetry of flow - particularly in the neck vessels and to 
a lesser extent in the larger cranial vessels. In the majority of 
subjects there is little difference between large vessel transit time 
values on the right and left sides.
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Repeatability of rCBF measures
As there is a high background count rate if rCBF measurements are 
repeated within a short period the quality of statistical analysis is 
decreased on the occasion of the repeat measurement. It is thus difficult 
to estimate the stability of regional CBF measurements. However the 
normal range of rCBF values is narrow and symmetry between the hemi­
spheres is less affected than individual values in repeat examinations.
Analysis of the baseline .rCBF data in terms of the differentiation 
of affective and non-affective groups using Mann-Whitney U tests failed 
to show any significant differences between any of the categorisations of 
affective/non-affective which were used. Presumably either no differences 
in rCBF were present in the baseline condition or the technique employed 
to measure rCBF was insufficiently sensitive to demonstrate it. It is 
unfortunate that the number of patients who had scans during a migraine 
attack was so small that no statistical comparison of the rCBF results 
was possible.
Undoubtedly, the interpretation of the rCBF results would have been 
much easier if results could also have been obtained from a control 
population (e.g. of patients with muscle-contraction headache). However 
rCBF measurement, whilst a very safe technique, does involve exposure to 
a small dose of radiation, a venepuncture and the inconvenience of 
attending for the examination. The Nuclear Medicine department was also 
extremely busy and would have been overloaded by scanning both groups of 
patients. An attempt was made to obtain a control population of patients 
without headache who were attending for scans of other body organs. They 
could have had a cerebral blood flow scan at the same time, with their
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consent, without any additional radiation or inconvenience. Again, 
however, this proved too time-consuming for the staff of the department.
The reporting of the rCBF scans for the migraine patients in the 
presence and also in the absence of migraine suggested that migraineurs 
generally have a more reactive vasculature than non-migraineurs.
The left/right ratios did not demonstrate any convincing asymmetry 
of flow in either the baseline condition or when migraine was present. 
However as the number of patients who had scans performed while a 
migraine was present was so small this was inconclusive and not 
generalisable to migraineurs as a whole. This was equally applicable to 
the comparison of the results for classical and common migraineurs 
obtained during the course of a migraine attack. The differences between 
the results for classical and common migraine were interesting 
nonetheless, and in accordance with the differences found between the two 
conditions using other techniques of rCBF measurement.
(ii) Review of original aims and hypotheses
Aims
(1) To determine the, prevalence of complaints of mood change in 
conjunction with migraine and to identify the type of mood change 
involved.
37$ of this sample of new referrals to a migraine clinic complained 
of experiencing mood changes in more than 50$ of their attacks. In order
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of frequency these mood changes were depression (28-3$), irritability 
(28«3$)> euphoria (13$) a°d anxiety (8 .7$).
(2) To define and quantify transient changes in mood components and 
assess their relationship with migraine attacks.
The self reports of mood changes did not correspond well with the 
alterations in mood components which the patients documented during the 
six week prospective rating period. No evidence was found for a 
prodromal change in mood components or for a change in mood components 
immediately following the migraine attack. However in 12 out of the 37 
patients who completed the prospective rating period there was a 
statistically significant increase in depression, anxiety and 
irritability scores on days when a migraine was present. These changes 
in mood components were not related to the frequency or duration of the 
migraines.
(3 ) To identify the factors in the individual which are related to 
changes in mood components.
The factors most associated with complaints of mood changes were 
current or past DSM-III diagnoses of affective disorder and increased 
MADRS and MRS scores. The latter presumably reflect increased levels of 
current distress. A subgroup of the patients who complained of mood 
changes had olfactory hallucinations which implied temporal lobe 
disturbance.
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(4) To determine the prevalence of psychiatric illness in migraine
sufferers and to assess its relationship with the acute mood changes 
associated with migraine attacks.
52.5$ of migraine patients in this study had current and past DSM-III 
diagnoses of affective disorder. 32.6$ of patients had current DSM-III 
diagnoses of affective disorder. This was closely related to complaints 
of changes in mood components in conjunction with migraine.
(5) To determine the relationship between patterns of cerebral blood 
flow and mood changes in migraine.
The number of patients who had scans during both the presence and 
absence of migraine was insufficient to investigate this fully.
No significant associations between rCBF and affective and non- 
affective groups of patients no matter how these were defined, were found 
in the baseline data.
The scan results from the baseline data and the small number of 
scans from occasions when migraine was present suggested that migraineurs 
generally had a more reactive vasculature.
The differences found between classical and common migraine in the 
presence and absence of migraine were too small for statistical analysis. 
Nevertheless they were interesting, particularly as they were in 
accordance with the results found using other forms of rCBF monitoring.
The hypotheses in the light of the results
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(1) That the mood changes associated with migraine are due to more than
the coincidental expression of two common conditions, i.e. migraine and 
affective disorder in the same individual.
This could not be confirmed in the present study. The factors most 
related to the complaints of changes in mood components in conjunction 
with migraine attacks were current and past DSM-III diagnoses of 
affective disorder and increased MADRS and MRS scores.
There were no obvious differences between 12 patients who had 
changes in mood components during migraine days in the prospective 
rating period and the total sample.
(2) That a relationship can be demonstrated between the mood changes and 
abnormalities in cerebral blood flow - specifically that dysphoria is 
associated with flow abnormalities in the left hemisphere and euphoria 
with flow abnormalities in the right.
No such pattern could be identified in the baseline data and too few 
patients had scans performed in the presence of migraine to allow any 
conclusion to be reached.
(3) That mood changes are more likely to be associated with classical 
than with common migraine.
The affective/non-affective designation based on the diary data and 
the presence or absence of past and present DSM-III diagnoses of
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affective disorder were both unrelated to the type of migraine.
(4 ) That unilateral migraine affecting the dominant hemisphere is 
associated with depression and unilateral migraine affecting the non­
dominant hemisphere is associated with euphoria.
Cerebral dominance could not be shown to be important in the self- 
reporting of the changes in mood components examined in this study. 
However right hemisphere dysfunction was 20 times more commonly 
associated with complaints of depression than left hemisphere 
dysfunction.
(5) That olfactory hallucinations which are experienced as part of the 
migraine attack can be related to regional cerebral blood flow changes in 
the temporal lobes.
Unfortunately these changes were present in only seven patients and 
it was impossible to obtain a sufficient number of scans in either the 
baseline condition or during the presence of migraine to investigate this 
possibility.
(iii) A critical appraisal of the study
(i) The lack of a control population
The initial intention of this study was to investigate the 
hypothesis that mood changes were part of migraine attacks. Patients who 
complained of mood changes were to be compared with those who did not.
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The need for a control group outwith the migraine clinic population was 
therefore not obvious when the study began. However the initial 
hypothesis that migraine-related mood changes could be separated from 
concurrent psychiatric illness could not be proven and the prevalence of 
affective disorder was much higher than anticipated. This makes it 
necessary to compare the results found for the prevalence of psychiatric 
disorder in this study with the rates found in community surveys and 
studies of other medically ill populations.
Community surveys
It is generally recognised that the rates for the occurrence of 
depression based on hospital admissions do not reflect the community 
picture.
However studies of hospital admissions by their nature focus on 
depressive illness. Community surveys include, in addition, depression 
as a symptom and as a syndrome. (264)
One large community survey in the USA, which covered both city and 
semi-rural populations, found a consistent trend for a decrease in 
depression scores (on the Centre for Epidemiologic Studies Scale) with 
age. (30$ of 18-25 year olds had high depression scores compared with 3- 
10$ of those over 65 years old.)
Unemployment and lower household income increased depression scores 
whereas increased education decreased them.
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This particular survey (265) also found that although women had 
higher rates for clinical depression and hospital admissions for 
depression than men depressive symptoms were only slightly increased in 
population surveys of women. These differences were reduced by adjusting 
for socio-economic variables.
There was no age trend for the frequency of psychoneuroses in women 
but this definitely increased with age in men.
Despite the effect of socioeconomic status on perceived sex 
differences in depression there is a wide variety of evidence from other 
sources that there is a real female preponderance in depression.
A 2:1, femaleimale ratio for all depression is found consistently in 
studies within psychiatric clinics in the USA. (This ratio is lower in 
manic-depressive psychosis and higher in neurotic depression.)
This sex ratio has also been found in community surveys of non­
patients.
As the sex difference is found in both 'patient' and 'non-patient' 
populations it cannot be accounted for by different patterns of health­
care seeking behaviour in men and women. (264)
A slightly more recent survey, again in the USA, compared both the 
lifetime and the six month prevalences of specific psychiatric disorders 
in three communities.
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The lifetime prevalence of a disorder is the proportion of people in 
a representative sample who have ever experienced the disorder up to the 
date of assessment. The six month prevalence refers to the occurrence of 
the condition in the six months prior to the interview.
Data was collected from 9>000 adults and DSM-III diagnoses were 
based on the Diagnostic Interview Schedule. The most predominant 
disorders for women in all three communities were depressive episodes and 
phobias. The lifetime prevalence of major depression for women in the 
three centres was 8-7$ (New Haven), 4*9$ (Baltimore) and 8.1$ (St Louis). 
The corresponding percentages for dysthymia were 3 .7$, 2.9$ and 3*4$*
The six month prevalence rates also found that the commonest 
diagnoses for women were phobias and major depression and that the rates 
of psychiatric disorder dropped sharply after age 45 years. (266,267)
In summary - community surveys show a female preponderance in 
depression. The second survey quoted is closer in design to the present 
one in that it quotes prevalence rates for DSM-III diagnoses. The life­
time prevalence rate for major depressive disorder is approximately 5-8$. 
Both studies found that younger adults had higher prevalence rates of 
disorder than older subjects. Higher figures in the first study are 
probably related to a different definition of depressive diosrder 
inherent in the use of the Centre for Epidemiologic Studies' depression 
scale which is based on ratings of items from self report inventories 
whereas the Diagnostic Interview Schedule is observer-rated.
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General medical patient populations
A study of 143 medical in-patients in the late 1960s used a 
combination of the Beck Depression Inventory and the Hamilton Rating 
Scale for Depression to establish a diagnosis of depression. The overall 
occurrence of depression was 21$; 26$ in women and 16$ in men. There was 
no age difference between depressed and non-depressed patients. Depressed 
women were much more commonly detected in middle or upper social 
classes. Medical staff under-diagnosed depression in lower social class 
patients.
Anxiety, irritability, inability to work, retardation and somatic 
preoccupation were non-specific symptoms which were found in more than 
50$ of non-depressed patients and in 75$ of the total sample. (268,269)
It has been recognised for many years that there is a considerable 
overlap between medical and psychiatric illness. The incidences quoted 
for psychiatric illness in medical patients have ranged from 25-83$ (270, 
271 )• However this is often overlooked in quiet and uncomplaining 
patients.
Psychiatric illness in medical outpatients may occur in the absence 
of evidence of organic disease (this has been quoted at the rate of 38$•
(272)) or psychiatric and medical illness may be concurrent. Depression 
and anxiety are recognised as the commonest psychiatric disorders 
occurring in hospital outpatient populations. (270,272) This is not 
always transient - particularly in patients with a previous psychiatric 
history. (267)
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It has been pointed out that psychiatric classifications and 
concepts are based on research conducted with psychiatric inpatients. It 
can be difficult to differentiate appropriate distress from affective 
disorders in medically ill patients. It has been estimated that 51$ 
medical outpatients and 14*6-61$ of medical inpatients suffer from 
affective disorder. The inpatient study used a psychiatric interview and 
the Cornell Medical Index, the outpatient studies used the GHQ 30. Most 
of these inpatients had improved four months after discharge. A previous 
psychiatry history tended to predict a chronic course. Disorders of 
moderate severity were the most common - particularly in younger women.
(273)
Overall it is clear that the incidence of affective disorder is high 
in general medical populations although it is often impossible to 
distinguish whether the rates quoted are for psychiatric illness in the 
presence or absence of medical (organic) disorder.
Relevance to the present study
The patients with affective disorder in this study also have a 
definite diagnosis of a medical condition. The studies quoted above do 
not usually supply sufficent information to indicate which are most 
closely related to this patient group. However Robins study suggests 
that the community prevalence of DSM-III diagnosis of affective disorder 
is much lower than that found in the migraine group.
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(ii) Limitations of measures used
The overlap between medically and psychiatrically ill populations 
and the fact that the rating scales available to measure emotional change 
have mainly been standardised with psychiatrically ill populations means 
that the scales are not specific enough to reliably differentiate between 
psychiatric and physical illness.
In this study a structured clinical interview was used to make the 
psychiatric diagnosis and rating scales were only present to make an 
assessment of the current severity of distress. This assisted in making 
the discrimination betwen medical illness alone with appropriate distress 
and medical and psychiatric illness occurring together but was still, to 
some extent, subjective and did not totally resolve the problem.
In the prospective rating period the IDA was used to measure 
fluctuations in mood components. In many ways it was surprising that 
only one third of the patients who completed the scales had changes in 
these mood components which were significantly associated with migraine 
attacks and that no such changes could be demonstrated before or after 
attacks. Possibly the IDA was not sensitive enough to pick up transient 
changes in mood or patients were more aware of their physical migraine 
symptoms than their affective state. Anecdotally, on the basis of 
information supplied by the patients at the initial interview, it is 
possible that close relatives are more aware of mood changes than the 
patients themselves - particularly irritability!
There is a particular lack of rating scales suitable for estimating 
euphoria and irritability in general population samples. It may be
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partly because of this deficiency that no patient could be shown to have 
euphoria during the prospective period using the VAS. Fluctuations in 
irritability were demonstrable using the IDA which has four items for 
inward and four items for outward irritability.
(iii) Difficulties in separating contributory factors inherent in 
multifactorial conditions
The literature review dealt with the problems in trying to define 
the roles of different contributory factors in migraine. The situation 
is very similar with regard to trying to differentiate the factors 
important in mood change. This is even more complex as the number of
factors is so great and so much is determined by the individual's
personality.
This makes it difficult to convincingly demonstrate an association 
between an alteration in mood components and events such as migraine 
attacks and menstrual periods. Complex statistical techniques are 
required to evaluate the relationships between continuous and dichotomous 
variables.
(iv) Bias
The initial self-reports of the frequency of change in mood in 
association with migraine attacks were very different from the results 
obtained in the prospective rating period. If it is accepted that the 
IDA data is more objective and therefore more reliable there is then the 
problem of explaining why patients attribute changes in mood to migraine
attacks when this is not, in fact, the case. Attribution theory offers
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one possible model for this. The presence of initial self reports of 
mood change was significantly associated with a DSM-III diagnosis of past 
and/or present affective disorder. Perhaps women with a persistent mood 
disorder become habituated to aeonstant level of distress and are aware 
of its only when the physical stress of a migraine is superimposed and 
their ability to cope is temporarily overwhelmed. They therefore falsely 
attribute changes in mood which are really chronic to the acute event of 
the migraine episode. (274)
(v) Lack of an independent witness
As mentioned earlier in the section on the reliability of results, 
the opportunity to interview a close member of the family can 
significantly improve the quality of the information avilable on both 
the personal and the familial history of physical and psychiatric 
illness.
It has been shown that 10$ of people under-report hospital 
admissions for medical illness and 30$ of women under-report 
hospitalisation and major illness in their children even when this has 
taken place within the last year. (261)
It would have been helpful in this study to interview a relative 
with regard to the frequency and type of the patient's mood changes and 
their reltionship to migraine episodes as well as to verify the 
historical details. However relatives did not generally attend the 
medical clinic with the patient and constraints on time and resources 
made it very difficult to arrange to see relatives separately.
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Robins has indicated that interview schedules which apply a lifetime 
strategy, such as the SCID, provide lifetime diagnoses which are 
acceptably close to 'best-estimate' diagnoses based on all sources of 
data available for most disorders. (266)
(vi) Data on the relationship of migraine and menstruation are not 
available for the entire sample
Unfortunately data on mood change, migraine and menstruation were 
not obtained from all patients but only from the last six menstruating 
women. Of these only one patient had a significant association between 
the three variables. In retrospect more could have been said about the 
relationship between migraine and menstruation if more data had been 
available. This is an area which deserves further study in its own 
right.
(vii) Limitations of regional cerebral blood flow monitoring
No significant differences in rCBF were found between affective and 
non-affective groups, however these were defined, in the baseline 
condition. This may indicate that no differences in rCBF were present or 
that the technique was insufficiently sensitive to show them up in this 
type of psychiatric disorder (i.e. in affective disorder as specified by 
DSM-III criteria).
The technique seemed to be more effective in discriminating between 
common and classical migraine during migraine episodes and this was in
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line with data already in the literature. However there were to few 
patients to investigate this thoroughly in the present study.
(4 ) Future research priorities
General areas of interest suggested by the literature review have 
already been covered in Chapter 19. A number of specific research topics 
were suggested by the study itself.
There is a great need to develop scales for rating emotional 
distress in physically ill patients which are also standardised in 
medically rather than psychiatrically ill populations. This involves 
tackling the difficult problem of defining what is an appropriate level 
of distress in the setting of physical ill health and what constitutes 
psychiatric illness.
Similarly more information is required on the fluctuations in mood 
components over time within the general population and the relationship 
between minor life stresses and migraine. Studies of subgroups of 
migraine patients are likely to be more useful than studies of 
migraineurs as a whole. Migraine patients with olfactory hallucinations 
during attacks are a particularly interesting group because of the 
association of the symptom with both temporal lobe disturbance and 
affective changes. Although relatively uncommon (15$ of this sample) 
with patience a large enough group could be collected for study. EEG 
and more specialised assessments using rCBF measurement and possibly 
positron emission tomography in this group would be relevant to 
understanding the pathophysiology of the hallucinations and the
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interrelationship between this and depression.
Similarly the relationship between migraine, menstruation and mood 
change needs further exploration, particularly the links between migraine 
and the premenstrual syndrome noted in the literature survey.
Finally there is considerable evidence from regional cerebral blood 
flow studies that common and classical migraine differ. In the present 
study classical migraine was significantly associated with complaints of 
depression and there was a suggestion of possible differences between 
classical and common migraine in rCBF studies performed in the presence 
of migraine. More studies of these types of migraine, particularly 
differences between them observed during migraine attacks are necessary 
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APPENDIX I
Migraine and Mood Change Information Sheet
Migraine - patients attending Dr. Price's out-patient clinic are being 
asked to help in a study of the association of mood change and migraine. 
Taking part in the study involves an interview with the researcher, a 
qualified psychiatrist, lasting 45 minutes and completing simple rating 
scales daily for the next 6 weeks. The latter take approximately 
5 to 10 minutes to fill in. The interview will involve providing the 
researcher with information about the symptoms suffered as part of 
your migraine and about your past and present mood. The rating scales 
provide a record of how your mood varies over a short period of time.
It is possible that some patients may be found to have mild psychological 
problems in addition to their migraine. They would be informed of this at 
the end of the 6 week period and could then decide whether they wished 
their G.P. to be informed. Any information which would be helpful to 
Dr. Price with regard to treatment of the migraine would be shared with 
him.
The treatment Dr. Price prescribes for migraine will not be influenced 
by whether or not a patient takes part in the study. Each patient is 
also free to withdraw from the study at any time without this affecting 
further medical treatment. All information obtained will be confidential.
Consent
I have read and understood the above information which has also been 
explained to me by Dr. Morrison. I agree to participating in the study 
and understand that I may withdraw at any time without thi3 affecting 





Supplementary information and consent for regional blood flow studies.
Patients who are taking part in the above study are being offered the 
opportunity to also have brain blood flow measurements performed. This is 
a very simple and straightforward procedure which is performed in the X-ray 
Department at the Western General Hospital by the Radiology Staff. The whol 
procedure takes approximately 5 minutes and the only discomfort involved is 
one injection into a vein in the patient's arm. A very small amount of a 
radioactive isotope is used to measure the blood flow on a special monitor - 
the radioactivity involved is approximately the same as that used in an 
ordinary skull X-ray investigation. Patients are being asked to have this 
test on two occasions - once when they have a migraine and once without one. 
The information obtained from the test should be very helpful in under­
standing the type of changes in blood flow which occur during migraine and 
their association with mood changes.
Patients are free to refuse to take part in this study or withdraw at any 
time without this interfering in their medical treatment in anyway. In­
formation obtained from the investigations will be passed onto Dr. Price 
routinely.
Consent
I agree to participating in the blood flow studies outlined above which 
I have had explained to me and discussed with me by Dr. Morrison.
Signature
Date










(N.B.) FREQUENCY MUST BE AT LEAST ONE ATTACK EVERY 6 WEEKS
FREQUENCY OF ASSOCIATED 
MOOD CHANGE
NEVER SOMETIMES USUALLY ALWAYS
CURRENT MEDICATION
CHANGE OF MEDICATION 
RECOMMENDED
YES/NO IF YES SPECIFY NEW TREATMENT
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MARITAL STATUS S M W D SEP.
CURRENT /HUSBAND’S 
EMPLOYMENT/ EMPLOYMENT




BILATERAL UNILATERAL R or L
DEFINITE
NEUROLOGICAL
PARESIS SENSORY LOSS SPEECH LOSS OF
R/L R/L DISTURBANCE CONSCIOUSNESS
QUESTIONABLE
NEUROLOGICAL
DIZZINESS BLURRED VISION DIFFICULTY THINKING
GENERAL NAUSEA VOMITING PHOTOPHOBIA
TYPE OF MOOD 
CHANGE
DEPRESSION ANXIETY EUPHORIA IRRITABILITY






PERSONAL HISTORY YES/NO IF YES GP/PSYCH OP/IP
PSYCHIATRIC ILLNESS • SPECIFY TYPE




NEVER SOMETIMES USUALLY ALWAYS
ORAL
CONTRACEPTIVE
YES/NO IF YES TYPE
MIGRAINE RELATED 
TO MENSTRUATION
NEVER SOMETIMES USUALLY ALWAYS 










- 3 9 0  -
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APPENDIX II
THE CLINICAL ANXIETY SCALE
Instructions for the use of the Clinical Anxiety Scale
The Scale is an instrument for the assessment of the present state 
of anxiety; therefore the emphasis on eliciting information for the 
ratings should be on how the patient feels at the present time. However,
the interview itself may raise, or lower, the severity of anxiety and the
interviewer should inform the patient that he should describe how he has 
felt during the period of the past two days.
Psychic tension (care should be taken to distinguish tension from 
muscular tension - see next item).
Score 4: Very marked and distressing feeling of being 'on edge',
'keyed up', 'wound up' or 'nervous' which persists with 
little change throughout the waking hours.
Score 5 : As above, but with some fluctuation of severity during 
the course of the day.
Score 2: A definite experience of being tense which is sufficient 
to cause distress.
Score 0: No feeling of being tense apart from the normal degree
of tension experienced in response to stress and which is 
acceptable as normal for the population.
Ability to relax (muscular tension)
Score 4: The experience of severe tension throughout much of the 
bodily musculature which may be accompanied by such 
symptoms as pain, stiffness, spasmodic contractions, and 
lack of control over movements. The experience is present 
throughout most of the waking day and there is no ability 
to produce relaxation at will.
Score 3: As above, but the muscular tension may only be experienced 
in certain groups of muscles and may fluctuate in severity 
throughout the day.
Score 2: A definite experience of muscular tension in some part of 
the musculature sufficient to cause some, but not severe, 
distress.
Score 1: Slight recurrent muscular tension of which the patient is 
aware but which does not cause distress. Veiy mild 
degrees of tension headache or pain in other groups of 
muscles should be scored here.
Score 0: No subjective muscular tension or of such degree which, 
when it occurs, can easily be controlled at will.
- 1 -
Startle response (hyperarousability)
Score 4 : Unexpected noise causes severe distress so that the
patient may complain in some such phrase as "I jump out of 
my skin". Distress is experienced in psychic and somatic 
modalities so that, in addition to the experience of fright, 
there is muscular activity and autonomic symptoms such as 
sweating or palpitation.
Score 3: Unexpected noise causes severe distress in psychic or 
somatic, but not in both modalities.
Score 2: Unexpected noise causes definite but not severe distress.
Score 1: The patient agrees that he is slightly "jumpy" but is not 
distressed by this.
Score 0: The degree of startle response is entirely acceptable as 
normal for the population.
Worrying (The assessment must take into account the degree to which
woriy is out of proportion to actual stress.)
Score 4: The patient experiences almost continuous preoccupation with 
painful thoughts which cannot be stopped voluntarily and the 
distress is quite out of proportion to the subject matter of 
the thoughts.
Score 3 : As above, but there is some fluctuation in intensity throughout 
the waking hours and the distressing thoughts may cease for an 
hour or two, especially if the patient is distracted by activity 
requiring his attention.
Score 2: Painful thoughts out of proportion to the patient’s situation 
keep intruding into consciousness but he is able to dispel 
or dismiss them.
Score 1: The patient agrees that he tends to worry a little more than 
necessary about minor matters but this does not cause much 
distress.
Score 0: The tendency to worry is accepted as being normal for the
population; for instance even marked worrying over a severe 
financial crisis or unexpected illness in a relative should 
be scored as 0 if it is judged to be entirely in keeping with 
the degree of stress.
Apprehension
Score 4: The experience is that of being on the brink of some disaster 
which cannot be explained. The experience need not be 
continuous and may occur in short bursts several times a day.
Score 3 : As above, but the experience does not occur more than once a 
day.
Score 2: A sensation of groundless apprehension of disaster which is
not severe although it causes definite distress. The patient 
may not use strong terms such as "disaster" or "catastrophe" 
but may express his experience in some such phrase as "I feel 
as if something bad is about to happen".
Score 1 : A slight degree of apprehensiveness of which the patient is 
aware but which does not cause distress.








: The patient is unable to keep still for more than a few 
minutes and engages in restless pacing or other purposeless 
activity.
: As above, but he is able to keep still for an hour or so at 
a time.
: There is a feeling of "needing to be on the move" which 
causes some, but not severe, distress.
: Slight experience of restlessness which causes no distress.




MONTGOMERY AND ASBERG (MADRS) DEPRESSION RATING SCALE
The rating should be based on a clinical interview moving from 
broadly phrased questions about symptoms to more detailed ones which 
allow a precise rating of severity. The rater must decide whether the 
rating lies on the defined scale steps (0,2,4,6) or between them 
(1,3,5)-
It is important to remember that it is only on rare occasions that a 
depressed patient is encountered who cannot be rated on the items in the 
scale. If definite answers cannot be elicited from the patient all 
relevant clues as well as information from other sources should be used 
as a basis for the rating in line with customary clinical practice.
The scale may be used for any time interval between ratings, be it 
weekly or otherwise but this must be recorded.
Item List
1 . Apparent sadness
2. Reported sadness
3 . Inner tension
4 . Reduced sleep
5 . Reduced appetite
6 . Concentration difficulties
7 . Lassitude
8 . Inability to feel
9» Pessimistic thoughts 
10. Suicidal thoughts
1 . Apparent Sadness
Representing despondency, gloom and despair, (more than just 
ordinary transient low spirits) reflected in speech, facial expression, 
and posture. Rate by depth and inability to brighten up.
0* No sadness.
1 .
2* Looks dispirited but does brighten up without difficulty.
3-
4» Appears sad and unhappy most of the time.
5.
6 . Looks miserable all the time. Extremely despondent.
- 1 -
2. Reported sadness
Representing reports of depressed mood, regardless of whether it is 
reflected in appearance or not. Includes low spirits, despondency or the 
feeling of being beyond help and without hope.
Rate according to intensity, duration and the extent to which the 
mood is reported to be influenced by events.
0* Occasional sadness in keeping with the circumstances.
1 .
2. Sad or low but brightens up without difficulty.
3-
4 . Pervasive feelings of sadness or gloominess. The mood is still 
influenced by external circumstances.
5-
6 . Continuous or unvarying sadness, misery or despondency.
3 . Inner tension
Representing feelings of ill-defined discomfort, edginess, inner 
turmoil, mental tension mounting to either panic, dread or anguish.
Rate according to intensity, frequency duration and the extent of 
reassurance called for. .
0. Placid. Only fleeting inner tension.
1 .
2. Occasional feelings of edginess and ill-defined discomfort.
3.
4 . Continuous feelings of inner tension or intermittent panic which 
the patient can only master with some difficulty.
5.
6 . Unrelenting dread or anguish. Overwhelming panic.
4 . Reduced sleep
Representing the experience of reduced duration or depth of sleep 
compared to the subject's own normal pattern when well.
0. Sleeps as usual.
1 .
2* Slight difficulty dropping of to sleep or slightly reduced, light 
or fitful sleep.
3*
4* Sleep reduced or broken by at least two hours.
5-
6 * Less than two or three hours sleep.
- 2 -
5» Reduced appetite
Representing the feeling of a loss of appetite compared with when 
well. Rate by loss of desire for food or the need to force oneself to 
eat.
0. Normal or increased appetite.
1 •
2. Slightly reduced appetite.
3-
4 . No appetite. Food is tasteless.
5-
6 . Needs persuasion to eat at all.
6 . Concentration difficulties
Representing difficulties in collecting one's thoughts mounting to 
incapacitating lack of concentration.
Rate according to intensity, frequency, and degree of incapacity 
produced.
0. No difficulties in concentrating.
1 .
2. Occasional difficulties in collecting one's thoughts.
3-
4 . Difficulties in concentrating and sustaining thought which reduces 
ability to read or hold a conversation.
5-
6 . Unable to read or converse without great difficulty.
7* Lassitude
Representing a difficulty getting started or slowness initiating and 
performing everyday activities.
0. Hardly any difficulty in getting started. No sluggishness.
1 .
2. Difficulties in starting activities.
3-
4 . Difficulties in starting simple routine activities which are carried 
outwith effort.
5-
6 . Complete lassitude. Unable to do anything without help.
- 3 -
8. Inability to feel
Representing the subjective experience of reduced interest in the
surroundings, or activities that normally give pleasure. The ability to
react with adequate emotion to circumstances or people is reduced.
0. Normal interest in the surroundings and in other people.
1 •
2. Reduced ability to enjoy usual interests.
3-
4- Loss of interest in the surroundings. Loss of feelings for friends 
and acquaintances.
5*
6 . The experience of being emotionally paralysed, inability to feel 
anger, grief or pleasure and a complete or even painful failure to 
feel for close relatives and friends.
9 . Pessimistic thoughts
Representing thoughts of guilt, inferiority, self-reproach, 
sinfulness, remorse and ruin.
0. No pessimistic thoughts.
1 .
2. Fluctuating ideas of failure, self-reproach or self depreciation. 
3*
4 . Persistent self-accusations, or definite but still rational ideas 
of guilt or sin. Increasingly pessimistic about the future.
5-
6 . Delusions of ruin, remorse or unredeemable sin. Self-accusations 
which are absurd and unshakable.
10. Suicidal thoughts
Representing the feeling that life is not worth living, that a
natural death would be welcome, suicidal thoughts, and preparations for
suicide.
Suicidal attempts should not in themselves influence the rating.
0. Enjoys life or takes it as it comes.
1 .
2. Weary of life. Only fleeting suicidal thoughts.
3*
4« Probably better off dead. Suicidal thoughts are common, and
suicide is considered as a possible solution, but without specific 
plans or intention.
5-
6 « Explicit plans for suicide when there is an opportunity. Active 
preparations for suicide.
- 4 -
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APPENDIX IV
MANIA RATING SCALE
Guide for Scoring Items - The purpose of each item is to rate the 
severity of that abnormality in the patient. When several keys are given 
for a particular grade of severity, the presence of only one is required 
to qualify for that rating.
The keys provided are guides. One can ignore the keys if that is 
necessary to indicate severity, although this should be the exception 
rather than the rule.
Scoring between the points given (whole or half points) is possible 
and encouraged after experience with the scale is acquired. This is 
particularly useful when severity of a particular item in a patient does 
not follow the progression indicated by the keys.
1 . Elated Mood 
0. Absent
1 . Mildly or possibly increased on questioning
2. Definite subjective elevation; optimistic, self-confident; cheerful;
appropriate to content
3- Elevated, inappropriate to content; humorous 
4* Euphoric; inappropriate laughter; singing
2. Increased Motor Activity-Energy 
0« Absent
1 . Subjectively increased 
2« Animated; gestures increased
3. Excessive energy; hyperactive at times; restless (can be calmed)
4» Motor excitement; continuous hyperactivity (cannot be calmed)
3 . Sexual Interest
0. Normal; not increased 
1 . Mildly or possibly increased
2. Definite subjective increase on questioning
3 . Spontaneous sexual content; elaborates on sexual matters; 
hypersexual by self-report
4» Overt sexual acts (towards patients, staff, or interviewer)
- 1 -
4» Sleep
0. Reports no decrease in sleep
1. Sleeping less than normal amount by up to one hour
2. Sleeping less than normal by more than one hour 
3* Reports decreased need for sleep
4 . Denies need for sleep
5 . Irritability 
0. Absent
2. Subjectively increased
4 . Irritable at times during interview; recent episodes of anger 
or annoyance on ward
6 . Frequently irritable during interview; short, curt throughout 
8 - Hostile, unco-operative; interview impossible
6 « Speech (Rate and Amount)
0. No increase 
2. Feels talkative
4- Increased rate or amount at times, verbose at times
6- Push; consistently increased rate and amount; difficult to interrupt
8 * Pressured; uninterruptible, continuous speech
7 . Language-Thought Disorder 
0. Absent
1 . Circumstantial; mild distractibility; quick thoughts 
2. Distractible; loses goal of thought; changes topics frequently; 
racing thoughts
3« Flight of ideas; tangentiality; difficult to follow; rhyming, 
echolalia
4» Incoherent; communication impossible
8 » Content 
0. Normal
2. Questionable plans, new interests
4 . Special project(s); hyperreligious
6 . Grandiose or paranoid ideas; ideas of reference
8 . Delusions; hallucinations
9 . Disruptive-Aggressive Behaviour
0. Absent, co-operative
2. Sarcastic; loud at times, guarded 
4« Demanding; threats on ward
6 . Threatens interviewer; shouting; interview difficult 
8 « Assaultive; destructive; interview impossible
- 2 -
10. Appearance
0. Appropriate dress and grooming
1. Minimally unkempt
2* Poorly groomed; moderately dishevelled; overdressed
3 . Dishevelled; partly clothed; garish make-up
4 . Completely unkempt; decorated; bizarre garb
11. Insight
0« Present; admits illness; agrees with the need for treatment
1. Possibly ill
2. Admits behaviour change, but denies illness
3- Admits possible change in behaviour, but denies illness
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Anorexia Nervosa ? 1
Bui 1m1a Nervosa ? 1
Eating Disorder NOS ? 1
ADJUSTMENT DISORDER
(CURRENT ONLY) (I) ? 1
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JjCI... 7/?/ft? Overview 1
i
i
INTRODUCTION OF INTERVIEW ( INCLUDING EXR.ANATION OF PURPOSE OF INTERVIEW AN#
'OBTAINING WRII1EN INhUKtEO CONSENT I F NECESSARY)------------------- ---------------------- -— ----------------
f *
DEMOGRAPHIC DATA
SEX } 1 male
2 female >
How old are you? AGE
Are you married? MARITAL STATUS
(most recent)
IF NO: Were you
ever?
(Children?)
Where do you live? NOTES:
(Who do you live with?)
What kind of work do you do? >ir -JPATION
(Do you work outside of 
the home?)
Are you working now?
j IF NOT WORKING NOW: Why 1s
that? What kind of work 
have you done?
i
How long have you worked there?
IF LESS THAN 6 MONTHS: Why 
did you leave your last job?
Have you always done that kind 
of work?
Has there ever been a period of 
time that you were unable to 
work?
IF YES: When? Why was that?
IF NOT OBVIOUS FROM WORK HISTORY: EDUCATIONAL LEVa -
How far did you get 1n school?
IF FAILED TO COMPLETE A 
PROGRAM IN WHICH THEY WERE 











PAST PERIOOS OF 
PSYCHOPATHOL OGY
1-
Have you ever> seen anybody 
for emotional or psychiatric 
problems?
IF YES: What was that for?
IF NO: Was there ever a time
when you# or someone else# 
thought you should see someone 
because of the way you were 
feel 1ng or act1ng?
Have you ever been a patient »
1n a psychiatric hospital?
IF YES: What was that for?
IF GIVES AN INADEQUATE AN­
SWER, CHALLENGE GENTLY: 
e.g.# "Wasn*t there something 
else? People usually donft 
go to psychiatric hospitals 
just because they are tired 
or nervous."
IF NO EVIDENCE OF PAST 
PSYCHOPATHOLOGY: Thinking back over 
your whole life# when were you the 
most upset?
(Why? What was that like?
How were you feeling?)
When were you feeling the best you 
have ever felt?
(Were you feeling so good that 
other people were worried about 
you?)
PSYCHOPATHOLOGY DURING PAST YEAR
Now I would like to ask you about 
the past year - since last (MONTH)?
Hon have things been going for you?
Has anything happened that has been 
especially hard for you?
What about difficulties at work or 
with your family?
&ID-NP 7/1/85 ,
h N r Overview
" ■ /
Ho has your mood been?
c
) What have your drinking habits 
been like?
Have you taken any drugs?
(What about marijuana# cocaine# 
other street drugs?)
What about your physical health?
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SCID-OP 7/1/85
AFFECTIVE SYNDROfCS
Current MDS Affective Syndromes A. 1
IN THIS SECTION# MAJOR DEPRESSIVE, MANIC, CYCLOTHYMIC AND DYSTHYMIC SYNDROKES 
ARE EVALUATED. THE DIAGNOSES ARE MADE IN C. AFFECTIVE DISORDERS, FOLLOWING 
B. PSYCHOTIC SCREENING.
CURRENT MAJOR DEPRESSIVE 
SYNDROME
No* I am going to ask you some 
questions about your mood.
IF CURRENTLY ILL: Since this
began.•.
IF NOT CURRENTLY ILL: In the
last month..'.'
...has there been 
a period of time when you were 
feeling depressed or down 
nearly every day?
K)S CRITERIA
A. At least 5 of the 
following symptoms have 
been present during the 
same two-week period; at 
least one of the symptoms 
was either (1) depressed 
mood# or (2) loss of 
Interest or pleasure.
NOTE: DO NOT INCLUDE SXS
THAT ARE CLEARLY DUE TO A 
PHYSICAL DISORDER# DELUSIONS# 
HALLUCINATIONS# INCOHERENCE 
OR MARKED LOOSENING OF 
ASSOCIATIONS.
(1) prominent depressed mood 
most of the day# nearly 
every day (either by subjec­
tive account# e.g.# feels 
"down," "low#" "hopeless#*1 
or observed by others to look 
sad or depressed)
DESCRIBE:
What about not being Interested 
1n things or unable to enjoy the 
things you used to?
IF YES: What was that like?
Was 1t nearly every day?
How long did 1t last?
(2) loss of Interest or 
pleasure In all or almost 








When was this the worst?
?-1nadequate Information l=absent or false 2=subthreshold 3=thresholc! or true
SCI D-OP 7/1/85 Current MDS Affective Syndromes A.
During this time...
..did your weight change? 
(Hew much?)
..how was your appetite? 
(What about compared to your 
usual appetite? Did you have 
to force yourself to eat?
Eat [less/more] than usual? 
Was that nearly every day?)
.how were you sleeping? 
(Trouble falling asleep# waking 
frequently# trouble staying 
asleep# waking too early# sleep­
ing too much? How many hours 
night compared to usual? Was 
“hat nearly every night?)
..were you so fidgety or rest- 
ess that you were unable to 
sit still? (If I had seen you# 
v^ ould I have noticed 1t? Was 
that nearly every day?)
IF NO: What about the op­
posite —  talking or mov­
ing more slowly than 1s 
normal for you? (If I had 
seen you# woul d I have 
noticed 1t? Was that 
nearly every day?)
(3) significant weight loss 
(when not dieting) or weight 
gain; or decrease or Increase 
In appetite nearly every day
DESCRIBE:




tion or retardation 
nearly every day (observ­
able by others and not 
merely subjective feelings 
of restlessness or being 
slowed down)
DESCRIBE:
..what was your energy like? 
c(Tired all the time? Nearly 
every day?)
^.d1d you feel worthless 
or guilty about things you 
had done or not done? 
(pearly every day?)
(6) fatigue or loss of 
energy nearly every day
DESCRIBE:
(7) feelings of worthless­
ness or excessive or In­
appropriate guilt nearly 
every day (not merely self- 





Inadequate Information l=absent or false 2=subthreshol d 3=threshold or true
SCI D-OP 7/1/85
During this time...
..did you have trouble 
thinking or concentrating?
(Was 1t hard to make deci­
sions about everyday things?)
(Nearly every day?)
..were you thinking a lot 
about death or about hurting 
yourself? (Nearly every 
day?)
(Did you do anything to hurt 
yourself?)
Current MDS Affective Syndromes A. 3
(8) diminished ability to 
think or concentrate, or 
1ndec1s1veness, nearly 
every day (either by sub­
jective account or observed 
by others)
DESCRIBE:
(9) recurrent thoughts of 
death of self or others, 
suicidal Ideation, or wishes 
to be dead, nearly every day; 
suicide attempt
DESCRIBE:
AT LEAST FIVE OF THE JBOVE 
CRITERIA [A (1-9)3 ARE CODED
«3«
? 1 2





ETIOLOGIC ROLE OF AN ORGANIC 
FACTOR IN FULL DEPRESSIVE 
SYNDROME
Just before this began, were 
you taking any drugs or 
medicines?
Drinking a lot?
Were you physically 111?
(What did the doctor say?)
IF YES TO ANY OF THESE 
QUESTIONS, DETERMINE IF ANY 
DEPRESSIVE EPISODE WAS NOT 
DUE TO AN ORGANIC MENTAL 
DISORDER. IF SO, CODE ”3".
B.(I) Not sustalned by a 
specific organic factor or 
substance (although there 
may be an organic precipi­
tant) .
XJ
IR/0 ORGI INO ORG! 
IAFF SYNI IETI0- L 
I I ILOGY I
I GO TO I 11 r 
1 PAST I ICON- I 
I MDS, I ITINUE T 
I A. 7 I Ij L
?=1nadequate Information l=absent or false 2= subthreshold 3=threshold or tru<
SCI D-OP 7/1/85 Current MDS Affective Syndromes A. 4
IF DURATION OF DEPRESSION B.(2) Not a normal reaction ? 1 3
HAS BEEN RELATIVELY BRIEF: to the loss of a loved one
Did this begin soon after (Uncomplicated Bereavement). 1
someone close to you died? (NOTE: Morbid preoccupation 1 1 1
with worthlessness, suicidal 1 R/0 1 ICUR-
IF YES, DETERMINE IF ANY Ideation, marked functional 1 UNCOMP. 1 IRENT
DEPRESSIVE EPISODE WAS NOT 1mpa1rment or psychomotor 1 BE- 1 IEPI-
DUE TO UNCOMPLICATED retardation, or prolonged 1 REAYE-I ISODE
BEREAVEMENT. IF SO, CODE duration, suggest bereave­ I MENT 1 INOT
”3”. ment complicated by Major 1 1 IDUE TO
Depression.) I GO TO 1 1UNCOMP
*1 PAST 1 IBE-
1 MDS, 1 IREAVE-
1 A. 7 1 IMENT
How old were you when you 
first had a lot of these 
symptoms for at least two 
weeks?
MAJOR DEPRESSIVE SYNDROME 
CRITERIA A AND B ARE CODED ”3"













How many separate times 
were you (depressed/OWN 
EQUIYfl_ENT) nearly every 
day for at least two weeks 
and had several of the 
symptoms that you described# 
11ke (SXS OF WORST EPISODE)?
Number of episodes of 
Major Depressive Syn­
drome (CODE 97 IF TOO 
NUMEROUS TO COUNT)
?=1nadequate Information l=absent or fal se 2=subthreshol d 3=threshold or tru
SCID-OP 7/1/85 Current MDS Affective Syndromes A. 5
MELANCHOLIA DURING CURRENT 
EPISODE
SEE A(2) OF CURRENT MAJOR 
DEPRESSIVE SYNDROM
MELANCHOLIA CRITERIA
A. Loss of pleasure 1n all 
or almost all activities.
* 1 2  13 x>
I WITHOUT] 
I MEL AN- I 
ICHOLIA I
.1
Have there been things that can 
make you feel better, like 
talking to a friend or hearing 
good news?
Is your feeling of (OWN EQUI­
VALENT FOR DEPRESSION) differ­
ent from the kind of feeling 
you would get 1f someone close 
to you died? (Or something 
else really bad happened to 
you?)
IF YES: How 1s 1t
different?
B. Lack of reactivity to 
all or almost all usually 
pieasurable stlmul1.
CODE "3" IF NOT REACTIVE TO 
ENVIRONKENTAL EVENTS OR SAYS 
NOTHING GOOD HAS HAPPENED
C. At least three of the fol* 
lowing:
(1) Distinct quality of 
depressed mood
CODE ”311 ONLY IF QUALI­
TATIVELY DIFFERENT FROM 
BEREAVEMENT (NOT MERELY 
MORE SEVERE OR ASSOCIATED 







? 1 2 3 x>
Do you feel worse 1n the 
morning, or 1n the evening, or 
doesn't 1t make any difference?
(2) the depression 1s re­
gularly worse 1n the morn­
ing
? 1 2 3 xx
Do you wake up as early as 
two hours before your usual 
time, without being able to 
get back to sleep?
Have you been pacing up and 
down?
Have you been so slowed down 
that you could hardly have 
a conversation or move at 
all?
?=Inadequate Information
(3) early morning awaken­
ing (at least two hours be­
fore usual time of awaken­
ing)
(4) marked psychomotor 
agitation or retardation
? 1 2 3 xx





SCID-OP 7/1/85 Current MDS Affective Syndromes A. 6
Have you had no appetite 
lost a lot of weight?
Do you feel guilty about 
anything?
?f Inadequate Information
or (5) marked anorexia or ? 1 2 3 . >
weight loss
(6 ) excessive or Inappro- ? 1 2 3 >
prlate gu11t (other than 
for being sick)
AT LEAST THREE «C" SXS *RE 1 3
CODED "3"
MELANCHOLIA CRITERIA A, B# 1 3 x





l=absent or false 2=subthreshold 3=threshold or tru
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PAST MAJOR DEPRESSIVE 
SYNDROME
(In the past...)
Past MDS Affective Syndromes A. 1
Have you ever had a period when 
you were feeling depressed or 
down nearly every day?
IF YES: What was that like?
How long did 1t last?
What about a time when you were 
uninterested 1n things or unable 
to enjoy the things you used to?
IF YES: What was that like? 
Was 1t nearly every day?
H w  long did 1t last?
Have you had more than one time 
like that?




A. At least 5 of the fol­
lowing symptoms have been 
present during the same two- 
week period; at least one of 
the symptoms was either
(1) depressed mood, or (2 ) 
loss of Interest or pleasure.
NOTE: DO NOT INCLUDE SXS THAT
ARE CLEARLY DUE TO A PHYSICAL 
DISORDER, DaUSIONS, HALLUCINA­
TIONS, INCOHERENCE OR MARKED 
LOOSENING OF ASSOCIATIONS.
(1) prominent depressed mood 
most of the day, nearly every 
day (either by subjective 
account, e.g., feels "down," 
"low," "hopeless," or ob­
served by others to look sad 
or depressed)
DESCRIBE:
(2) loss of Interest or 
pleasure 1n all or almost 












?s1nadequate Information 1-absent or false 2=subthreshold 3=threshold or tr^uif
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J
Past MDS Affective Syndromes A. 8
V
FOCUS ON THE WORST EPISODE 
THAT THE SUBJECT CAN REfCKBER
During that time...
..did your weight change? 
(;How much?)
..how was your appetite? 
(What about compared to your 
usual appetite? Did you have 
to force yourself to eat?
Elat Cless/more] than usual? 
Was that nearly every day?)
how were you sleeping? 
(Trouble falling asleep, waking 
frequently, trouble staying 
asleep, waking too early, sleep­
ing too much? How many hours 
a night compared to usual? Was 
that nearly every night?)
(3) significant weight loss 
(when not dieting) or weight 
gain; or decrease or Increase 
In appetite nearly every day
DESCRIBE:




..were you so fidgety or rest­
less that you were unable to 
sit still? (If I had seen you, 
would .I have noticed 1t? Was 
that nearly every day?)
IF NO: What about the op­
posite —  talking or mov­
ing more slowly than 1s 
normal for you? (If I had 
seen you, would I have 
noticed 1t? Was that 
nearly e^ery day?)
(5) psychomotor agita­
tion or retardation 
nearly every day (observ­
able by others and not 
merely subjective feelings 




..what was your energy like? 
(Tired all the time? Nearly 
every day?)
(6) fatigue or loss of 
energy nearly every day
DESCRIBE:
x>
..did you feel worthless 
orj* guilty about things you 
had done or not done? 
(Nearly every day?)
(7) feelings of worthless­
ness or excessive or Inappro­
priate guilt nearly every 
day (not merely self-reproach 





?=1nadequate information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 Past MDS Affective Syndromes A. 9
During that time...
..did you have trouble 
thinking or concentrating?
(Was 1t hard to make deci­
sions about everyday things?)
(Nearly every day?)
(8) diminished ability to 
think or concentrate, or 
1ndec1s1veness, nearly 
every day (either by sub­





..were you thinking a lot 
about death or about hurting 
yourself? (Nearly every 
day?)
(Did you do anything to hurt 
yourself?)
(9) recurrent thoughts of 
death of self or others, 
suicidal Ideation, or wishes 
to be dead, nearly every day; 
suicide attempt
DESCRIBE:
? 1 2 xx
/
AT LEAST FIVE OF THE ABOVE 
CRITERIA ARE CODED "3”
xx
IGO TO I 





ETIOLOGIC ROLE OF M  ORGANIC 
FACTOR IN FULL DEPRESSIVE 
SYNDROME
Just before this began, were B.(l) Not sustained by a ? 1 j 3 x®<
you taking any drugs or specific organic factor or
medicines? substance (although there  I_  j_|__
may be an organic preclpl- I Ilf I x
Drinking a lot? tant). IR/0 ORGI INO ORGI
IAFF SYNI IETI0L I *
Were you physically 111? j I I I
(What did the doctor say?) IGO TO I ICON- I v
ICURRENT I ITINUE I ,
IF YES TO ANY OF THESE IMANIC I U _____ I
QUESTIONS, DETERMINE IF ANY ‘ : ISYND., I
DEPRESSIVE EPISODE WAS NOT I A. 11 I
DUE TO AN ORGANIC MENTAL I______ I
DISORDER. IF SO, CODE "3".
?=1nadequate Information l=absent or false 2-subthreshol d 3=threshold, or true
SCID-OP 7/1/85 Past MDS Affective Syndromes A. 1(
IF DURATION OF DEPRESSION B.(2) Not a normal reaction ? 1 3
HAS BEEN RELATIVELY BRIEF: to the loss of a loved one
Did this begin soon after (Uncomplicated Bereavement). 1 __|
someone close to you died? (NOTE: Morbid preoccupation 1 1 1
with worthlessness, suicidal 1 R/0 1 IAT
IF YES, DETERMINE IF ANY Ideation, marked functional IUNC0MP.} 1 LEAST
DEPRESSIVE EPISODE WAS NOT 1mpa1 rment or psychcmotor 1 BE- I 10NE
DUE TO UNCOMPLICATED retardation, or prolonged 1 REAVE-1 IEPI-
BEREAVEMENT. IF SO, CODE duration, suggest bereave­ 1 MENT I ISODE
"3". ment complicated by Major 1 1 INOT
Depression.) IGO TO 1 J DUE TO
ICURRENTI IUNC0MP
NOTE: CODE "3ft IF AT LEAST IMANIC 1 IBE—
ONE EPISODE IS NOT UNCOM­ ISYND., I IREAVE-




MAJOR DEPRESSIVE SYNDROME 1 3
CRITERIA A AND B ARE CODED "3"
160 TO IIPAST | 




I A. 11 I
How old were you when you 
first had a lot of these 
symptoms for at least two 
weeks?
|How many separate times 
were you (depressed/OWN 
EQUIVALENT) nearly every 
day for at least two weeks 
and had several of the 
symptoms that you described, 
11ke (SXS OF WORST EPISODE)?
Age at onset of Major 
Depressive Syndrome
Number of episodes of 
Major Depressive Syn­
drome (CODE 97 IF TOO 
NUMEROUS TO COUNT)
?=1nadequate Information l*=absent or false 2=subthreshold 3=threshold or t
SCID-OP 7/1/85 Current MS Affective Syndrome
CURRENT MANIC SYN DROVE
IF THOROUGH OVERVIEW OF PRE­
SENT ILLNESS PROVIDES NO BASIS 
FOR SUSPECTING A CURRENT MANIC 
SYNDROME* GO TO PAST MS, A. 15.
IF CURRENTLY ILL: Since this,
bo^dn...
IF NOT CURRENTLY ILL: In the
last month...
...has there 
been a period of time when 
you were feeling so good or 
high that other people thought 
you were not your normal self 
or you were so high that you 
got Into trouble? <D1d any­
one say you were manic?)
IF UNCLEAR: Was that more
than just feeling good?
IF NO: What about being
unusually Irritable or 
getting Into fights or 
arguments?
What was that like?
How long did that last?
When were you the most (OWN 
EQUIVALENT FOR EUPHORIA OR 
IRRITABILITY)?
FOR THE WORST PERIOD OF 





A. One or more distinct peri­
ods lasting at least one week 
(or any duration 1f marked 
Impairment In social or 
occupational role functioning) 





IF IRRITABLE MOOD ONLY, 
CHECK HERE AFTER CODING 
ABOYE __
x
IGO TO I 




B. During the period of mood 
disturbance, at least three 
of the following symptoms 
have persisted (four If the 
mood 1s only Irritable) and 
have been present to a sig­
nificant degree:
..how did you feel about 
yourself?
(More self-confident than 
usual?)
(Any special powers or 
ab1l1t1es?)
(1) Inflated self-esteem 




?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85. Current MS Affective Syndromes : A. 3
)ur1ng this time...
{••did you need 1 ess si eep 
than usual?
IF YES: Did you s t m
feel rested?
(2) decreased need for 
sleep# e.g., feels rested 
after only three hours of 
si eep
DESCRIBE:
j..were you more talkative than 
usual? (People had trouble 
popping you or understanding 
you? People had trouble 
getting a word In edgewise?)
.were your thoughts racing 
through your head?
..did you have trouble con­
centrating because any little 
1:h1ng going on around you . 
could get you off the track?
..how did you spend your time? 
(Work, friends, hobbles?)
lyere you so active that your 
rlends or family were con­
cerned about you?
IF NO: Were you physically
restless? How bad was 11?
..did you do anything that could 
have caused trouble for you or 
your family? (Buying things 
you d1dn*t need?) (Anything 
sexual that was unusual for 
you?) (Reckless driving?)
(3) more talkative than 
usual or pressure to keep 
talking
DESCRIBE:
(4) flight of Ideas or sub­
jective experience that 
thoughts are racing
DESCRIBE:
(5) d1stract1b1Hty, I.e., 
attention too easily drawn 
to unimportant or Irrele­
vant external stlmul1
DESCRIBE:
(6 ) Increase 1n activity 
(either socially, at work, 
or sexually) or physical 
restlessness
DESCRIBE:
? 1 2 3 >
? 1 2 3 x
(7) excessive Involvement 
1n activities that have a 
high potential for painful 
consequences which 1s not 
recognized, e.g., buying 
sprees, sexual Indiscre­
tions, foolish business In­
vestments, reckless driving
DESCRIBE:
? 1 2 3 x
? 1 2 3 x
7 1 2 . 3  x:
’^ Inadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 Current MS Affective Syndromes A.
AT LEAST THREE "B" SXS ARE 
CODED "3" (FOUR IF MOOD ONLY 
IRRITABLE)
IGO TO | 
I PAST | 
I MANIC I 
ISYND.,I 
IA. 15 I
IF NOT KNOWN: At that time,
did you have serious prob­
lems at home or at work 
(school) because you were 
(SYMPTOMS) or did you have 
to be admitted to the hospital?
ETIOLOGIC ROLE OF AN ORGANIC 
FACTOR IN FULL MANIC SYNDROME
Just before this began, were 
you taking any drugs or 
medicines? Drinking a lot?
C. The episode of mood 
disturbance was sufficiently 
severe to cause marked Im­
pairment 1n social or occu­





D. Not sustained by a specific 
organic factor or substance 
(although there may be an 
organic precipitant)
MANIC SYNDROM CRITERIA 
A, B, C AND D ARE CODED "3"
I R/0 I 
I ORG I 











I CUR- I 
I RENT I 
I MANIC I 
ISYND.I




?=1nadequate Information l=absent or false 2-subthreshold S^ thresholid or tr
<;CID-OP 7/1/85
Ifow old were you when you 
1rst had serious problems 
r had to go to the hospital 
because you were (OWN BQUIV- 
AL ENT/MANIC)?
Current MS Affective Syndromes A. 1
Age at onset of Manic 
Syndrome.
How many separate times 
were you (HIGH/OWN EQUIV­
ALENT) and had several of 
these problems for a week 
or more (or were hospita­
lized)?
Number of episodes of 
Manic Syndrome (OODE 97 
IF TOO INDISTINCT OR 
NUMEROUS TO COUNT)
V
?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or tri
i
SCI D-OP 7/1/85 Past MS Affective Syndromes A. 1
PAST MANIC SYNDROM
Have you ever had a time 
when you were feeling so 
good or high that other people 
thought you were not your normal 
self or you were so high that 
you got Into trouble? (Did 
anyone say you were manic?)
IF UNCLEAR: Was that more 
than just feeling good?
IF NO: What about being
unusually Irritable or 
getting Into fights or 
arguments?
When was that?
What was 1t like?
Have you had more than one 
time like that?
IF YES: Which time were 
you the most (HIGH/OWN 
EQUIVALENT)?
(During that time...)
..how did you feel about 
yourself?
(More self-confident than 
usual?)
(Any special powers or 
abll1t1es?)
..did you need less sleep 
than usual?
IF YES: Did you still
feel rested?
MANIC SYNDROME CRITERIA
A. One or more distinct peri­
ods lasting at least one week 
(or any duration 1f marked 
Impairment 1n social or 
occupational role functioning) 










IF IRRITABLE MOOD ONLY, 
CHECK HERE AFTER CODING 
ABOVE__
B. During the period of mood 
disturbance* at least three 
of the following symptoms 
have persisted (four 1f the 
mood 1s only Irritable) and 
have been present to a sig­
nificant degree:
(1) Inflated self-esteem ? 1 2 3 x>




(2) decreased need for ? 1 2 3 x>
sleep* e.g., feels rested -
after only three hours of 
si eep
DESCRIBE:
?=Inadequate Information l=absent or false 2=subthreshold 3=threshold or tru<
i
! 4.
SCI D-OP 7/1/85 Past MS
During that time...
• were you more talkative than 
usual?. (People had trouble 
stopping you or understanding 
you? People had trouble 
getting a word 1n edgewise?)
Affective Syndromes ,A. 3
(3) more talkative than 
usual or pressure to keep 
talking
DESCRIBE:
..were your thoughts racing 
through your head?
(4) flight of Ideas or sub­
jective experience that 
thoughts are racing
DESCRIBE:
..did you have trouble con- (5) d1stract1b1Hty* I.e.* ? 1 2  3 >
centratlng because any Httle attention too easily drawn
thing going on around you to unimportant or Irrele-
could get you off the track? vant external stimuli
DESCRIBE:
..how did you spend your time? 
(Work* friends* hobbles?)
Were you so active that your 
friends or family were con­
cerned about you?
IF NO: Were you physically
restless? How bad was 1t?
..did you do anything that could 
iave caused trouble for you or 
your family? (Buying things 
you d1dn*t need?) (Anything 
sexual that was unusual for 
you?) (Reckless driving?)
(6) Increase 1n activity 
(either socially* at work, 
or sexually) or physical 
restlessness
DESCRIBE:
? 1 2  3 >
(7) excessive Involvement 
1n activities that have a 
high potential for painful 
consequences which Is not 
recognized* e.g.* buying 
sprees, sexual Indiscre­
tions* foolish business In­
vestments* reckless driving
DESCRIBE:
tr.. ?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or tri
i.
SCID-OP 7/1/85 Past MS Affective Syndromes A.
AT LEAST THREE "B" SXS ARE 
CODED "3" (FOUR IF MOOD ONLY 
IRRITABLE)
IGO TO CY- j 
ICLOTHYMIC I 
ISYND. A.181
IF NOT KNOWN: At that time,
did you have serious prob­
lems at home or at work 
(school) because you were 
(SYMPTOMS) or did you have 
to be admitted to the hospital?
C. The episode of mood 
disturbance was sufficiently 
severe to cause marked 1m- 
palrment 1n soc1al or occu­






ETICLOGIC ROLE OF AN ORGANIC 
FACTOR IN FULL MANIC SYNDROME
Just before this began, were 
you taking any drugs or 
medicines? Drinking a lot?
D. Not sustained by a specific 
organic factor or substance 
(although there may be an 
organic precipitant)
MANIC SYNDROKE CRITERIA 









How old were you when you Age at onset of Manic
first had serious problems Syndrome,
or had to go to the hospital 
because you were (OWN BQUIV- 
AL ENT/MANIO? ‘ ;
Number of episodes of   j_ x
Manic Syndrome (CODE 97 x
IF TOO INDISTINCT OR 
NUMEROUS TO COUNT)
How many separate times were 
you (HIGH/OWN EQUIVALENT) 
and had several of these 
problems for a week or more 
(or were hospitalized)?
?*Inadequate Information l=absent or false 2=subthreshold 3-threshold or tru«




SKIP TO B. PSYCHOTIC SCREENING, IF THE OVERVIEW INDICATES THAT A CHRONIC PSYCHOTIC 
DISORDER IS LIKELY.
[Other than the times we1 ve 
talked about when you were 
(OWN EQUIVALENT FOR W)S OR MS)3 
During the past couple of . 
years, have you had lots of 
ups and downs, that 1s, some 
days you feel too good or 
even a little high, and other 
days you feel down or de­
pressed?
IF YES; Are the good days 
really too good, or are 
they just better than the 
bad days?
IF YES: What are you
like at those times?
How often do you have 
these (OWN EQUIVALENT OF 
"j- UPS AND DOWNS)? Describe 
;-l the typical pattern. How 
long do they usually last?
A. During the past two years, 
there have been numerous 
periods with abnormally ele­
vated, expansive or Irritable 
mood that did not meet the 
criteria for a Manic Syndrome, 
and numerous periods with 
depressed mood or loss of 
Interest or pleasure that did 
not meet the criteria for a 
Major Depressive Syndrome.
DESCRIBE;
IGO TO I 
IDYS- I 





What 1s the longest period 
pf time 1n the last two years 
ithat you felt okay without 
e1ng either high or low 
OR OWN EQUIVALENT)? (How long 
o you feel normal in between 
hese ups and downs?)
IDurlng the times that you 
are a little high (OR OWN 
BQUIYfl-ENT), do you usually...
...need less sleep than 
usual?
...feel particularly full 
of energy?
B. -For the past two years, 
never without hypomanlc or 
depressive symptoms for 
more than three months.
C. During hypomanlc periods 
there are at least three of 
the following:
(1) decreased need for 
si eep
(2) more energy than 
usual





u ?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or tri
SCID-OP 7/1/85 Cycl othymlc Affective Syndrome.s A.
During the times that you 
are a little high (OR OWN 
BQUIVALENT)# doyouusually...




..get a lot more done?
..i have unusually good Ideas 
and think especially: clearly.?;
(4) Increased producti­
vity# often associated with 




? 1 2 1 3
... go out of your way to be 
with or talk with people?
(6) uninhibited people- 
seeking (extreme gregari­
ousness)
... do anything sexual that Is 
unusual for you?
(7) hypersexuality without 
recognition of possibility 
of painful consequences
? 1 2 3
...do things that cause or 
could cause trouble for you or 
your family? (Buying things 
you don*t need? Reckless 
driving?)
(8) excessive Involvement 
1n pleasurable activities 
-with lack of concern for the 
high potential for painful 
consequences# e.g.# buying 
sprees# foolish business In­
vestments# reckless driving
? 1 2 • 3
. •.feel physical ly restless? 
(Have trouble sitting still?)
(9) physical restlessness ? 1 2
...talk more than usual? (10) more talkative than 
usual
? 1 2
...feel overly optimistic 
about the future? 1
(11) ibveroptimism ? 1 2 3
?=1nadequate information l=absent or false 2-subthreshold 3=threshol 1 or trd(
SCID-OP 7/1/85 Cycl othymlc Affective Syndromes A. 2\
During the times that you  .....
ire a little high (OR OWN : 
EQUIVALENT)# do you usually...
... laugh and joke about things 
tlhat other people donft find 
f^ unny (or think are 1n poor 
-taste)?
New tell me what you are 
like during the times that 
ou are feeling down.
(12) 1napproprlate i augh- 
1ng> joking# punning
AT LEAST THREE "C" HYPOMANIC 
SXS ARE CODED "3"
D. During the depressive 
periods# there are at 
least three of the symptoms 
listed 1n criterion C of 









IGO TO I 
IDYSTHYMIC I 
ISYND. A.21I
EXPLORE POSSIBLE ETIOLOGIC 
ROLE OF SUBSTANCE USE
Were you taking any drugs or 
medicines when you were (OWN 
EQUIVALENT FOR HYPOMANIC AND 
DEPRESSIVE PERIODS)?
Were you drinking a lot?
When was the last time you 
felt OK (NO DYSTHYMIC SXS) 
or more than three months?
E. Not sustained by a 
specific organic factor or 
substance# e.g.# repeated 
Intoxication from drugs or 
alcohol.
CYCLOTHYMIC SYNDROME 
CRITERIA A, B, C# D, AND 
E ARE CODED "3"









IGO TO NCYCLO- 




=Inadequate Information 1=absent or fal se 2-subthreshold






IF EVER HAD A MAJOR DEPRESSIVE 
SYNDRONE: Other than the t1me(s) 
that we have already talked 
about when you were (OWN EQUI­
VALENT FOR MDS)...
During the past couple of 
years# have you been bothered 
by depressed mood or not 
being Interested 1n things 
you ordinarily enjoyed# more 
days than not?
IF YES: What was 1t like?
IF EVER HAD A MAJOR DEPRESSIVE 
SYNDROME: Did this (PERIOD OF
MILD DEPRESSION) first begin 
right after the time you had a 





A. During the past two years 
there has been depressed mood 
or loss of Interest or plea­
sure 1n all or almost all 
activities more days than not 
that did not meet the criteria 
for a Major Depressive Syn­
drome# and did not develop Im­
mediately after one (I.e.# was 
not a partial remission of a 
Major Depressive Syndrome).
DESCRIBE:
? 1 2 
I
IGO TO I 
I NEXT I 
I MODULE I
What 1s the longest period 
of time 1n the last two 
years# when you ha\^ e not 
felt depressed (OR CWN 
EQUIVALENT)?
B. For the past two years# 
never without depressive 
symptoms for more than three 
months at a time (may have 
had a superimposed MDS at 
some time during period# e.g.# 
currently).
CODE "1" IF NORMAL MOOD FOR . 
MORE THAN THREE MONTHS AT A 
TIME
IGO TO I 
I NEXT I 
IMODULEJ
During these periods of (OWN 
EQUIVALENT FOR MILD DEPRES­
SION) # do you often...
C. When depressed* at least 
three of the following symp­
toms are present:
...have trouble sleeping or 
sleep too much?
(1) Insomnia or hyper­
somnia
...have little energy to do 
things or feel tired all of 
the time?
(2) low energy level or 
chrorflc tiredness
?=1nadequate Information 1=absent or false 2sssubthreshold 3=thresho' d or tn
SCID-OP 7/1/85
During these periods of (OWN 
EQUIVALENT FOR MILD DEPRES­
SION) # do you often.••
...feel down on yourself? 
(feel worthless# or a 
failure?)
Dysthymic Affective Syndromes--/
(3) feelings of Inadequacy ? 1 2 3
...have trouble getting 
things done or doing things 
well? I
(4) decreased effective­
ness or productivity 
at school# work# or home
? 1 2 3
...have trouble concentrating 
r thinking clearly?
..avoid being with people?
...have little or no Interest 
1n doing things that you or­
dinarily enjoy?
(5) decreased attention# 
concentration# or ability 
to think clearly
(6 ) soda! withdrawal
(7) loss of Interest 1n or 
enjoyment of pleasurable 
activities# Including sex
? 1 2 3
? 1 2 3
? 1 2 3
...feel Irritable or get angry 
easily?
(8) Irritability or exces­
sive anger
? 1 2 3
...find yourself less active 
dr talkative than usual?
(9) less active or talka­
tive than usual
1 2  3
...feel restless? (10) feel rest! ess ? 1 2 3
...feel pessimistic about the 
future# or brood about the 
past or feel sorry for your- 
sel f?
(1 1) pessimistic attitude 
toward the future# brood­
ing about past events# or 
feeling sorry for self
? 1 2 3
...get tearful or cry?
...think about death or wish 
you were dead?
(12) tearfulness or crying ? 1 2 3
(13) thoughts of death or ? 1 2 3
suicide
7*inadequate information 1-absent or false 2esubthreshold 3=threshold or
SCID-OP 7/1/85 Dysthymic Affective Syndromes A. 2
\
AT LEAST THREE DEPRESSIVE 1 3 *
SXS ARE CODED "3" | ^
I I I
IGO TO I !
INEXT | I 
IMODULE I
EXPLORE POSSIBLE ETICLOGIC 
ROLE OF SUBSTANCE USE
Have you been taking any drugs 
or medicines during this time?
D. Not sustained by a spe­












DYSTHYMIC SYNDROtt CRITERIA 
A, B» C, AND D ARE CODED "3"
IGO TO I JDYS- 




When was the last time you Age at onset of current   x)
felt OK (NO DYSTHYMIC SXS) Dysthymic Syndrome. ■, $c
for more than three months? !
?=Inadequate Information l^absent or false 2=subthreshold 3=threshol<J or true
:ID-0P 7/1/85 Psychotic Screening . B. 1
PSYCHOTIC SCREENING
THIS MODULE IS FOR DETERMINING WHETHER NON-ORGANIC PSYCHOTIC 
SYMPTOMS HAVE BEEN PRESENT AT ANY TIFt DURING THE SUBJECT*S LIFE. 
(IN SOf€ CLINICAL AND RESEARCH SETTINGS SUBJECTS WITH A HISTORY 
6 F NON-ORG/WIC PSYCHOTIC SYMPTOMS WILL BE EXCLUDED.)
FOR PSYCHOTIC SYMPTOMS CODED "3"* DETERMINE WHETHER THE SYMPTOM 
IS "NOT ORGANIC" OR WHETHER THERE IS A POSSIBLE OR DEFINITE 
ORGANIC CAUSE. THE FOLLOWING QUESTIONS MAY BE USEFUL IF THE 
OVERVIEW HAS NOT ALREADY PROVIDED THE INFORMATION:
When you were (PSYCHOTIC SXS)* were you taking any drugs or 
ihedldnes? Drinking a lot? Physically 111?
IF HAS NOT ACKNOWLEDGED PSYCHO­
TIC SXS: Now I am going to
ask you about unusual experi­
ences that people sometimes 
have.
IF HAS ACKNOWLEDGED PSYCHOTIC 
SXS: You have told me about
(PSYCHOTIC EXPERIENCES). Now 
I am going to ask you more 
about those kinds of things.
DELUSIONS
A false personal belief based 
on Incorrect Inference about 
external reality and firmly 
sustained 1n spite of what al­
most everyone else believes 
and 1n spite of what consti­
tutes Incontrovertible and 
obvious proof or evidence to 
the contrary. Code overvalued 
Ideas (an unreasonable and 
sustained belief that 1s main­
tained with less than delu­
sional Intensity) as "2 ."
V'DId it ever seem that people 
were talking about you or taking 
. special notice of you?
.What about receiving special 
messages from people or from 
the way things were arranged 
ajround you* or from the news­
paper* radio or TV?
Delusions of reference* I.e.* 
personal significance 1s 
falsely attributed to objects 







?^1nadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 Psychotic Screening B. !
f -*■
What about anyone going out of 
the way to give you a hard time* 
or trying to hurt you?
IF YES: Do you know why
this happened to you?
Did you ever feel that you were 
especially Important in some way# 
or that you had powers to do 
things that other people couldnft 
do?
Did you ever feel that parts of 
your body had changed or stopped 
working (when your doctor said 
there was nothing wrong with 
you)? (What did your doctor 
say?)
Persecutory delusions# i.e., f 1 2 3
the individual (or his or her I I
group) 1s being attacked# 1
harassed# cheated# persecuted# 1 I 3
or conspired against.
1 POSS/DEF iNOT
DATES: 1 ORG |ORG
DESCRIBE:
Grandiose delusions# I.e.# ? 1 2 3
content Involves exaggerated 






DESCRIBE: I ORG 
1 _
ORG
Somatic delusions# I.e.# 
content Involves change or 
disturbance 1n body functioning
DATES:
DESCRIBE:
1 2  3
Other delusions, e.g.# 












?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or tru
SCID-OP 7/1/85
j~ ■
Psychotic Screening B. 3
.Did you ever hear things 
that other people couldnft 
. hfear# such as noises# or the 
voices of people whispering 
or talking?
! What did you hear?
* _ Did you ever have visions or 
'• see things that other people 




A sensory perception without 
external stimulation of the 
relevant sensory organ.
Auditory hallucinations 
when fully awake and heard 











A psychotic symptom has been 
present at some time
EXPLORE DETAILS AND DESCRIBE DIAGNOSTIC 
SIGNIFICANCE (E.G., SUBSTANCE-INDUCED 
PSYCHOTIC DISORDER, SCHIZOPHRENIA, 
PSYCHOTIC AFFECTIVE DISORDER, OR A 
TRANSIENT SX OF A NONPSYCHOTIC DISORDER, 
SUCH AS BORDER. INE PERSONA. ITY DISORDER 
OR POST-TRAUMATIC STRESS DISORDER)
DESCRIBE:
?= Inadequate Information l^absent or fal se 2=subthreshol d




















? 1 2 3
1
I 1 
1 GO TO 1
I
1








SCID-OP 7/1/85 , Affective Disorder!; C. 1
AFFECTIVE DISORDERS
GO TO NEXT MDDULE IF THERE HAS NEVER BEEN AN AFFECTIVE SYNDRONE 
(MAJOR DEPRESSIVE, MANIC, CYaOTHYMIC, OR DYSTHYMIC), OR IF AN 
AFFECTIVE SYNDRONE OCCURRED ONLY AS PART OF SCHIZOAFFECTIVE 
DISORDER.
THIS SECTION IS FOR MKING AFFECTIVE DISORDER DIAGNOSES AFTER THE 
PRESENCE OF AN AFFECTIVE SYNDROME HAS BEEN ESTABLISHED AND PSYCHOTIC 
FEATURES HAVE BEEN RULED IN OR CUT.
CHECK THE APPROPRIATE DIAGNOSES AND SUBTYPES BELOW. (IF YOU ARE HERE, 
YOU HAVE ALREADY COLLECTED ALL THE INFORMATION NECESSARY TO MAKE THESE 
DETERMINATIONS.)
BIPOLAR DISORDER (one or more manic episodes, with or 
without major depressive episodes)
INDICATE SUBTYPES: Currently manic 
Currently depressed 
Currently mixed
Currently with mood-congruent psychotic 
features, I.e., all delusions Involved 
the theme(s) of either guilt, disease, 
death, nihilism or deserved punishment













CYCLOTHYMIC DISORDER (past two years)
BIPOLAR DISORDER NOS 
Exampies:
DESCRIBE:
(1) Bipolar II: An Individual has had at least one hypomanlc
episode and at least one major depressive episode but never had 
either a manic episode or cyclothymia.
(2) An Individual has had one or more hypomanlc episodes but does 





SCID-OP 7/1/85 Affective Disorders
MAJOR DEPRESSION (no history of manic or hypomanlc episodes) ? *1,. 3
CHECK SUBTYPE (ONE ONLY):
1   currently without melancholia or psychotic features
i
1 ____  currently with melancholia
I '
  currently with mood-congruent psychotic features*
I.e.* all delusions Involved the theme(s) of either 
guilt* disease* death* nihilism or deserved punishment
  currently with mood-1 neongruent psychotic features
DYSTHYMIC DISORDER (past two years; no history of manic or ? 1 3
hypomanlc episodes)
DEPRESSIVE DISORDER NOS DESCRIBE: ? 1 3
Examples:
: (1) Major depressive episode superimposed on residual
Schizophrenia
(2) Intermittent dysthymic episodes
(3) Non-stress-related minor depression
SCID-OP 7/1/85 Af f ectlve, D1 sorder*s C.i
CHRONOLOGY FOR MANIC EPISODES
IF NO MANIC EPISODE EVER, CHECK HERE AND SKIP TO CHRONOLOGY 
FOR MAJOR DEPRESSIVE EPISODES .
IF UNCLEAR: During the past
month, have you been (OWN 
EQUIVALENT FOR EUPHORIC OR 
IRRITABLE MOOD)?
Has had euphoric or Irritable ? 1
mood during past month I
When were you last (OWN EQUIV* 
ALENT FOR EUPHORIC OR IRRI­
TABLE MOOD)?
Number of months prior to 
Interview when last had 
euphoric or Irritable mood








IF UNCLEAR: During the past 
month, have you had (LIST OF 
MANIC SXS CODED "3*')?
During the past five years, 
how much of the time have 
you been bothered by (ANY 
SXS OF MANIC SYNDRONE)?
Has met symptomatic criteria 
for manic syndrome during the 
past month (criteria A and B)
Duration 1n months during past 
five years that any manic 
symptoms were present
■ « u v  '
3 ' x
= »• M  
;-DL JA'~X 
i C
CHRONOLOGY FOR MAJOR DEPRESSIVE EPISODES
IF NO MAJOR DEPRESSIVE EPISODE EVER, CHECK HERE AND SKIP TO 
NEXT MODULE .
IF UNCLEAR: During the past
month, have you been (OWN EQUIV­
ALENT FOR DEPRESSED MOOD OR 
LOSS OF INTEREST OR PLEASURE)?
Has had depressed mood or 
loss of Interest or pleasure 
during past month
When did you last have (OWN 
EQUIVALENT FOR DEPRESSED 
MOOD OR LOSS OF INTEREST OR 
PLEASURE)?
Number of months prior to 
Interview when last had 






. j V v *
IF UNCLEAR: During the past 
month, have you had (LIST OF 
DEPRESSIVE SXS CODED "3")?
During the past five years, 
how much of the time have 
you been bothered by (ANY 
SXS OF DEPRESSIVE SYNDROKE)?
Has met symptomatic criteria 
for depressive syndrome during 
the past month (criterion A)
Duration 1n months during past 
five years that any depressive 
symptoms were present
3 ax






' s u b s t a n c e d e p e n d e n c e  d i s o r d e r s
- ALCOHOL DEPENDENCE (LIFETIIC)
■* '
What ire your drinking habits 
11ke?
. How much do you drink?
!
* Was there ever a period 1n 
■your life when you drank too 
^ much?
j




IF NEVER OR ONLY RARELY DRINKS 
ALCOHOL# CHECK HERE AND SKIP 
xTO NEXT SECTION ____
When 1n your life were you
drinking the most?
(How long did 1t last?)
^Now I am going to ask you 
.several questions about that 
time.
j.. '
s IF CAN*T IDENTIFY A PARTI- 
~ CULAR PERIOD# REPHRASE EACH
- QUESTION TO BEGIN WITH 
"Have you ever..."
f)1 d you often spend a lot of time 
thinking about drinking or making 
sure; that you had alcohol 
a^vall able?
A1cohol SDD D. 1
CRITERIA
At least three of the following:
(1) Frequent preoccupation 
with seeking or taking al­
cohol
xx
Did you often find that when you 
"Started drinking you ended up 
prinking much more than you 
thought you would?
*4 ■
What about drinking for a much 
longer period of time than you 
thought you would?
?c1nadequate Information l=absent or false
(2) Often takes alcohol 1n 
larger amounts or over a 
longer, period than he or she 
Intended I
xx
2=subthreshold 3=threshold or true
Did you find that you needed to 
drink a lot more 1n order to get 
high than you did when you first 
started drinking?
What about finding that when you 
drank the same amount# 1t had 
much less effect than before?
Did you ever have the shakes when 
you cut down or stopped drinking 
(that 1s# your hands shook so much 
that other people would have been 
able to notice 11)?
(3) Tolerance: need for In­
creased amounts of alcohol 
1n order to achieve Intoxica­
tion or desired effect# or 
diminished effect with con­
tinued use of the same amount
(4) Withdrawal symptoms# 
such as coarse tremor 
("shakes*1)# seizures# DTs. 
(Do not Include simple 
"hangover.")
After not drinking for a few (5) Relief drinking: often
hours or more# did you often drinks to relieve or avoid
drink to keep yourself from get- withdrawal symptoms
ting the shakes or becoming sick?
What about drinking when you were 
having the shakes or feeling sick 
so that you would feel better?
Did you try to cut down or stop (6) Persistent desire or
drinking alcohol? repeated efforts to cut dcwn
or control alcohol use
IF YES: Did you ever
actually stop drinking alto­
gether?
(How many times did you try 
to cut down or stop alto­
gether?)
IF NO: Did you want to stop
or cut down?
IF YES: Is this something
you kept worrying about or 
was 1t just a passing 
concern?
?=1nadequate information l=absent or false 2=subthreshold
< SCID-OP 7/1/8S AT cohol SDD D. 3
~ Did you have a time when you were 
 ^ Intoxicated or high or very 
hungover* when you were doing 
"" something Important* like being at 
school or work* or taking care of 
children?
A What about missing something 
( Important* like staying away from 
 ^ school or work or missing an 
„ appointment because you were 
Intoxicated* high or very 
hungover?
■* Did you ever drink while doing 
something where 1t was dangerous 
to drllnk at all?
(7) Often Intoxicated or 
Impaired by alcohol use when 
expected to fulfill social 
or occupational obligations* 
or when substance use 1s 
hazardous (e.g.* doesn*t go 
to work because hungover or 
high* goes to work high* 
drives when drunk)
? 1 2 3 xx
Did you drink so often that 
you started to drink Instead 
,of working or spending time at 









ew that you had 






What dbout continuing to drink 
when you knew that 1t was In­
creasing problems you were having 
with other people, such as with 
family members or people at work?
(8) Has given up some 
Important social* occupation­
al or recreational activity 
1n order to seek or take the 
substance
(9) Continuation of alcohol 
use despite a physical disor­
der or a significant social 
or legal problem that the 
individual knows 1s exacer­
bated by the use of alcohol
xx
AT LEAST 3 ITEMS ARE CODED "3"
NOTE: IN A SUBJECT WHO DBJIES
BEHAVIORAL EVIDENCE OF THE DIS­
ORDER, A PROVISIONAL DIAGNOSIS 
IS WARRANTED IF THERE IS EVIDENCE 
OF A MENTAL OR PHYSICAL DISORDER 
OR CONDITION THAT IS USUALLY A 
COMPLICATION OF PROLONGED 
ALCOHOL USE, E.G., DT»S, CIRRHO­












IF UNCLEAR: During the past 
month# have you had problems 
w 1th al cohol ?
A1 cohol
Has had some symptomCs) of 
Alcohol Dependence during 
past month
SDD D.
When did you last have problems 
with alcohol?
Number of months prior to 
Interview when last had 
symptoms of Alcohol Dependence
IF UNCLEAR: During the past 
month# have you had (LIST OF 
ALCOHOL DEPENDENCE SXS CODED 
"3")?
During the past five years# 
how much of the time have 
you had problems with alcohol?
How old were you when you first 
had (LIST OF ALCOHOL DEPENDENCE 
SXS CODED "3”)?
Has met criteria for Alcohol 
Dependence during past month
Duration 1n months during past 
five years that any symptoms of 
Alcohol Dependence were present

































?=1nadequate Information l=absent or fal se 2=subthreshold 3=threshold or true
K SCID-OP 7/1/85 Non-AT cohol SDD D. 5
* NON-ALCOHOLIC SUBSTANCE 
^ DEPENDENCE (LIFETIME)
~ Now I would like to ask you 
t* about your use of certain
* drugs or medicines that affect 
how you think or feel. I am
^talking about things like 
' sleeping pills or tranquill­
izers ’that a doctor might 
^prescribe# and also about 
idrugs that you would probably
* get on the street# like narco- 
0 tics# stimulants# marijuana#
cocaine and psychedelics. 
.“’"Have you ever taken any drugs 
^ Hke 1:hese to get high# to 
* sl eep better or to change 
'* your mood?
IF A DRUG THAT IS S0f€TIteS 
PRESCRIBED: Was that pre- 
, scribed or did you take 1t 
on your own?
.J
IF PRESCRIBED: Did you take
? more than was prescribed?
rt
Vi
IF EVER HAS TAKEN ANY OF 
THESE DRUGS ON OWN OR MORE 
THAN WAS PRESCRIBED: Have
you taken any of these drugs 
more than twenty times (on 
your own)? (Have you ever 
used any of these drugs 
nearly every day for a week 
or longer?)
Has taken non-alcoholic 
drug on his or her own 
more than twenty times to 
sleep or to alter mood 
or thinking# or nearly 
every day for more than 
one week
xx
c:IF YESl ASK ABOUT EACH DRUG a  ASS
INS THE SPECIFIC DRUGS NOTED BaOW. 
RUG a  ASS USED 20+ TIkES OR EVERY 





DRUG a  ASS USED 20+ TINES ON OWN SPECIFIC DRUG USED ("MULTiaE" IF  
A VARIETY OF DRUGS WITHIN A CLASS)
Barbiturates-sedatives-hypnotlcs 
(e.g.# quaalude# seconal# vallum 
librium# "downers”)
Cannabis (e.g.# marijuana# THC# 
"grass#” "weed#" "reefer#" "pot")
40.
*?= Inadequate Information 1=absent or false 2=subthreshol d 3=threshol d or true
SCID-CP 7/1/85 Non-Al cohol SDD D.
DRUG a  ASS USED 20+ TIMES ON OWN SPECIFIC DRUG USED (’’MULTIPLE’1 IF 
A VARIETY OF DRUGS WITHIN A CLASS)
Stimulants (e.g., amphetamine,
"speed, "/’uppers")
Opioids (e.g., heroin, morphine, 
methadone, darvon, opium, codeine, 
demerol, percodan)
Cocaine ("coke")
Halluc1nogens-PCP (e.g., LSD, "acid," 
mescaline, peyote, psilocybin, STP, 
"angel dust," "peace pill")
Other (e.g., steroids, "glue")
WRITE "1," "2," OR "3" FOR EACH ITEM 
'OR EACH DRUG CATEGORY THAT THE 
OBJECT HAS USED 20+ TIMES OR EVERY 
AY FOR ONE WEEK. QUESTIONS SHOULD BE 
FOCUSED ON THE TINE PERIOD WHEN THE 
SUBJECT WAS TAKING THE LARGEST AMOUNTS 
OF THE DRUG.
At least three of the following:
BARB- CANN STIMU OPI COCA HALL-





Did you often spend a lot of time 
thinking about taking (DRUG) or 
making sure that you had (DRUG) 
av a11 abl e?
(1) Frequent preoccupation with 
seeking or taking drug
Did you often find that when you 
started taking (DRUG) you ended up 
taking much more of 1t than you 
thought you would?
What about taking 1t over a much 
longer period of time than you 
thought you would?
(2) Often takes drug 1n 
1arger amounts or over a 
longer period than he or 
she 1ntended
(xx) (xx) (xx) (xx) (xx) (xx)





?= Inadequate Information l=absent or false 2=subthreshold 3=threshold or true4









Did ylou find that you needed to
take a lot more (DRUG) 1n order
to gejt high than you did when
you f1rst, started taking 11?
What about finding that when you 
took fthe same amount* It had 
much iless effect than before?
(3) Tolerance: need for In­
creased amounts of drug 1n 
order to achieve Intoxication 
or desired effect* or dimi­
nished effect with continued 
use of the same amount
(xx) (xx) (xx) (xx) (xx) (xx) (xx
Have you ever had withdrawal 
symptoms* that 1s* felt sick 
when you cut down or stopped 
taking (DRUG)?
IF YES: What symptoms did
you have? IF UNCLEAR 
WHETHER SYMPTOMS REPRESENT 
WITHDRAWAL, CONSULT DSM-III 
CFlITERIA FOR WITHDRAWAL 













(xx) (xx) (xx) (xx) (xx) (xx) (x>
not taking (DRUG) for a few 
or more* did you often take 
keep yourself from getting 
(WITHDRAWAL SXS)? What about 
(DRUG) when you were feeling 
(WITHDRAWAL SXS) so that you 
feel better?
(5) Relief drug use: often
takes drug to relieve or 
avoid withdrawal symptoms (xx) (xx) (xx) (xx) (xx) (xx) (x:
i X X .
I  ;
] ?fc1nadequate Information l=absent or false 2=subthreshold 3=threshold or true











Did you try to cut down or stop 
taking (DRUG)?
IF YES: Did you ever actually
stop taking [DRUG] altogether? 
(How many times did you try to 
cut down or stop altogether?
IF NO: Did you want to stop
or cut down?
IF YES: Is this something
you kept worrying about or 
was 1t just a passing 
concern?
(6) Persistent desire or 
repeated efforts to cut 
down or control drug use
Did you have a time when you were 
Intoxicated or high from (DRUG) 
when you were doing something 
Important* like being at school or 
work* or taking care of children?
What about missing something 
Important* like staying away from 
school or work or missing an 
appointment because you were 
•ntoxlcated or high?
Did you ever take (DRUG) while 
doing something where 1t was 
dangerous to take (DRUG) at all?
(7) Often Intoxicated or 
Impaired by drug use when 
expected to fulfill social 
or occupational obliga­
tions* or when substance 
use 1s hazardous (e.g.* 
doesnft go to work because 
high* goes to work high* 
drives when Intoxicated)
(xx) (xx) (xx) (xx) (xx) (xx) (xx)
>.T
■/
(xx) (xx) (xx) (xx) (xx) (xx) - (XX) ,
JC/t
^inadequate Information 1-absent or false 2=subthreshold 3=threshold or-trjue
SCID-OP 7/1/85 Non-Al cohol SDD D. 9
BARB- CANN STIMU OPI COCA HALL-
SED. ABIS LANTS OIDS INE PCP OTHI
Did you take (DRUG) so often that 
you sjtarted to take (DRUG) Instead 
of working or spending time at 
hobblps or with your family or 
friends?
(8) Has given up some 
Important social# occupa­
tional or recreational 
activity 1n order to seek 
or take the substance
Did y^ HJ keep taking (DRUG) even 
-though you knew that you had a 
physical problem or Illness that 
was made worse by (DRUG)?
What about continuing to take 
(DRUG) when you knew that 1t was 
Increasing problems you were having 
with other people# such as with 
family members or people at work?
(9) Continuation of drug use 
despite a physical disorder 
or a significant social or 
legal problem that the Indivi­
dual knows 1s exacerbated by 
the use of the drug
(xx) (xx) (xx) (xx) (xx) (xx) (xx
(xx) (xx) (xx) (xx) (xx) (xx) (xx!
AT LEAST THREE ITEMS CODED "3"
(xx) (xx) (xx) (xx) (xx) (xx) (xx)
AT LEAST THREE ITEMS FOR ONE OF 1 3 x>





, IDENCE I 
I______ i
NOTE:, IN A SUBJECT WHO DENIES BEHAVIORAL EVIDENCE OF THE DISORDER,
A PROVISIONAL DIAGNOSIS IS WARRANTED IF THERE IS EVIDENCE OF A 
PHYSICAL DISORDER OR CONDITION THAT IS USUALLY A COMPLICATION OF 
DRUG USE, E.G., NEEDLE MARKS OR ABSCESSES ON THE ARMS.
?=1nadequate Information l=absent or false 2=subthreshol d 3=threshold or true
SCID-OP 7/1/85 Non-Alcohol SDD D. 10
CHRONOLOGY
IF UNCLEAR: During the past 
month* have you had problems 
with (DRUG)?
Has had some symptom(s) of 
Non-alcohol Substance Dep­
endence during past month
xx
When did you last have problems 
with (DRUG)?
Number of months prior to 
interview when last had 
symptoms of Non-alcohol 
Substance Dependence
IF UNCLES: During the past 
month* have you had (LIST OF 
NON-ALCOHOL SUBSTANCE DEPEN­
DENCE SXS CODED "3")?
During the past five years* 
how much of the time have 
you had problems with (DRUG)?
How old were you when you first 
had (LIST OF NON-ALCOHOL SUB­
STANCE DEPENDENCE CODED »3")?
Has met criteria for Non­
alcohol Substance Depen­
dence during past month
Duration 1n months during past 





















Have you ever had an attack 
Ahen you suddenly felt 
frightened or extremely un­
comfortable In a situation 
In which you d1dnft expect to 
feel uncomfortabl e?
IF YES: Tell me about 1t. 
How many times did that 
happen? In what situa­
tions?
Anxiety Disorders E. ■]
PANIC DISORDER CRITERIA
A. At some time during the 
Illness at least three panic 
attacks (discrete periods of 
Intense discomfort or fear) 
that were (1) unexpected (1. e.# 
did not occur Immediately 
before or upon exposure to a 
situation that almost always 
caused anxiety)# and (2) not 
triggered by situations 1n 
which the Individual was the 
focus of others1 attention.





Have you ever had three 
attacks like that 1n a three- 
week period?
IF NO: Did you worry a lot 
about having another one? 
(How long did you worry?)
B. Either the three attacks 
of criterion A occurred 
within a three-week period# 
or one or more attacks were 
followed by a period of at 
least a month of persistent 
fear of having another attack.





When was the last bad one?
i
Now I am going to ask you 
about that attack. What was 
the first thing you noticed? 
ITien what?
Cfurlng that attack...
..were you short of breath? 
(Have trouble catching your 
b reath?)
..did you feel as If you were 
choklng?
..did your heart.race# pound 
dr skip?
C. At least four of the fol­
lowing symptoms developed 
during at least one of the 
attacks:
(1) shortness of breath 
(dyspnea) or smothering 
sensatlons
(2) choking
(3) pal pltatlons or 
accelerated heart rate  
(tachycardla)
? 1 2 3 x
? 1 2 3 x
? 1 2 3 x:
?s1nadequate Information l=absent or false 2=subthreshold 3=threshold or tru<
SCID-OP 7/1/85 Panic Anxiety Disorder:; E. 2
During that attack...
..did you have chest pain or 
pressure?
.. did you sweat?
..did you feel Hke you might 
faint (pass out)?











..were you dizzy or lightheaded# 
or did you feel unsteady# Hke 
you might fall?
(7) dizziness# Ught- 
headedness or unsteady 
feel 1ngs
? 1 2 3 xx
..did you have nausea or upset 
stomach or the feeling that 
you were going to have diarrhea?
(8) nausea or abdominal 
distress
? 1 2 3 xx
..did things around you seem 
unreal or did you feel 
detached from things around 
you or detached from part of 
your body?
(9) depersonalization or 
dereal1zat1on
? 1 2 ,3 xx
..did you have tingling or (10) numbness or tingling ? 1 2 3
numbness 1n parts of your body? sensations (paresthesias) ;
..did you have flushes (hot 
flashes) or chills?
(11) flushes (hot 
flashes) or chills
? 1 2 3 xx
.did you tremble or shake?
..were you afraid that you 
might die?
(12) trembling or shaking
(13) fear of dying
xx
XX
..were you afraid you were going 
crazy or might lose control?
(14) fear of going crazy 
or doing something uncon­
trol 1 ed
? 1 2 xx
?=1nadequate Information l=absent or false 2ssubthreshold 3=threshold or*true
SCID-OP 7/1/85 Panic Anxiety Disorders E. 3
AT LEAST FOUR "C" SXS ARE 
CODED "3"
Ov
when you have bad attacks* how 
ljong does 1t take from when 1t 
t>eg1ns to when you have most of 
the symptoms? (Is 1t often less 
than ten minutes?)
D. During at least some of 
the attacks* at least four 
of the "C” symptoms occurred 
within ten minutes of the 
beginning of the first nC!l 
symptom noticed 1n the attack.





IGO TO I 
I LIMITED I 
ISYMPTOM I 
I ATTACKS I 
IE. 6 I
Just before you began having 
panic attacks* were you taking 
any drugs* stimulants or medi­
cines?
IF YES: Did you keep
having the attacks after 
you stopped?
Were you physically 111?
(What did the doctor say?)
IF YES: Did you ever have
I these attacks when you 
1 werenft (taking any drugs or 
j medicines, physically 111?)
E. Not sustained by a known 




NOTE: Mitral valve prolapse
may be an associated condl- 
dltlon but does not rule out 
a diagnosis of Panic Disorder.
NOTE: CODE "3" IF DRUG OR 
ALCOHOL USE OR PHYSICAL 
ILLNESS WAS NOT ETIOLOGIC 
TO PANIC ATTACKS
PANIC DISORDER CRITERIA 
A* B, C, D AND E ARE 
CODED "3”
IGO TO I 
lLIMITED I 
I SYMPTOM I 
IATTACKS I 
IE. 6 I 
I______ I
IGO TO I IPANIC 
lLIMITEDIIDIS- 
I SYMPTOM|IORDER
I ATTACKS I I _
IE. 6 I
?l=1nadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 Panic Anxiety. Disorders! E. 4
PANIC DISORDER SUBTYPES- 
PAST MONTH
IF NOT OBVIOUS FROM OVERVIEW:
Are there situations or places 
that you avoid because you are 




I 1. Panic Disorder without 
I Phobic Avoidance Mt
(Tell me all the things 
you avoid* or can only do 
by forcing yourself?)
(What about going out of 
the house alone* being 1n 
crowds or certain public 
places like tunnels, 
bridges, buses or trains?)
(How often do you go out­
side of your house alone?)
(Do you often need a com­
panion?)
(What effect does avoiding 
these situations or places 
have on your life?)
CHRONOLOGY
IF UNCLEAR: During the past 
month* have you had any panic 
attacks (even little ones), or 
worried a lot that you might 
have one* or have you avoided 
situations or places because 
you were afraid you might have 
one?
2. Panic Disorder with Limited 
Phobic Avoidance (significant 
phobic avoidance or endurance 
despite Intense anxiety)
13. Panic Disorder with Agora-
I phobia (generalized travel
I restrictions* often needs a
I companion away from home* or
I markedly altered life style)
If no panic attacks during last 6 
months specify: (No current panic
attacks)
(CODED IN CHRONOLOGY SECTION BELOW)
Has had some symptom(s) of 
Panic Disorder during past 
month
xx
When did you last have (ANY SX 
OF PANIC DISORDER)?
Number of months prior to 
Interview when last had 
a symptom of Panic Disorder
I
IF UNCLEAR: During the past 
month, how many panic attacks 
have you had?
Has met symptomatic criteria 
for Panic Disorder during past 






?=1nadequate Information l=absent or false 2-subthreshold 3=threshold or true
SCID-OP 7/1/85 Panic Anxiety Disorders E.'5
During the past five years# Duration In months during past ___  I x
how much of the time have five years that any symptoms of x
you been bothered by (PANIC Panic Disorder were present
ATTACKS, PERSISTENT FEAR OF
HAVING AN ATTACK, OR PHOBIC
AVOIDANCE)?
How old were you when you first Age at onset of Panic Disorder .__     x
started having a lot of panic (at least three attacks over a x
attacks (or worried all the three week period or one or
time that you might have one)? more attacks followed by per-




f=1nadequate Information l=absent or false 2=subthreshold 3=threshold or tri
SCID-OP 7/1/85 Limited Symptom Attacks Anxiety Disorders E.^ (
LIMITED SYMPTOM ATTACKS WITH 
PHOBIC AYOIDANCE (AGORAPHOBIA 
WITHOUT PANIC ATTACKS)
SKIP IF EVER HAD PANIC 
ATTACKS
Were you ever afraid of going 
out of the house alone, being 
in crowds or certain public 
places Hke tunnels, 
bridges, buses or trains?
What were you afraid could 
happen?
LIMITED SYMPTOM ATTACKS WITH 
PHOBIC AVOIDANCE (AGORAPHOBIA 
WITHOUT PANIC ATTACKS)
A. Fear of being outside the 
home alone or 1n public places 
because of the possibility of 
developing a symptom that 1s 
Incapacitating, such as dizzi­
ness, loss of bladder or bowel 
control or cardiac distress.
PRIMARY FEAR Check:
  becoming dizzy or falling
 loss of bladder or bowel
control
  fear of cardiac distress
  other (Specify:_________









(CODE FROM PREVIOUS 
INFORMATION)
B. Never had an unexpected 
panic attack, as defined 1n 







Tell me all the things you 
avoided (or could only do 
by forcing yourself?)
(How often did you go out­
side of your house alone?)
(Did you often need a com­
panion?)
(What effect did avoiding 
these situations or places 
have on your life?)
C. As a result of A. there are 
either travel restrictions, 
need for a companion when away 
from home, or altered life 
style, or there 1s endurance 







?=Inadequate Information l=absent or false 2=subthreshold 3=threshold lor true
!





Tlr UNCLEAR: During the past 
<pnth, have you avoided 
HCBIC SITUATIONS)?
LIMITED SYMPTOM ATTACKS WITH 
PHOBIC AVOIDANCE (AGORAPHOBIA 
WITHOUT PANIC ATTACKS) CRI­
TERIA A, B, AND C ARE CODED 
"3«
x>
Has had some symptom(s) of 
Limited Symptom Attacks with 
Phobic Avoidance
len did you last avoid (PHOBIC•* vwii u u wi
SITUATIONS)
During the past five years, 
hew much of the time have 
you avoided these situations 
because you were afraid?
How old were you when you first 
bad this problem?
Number of months prior to 
Interview when last had 
a symptom of Limited Symptom 
Attacks with Phobic Avoidance
Duration 1n months during past 
five years that any symptoms of 
Limited Symptom Attacks with 
Phobic Avoidance were present
Age at onset of Limited Symptom 
Attacks with Phobic Avoidance
IGO TO IlLIMITED I 
(SOCIAL 11 SYMPTOM I 
IPHOBIA11ATTACKS I
IE. 8 I(WITH I 
(PHOBIC I 
















Inadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 Social Phobia Anxiety Disorders E. 8
SOCIAL PHOBIA
Is there anything that you 
were ever afraid to do or 
felt uncomfortable doing In 
front of other people, like 
speaking, eating or writing?
Anything else?
What were you afraid would 
happen when___________ ?
IF NOT OBVIOUS: Have you
ever been afraid that (WHAT 
INDIVIDUAL FEARED WOULD 
HAPPEN) would happen when 
you were alone?
Did you always feel anxious 
when you (CONFRONTED PHOBIC 
STIMULUS)?
SOCIAL PHOBIA CRITERIA
A. A persistent and compelling 
desire to avoid one or more 
situations 1n which the Indi­
vidual 1s the focus of others1 
attention and fears that he or 
she may behave 1n a way that 
will be hun1l1at1ng or embar­
rassing.
PHOBIC SITUATION(S) Check:
  public speaking
 _ eating 1n front of others
 writing 1n front of others
  generalized (most social
situations)
  other (Specify:_______ )
x*
I I










B. What the Individual fears 
will happen occurs only when 
he or she 1s the focus of 
others1 attention; or 1f 1t 
occurs while alone, causes 
little or no distress (I.e., 







NOTE: SOCIAL PHOBIC SYMPTOMS 
THAT HAVE DEVaOPED CLEARLY 
SECONDARY TO PANIC DISORDER DO 
NOT teET THIS CRITERION.
C. During some phase of the 
Illness, exposure to the spe­
cific phobic stimulus (or 
stimuli) almost invariably 




IGO TO I 
ISIMPLE I 
I PHOBIA, I 
IE. 11 I 
I______ I
?=1nadequate Information l=absent or false 2=subthreshold 3®threshold. or tru
SCID-OP 7/1/85 Social Phobia Anxiety Disorders E. 9
IF NOT OBVIOUS: Did you go
out of your way to avoid
J ___________  ?*
, IF NO: How hard 1s 1t
i for you to___________?
D. The sltuatlon(s) 1s 
avoided or endured with 
Intense anxiety.
? 1 2 3 x:




IF NOT OBVIOUS: How Important 
was 1t to you to be able to 
  ?
(How bothered were you 
that you were afraid 
of_________  ?)
E. The fear or the avoidant 
behavior causes marked dis­
tress or Interferes with 
soda! or occupational func­
tioning.
x:
IGO TO I 
ISIMPLE I 
I PHOBIA,I 
IE. 11 I 
I I
Did you think that you were 
more afraid of (PHOBIC 
ACTIVITY) than you should 
have been (or than made 
sense)?
IF NOT ALREADY CLEAR: 
RETURN TO THIS ITEM AFTER 
COMPLETING SECTION ON 
03SESSIVE COMPULSIVE DIS­
ORDER.
F. Recognition by the Indivi­
dual that his or her fear 1s 
excessive or unreasonable.
G. The phobic stimulus (or 
stimuli) 1s unrelated to the 
content of the obsessions of 
Obsessive Compulsive Dis­
order or to a Psychosexual 
Dysfunction.




IGO TO I 
ISIMPLE I 
IPHCBIA, I 
IE. 11 I 
I - I
SOCIAL PHOBIA CRITERIA A, 1 3 x:
B, C, D, E, F, AND G ARE
CODED "3" ____I_ _ l __
I II I
IGO TO I I SOCIAL I 
ISIMPLE 1 I PHOBIA!
I PHOBIA, I I_____ I
IE. 11 I 
I I
? = 1nadequate Information l=absent or false 2=subthreshold 3=threshold or tru<
SCID-OP 7/1/85 Soda! Phobia Anxiety Disorders E. ]
CHRONOLOGY
IF UNCLEAR: During the past 
month, have you been bothered 
by (SOCIAL FHOBIA ACTIVITY)?
Has had some symptom(s) of 
Social Phobia during past 
month
When were you last bothered by 
(SOCIAL PHOBIA ACTIVITY)?
Number of months prior to 
interview when last had 
a symptom of Social Phobia
During the past five years, 
hew much of the time have 
you been bothered by (SOCIAL 
PHOBIA ACTIVITY)?
How old were you when you first 
were bothered by (SOCIAL PHOBIA 
ACTIVITY)?
Duration 1n months during past 
five years that any symptoms of 
Social Phobia were present
Age at onset of Social Phobia __
?=1nadequate Information l=absent or false 2-subthreshold 3=threshold or tru<
SCID-OP 7/1/85
MPLE PHOBIA
Are there any other things 
that you have been especial­
ly afraid of# Hke heights# 
seeing blood# closed places# 
or certain kinds of animals?
What are you afraid could 
happen when _ _______ ?
Did you always feel anxious 




A. A persistent fear of a 
circumscribed stimulus (ob­
ject or situation)# other 
than of having a panic 
attack (Panic Disorder) or 
of humiliation or embarrass­
ment 1n certain social 
situations (Social Phobia).
Anxiety Disorders E. 11




  closed spaces
  blood/1 njury
  other: ________
B. During some phase of the 
Illness# exposure to the spe­
cific phobic stimulus (or 
stimuli) almost Invariably 




















Did you go out of your way 
to avoid____________?
IF NO: How hard was 1t
for you to_______ _ ?
IF NOT OBVIOUS: How Impor­
tant was 1t to you to be 
able to ______  ?
(How bothered were you 
that you were afraid of 
  ?)
C. The object or situation 
1s avoided or endured with 
Intense anxiety.
xx
D. The fear or the avoidant 
behavior causes marked dis­
tress or Interferes with 
social or occupational 
functioning.
IGO TO I 








?4lnadequate Information l=absent or false 2=subthreshol d 3=threshold or true
SCID-OP 7/1/85 Simple Phobia Anxiety Disorders E. 1
Did you think that you were
more afraid of __________
than you should have been 
(or than made sense)?
IF NOT ALREADY CLEAR: 
RETURN TO THIS ITEM AFTER 
COMFLETING SECTION ON OB­
SESSIVE COMPULSIVE DIS­
ORDER.
E. Recognition by the Indivi­
dual that his or her fear 1s 
excessive or unreasonable.
F. The phobic stimulus 1s 
unrelated to the content of 
the obsessions of Obsessive 
Compulsive Disorder.
SIMFLE PHOBIA CRITERIA 
A, B# C, D, E, AND F 
ARE CODED "3"










IGO TOI ISIMPLE! 
I CBS- 11 PHOBIA I
ICONP. 11 _ I
IE. 131
IF UNCLEAR: During the past 
month# have you been bothered 
by (SIMPLE PHOBIA)?
Has had some symptom(s) of 
Simple Phobia during past 
month
x>
When were you last bothered by 
(SIMPLE FHOBIA)?
Number of months prior to 
Interview when last had 







During the past five years# 
how much of the time have 
you been bothered by (SIMPLE 
PHCBIA)?
Duration 1n months during past 
five years that any symptoms of 
Simple Phobia were present
How old were you when you first* Age at onset of Simple Phobia 
were bothered by (SIMFLE PHOBIA)?
?=Inadequate Information l=absent or false 2=subthreshold 3=thresholo or true
SCI D-OP 1/1/85 Obsessive Compulsive Disorder
OBSESSIVE COMPULSIVE DISORDER
Now I would like to ask you 
if you have ever been bo­
thered by thoughts that kept 
coming back to you even when 
you tried not to have them?
IF YES; DISTINGUISH FROM 
BROODING ABOUT PROBLEMS 
(SUCH AS HAVING A PANIC 
ATTACK) OR ANXIOUS RJMI- 
NATION ABOUT REALISTIC 
DANGERS; What were they? 
(What about awful thoughts* 
or thoughts that didn’t 
make any sense to you—
11ke actually hurting 
someone even though you 
didn’t want to, or being 
contaminated by germs 
or dirt?
OBSESSIVE COMPULSIVE DISORDER 
CRITERIA
A, Either obsessions or com­
pulsions:
Obsessions: (1), (2) and (3):
(1) Recurrent, persistent 
Ideas, thoughts, Impulses, 
or Images that are experi­
enced as Intrusive, unwanted, 
and senseless or repugnant 
(at least Initially).
(2) The Individual attempts 
to Ignore or suppress them 
or to neutralize them with 
some other thought or action.
(3) The Individual recog­
nizes that they are the 
product of his or her own 
mind and not Imposed from 
without (as 1n thought 
Insertion).
? 1 2 3 x
? 1 2 3 x:




V? Was there anything that you 
had to do over and over 
again and couldn’t resist- 
doing, like washing your 
'!hands again and again, or 
! checking something several 
I times to make sure you’d 
’ dpne 1t right?
IF YES: What did you
have to do? (What were 
you afraid would happen 
1f you didn’t do 1t?) 
(How many times did you
have to ? How
much time did you spend 
each day _____ _?)
Compulsions: (1), (2) and (3):
(1) Repetitive, purposeful 
and Intentional behavior that 
1s performed according to 
certain rules or in a stereo­
typed fashion.
(2) The behavior 1s not an end 
1n Itself, but 1s designed to 
neutralize or prevent extreme 
discomfort or some dreaded 
event or situation. However, 
either the activity 1s not 
connected 1n a realistic way 
with what 1t 1s designed to 
neutralize or prevent or 1t 1s 
clearly excessive.
? 1 2 3 x>
IGO TO GAD! I
IE. 16 I !





?*Inadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 Obsessive Compulsive Disorder
IF UNCLEAR: Do you think
that you (DO COMPULSIVE 
BEHAVIOR) more than you 
should?, (Do you think 
[COMPULSION] makes sense?)
What effect did this (OBSES­
SION OR COMPULSION) have on
your life? (Did__________
bother you a lot?)
Did anyone 1n your family* or 
your friends* have to go out 
of thel r way because of your 
(OBSESSION OR COMPULSION)?
(3) Recognition by the In­
dividual that the behavior 
Is excessive or unreasonable.
? 1 2 3 “3




B. The obsessions or compul­
sions cause marked distress 
or Interfere with the Indi­
viduals soda! or occupa­
tional functioning.
DESCRIBE:
IGO TO GAD 
IE. 16 I
OBSESSIVE aWULSIVE DIS­
ORDER CRITERIA A AND B 
ARE CODED "3"
Specify: without phobic
avoidance, with limited 












?=1nadequate information l=absent or false 2=subthreshold 3=thresholdj or true
SCI D-OP 7/1/6S Obsessive Compuls1ve Disorder
CHRONOLOGY
::F UNaEAR: During the past 
tyonth# have you had any 
OBSESSIONS OR COMPULSIONS)?
Has had some symptom(s) of 
Obsessive Compulsive Disorder 
during past month
When did you last have (ANY 
(BSESSIONS OR COMPULSIONS)?
Number of months prior to 
Interview when last had 
a symptom of Obsessive 
Compulsive Disorder
IF UNCLEAR: During the past 
inonth, did the (OBSESSIONS OR 
COMPULSIONS) have any effect on 
your life or bother you a lot?
During the past five years* 
how much of the time have 
you been bothered by 
(OBSESSIONS OR COMPULSIONS)?
How old were you when the 
(OBSESSIONS OR COMPULSIONS) 
first had any effect on your 
life or bothered you a lot?
Has met criteria for Obsessive 
Compulsive Disorder during past 
month (criteria A and B)
Duration 1n months during past 
five years that any symptoms of 
Obsessive Compulsive Disorder 
were present
Age at onset of Obsessive 







?4lnadequate information l=absent or false 2=subthreshold 3=thresh old or true
SCI OOP 7/1/85
GENERALIZED ANXIETY DISORDER 
(CURRENT ONLY)
For most of the time during 
the last six months...
...have you been 
anxious or nervous?
...have you worried 
a lot?
CODE BASED ON PREVIOUS 
INFORMATION. REVISE AT 
END OF INTERVIEW IF 
NECESSARY.
GAD Anxiety Disorders^ E. 3
GENERALIZED ANXIETY DISORDER 
CRITERIA
A. During the last six months# 
the Individual has been 
bothered more days than not 
by anxious mood (nervousness)# 
or worry about possible mis­
fortune to self or others.
DESCRIBE:
B. Not occurring only during 
the course of another Axis I 
disorder# such as a psychotic 
disorder# an Affective Dis­
order# a Substance Dependence 









When you feel that way# what 
1s 1t like?
C. At least six of the fol­
lowing eighteen symptoms 
are present some of the 
time when anxious:
At these times...
...do you tremble, twitch 
or feel shaky?
.Motor .tension
(I) trembling# twitching 
or feeling shaky
? 1 2
...do your muscles often 
feel tense# sore or achy?
(2) muscle tension# aches 
or soreness
? 1 2 3
... do you often feel phy- 
slcally restless— canft 
sit s t m ?
...do you tire easily?
... do you feel short of 
breath? (have trouble 
getting your breath?)
(3) restlessness ? 1 2 | 3
(4) easy fatigability
.Autonomic .hyperactivity.
(5) shortness of breath 
or smothering sensation
? 1 2
?=1nadequate information l=absent or false 2=subthreshold 3=thresholq or tru<
SCID-OP 7/1/85 GAO Anxiety Disorders E
At these times...
...does your heart often 
pound or race?
...do you often sweat a lot? 
Are your hands often cold 
or clamny?
(6) palpitations or ac­
celerated heart rate 
(tachycardia)
(7) sweating, or cold, 
clammy hands
? 1 2 3
? 1 2 3
...does your mouth often 
feel dry?
(8) dry mouth ? 1 2 3
...do you often feel dizzy 
or lightheaded?
...1s your stomach^often 
upset, or do you have 
nausea or diarrhea?
...do you have flushes (hot 
flashes) or chills?
...do you urinate more of­
ten than usual?
...do you have trouble 
swallowing, or get a li 
1n your throat?
ump
...do you feel keyed up 
or on edge?
...do sudden noises startle 
you?
...are you often so nervous 
you have trouble concentra­
ting?
...do you often have trouble 
falling or staying asleep?
(9) dizziness or Ught- 
headedness
(10) nausea, diarrhea or 
other abdominal distress
(11) flushes (hot flashes) 
or chills
(12) frequent urination
•(13) trouble swallowing 
or lump 1n throat
ILiallance And scanning
(14) feeling keyed up or 
on edge
(15) exaggerated startle 
response
(16) difficulty concentra­
ting or mind going blank 
because of anxiety
(17) trouble falling or 
staying asleep
1 2 3
? 1 2 3
? 1 2 3
? 1 2 3
? 1 2 3
? 1 2 3
? 1 2 3
? 1 2 3














SCI D-OP 7/1/85 GAD Anxiety Disorders E. /I
At these times...
...are you often Irritable 
or especially Impatient?
(18) Irritability






Have you been taking any 
drugs? Have you been phy­
sically 111?
IF YES: EXPLORE POS­
SIBLE RELATIONSHIP 
BETWEEN ORGANIC FACTOR 
AND ANXIETY
D. Not sustained by a speci­


















I PIS- I 
IORDER I
?=1nadequate Information l^absent or false 2=subthreshold 3=threshold or true
SCID-OP 7/1/85 GAD Anxiety Disorders £• 1
CHRONOLOGY 
IF UNCLES: During the past Has had some symptom(s) of x:
iionth# have you had (ANY SX 
OF GAD)
Generalized Anxiety Disorder 1 1 
during past month i i
1 1
When did you last have (ANY SX 
OF GAD)?
Number of months prior to _ __ __ I
Interview when last had 1 
a symptom of Generalized 1 
Anxiety Disorder 1
IF UNCLEAR: During the past 
month# have you had (LIST OF
Has met symptomatic criteria ? 1 3 





GAD SXS CODED "3")?
During the past five years# 
how much of the time have 
you been bothered by (ANY 
SX OF GAD)?
How old were you when you first 
were bothered a lot by anxiety 
of worry and had a lot of (SXS 
GAD)?
during past month (criteria A#
6 and C)
Duration 1n months during past 
five years that any symptoms of 
Generalized Anxiety Disorder 
were present
Age at onset of Generalized 






• * '* ?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or true
s u l u - u t //!/ 85 Somatlzati on Somatoform G.
ave you ever...
..had a period of amnesia# that 
1s# a period of several hours or 
cays when you couldn't remember 
Anything afterwards about what 
happened during that time?
..had a seizure or convulsion?
..had trouble walking?
..been paralyzed or had periods 
of weakness when you couldnft 
11ft or move things that you 
cbuld normally?
..been completely unable to 
urinate for a whole day (other 
tjhan after childbirth or sur­
gery)?
Now I'm going to ask you some 
questions about sex.
Would you say that your sex life 
has been Important to you or 
could you have gotten along as 
well without it?
Has having sex often been physi­
cally painful for you?
FOR ^N: Have you often had any 
other sexual problem# like 
having an erection?
O^her than during your first 
year of menstruation (or during 
menopause)# have you had 
Irregular periods?
(24) amnesia
(25) seizure or convulsion
(26) trouble walking
(27) paralysis or muscle weak­
ness
(28) urinary retention or diffi­
culty urinating
Esychosexual symptoms for ihe 
major part o f individual's life 
After opportunities lo r  -sexual 
-activity
(29) sexual Indifference
(30) pain during Intercourse
(31) Impotence
? 1 2 3
? 1 2 3
? 1 2 3
? 1 2 3
? 1 2 3
fem ale -reproductive  symptoms judged 
.by Jtbe .In d iv id u a l as  occurring more 
fre q u e n tly  o r  severely than I d most 
jtomen





IF YES; More than most women?
?=1nadequate Information l=absent or false 2=subthreshold 3=threshold or true
SCI D-OP 7/1/85 Sanitization
Have you ever had...
..pain 1n your genitals 
(other than during Inter­
course)?
..pain when you urinate?
..pain anywhere else 
(other than headaches)?
Have you ever been bothered 
by...
..shortness of breath






..lost your voice for more than 
a few minutes?
..been completely deaf for a 
period of time?
..had double vision for a 
period of time?
..had blurred vision (when you 
didn't need glasses)?
..been completely blind for 
more than a few seconds?
..had fainting spells or been 
Cunconscious?
(10) pain In genitals other 
than during Intercourse
(11) pain during urination
(12) other pain (other than 
headaches)
Cardiopulmonary (other .than 
during panic attacks)





Conversion AT -pseudoneurologlcal 
.(other .than .during panic attacks)
(17) difficulty swallowing





(23) fa inting or loss of 
consciousness






















When you had (SYMPTOM) were you 
taking any medicine# drugs or 
alcohol ?
] F HAS HAD * PAN IC ATTACKS: Was 
that only when you were having 
a! panic attack?
[>1d you take any medicine for It?
Did 1t Interfere with your life 
a lot?
Now I am going to ask about 
specific physical symptoms 
ou may have had.
Hlave you ever had a lot of 
tlrouble with...
..abdominal or belly pain (not 
dountlng times when you were 
m|enstruat1 ng)?
• nausea— feeling sick to your 
sftomach but not actually 
omltlng?
vomiting (when you weren’t 
pregnant)?
excessive gas or bloating 
f your stomach or abdomen?
Somatization Somatoform G. \
..loose bowels or diarrhea
ave there been any foods that 
ou couldn’t eat because they 
made you sick? What are they?
Hpve you ever had...
.a lot of trouble with 
back pain?
.pain 1n your joints?
.pain In your arms or legs 
other than 1n the joints?
4. caused the Individual to take 
medicine (other than aspirin)# 
see a doctor or alter life style
SYMPTOM LIST
Gastrointestinal
(1) abdominal pain (other than 
when menstruating)
(2) nausea (other than motion 
sickness)
















1 2  3
1 2  3
1 2  3
x:
x:
?t Inadequate Information l=absent or false 2=subthreshold 3=threshold or trui
a.
SCID-OP . 7/1/85 Somatization Somatoform
SOMATOFORM DISORDERS
SCREENING QUESTIONS NOTES
Over the last several years* 
what has your physical health 
been like?
Do you have any serious physi­
cal problems? (What?)
In the last few years* how 
often have you had to go to 
a doctor because you werenft 
feeling well? (What for?)
Do you worry much about your 
physical health?
IF NOTHING SUGGESTS THE POSSI­
BILITY OF A SOMATIZATION DIS­
ORDER, CHECK HERE  AND
GO TO EATING DISORDERS.
SOMATIZATION DISORDER SOMATIZATION CRITERIA
How old were you when you first A. A belief that he or she has ? 1 2
started to have a lot of physical been sickly or had many physical
problems or Illnesses? problems for several years  I_
beginning before the age of 30. I 1






FOR EACH SYMPTOM REPORTED, 
DETERMINE THAT THE FOUR 
CRITERIA FOR SIGNIFICANCE 
ARE *€T BY SUCH QUESTIONS AS:
Did you tell a doctor about 
(SYMPTOM)?
What was his diagnosis? (What 
did he say was causing 1t?)
Did he find anything abnormal 
when he took tests or x-rays?
B. At least 12 symptoms for women 
and 10 for men from the 11st of 
symptoms below. To count a 
symptom as significant (a code of 
"3") the following criteria must 
be met:
1. not adequately explained by 
physical disorder or Injury
2. not due to medication, drugs 
or alcohol -
3. not occurring only during a 
panic attack
?=1nadequate Information l=absent or false 2=subthreshold 3=threshold
!
SCID-OP 7/1/85 Somatization Somatoform' 6.- 5
What about very painful periods?
i
j IF YES: More than most women?





(34) excessive menstrual 
bleeding
IF YES: More than most women?
HAS GIVEN BIRTH: Did you vomit (35) vomiting throughout 
roughout any pregnancy? pregnancy
AT LEAST 12 "B" SXS FOR 
WOMEN OR 10 "B" SXS FOR 
ARE CODED "3"
SOMATIZATION DISORDER 
CRITERIA A AND B ARE 
CODED "3”
CHRONOLOGY
IF UNCLES: During the past 
month# have you had (MY SXS OF 
SOMATIZATION DISORDER CODED 
«3«)?
Has had some symptom(s) of 
Somatization Disorder during 
past month
i 2 y::-3 ' v
1 2  3







When did you last have (ANY SX 
OF SOMATIZATION DISORDER CODED 
"3")?
Number of months prior to 
interview when last had 




During the past five years#
much of the time have 
been bothered by (ANY
SX OF SOMATIZATION DISORDER)?
How old were you when you first 
stai-ted having a lot of (SXS OF 
SOMATIZATION DISORDER)?
Duration 1n months during past 
five years that any symptoms of 
Somatization Disorder were 
present


























What part(s) of your body bother 
youj?
Whejn did you first have this 
tro|ubl e?
What do you think 1s wrong?
(Do you think that these could 
be due to a serious physical 
disease?)
HYPOCHONDRIASIS CRITERIA
A. Preoccupation with the fear 
of having# or the belief that 
one has# a serious disease# 
based on the Individual’s In­
terpretation of physical signs 




IGO TO I 
INEXT I 
I MODULE I
Have you been to a doctor for 
these symptoms?
^ What tests were done?
What did the doctor say was 
wrong?
B. Thorough physical evaluation 
does not support the diagnosis 
of any physical disorder that 
can account for the physical 




IGO TO I 
INEXT I 
I MODULE I
Were you reassured by what the 
doctor said? (Did you feel 
better when he told you that 
...?)
What did the doctor say was 
wrong?
C. The fear of having or 
belief that one has a dis­
ease persists despite 
medical reassurance.
? 1 2







D. Duration of the disturbance 















IF UNCLES: During the past 
month# have you had CHYF>0- 
Ch ONDRIACAL FEAR OR BELIEF)?
Hypochondr1as1s
E. Not occurring only during 
the course of Schizophrenia# 
Schizoaffective Disorder# 
Paranoid Disorder# or an 
episode of Major Depression 
with Melancholia or psychotic 
features.
HYPOCHONDRIASIS CRITERIA 
A, B# C, D, E, AND F ARE 
CODED "3"
Has had some symptom(s) of 










IGO TO 11 HYPO-! 
INEXT 11CHON-I 
IMODULE!IDRIA-I 
I I ISIS I
XX
When did you last have (HYPO­
CHONDRIACAL FEAR OR BELIEF)?
Number of months prior to 
Interview when last had 









UNCLES: During the past 
d>nth# have you had (SXS OF 
YPOCHONDRIASIS)?
During the past five years# 
how much of the time have 
yiu been bothered by (HYPO- 
CHONDRIACAL FEAR OR BELIEF)?
Has met symptomatic criteria 
for Hypochondriasis during past 
month (criteria A# B and C)
Duration 1n months during past 




Hbw old were you when you first 
had (HYPOCHONDRIACAL FEAR OR 
BELIEF)?
Age at onset of Hypochondriasis 
(criteria A# B and C)
x>
x>




Now I would like to ask you 
some questions about your 
eating habits and your weight.
Have you ever had a time when 
you weighed much less than 
other people thought you ought 
to weigh?
IF YES: How old were you 
then? How much did you 
weigh? How tall were you?
At that time, were you very 
afraid that you could become 
fat?
Anorexia Nervosa Eating Disorders
At your lowest weight, how 
did you think you looked? 
(Did you still feel too fat 
or that part of your body 
was too fat?)
FOR FEMALES: Before this time, 
were you having your periods? 
Did they stop? (For how long?)
ANOREXIA NERVOSA CRITERIA
A. Refusal to maintain body 
weight over a minimal normal 
weight for age and height, e.g., 
weight loss leading to 
maintenance of body weight 15X 
below expected; failure to make 
expected weight gain during 
period of growth, leading to 
body weight 15* below expected.
B. Intense fear of becoming 
obese, even when underweight.
C. Disturbance 1n the way 1n 
which onefs body weight, 
size or shape 1s experienced, 
e.g., claiming to "feel 
fat” even when emaciated; 
belief that one area of the 
body 1s "too fat" even when 
obviously underweight.
D. In females, absence of at 
least three consecutive 
menstrual cycles when other­
wise expected to occur 
(primary or secondary 
amenorrhea).
IGO TO I 
IBULI-I 




IGO TO I 
IBULI-I 




IGO TO I 
IBULI-I 





?=Inadequate Information l=absent or false 2=subthreshold
IGO TO I 
IBULI-I 










H ave you ever had eating 
binges during which you ate a 
1 ot of food In a short period 
of time— less than two hours?
During these binges, did you 
feel that your eating was 
out of control?
ANOREXIA NERYOSA CRITERIA 
A, B, C, AND D ARE OODED "3"
BULIMIA NERVOSA CRITERIA
A. Recurrent episodes of 
binge-eating (rapid con­
sumption of a large amount 
of food 1n a discrete 
period of time, usually 
less than two hours).
B. During the eating binges 
there 1s a feeling of lack 
of control over the eating 
behavior.
IGO T01 IANO- 
IBULI-I IREXIA 
IMIA I INER- 








? 1 2 3 X)
IGO TO I 
INEXT I
x>
Did you do anything to 
counteract the effects of the 
binges? (Like making yourself 
vomit, tak1ng 1axatlves# 
strict dieting, fasting?)
C. The Individual regularly 
engages 1n either self- 
induced vomiting, use of 
laxatives, or rigorous 
dieting or fasting 1n order 








Inadequate Information l=absent or fal se 2=subthreshol d 3=threshold or true
$ULD-UP 7/1/85 Bul 1m1a Nervosa
! i
Eating Disorder^ 3W
During this time, did you have 
eating binges as often as twice 
a week for three months?
D. A minimum average of two 
binge-eating episodes per 





BULIMIA NERVOSA CRITERIA 
A, B, C, AND D ARE CODED "3"
xx/
IBILI-1 
I MI A I
INE 
I VO










?=inadequate information l=absent or false 2-subthreshold 3=threshold dr true>
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APPENDIX VII
Social Class by occupation
Affective (initial Interview)
Patient's No. Patient's Occupation Husband's Occupation Social Class
102 Cashier Supervising engineer I
103 Owns dress shop Stockmarket II
104 Housewife Soldier Excluded
105 - Physiologist I
108 Housewife Engineer I
109 University lecturer Architect I
110 Computer operator - IIIN
112 Housewife Nautical surveyor II
113 Cleaner Factory worker V
114 Housewife Unknown Unknown
115 Teacher - II
116 Housewife Heavy goods driver IIIM
117 Records officer - IIIN
118 Teacher - II
119 Retired teacher Unknown II
120 Student - Excluded
121 Part-time secretary Painter & decorator IIIM
- 479 -
Social Class by occupation
Non-Affective 









































Customs & Excise officer II
Press photographer IIIN
Retired II




















Log linear modelling of the interaction between cerebral dominance, 
laterality of migraine, the type of migraine and self report of anxiety, 
depression, euphoria and irritability.
Depression
Scaled Deviance df Deviance Change df 
Null Fit 59.3 49
Type + Laterality
+ Deviance 44.7 A3 14.6 6
Type + Laterality 44.8 44 0.1 1
Thus dominance is not significantly associated with depression, but 




Dr. Diana Morris, 
Astra Alab AB_».
S-151 85 Sodertalje, 
Sweden.
Dear Diana,
Thank you for your letter. Going through all your data again I think it 
is clear that the values all come within our normal range both in the basal 
state and during migraine, and that there are no significant asymmetries or 
abnormalities of the distribution pattern which I can identify as being 
associated with migraine. Indeed the only significant difference is the 
fact that all three patients with classical migraine showed a small 
increase in transit times during migraine, whereas both patients with 
common migraine showed a decrease. Although the numbers are small, this 
is obviously very suggestive and will probably justify a larger scale 
study.
The big unknown is the delay between the onset of migraine and performing 
the examination. I do not have a note of this and I think it may have 
varied from one patient to another. There is one reference (which 
unfortunately I cannot now lay my hands on) which suggests that the blood 




c.c. Prof. Kendall’s Secretary, Royal Edinburgh Hospital.
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APPENDIX X
Regional CBF Results - Baseline-Non Affective Group (initial Interview)
Patient IP IP NET CTT CTT CTT CTT NET CTT CTT CTT CTT NET FF 
ID No ArrivalTran-CTT (L)F (l )T (l )P (L)O CTT (R)F (R)T (R)P (R)0 FF (L)F 
sit (L) (R) (L)
Classical
220 5-0 6*4 4.2 3.2 3.35 3.75 5.39 4.1 2.83 2.75 4*01 5-84 0.22 0.20
211 8.0 8 .4 • 4.2 4-01 3.75 4.29 4.92 3.9 3-38 3.17 4-07 4.51 0.24 0.25
215 3*0 6.0 5.2 3.94 2.34 3.75 7-58 4.7 3-76 2.33 3-56 7.05 0.25 0.3
218 6.2 6.2 5.5 5-64 4-76 5-17 6 »56 5.3 5 * 59 4.47 4-88 6.15 0.18 0.18
207 5-6 5*6 2.8 1 -98 2.08 3.15 3.7 2.6 2.24 1.84 2-48 3.99 0.39 0.52
212 5-1 5.4 3.5 2.68 2.99 3.25 4.7 3.6 2.58 2.85 3-74 5-38 0.3 0-38
210 3-6 4.3 3.8 4.1 3.08 3.5 4.5 3.8 3-62 3.39 3*66 4.43 0.28 0-25
213 6-9 5.3 5-8 4 .68 4.79 5-79 7.12 5.0 4.2 4.12 4.71 6.1 0.17 0.21
209 4-2 4.0 4.4 3.71 3.66 4.57 5.61 3.8 3-38 3.31 3-73 4-62 0.24 0.27
Common
225 4-2 4.4 4.5 4.35 4.17 4.11 5-42 4*6 4-47 4-20 4-10 6*36 0.20 0.23
208 5-0 5.3 5-9 5.0 4.68 5.61 6.39 6.2 4.5 4-64 5.94 7.33 0.18 0-21
205 4*5 4.5 6 5-36 5-4 5.93 7.35 5.7 4.53 4.49 5.92 7.54 0.16 0.19
204 4.7 4.7 2.5 2.33 2.11 2.33 3-02 2.4 2.42 1 .83 2.42 3.14 0.4 0.44
201 4.2 5.7 4.2 4.55 3-72 4.11 4.59 4.1 3.93 3-67 3-96 4.24 0.25 0.23
224 4*8 3.9 3.6 3*02 2.55 3*01 4-65 3.7 3.11 2.55 3.33 4-83 0.31 0-33
IP = Input Function L = Left hemisphere
CTT = Cortical Transit Time R = Right hemisphere
FF = Fractional Flow F = Frontal region
CVTT = Large Vessel Transit Time T = Temporal region
P = Parietal region 
0 = Occipital region.
- 1 -
IP = Input Function 
FF = Fractional Flow
CTT = Cortical Transit Time 
LVTT = Large Vessel Transit Time
FF FF FF NET FF FF FF FF NET LVTT LVTT LVTT LVTT NET LVTT LVTT LVTT LVT'
(li)T (L)p (L)0 FF (E)F (K)T (R)P (R)0 LVTT(L)F (l)T (L)P (L)O LVTT(R)F (R)T (E)P (R> 
(E) (L) (E)
o•o 0.27 0 .20 0.23 0.35 0.37 0.26 0.19 3-7 1 -94 1 .68 1 .52 1 -56 3 8 1 .96 1 .78 1 .53 1 .fr
0.27 0.24 0.21 0.27 0.30 0.32 0.25 0.22 3.9 3-71 3-56 3*73 4 .4 4 0 3-74 3-59 3-74 4*8'
0.44 0.28 0.16 0.26 0.30 0.44 0.28 0.17 6.2 6.47 6-37 6.24 6.08 6 3 6*51 6.35 6 .4 6 *1^
0.22 0 .2 0.15 0.19 0.18 0.23 0.21 0.17 3-6 3*75 3-65 3-67 3-58 3 6 3.74 3-63 3-63 3-71
0-5 0.33 0.28 0.42 0.46 0-56 0.42 0.27 2.6 2.72 2.5 2.63 2.89 2 6 2 .70 2.55 2.67 2.7;
0.35 0.32 0.22 0.29 0.39 0-36 0.28 0.18 5.5 5-74 5-35 5-36 5.54 5 7 5-86 5-47 5 • 68 5-8^
0-33 0*29 0.23 0.27 0.29 0-3 0.27 0.23 4.5 4.54 4-29 4-38 4-67 4 4 4.23 4.424.6
0.21 0.17 0.14 0 .20 0.24 0.25 0.22 0.17 5.4 5 .4 5*26 5.35 5.66 5 3 5.47 5.34 5.25 5-42
0.28 0.22 0.19 0.27 0.3 0.31 0.27 0.22 4-0 4-06 3-93 3-98 4.17 4 1 4.23 4,05 4-07 4-16
0 • ro 0.25 0.19 0.20 0.22 0.24 0.25 0.17 4*8 5-36 4.99 4-85 4.75 4 8 5.41 5.06 4-89 4.74
0.22 0.18 0.16 0.17 0 .22 0.22 0.17 0.14 3.6 3-52 3-48 3.52 3-77 3 6 3-76 3.57 3-38 3-66
0.19 0.17 0.13 0.18 0.22 0.23 0.17 0.14 3.4 3-63 3-45 3.42 3-36 3 5 3-64 3.49 3.42 3.43
CO•0 0.43 0.34 0.4 0.43 0.56 0.43 0.29 2.2 2.28 2.11 2.21 2.22 2 2 2.28 2.21 2.24 2.17
0.27 0.24 0.22 0.25 0.26 0.27 0.25 0.21 5-3 5-26 5.18 5.33 5.55 5 3 5-38 5.23 5-37 5.35
0.4 0.34 0.22 0.29 0.33 0.4 0.31 0.21 4-0 4*18 4.1 4-06 3.97 4 1 4*16 4 .O9 4-05 4-07
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APPENDIX X
Regional CBF Results - Baseline - Affective Group (initial Interview)
Patient IP IP NET CTT CTT CTT CTT NET CTT CTT CTT CTT NET FF 
ID No Arrival Tran-CTT (L)F (L)T (L)P (l )0 CTT (R)F (R)T (R)P (R)0 FF (l )F 
sit (L) (R) (L)
Classical
104 5-1 8.7 5-2 5-23 4-81 5-32 6.04 5-4 4-96 5-14 5-75 6.44 0.19 0.19
118 5-9 5-9 2.2 1.47 1 -74 2.41 3.16 2.0 1 .44 1 -45 2.13 2.87 0.48 0.71
102 3-6 3-6 3-8 3-5 3-58 3-67 4-47 4-1 3-83 3-27 4-34 4.9 0.26 0.29
120 8.3 5.7 6.0 4-96 5-05 6.02 7.42 5.5 4*6 4-66 5-57 7.35 0.17 0.2
105 4«8 7.1 4.7 4.42 4-1 4-99 5-31 4 .8 4.45 4.14 5-05 5-23 0.22 0.23
119 6.0 9-3 9.0 7.74 9-02 8-58 9-87 8 .4 8.64 8.11 6.93 9-74 0.12 0.14
Common
103 7-5 7.5 3.6 2.92 2.61 3-32 5.16 4.2 3-01 2.88 3-71 6-59 0.31 0.35
110 5.7 5.7 2.9 3*23 2.27 2.91 3-24 2.9 3.08 2.2 2.68 3-88 0.37 0.34
113 6.1 6.1 3.0 2.3 2.44 3.10 4-22 3-1 2.64 2.2 3-37 5-09 0.35 0.45
106 4.2 3-8 3-9 3-6 3-17 3-86 4-98 4-0 3-4 3.21 3*86 5-58 0.26 0.28
- 1 -
FF FF FF NET FF FF FF FF NET LVTT LVTT LVTT LVTT NET LVTT LVTT LVTT LV3
(L)T (L)P (L)0 FF (R)F (R)T (R)P (R)0 LVTT(L)F (L)T (L)P (L)0 LVTT(R)F (r )T (R)P (R) 
(H) (L) (R)
0.21 0.19 0.17 0.18 0.21 0.20 0.18 0.16 7*6
0.61 0.42 0.31 0.52 0.70 0.73 0.48 0.33 1 .3
0.28 0.27 0.21 0.24 0.27 0.31 0.23 0.19 3 .8
0.2 0.17 0.13 0.19 0.22 0.22 0.18 0.14 3.6
Lf\C\i•c 0 .2 0.19 0.21 0.23 0.24 0.2 0.2 7.1
0.13 0.12 0.11 0.13 0.13 0.14 0.15 0.12 3.1
0.4 0-3 0.23 0.27 0.34 0-36 0.28 0.17 1 -9
0.45 0.35 0.32 0.38 0.36 0.47 0-38 0.27 2.1
0.42 0.33 0.25 0.34 0.41 0.47 0.31 0.21 2.2
0.35 0.27 0.2 0.26 0.29 0.32 0.27 0.18 4.3
7-46 7.34 7-62 8.13 7.5 7.50 7.27 7.59 7.6
1 .62 1 .37 1 -39 1 .11 1 .4 1 .61 1 .50 1 .58 1*2
00 CD cr\ 3-76 3-79 3-7 3-8 3*84 3* 80 3*74 3 0
3-65 3.5 3*55 3*78 3-6 3-72 3*53 3-56 3 0
7-14 6 *84 6*86 7-48 7.1 7*3 7.02 6.76 7 0
CM•to 2.95 3.07 3.07 3-0 3*17 3-01 3 *04 3 «C
1-98 1 .81 1 .96 1 .83 1 .8 1 -93 1 .8 1 .86 1 O
1 .91 1 .85 2.25 2.52 2.0 1 .91 1 .82 2.08 2 0
2.37 1-9 2.09 2.48 2.1 2.3 1 .96 1 *94 2.C




Regional CBF Results - During Migraine
Patient ID IP IP NET CTT CTT CTT 




NET CTT CTT CTT CTT 








104 8.5 6.9 6-3 5*41 5*78 6.62 8.05 6.1 4-84 5-23 6.06 7.44 0.16 0.19
220 7.9 5-8 5*0 4-03 4 .06 5-33 7.09 4.7 3-51 3.88 4-84 6.76 0.19 0.25
220 (repeat
examination) 2*28 2.5 5*66 5*53 2.14 2.37 3-25 5*67 0.44
211 6 .0 6 .4 6.1 6-3 5-48 6.54 7.23 6.0 5*69 5*12 5-85 7-22 0.16 0.16
Common
225 4*8 5-9 3*2 3-48 2.86 2-74 4*02 3-4 3-3 2.57 3-15 5.18 0.3 0.3
208 4 4 4 .5 4.21 3*82 4*01 5*86 4-6 4.09 3-77 4-46 7.12 0 .22 0.24
FF FF FF NET FF FF FF FF NET LVTT LVTT LYTT LVTT NET LVTT LVTT LVTT LVT!]
(L)T (L)P (L)0 FF (R)F (R)T (R)P (R)0 LVTT(L)F (l )T (L)P (l )0 LVTT(R)F (R)T (R)P (R)(
(R) (L) (R)
0.18 0.16 0.13 0.17 0.21 0.19 0.17 0.14 4*4 4.55 4.41 4 .48 4-46 4-6 4.72 4.55 4.54 4*6
0.25 0.19 0.16 0.21 0.29 0.26 0.21 0.15 3-5 3-95 3-77 3*78 3-65 3-9 4.32 4*02 4-02 4-12
0 .42 0.28 0.19 0.48 0.44 0 .32 0.17 4-83 4.53 4.55 4.44 4 .8 8 4.55 4.54 4.32
0.18 0.16 0.14 0.17 0.18 0 .2 0.17 0.14 4*9 4.95 4.79 4-76 5-24 5-0 4.97 4-89 4-87 5.1S
0.35 0.37 0.26 0.28 0»31 0-4 0-32 0.21 6-0 6.17 6.1 6.01 5-91 6 .0 6.17 6.17 6.01 6 .0^





29 3 .56 + - .52 18 3 .8 3 + - .84
40 3 .5 8 + - .42 34 3 .2 7 + - . 38
43 3 .8 7 + - .37 40 4 .3 4 + - .41
24 4 .47 + - .54 25 4 .90 + - .73
FRACTIONAL FLOW
29 .29 +- .04 18 .27 + - .04
40 .28 + - .03 34 . 31 + - .03
43 .27 + - . 0 3 40 . 23 + - .02
31 .21 + - .04 35 .19 + - .04
LARGE UESSEL TRANSIT TIME
29 3 .3 8  + - .08 13 3 .8 4 + - .08
40 3 .7 8  + — .09 34 3 .80 + - .10
43 3 .7 9  +- . 1 0 40 3 .74 + - . 1 1
30 3 .70  + — .23 35 3 .7 7 + - .19
i il —
L NETT T R A NS IT TINE 
L 3.0 +-.6 N = 13?
R -1.1 » . 8  N « 1 17
R L F R A C T I O N A L  FLOU 
L .26 ♦ - . O S  N = 1 4 5
R .2*1 ♦- .0 6 N » 12 7
L LARO E VESS E L  TT R 
L 3.0 +-.1 N = 1 4 4 
R 3.8 i - . 1 H - 12 7
i l l  M i l  M M  M M    ...................
Vo. \oz




ORRTVAI TIME 3.6 SEC.
TRANS1 I IIME 3.6 SEC.
M > .  V o  1 0J
CORTICAL TRANSIT TIME
24 2 .9 2 + - .59 23 3.61 + - .57
36 2 .81 + - .48 38 2 .8 8 + - .45
38 3 .3 2 + - .41 44 3.71 + - . 66
39 5 .1 6 + - 2 .8 2 41 8. 59 + - 3 .2 6
FRACTIONAL FLOW
24 . 35 + — .06 23 .34 + - .06
3 £> .46 + - .08 38 .36 + - . 0 6
38 .31 +- .04 44 .28 + - . 05
39 .23 + - .08 45 .17 + - .08
LARGE VESSEL TRANSIT TIME
24 1 .98 + - .07 23 1 .93 + - .08
38 1 .81 +- .14 38 1 .80 + - . 1 3
38 1 .96 + - .38 44 1 .86 + - .31
39 1 .83 +- . 56 45 1 .62 + - .55
L NFTT TRANSIT TIME R L FRACTIONAL FLOW R 
L 3 . b *-1.9 H-137 L .31 *-.10 H -13 3
R 4.2 +-2.4 M “ 146 R .27 +-.10 M-152
L L AR 6E VESSEL TT R 
L 1.3 >-.4 H » 133 
R 1.0 +-.4 M =15 2
IHPUT FUNCTION
ARRIVAL TIME 7.5 SEC.
TRANSIT TIME 7.5 SEC.
|.h% Wi>. Ictf
CORTICAL TRANSIT TINE
28 5.41 + - .75 14 4.84 + - . 46
33 5.78 + — 1 .60 26 5. 23 + - .89
39 6.62 +- 2.45 25 6.06 + - .87
38 8.05 +- 1.96 26 7.44 + - 1 .09
FRACTIONAL FLOW
20 . 1 9 + -  .03 14 .21 + - .02
33 .18 +- .04 26 .19 + - .03
39 .16 +- .04 25 .17 + - .02
38 .13 + — .03 28 .14 + - .02
LARGE VESSEL TRANSIT TIME
20 4.55 +- .11 14 4.72 + - .07
33 4.41 +- .23 26 4 .55 + - .21
39 4.48 +- .36 25 4.54 + - > Jit JL.
38 4.46 +- .38 26 4.60 + - .20
L HETT TRANSIT TIME R 
L 6 .3 + -1 .6 N= 1 25
R 6 . 1 i 1.4 H-92
L FRACTIONAL FLOU R 
L .16 +-.84 N = 1 3 8
R .17 +-.04 H-95
£
S
L LARGE VESSEL TT R 
L 4.4 +-.3 H * 138 
R 4.6 *-.2 H»95
INPUT FUHCTIOM
A R R TV AI TIME 8.5 SEC.





23 5.23 + - .72 20 4 .96 + - .72
36 4.81 + - .48 38 5.14 + — • o <t‘
39 5.32 + - . 50 40 5.75 + - .6?
28 6.64 + - 1 .33 24 6.44 +- 1.05
FRACTIONAL FLOW
23 .19 + - .03 20 .21 + - . 0 3
36 .21 +- .02 38 .20 + - .02
39 . 19 +- .02 40 . 1 8 + - .02
28 .17+- .03 24 .16 + - . 0 3
LAR6E UESSEL TRANSIT TIME
23 7.46 +- .15 20 7.50 + - .20
36 7.34 +- .14 38 7.27 + - .16
39 7.62 +- .32 40 7.59 + - .34
28 8.13 +- .61 24 7.84 + - .47
L NETT TRANSIT TIME R 
L 5.2 ♦ -.? N-123
R 5.-4 + -.? N=114
L FRACTIONAL FLOU R
L .13 . 03 H-125
R .18 +-.03 N =121
BBBjffiHiaHHHinai
L LARGE VESSEL TT R 
.6 ■*■-.5 N ■ 12 6 
. .5 + -.4 N = 12 2
INPUT FUNCTION
ARRIVAL TINE 5.1 SEC.
TRANSTT TIME 8.7 SEC.
M * .  M o .  loST
CORTICAL TRANSIT TINE
28 4 .4 2 + - .85
43 4 .10 + - .57
45 4 .9 ? + - .55
35 5.31 + - 1 .0?
FRACT IONAL. FLOW
28 . 23 + - .04
43 .25 + - .03
45 .26 + - .02
35 .1? + - .04
LARGE MESSEL TRANSIT
28 7 .14 + - .35
43 6 .84 + - .41
45 6 .8 6 + - .47
35 7 .4 8 + - .77
16 4.45 + - .73
33 4.14 + - .47
39 5.85 + - .71
34 5. 23 + - ■ 8^ >
16 . 23 + - . 0 3
33 .24 + - .03
39 .20 + - . 03
34 . 20 + - . 0 3
TIME
16 7.30 + - .24
33 7.02 + - .42
3? O . 7 £• + - .45
34 7.51 + - .46
NETT TRANSIT TIME 
4.7 +-.3 N « 15 2 
*1.8 ♦ - . 8 N » 122
FRACTIONAL FLOU 
L .22 + - .94 M “ 152
R .21 +-.04 H-122
L LAKliE VESSEL TT R 
L 7.1 +-.6 H « 152 
R 7.1 >-.5 H« 122
IMPUf FUMCTIOH
ARRIVAL TIME 4.8 SEC.
TRANSIT TIME 7.1 SEC.
h b .  N o  IC(*
CORTICAL TRANSIT TIME
23 3.60 + — > 30
37 3.17 +— .62
43 3.86 +- .57
34 4.98 +- .99
FRACTIONAL FLOW
23 .28 +- .62
37 .33 + — .07
43 .27 +- .05
35 .20 +- .04
LARGE VESSEL TRANSIT
23 4.46 +- .25
37 4.26 +- .06
43 4.27 +- .25
35 4.38 +- .37
15 3.40 + - . 1 5
37 3.21 + - .54
40 3.86 + - . 62
28 5.58 + - .97
15 . 29 + - .01
37 .32 + - .05
40 .27 + - .05
31 .18 + - .03
I ME
15 4.66 + ~ .28
37 4 .23 + - . 0 7
40 4.26 + - .14
31 4 .35 + - . 28
L HETT TRAMSIT TIME 
L 3.9 1 .0 H « 137
R -4.0 + - 1 . 1 M * 12 0
L FRACTIONAL FLOU 
L .26 + -.G7 H » 14 4




L LAR6E VESSEL TT R 
L 4.3 +-.3 H * 14 4 
R 4.3 +-.2 N = 1 29
• «
INPUT FUNCTION
ARRIVAL TIME 4.2 SEC.
TRANSIT TIME 3.6 SEC.
l &.Kfo |(0
CORTICAL TRANSIT TIME
38 3.23 + - 1.10 25 3.08 +- 1.16
43 2.27 + - .41 40 2.20 + - .43
43 2.91 + - .31 43 2.68 + - .43
30 3.24 + - .76 27 3.88 + - 1.07
FRACTIONAL FLOW
30 .34 + - .09 25 . 36 + - .10
43 .45 +- .09 40 .47 + - .09
43 .35 + ~ .04 43 .38 + - .08
30 .32 +- .07 27 .27 + ~ .07
LARGE VESSEL TRANSIT TIME
30 1.91 +- . 1 0 25 1 .91 + - .15
43 1.85 +- .08 40 1 .82 + - .68
43 2.25 +- . 36 43 2.03 + - .29
30 2.52 +- .46 27 2.32 + - . 53
L HETT TRANSIT TIME R L FRACTIONAL FLOU 
L 2.9 +-.8 H * 14 6 L .37 +-.03 H-146
R 2.9 +-1.0 N-135 R .38 +-.11 N» 135
£
L LARGE VESSEL TT R 
L 2.1 +-.4 H * 146 
R 2.0 +-.3 N-135
INPUT FUNCTION
ARRIVAL TIME 5.7 SEC.
TRANSIT TIME 5.7 SEC.
gnasnnrMMni
I I I  "111 I M I W I II l i l  ■ — l l l l l l l l l l l ....................
IA. Uo US
CORTICAL TRANSIT TINE
24 2.30 + - .40 22 2.64 + - .78
39 2.44 + - .44 2.20 + - .45
43 3.16 + - .58 40 3.37 + - .74
36 4 .22 + - 1 .20 31 5.09 + - 1 .50
FRACTIONAL FLOW
24 .45 +- .09 22 .41 + - . 1 0
39 .42 +- .08 36 .47 + - . 1 0
43 .33 +- .06 40 .31 + - .05
36 .25 +- .06 31 .21 + - .06
LARGE UESSEL TRANSIT TIME
24 2.37 +- .25 22 2.30 + - .29
39 1.90 +- . 30 36 1 .96 + - . 22
43 2.09 +- .35 40 1 .94 + - .26
36 2.48 +- . 56 31 2.04 + - .42
L HETT TRANSIT TIME R L FRACTIONAL FLOU 
L 3.0 +-.8 H * 138 L .35 +-.10 H - H 2
R 3.1 +-1.8 N = 1 13 R .3-4 +-.13 N =12 3
L LAR GE V E S S E L  TT R 
.2 +-.5 H-1-12 
.1 +-.3 N - 1 2 3
INPUT FUNCTION
ARRIVAL TIHE 6.1 SEC.
TRANSTT TTNF 6.1 SEC.
CORTICAL TRANSIT TIME
24 1 .47 + - .30 17 1 .44 + - .20
43 1 .74 + - .40 33 1 .45 + - . 35
48 2.41 + - . 31 40 2 .1 3 + - .30
30 3 .1 6 + - .7? 26 2 .8 7 +■ - .84
FRACTIONAL FLOW
24 .71 +- .15 17 . 70 + - .09
43 .61 +- .15 33 .73 + - . 1 8
48 .42 +- . 05 40 .48 + - .68
36 .31 + ~ .10 33 .33 + - .12
LARGE UESSEL TRANSIT TIME
24 1.62 +- .07 17 1 .61 + — .06
43 1.37 +- .25 33 1 .50 + - .06
48 1.39 +- .29 40 1 .58 + - .09
36 1.11 +- .54 33 1 .29 + - .54
L HETT TRANSIT TIME R 
L 2.2 8 H-146
R 2.0 + - .7 N = 1 16
L FRACTIONAL FLOU R 
L .48 +-.13 H » 15 8
R .52 +-.22 N= 1 30
fJlPl
L LARGE VESSEL TT R 
L 1.3 +-.4 N-158
R 1.4 +-.4 N =130
• •
INPUT FUNCTION
ARRIVAL TIME 5.3 SEC.
TRANSIT TIME 5.9 SEC.
CORTICAL TRANSIT TIME
23 7 .7 4  + -  2 .2 4 24 8 .6 4 + - 2 .7 8
46 9 .6 2  + -  4.01 43 3.1 1 + - 2 .80
53 8 .5 8  + -  2 .3 2 41 6 .9 3 + - 1 .83
57 9 .8 7  + -  3 .9 5 50 9 .74 + - 4 .2 5
FRACTIONAL FLOW
28 .14 + -  .04 24 . 1 3 + - .04
46 .13 + -  .05 43 .14 + - .04
53 .12 + — .03 41 .15 + - .03
64 .11 + -  .05 50 .12 + — .04
LARGE VESSEL TRANSIT TIME
28 3 .2 3  + — .18 24 3 .1 7 + - .24
46 2 .9 5  + -  .22 43 3.01 + - .15
53 3 .0 7  + — .20 41 3 .0 4 + - .18
64 3 .0 7  + -  .45 50 3 .0 3 + - .31
...... i n — in  H i — ■ [■ — Minimum...
L HETT TRANSIT TIHE R 
L 3.0 +-3.4 N =18 4
R 8.4 • -3 .3 N ■ 1 5 8
L FRACTIONAL FLOU R 
L .12 +-.04 N = 1 9 1
R .13 +-.04 H * 158
rfiiiiwuai
L LAR6E VESSEL TT R 
L 3.1 +-.3 N =191 
R 3.0 • .2 N »158
INPUT FUNCTION
ARRIVAL TIHE 6.0 SEC.
TRANSI I TIME 3.3 SEC.
| . b .  t o  » X O
CORTICAL TRANSIT TIME 
23 4 .9 6  + -  .47 24 4 .60 + - .31
46 5 .0 5  + - .71 40 4 .6 6 + - .61
44 6 .0 2  + - 1 .0? 40 5 .5 7 + - .72
43 7 .4 2  + — 1 .2? 31 7 .3 5 + - .9?
FRACTIONAL FLOW 
23 .20 + -  .02 24 . 22 + - .0 1
40 .20 + - .02 40 .22 + - .03
45 . 1 7 + - .03 40 . 13 + - .02
43 . 1 3 + - .03 31 .14 + - .02
LAR6E VESSEL 
23 3 .6 5  +-
TRANSIT TIME 
.13 24 3. 72 + - . 1 1
40 3 .50  + - .15 40 3. 53 + - .13
45 3 .5 5  +- .34 40 3 .5 6 + - .20
43 3 .7 3  + — .5? 31 3.31 + - .42
:i;i -sagffli
L NF.TT TRANSIT TIME 
L 6.0 •- 1 . 4 H- 156
R 5.5 +-1.3 N »135
FRACTIONAL FLOU 
17 + -.0-1 H-162
13 +-.0*1 N = 1 3 5
L IARfiF VESSEL TT R 
L 3.6 * . 4 H-162
R 3.6 ♦ — . 3 N -13 5
INPUT FUNCTION
ARRIVAL TIHE 8.3 SEC.
TRANSIT TIME 5.7 SEC.
Lb. Ho.2.0'
CORTICAL TRANSIT TINE
24 4 .5 5 + - .97 19 3 .9 3 + - . 88
38 3 .7 2 + - .48 35 3. 87 + - . 36
35 4.11 + - .28 43 3 .9 8 + - . 28
24 4 .59 + - .84 29 4 .84 + - . 31
FRACTIONAL FLOW
24 .23 +- .05 1 9 ■ 26 + - .04
38 .27 + - .03 35 .27 + - .02
35 .24 +- . ©2 43 . 25 + - .02
24 .22 +- .03 29 .21 + - .03
LARGE CESSEL TRANSIT TIME
24 5 .2 8  + - .14 19 5 .3 8 + - .07
38 5 .1 8  +- . 08 35 5 .2 3 + - .03
35 5 .3 3  + - .15 43 5 .3 7 + - .09
24 5 .5 5  +- . 43 29 5 .3 5 + - .15
  " " T ir m — H m i i g M iT iw m r n t i tm ' iiwriiftmtu""
L NETT IRANSIT TIME R 
L 4.2 + -.? H-121 
R -1.1 + -.? M * 126
L FRACTIONAL FLOU R 
L .25 +-.04 H-121
R .25 +-.04 H «* 126
■y ,y   I
L LARUE VESSEL TT R 
L 5.3 +-.3 H-121
R 5.3 +-.1 H ■126
INPUT FUNCTION
ARRIVAL TIME 4.2 5 E C .
TRANSIT TIHE 5.7 SEC.
l b* N O
CORTICAL TRANSIT TIME
24 2.33 + - .48 15 2.42 + - .48
41 2.11 + - .19 33 1 .33 + - . 28
45 2.33 + - .27 40 2.42 + - .43
40 3 .02 + - . 87 28 3.14 + - .50
FRACTIONAL FLOU
24 .44 + - .68 15 .43 + - .07
41 .48 +- .04 33 .58 + — .03
45 .43 +- .05 40 .43 + - .08
41 .34 +- .03 33 .29 + - . 0 8
LARGE UESSEL TRANSIT TINE
24 2.23 +- .08 15 2.23 + - .05
41 2.11 +- .07 33 2.21 + - .07
45 2.21 +- . 1 1 40 2.24 + - .09
41 2.22 +- .17 33 2.17 + - .19
a  -U.U iH i t i lW H I
FRACTIONAL FLOU 
L .40 +-.12 M -16 4
R .-10 +-.15 H-12S
L HE1i IRAHSIT TIHE 
L 2.5 +-.6 H “ 150 
R 2.4- +--6 H-1 14
L LAR8E VESSEL TT R 
+ -.2 H « 16 4 
+ -.2 H * 130
IHPUI FUHCTIOH
ARRIVAL TIME 4.7 SEC.
TRANSIT TIME 4.7 SEC.
f . b . KJb . 2.0S'
CORTICAL TRANSIT TIME
27 5.36 + - .36 20 4.53 +- .44
3? 5.40 +- .82 41 4.4? +- .80
40 5.93 +- .81 43 5.92 +- .8?
32 7.35 +- 1.56 31 7.54 + - 1.36
FRACTIONAL FLOW
27 .19 +- .01 20 .22 +- .02
3? .1?+- .03 41 .23+- .64
40 .17 +- .02 43 . 17 +- .03
36 .13 +- .04 31 .14 +- .02
LARGE WESSEL TRANSIT TINE
27 3.63 +- .10 20 3.64 +- .07
3? 3.45 +- .12 41 3.4? +- .08
40 3.42 +- .12 43 3.42 +- .12
3 C• J i oO + i d 1 31 3.43+— .30
* "i;':&&-S88 m”tljiMMMHtt>MMIIIlTlimnwillllllllll..........
L FRACTIONAL FLOU R 
L .16 +-.04 N = l 4 3
R .18 +-.05 N» 1 40
I HETT TRANSIT TINE 
L 6.0 +-1.2 H = 13 8
R 5.7 »-1.S N » 13 5
n ——  111111
$
s
L LAR6E VESSEL TT R 
L 3.4 +-.2 N =15 0 
R 3.S t .2 N-140
INFUT FUNCTION
ARRIVAL TIME 4.5 SEC.





25 1.98 +- . 30
38 2.68 +- .47
40 3.15 + - .56
41 3.70 +- .77
FRACTIONAL FLOW
25 .52 +- .07
38 .50 +- . 1 1
40 .33 +- .07
41 .28 +- .06
LARGE MESSEL TRAN!
25 2.72 +- .13
38 2.50 +- .07
40 2.63 +- . 1?
41 2.8? +- .35
17 2.24 + - .40
34 1 .84 + ~ . 37
40 2.43 + - .48
40 3.9? + “ 1.10
17 .46 + - .08
34 . 5& + - . 1 1
40 .42 + - .10
40 .27 + - .07
TINE
17 2.70 + - . 1 6
34 2.55 + - .06
40 2.67 + - . 1 1
40 2. 72 + - .28
L HETT TRANSIT TIME R 
L 2.8 >-.3 H-144
R 2.6 + - . 9 N = 1 26
L LARGE VESSEL TT R 
.6 >-.2 H ■137 
.6 +-.1 N -12 9
L FRACTIONAL FLOU R 
L .33 + - • 13 H-144
R .42 +-.14 N * 131
INPUT FUNCTION
ARRIVAL TIME 5.6 SEC.
TRANfiTT TIME 5.6 SEC „
CORTICAL TRANSIT TIME
18 5.00 + - .98 16 4.50 + - .57
32 4 .6 8 + - .84 28 4 . *4 + - .52
36 5.61 + - .86 34 5 .9 4 + - 1 .12
59 6 .3 9 + - .93 54 7 .3 3 + - 1.11
FRACTIONAL FLOW
18 .21 +- .04 16 . 22 + — . 0 3
32 .22 +- .04 28 .22 + - .02
36 .18 +- .03 34 .17 + - .04
59 .16 + - .02 54 .14 + - .02
LARGE VESSEL TRANSIT TIME
13 3 .5 2  + - .07 16 d • 7u + - .23
32 3 .4 8  +- .08 28 3 .5 7 + - .21
36 3 .5 2  + — .26 34 3 .3 8 + - .22
59 3 .7 7  +- .45 54 3. £>8 + - .48
L HETT TRANSIT TIHE R L FRACTIONAL FLOU 
L 5.9 ♦ -1.4 H-15S L .18 + -.0S H-162
R 6.2 +-1.6 N = 13 ? R .1? +-.85 H= M 2
VIP
IkiaMfiU
L LARGE VESSEL TT R 
L 3.6 >-.3 H-161
R 3.6 + - .4 N = M 1
INPUT FUNCTION
ARRIVAL TIME 5.0 SEC.
TRANSIT T THE 5.3 SEC.
(. b . H o .  2.0$
CORTICAL TRANSIT TIME
19 4.21 + - .45 16 4 .0 9 + -  .34
30 3 .8 2 + - .61 29 3 .7 7 + -  .61
36 4.01 + - .68 32 4 .4 6 + -  .82
52 5 .8 6 + - 1 .17 41 7 .1 2 +-  1.70
FRACTIONAL FLOW
19 .24 +- .03 16 . 25 + - .02
30 .27 +~ .04 29 .27 + - .04
36 .26 +~ .05 32 .23 + - .04
52 .18 +- .03 41 .15 + - .03
LARGE VESSEL TRANSIT TIME
19 4 .2 5  + - .15 1 6 4 .3 7 + - .27
30 4.11 + - .17 29 4 .6 9 + - .20
36 3 .9 5  +- .17 32 3 .9 6 + - .15
52 4 .0 8  +- .30 41 4 .10 + - . 1 8
Um
L HETT IKftHSIT TIHE R L FRACTIONAL FLOU 
L 4.5 +-1.1 H-131 L .22 +-.06 H-1-M
R 4.6 + -I.1 H-101 R .20 +-.07 N-134
m  the base
L LARUE VESSEL TT R 
L 4.8 +-.2 H =* 1 4 2 
R 4.0 +-.S H ■132
INPUT FUNCTION
ARRIVAL TIHE 7.9 SEC.
TRANSIT TIHE 6.4 SEC.
Cerebrai Scintigraphy 
750M8q 99mTc Pertechnetate
The cortical transit times are longer 
line study than during a migraine*
21 J u i y  1/37 11*V. M E R R I C K
l.fc.Mo 2.0*1
CORTICAL TRANSIT TIHE
25 3 .71 + - .36 20 3 . 3 3 + - . 28
46 3 . 6 6 + - .80 37 3.31 + - . 46
48 4 . 5 7 + - . 78 39 3 . 7 3 + - .30
3? 5.61 + - 1 . 38 30 4 . 6 2 + - . 94
FRACTIONAL FLOW
25 .27 + - .02 20 . 30 + - . 02
4 o . 28 + - . 05 37 .31 + - .04
48 . 22 + - . 03 39 .27 + - . 0 2
3? . 1 9 + - .04 30 .22 + ■— .04
LARGE MESSEL TRANSIT TIME
25 4 . 0 6 + - .10 20 4 . 2 3 + - . 07
46 3 . 9 3 + - . 1 1 37 4 . 0 5 + - . 0 8
48 3 . 9 8 + - . 15 39 4 . 0 7 + - .10
39 4 . 1 7 + - . 36 30 4 . 1 8 + - . 26
i im m i i i i i w i i i i i i  i iiiiiii n i i i i iiniiiiiiH.....
L NFTT TRANSIT TIME R 
L «.i t-1.2 H - 158 
R 3.8 +-.8 M “ 126
L FRACTIONAL FLOU R 
L .2*1 +-.06 H« 1 58
R . 2? +-.05 H “ 126
I
L I OROF VE5SEL TT R
L 4.0 » - . 2 M “ 158 
R 4 . I +-.2 H»126
• •
INPUT FUNCTION
ARRIVAL I IME *1.2 SEC.
TRriMSIT TIME -1.0 SEC.
(.to* Mo 2JO
CORTICAL TRANSIT TIME
24 4 .16  + - .70
44 3 .0 8  + ~ .35
45 3 .50  + - .32
48 4 .50  + - .96
FRACTIONAL FLOW
24 .25 +- .04
44 .33 + - .04
45 .29 + - .03
48 .23 + - .04
LARGE MESSEL TRANSIT
24 4 .5 4  + - .16
44 4 .2 9  + - . 06
45 4 .3 3  + - .14
47 4 .6 7  +- .42
27 3 .6 2 + - .35
40 3 .3 9 + - .54
45 6 . 6v> + - .30
37 4 .43 + - .72
27 .29 + - . 0 £•
40 .30 + - .04
45 .27 + - .02
37 . 23 + - .03
TIME
27 4 .4 3 + - .09
40 4 .23 + - .09
45 4 .42 + - .14
37 4 .60 + - . 36
L HETT TRANSIT TIHE R L FRACTIONAL FLOU 
L 3.8 +-.3 H-161 L .28 +-.05 H-161
R 3.8 +-.7 N-143 R .27 +-.05 N=149
i
L LARGE VESSEL TT R 
L 4.5 *-.3 H *160 
R 4.4 +-.2 H- 149
INPUT FUNCTION
ARRIVAL TIHE 3.6 SEC.
TRANSIT TIME 4.3 SEC.
1*5 . No. I'*
BA*£J~ihf6
CORTICAL TRANSIT TIHE
21 4.01 + - .51 21 3 .3 8 + - .28
35 3 .7 5 + - .28 36 3 .1 7 + - .37
42 4 .2 9 + - . 56 41 4 .0 7 + - .53
46 4 .9 2 + - 1.01 39 4.51 + - .60
FRACTIONAL FLOW
21 .25 +- .04 21 .30 + - .02
35 .27 + - .02 36 .32 + - .04
42 .24 +- .03 41 .25 + - . 0 3
46 .21 + - .04 39 .22 + - .03
LARGE MESSEL TRANSIT TINE
21 3.71 + - .23 21 3 .74 + - .13
35 3 .5 6  + — .17 36 3 .5 9 + - .10
42 3 .7 3  + - .52 41 3 .74 + - .37
46 4 .40  +- .74 39 4 .8 7 + - .28
// / l u
 ---
L HETT TRANSIT TIHE R 
L 4.2 + -.? N = 1 37 
R 3.8 »-.? H * 137
«
 i minim i ii«f—Miitmn n -" I
L LAR6E VESSEL TT R 
L 3.3 +-.6 N ■= 1 42 
R -1.U «-.6 H - 136
• •
INPUT FUNCTION
ARRIVAL TTHE 8.0 SEC.
TRANSIT IIHE 8.4 SEC.
L FRACTIONAL FLOU R 
L .24 +-.04 N =14 4
R .27 +-.Q5 N * 137
I* b ,  K o  H i
D VAifffi H U A A l U t
CORTICAL TRANSIT TIME
23 6 .30 + - .78 15 5 .6 9 + - .58
4 l 5 .4 8 + - . 56 33 5 .1 2 + - .41
46 6 .54 + - 1 .69 42 5 .8 5 + - .53
56 7. 23 + - 1 .33 47 7 .2 2 + - .82
FRACTIONAL FLOW
23 .16 +_ .02 15 .18 + - .62
41 .13 + - .02 33 .20 + - .02
46 . 1 6 + - . 03 42 .17 + - .02
56 . 14 + - .02 47 .14 + - .02
LARGE UESSEL TRANSIT TIME
23 4 .9 5  + - .12 15 4 .9 7 + - .03
41 4 .7 9  +- .14 33 4 .89 + - .09
46 4 .7 6  + - .28 42 4 .8 7 + - .18
56 5 .24  +- . o 1 47 5 .1 5 + - .27
L HETT TRANSIT TIHE 
L 6 .1  + - . 8  H -143
R 6.8 + -.S 1U132
FRACTIONAL FLOU
.16  + -  .03  
.17  + - .G 3
N- 166
N = 1 3 7
L LARGE VESSEL TT R 
L 4 .3  + - . 3  H *  158 
R 5 . 0  + - . 2  N= 136
INPUT FUNCTION
ARRIVAL TIME 6.0 SEC.
TRANSIT TTNE 6.4 SEC.
3» 
ui
CORTICAL TRANSIT TIME 
20 2 .6 8  +- .26 20 2 .5 8 + - . 30
36 2.99 + - .54 37 2 .8 5 + - .47
3? 3 .2 5  + - . 55 40 3 .74 + - .63
40 4 .70  +- 1 .31 27 5 .3 8 + - . 89
FRACTIONAL FLOW 
20 .38 +- .04 20 . 39 + - . 0 5
36 .35 +- .06 37 . 36 + - . 0 6
39 .32 + - . 06 40 .28 + - .05
41 .22 + - .05 30 . 1 8 + - .04
LARGE MESSEL 
20 5 .7 4  + -
TRANSIT TIME 
. 22 20 5 .8 6 + - .14
36 5 .3 5  + - . 23 37 5 .4 7 + - .27
39 5 .3 6  +- .36 40 5 .6 8 + - .31
41 5 . 5 4 + - . £*0 30 5 .84 + - .44
L HETT TRANSIT TIHE R 
> - 1 . 1  H* 135 
+ -1.2 N = 12 4
L LARGE VESSEL TT R 
L 5 . 5  >-.*1 H ■ 138 
R 5 . 7  +- .-4  H -  1 2 8
L FRACTIONAL FLOU R 
L .30  > - . 0 8  H « 138
R .23  + - . 0 3  N = 12 8
INPUT FUNCTION
ARRIVAL TIHE S.1 SEC.
TRAHSTT TINE 5.4 SEC.
t.fc. NO 2IS
CORTICAL TRANSIT TIME
18 4 .6 8  + - .28
30 4 .7 9  +- .45
28 5 .7 9  + — .70
38 7 .1 2  + - 1 .01
FRACTIONAL FLOW
18 .21 + - .01
30 .21 + - .02
28 . 1 7 + - .02
38 .14 + - .02
LARGE MESSEL TRANSIT
18 5 .40  + ~ .09
30 5 .2 6  + - .09
28 5 .3 5  + - .14
38 5 . w*C' + — . 33
14 4.20 + -  .18
24 4 .1 2 + -  .47
32 4.71 + -  .76
40 6 .10 + -  1 .09
14 .24 + - .01
24 .25 + - .03
32 . 22 + - . 0 4
40 .17 + — .02
TIME
14 5 .4 7 + - .06
24 5 .34 + - .09
32 5 .2 5 + - .13
40 5 .4 2 + - .37
L NFTT TRANSIT TIME 
L 5 . 8  ‘ - 1 . 3  H* 115




.17 + - . 0 4  
.28  + - . 9 5
12 1 
116
L I ARfiF VESSEL TT R 
L 5 . 4  • - .3  H-12 1 
R 5 . 3  + - . 3  N» 116
INPUT FUNCTION
ARRIVAL H U E  6.3 SEC.
TRANSIT TIHE 5.3 SEC.
l.fc.Wo
CORTICAL TRANSIT TIME
14 3.94 +- 1.87 14 3.73 + - 1 .49
27 2.34 + — . 38 27 2.33 + - .33
33 3.75 +- 1.12 35 3.53 + - .42
52 7.58 +- 3.78 48 7.05 + - 4 . 28
FRACTIONAL FLOW
14 .36 +- .12 14 .30 + - .10
27 .44 +- .08 27 .44 + - .08
33 .28 +- .05 35 . 28 + - .03
58 .18 +- .10 52 .17 + - .08
LARGE UESSEL TRANSIT TIME
14 8.47 +- .12 14 3.51 + - .09
27 8.37 +- . 1 0 27 8.35 + - .07
33 8.24 +- .15 35 8.40 + - .10
81 8.08 +- .27 58 8.14 + - . 28
L HETT TRANSIT TIME 
L 5 . 2  > * 5 . 6  H»12?
R 4 . 7  > - 3 . 3  H * 12 4
* Sill
FRACTIONAL FLOU 
.25  > - . 1 5  H -140
.26  > - . 1 3  N»132
M M —
L LARGE VESSEL TT R 
L 6 . 2  > - . 3  H• 1 4 3  
R 6 . 3  > - . 2  N = 1 3 7
INPUT FUNCTION
ARRIVAL TIHE 3.0 SEC.
TRANSIT TIME 6.0 SEC.
1.5. Kfo • X l S
CORTICAL TRAMIS IT  TIME
23 5 .6 4  + - 1 .04 1 9 5 .5 9 + - .93
43 4 .7 6  +— .'74 35 4 .47 + - .64
56 5 .1 7  + - .38 40 4 .8 3 + - .42
37 6 .5 6  + — 2 .02 41 6 .1 5 + - 1 .48
FRACTIONAL FLOW
24 .13 + — .04 1? . 18 + - .03
43 .22 + - .04 35 .23 + - .03
56 .20 + - .03 40 .21 + - .02
44 . 1 5 + - .05 41 .17 + - .03
LARGE VESSEL TRANSIT TIME
24 3 .7 5  + - .20 1? 3 .74 + - .69
43 3 .6 5  +- .12 35 3. 63 + - .07
50 3 .6 7  +- .15 40 3 .6 3 + - .09
44 3 .5 8  +- . 32 41 3.71 + - .20
.'mwrnmmmsaaam
L HETT TRANSIT TIME 
L 5.5 + -1.4 H = 15 3
R 5.3 ♦ - 1 . 2 N « 135
i







H * 1 ? 0 
N- 14 1
s s
::::: ; s m  * s
L LMK8E VESSEL TT R 
L 3.6 +-.3 N-170
R 3.6 «--.2 N» 1 *11
« •
INPUT FUNCTION
ARRIVAL TIME 6.2 S E C .




18 3 .26 + - .34 15 2 .8 3 + -  .21
34 3 .3 5 + - .42 30 2 .7 5 + -  .48
3? 3 .7 5 + - .52 35 4.01 + -  1 .12
63 5 .3 9 + - 1 .51 50 5 .84 +-  2 .2 3
FRACTIONAL FLOW
IS .32 +- .04 15 . 35 + - . 0 3
34 . 30 + - .04 30 .37 + - .07
39 .27 +- .04 35 .26 + - .06
63 . 20 + - .05 50 .19 + - .05
LARGE MESSEL TRANSIT TIME
18 1.94  + - .26 15 1 .96 + - .28
34 1 .68  + - .32 30 1 .78 + - .27
39 1.52  + - .32 35 1 .53 + - .23
1 .56  + - .42 50 1 .64 + - .40
€
Mi— i
L NETT TRANSIT TIHE 
L 4.2 »--.8 N-142
R 4 . I + -I.0 N-119
FRACTIONAL 




L LAPOE VESSEL TT R 
L 3.7 «-.4 H * 17 4 
R 3.8 +-.4 H « 141
• •
INPUT FUNCTION , , /
>CV f / yy^C{ J*2cl
ARRIVAL TIME S.0 SEC . ^  
TRAN5IT TIME 6.4 SEC.
li b . f T o .  * 2 0
CORTICAL TRANSIT TIME
19 , 4 . 0 3  + -  . 28
32 4 . 0 6  + -  . 47
37 5 . 3 3  + -  1 . 0 2






. 2 5  + -  
. 2 5  + -  














LARGE VESSEL TRANSIT TIME
3 . 5 1  + 
3 . 8 8  +■ 
4 . 8 4  + 
6 . 7 6  +*
. 2 9  + 
. 2 6  +■ 
.21 +• 
. 1 5  +■
.21 
. 54  















2 .1 4  + -  
2 .3 7  +— 
3 .2 5  + -
.48 + 
.44 + ■ 










19 3.95 + - .32 17 4.32 + - .30 16 4.88 + - .27
32 3.77 + - .33 29 4.02 + - .34 32 4.55 + - . 22
37 3.78 + - .50 28 4.02 + - .37 34 4.54 + - .31
35 3.65 +•- .59 25 4.12 + - .47 41 4.32 + - . 39
L NETT TRANSIT TINE 
L 5.0 + - 1 . 2 H = 1 1 7






.19 +-.87 N = 1 4 2
.21 +-.07 N * 111
cerebral Scintigraphy 
750MBq 99f«Tc Pertechnetate
Tne large vessel transit time nas become more 
asymmetries! than in the .case line stuoy cut the 
cortical transit times are unchanged.
23 July 1987 H.V, MERRICK
I
L LARGE VESSEL TT R 
L 3.5 +-.6 N -15 2 
R 3.3 i-.6 N -114
• •
INPUT FUNCTION
ARRIVftt TINE 7.9 SEC.











0^ - H  . 86
f r a c t i o n a l  FLOW
(. O .No 2.1
L = 2.9 +-.7 <114 > 
R = 2 . 9 +— .9 <109 >
18.02.87 FRACTIONAL FLOW
L = 2.3 +-.6 <114 > 
R = 2.3 +-.7 <109 >
18.02
L = 3.7 +-1.0 < 114 > 
R = 3.6 +-1.0<106>
R !
NETT MEAN TRANSIT TIME
Cerebrai Scintigraphy 
750f18q 99mTc Pertechnetate
There is no evidence of abnormal perfusion or 
abnormal permeability.
87 *<F>
19 Feb 19.9/ A. NOTGHI
I.h. Ho.2X<4
CORTICAL TRANSIT TIME
21 3 .0 2 + - .24 16 3.11 + -  .45
31 2 .5 5 + - .46 28 2 .5 5 + -  .45
36 3 .0 3 + - .51 32 3 .3 3 + -  .51
56 4 .6 5 + - 1.11 49 4 .8 3 +-  1 .02
FRACTIONAL FLOW
21 .33 +- . 03 16 . 33 + - . 05
31 .40 +- .08 28 . 40 + - .G3
36 .34 +- . 06 32 . 31 + - . 65
58 .22 +- .05 51 .21 + - .04
LARGE VESSEL TRANSIT TIME
21 4.18 +- .07 16 4.16 + - . 06
31 4.10 +- .08 28 4.09 + - .07
36 4.06 + — .08 32 4.03 + - .06
58 3.97 + - . 23 51 4.07 + - .15
L NETT TRANSIT TIME R L FRACTIONAL FLOU R 
L 3.6 + -1.2 H-1-M L .31 +-.03 H -1 -16
R 3.7 + -1.2 N = 1 25 R .23 +-.03 N =12 7
L LARGE VESSEL TT R 
L *1.0 +-.2 H ■ 1 *16 
R -4.1 +-.1 N = 1 2 7
INPUT FUNCTION
ARRIVAL TIME 4.8 SEC.
TRANSTT TTME 3.3 SEC.
CORTICAL TRANSIT TIME
17 4 .3 5  +- .38
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Abbreviated Case Summaries 
Pilot study group
(101) This 40 year old, married, music teacher has a 10 year history of 
common migraine. Her headaches are bilateral and usually associated with 
irritability. She has had outpatient psychiatric treatment twice - (i) 
an episode of major depression following the death of her father when she 
was 19 for which she had 3-6 months of antidepressant therapy, (ii) an 
anxiety state treated with minor tranquillisers over a two year period 20 
years later. She meets DSM-III criteria for panic disorder without 
phobic avoidance and has a sister who has panic attacks for which she 
been treated by a psychologist.
(106) This 59 year old, married, retired teacher has a 35 year history of 
common migraine which is usually associated with euphoria. The headaches 
are unilateral and affect the dominant hemisphere. Both her mother and 
her son also have migraine. An aunt, who has recurrent depression, has 
received treatment in a psychiatric hospital. Her own previous 
psychiatric history is of postnatal depression following the birth of a 
premature baby. This was treated by her GP without medication. She 
describes a feeling of wellbeing which occurs regularly 1-2 days prior to 
migraine attacks. At these times she is much more confident and active 
than usual.
(107) A 45 year old, single, agricultural advisory worker with a 36 year 
history of classical migraine. The unilateral headache usually affects 
the non-dominant hemisphere and rarely the dominant hemisphere. She
muddles words when speaking and also has occasional visual disturbance. 
The migraines are usually accompanied by feeling withdrawn, slightly 
anxious and irritable. This lasts approximately 24 hours. There is no 
personal or family history of psychiatric illness.
(111) This 43 year old, single, teacher has a 20 year history of 
classical migraine preceded by a visual aura. She says she also has a 
feeling of euphoria for up to 24 hours prior to attacks. The euphoria 
consists of feeling more self confident and talkative than usual and 
finding that her thoughts are speeded up. This has only begun in the 
last 1-2 years. She has a four year histoiy of DSM-III major depression
and one of her sisters also has a history of depressive illness. She
also complains of perceptual distortion during migraines when her head 
and neck feel swollen although they look the same in the mirror.
New referrals.
Affective group (on the basis of self report at initial interview)
(102) A 44 year old, married, cashier with a 20 year history of
unilateral classical migraine affecting the dominant hemisphere. She 
complains of euphoria and irritability on the day before a migraine 
attack. Her aura preceding the headache consists of sensory loss 
ipsilateral to the headache, scotoma and dizziness. She feels her head 
and neck are internally "blown out" but not enlarged in size and also had 
an unpleasant taste in her mouth during migraines. The euphoria prior to 
attacks consists of feeling more talkative, racing thoughts, distract- 
ibility and poor concentration. The euphoria has only been present for 
the last six years. She has had cyclothymic disorder over the same
- 2 -
period. Her previous psychiatric history consists of treatment with minor 
tranquillisers over a seven year period during her first marriage. Her 
husband had a serious alcohol problem.
(103) A 41 year old, married, dress shop owner with a ten year history of 
unilateral common migraine affecting the non-dominant hemisphere. Her 
migraine is always accompanied by irritability and frustration with 
herself for having a headache. She has seen a psychiatrist as an 
outpatient because of postnatal depression. At present she meets DSM-III 
criteria for major depression. This started four years ago after moving 
to Australia with her husband. At that time she felt isolated and cut 
off from her family. The depression has not resolved since her return to 
Scotland. There are marital difficulties and she feels angry with her 
husband for not discussing major decisions with her before making choices 
which affect both of them. Her husband's job in the stockmarket also 
causes financial insecurity for the family.
(104) This 25 year old housewife has a 15 year history of classical 
migraine with an aura consisting of right-sided paresis and speech 
disturbance. She complains of irritability which is always associated 
with her headaches. She meets diagnostic criteria for cyclothymic 
disorder and says this has been present since she was 14. However she 
also had a major depressive illness over a two year period following a 
move abroad because of her husband's job. During that episode she was 
charged with assaulting a neighbour and placed on six months probation. 
She finds her husband generally unsympathetic and unsupportive.
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(105) A 34 year old, married, housewife with unilateral classical 
migraine involving the non dominant hemisphere. The aura consists of 
ipsilateral paresis and sensory loss and slurred speech. She complains 
of depression and anxiety lasting approximately 48 hours in association 
with migraines. These symptoms would meet DSM-III criteria for 
depression except for their brevity. She had a past episode of major 
depression at the age of 21 following a friend's suicide and was treated 
with antidepressants by her GP for a year. She has olfactory 
hallucinations (she smells oranges) during her migraine attacks.
(108) A 29 year old, married, housewife with unilateral classical 
migraine affecting the dominant hemisphere. The aura consists of 
ipsilateral paresis and sensory loss and speech disturbance. She says 
her migraines are always accompanied by irritability. She meets DSM-III 
criteria for bipolar illness. This started with a depressive episode 
when she was 18 after she broke off an engagement. She had her first 
hypomanic episode at the age of 25* Her most severe episode of 
depression occurred between 1977-79 when abroad because of her husband's 
job. This was accompanied by alcohol abuse which led to alcohol 
dependence.
(109) This 51 year old, married, housewife has a 25 year history of 
common migraine and says she always has a brief episode of euphoria after 
the headache is over. Her father had psychiatric outpatient treatment 
for depression and she was treated by her GP for postnatal depression for 
two years. Her husband had chronic osteomyelitis and was in hospital 
during most of this pregnancy. She has had dysthymic disorder since 
adolescence. Her migraine are accompanied by unpleasant olfactory and
- 4 -
gustatory hallucinations.
(110) This 44 year old, married, computer operator has a 10 year history 
of unilateral common migraine affecting the non-dominant hemisphere. She 
says depression and irritability always accompany migraine attacks. These 
symptoms would meet DSM-III criteria for major depression in all 
respects except duration. She had a major depressive illness at the age 
of 32 following the break-up of her first marriage. She is sufficiently 
worried that her headaches might be connected with a CVA or a tumour to 
justify a diagnosis of hypochondriasis. However the hypochondriacal 
fears are understandable in view of the increase in the frequency and 
severity of her migraines over the last few months and the failure of 
medication to control them. She was reassured to some extent by referral 
to the clinic and physical examination. During migraines her head feels 
larger than usual and she smells gas. (She has, in fact, repeatedly 
called out the Gas Board to investigate this with negative results. She 
had not recognised the connection with her migraine until the interview.)
(112) A 53 year old, married, housewife with a 17 year history of 
unilateral classical migraine affecting the non-dominant hemisphere. The 
migraines are always associated with irritability and a feeling that life 
is not worth living. This lasts 24-48 hours. She herself had no current 
or past psychiatric illness but her mother died of a CVA in a psychiatric 
hospital after having ECT for depression.
(113) This 51 year old, married, cleaner has a 16 year history of 
unilateral common migraine affecting the non-dominant hemisphere. She 
usually notices increased irritability (she shouts more at others) and
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activity during the few hours before a migraine attack. There are no 
current or past psychiatric diagnoses.
(114) A 22 year old, married, housewife with a six year history of 
classical migraine. She has an aura of paresis and speech disturbance. 
She says that she always experiences depression and irritability with her 
migraines. She has had two episodes of major depression: -
(i) in 1981 when she was treated with antidepressant medication just 
after joining the RAP.
(ii) after the birth of her first child. She felt let down by her 
husband and they were separated for five of the nine months during which 
this illness was present.
She has olfactory hallucinations of an unpleasant smell in association 
with her migraine.
(115) A 51 year old, separated, teacher with a five year history of 
unilateral classical migraine affecting the non-dominant hemisphere. 
Attacks are associated with ipsilateral sensory loss and by visual 
disturbance. She complains of depression which always accompanies her 
migraines and lasts approximately 48 hours. She also meets diagnostic 
criteria for longstanding dysthymic disorder. One of her daughters was- 
treated for suicidal ideas and agoraphobia at age 16 - this would seem 
most likely to have been a depressive illness.
(116) This 37 year old, married, housewife has a 1-2 year history of 
classical migraine. Her aura is made up of paresis, sensory loss and 
disturbance of speech and vision. She complains of always experiencing 
depression and irritability along with her migraines. She had outpatient
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psychiatric contact five years ago because of depression. She feared 
losing her baby due to back problems and had had a miscarriage shortly 
before this pregnancy. She also had an episode of major depression 
lasting four weeks in 1983 following a move to a new home. She is 
currently suffering from major depression with melancholia and has 
hypochondriacal fears that her headaches might be caused by a brain 
tumour. Her husband has just lost his job and the family were intending 
to move to Crewe to be closer to his mother when she died two days before 
the removal took place. She and the family are now staying with her 
mother and have no clear plans for the future.
(117) A 57 year old, unmarried, clerical officer with a 15 year history 
of common migraine. Her episodes of migraine are always accompanied by 
depression. The depression consists of feeling 'fed up', poor sleep, 
restlessness and yet also feeling tired and poor concentration. It lasts 
approximately 72 hours. This lady meets criteria for the dysthymic 
syndrome at present.
(118) This 22 year old, unmarried, teacher has a six month history of 
unilateral classical migraine affecting the non-dominant hemisphere. The 
aura consists of contralateral hemiparesis and the attacks are always 
associated with depression, anxiety and irritability. She meets DSM-III 
criteria for major depression at present. This depressive episode seems 
to have been precipitated‘by a recent termination of pregnancy. The 
pregnancy resulted from an affair with a married man and she was angry 
that he was not more supportive towards her.
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(119) A 61 year old, married, retired teacher with a 44 year history of 
unilateral classical migraine affecting the dominant hemisphere. The 
aura prior to the migraine is primarily visual (scotomata). She 
complains of brief episodes of euphoria prior to migraines. She also has 
a 16 year history of obsessive compulsive disorder and a 4-5 year 
history of generalised anxiety disorder. She denies any major life 
stresses at the moment.
(120) This 22 year old, single, surveyor has a one year history of 
unilateral classical migraine which usually affects the dominant 
hemisphere. The aura consists of speech disturbance and impairment of 
vision. She complains of usually experiencing depression prior to 
migraine. She has current generalised anxiety disorder and relates this 
to the stress involved in doing her final exams and dissertation at 
college and starting work in what is still a very male-orientated 
profession. She has olfactory hallucinations of an unpleasant smell 
during migraine attacks.
(121) This 42 year old, married, secretary has a two year history of 
classical migraine. There is disturbance of vision prior to attacks.
She usually experiences depression and irritability associated with 
migraines. She meets the criteria for the dysthymic syndrome. This has 
been present for approximately two years and dates back to an episode of 
sciatica. Following this illness she was forced to reduce her physical 
activities and thus lost many of her interests. The sciatica coincided 
with her teenage children reaching the stage where she no longer felt 
that they needed her and her marriage is no longer offering her support. 
She feels she is taken for granted by her husband and children.
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Non-affective Group
(201) A 20 year old, single, auxiliary nurse with a seven year history of 
common migraine. There is no personal or family psychiatric history and 
she denies ever experiencing mood change as part of her migraine other 
than a feeling of wanting to he left alone when she is unwell.
(202) This 20 year old, unmarried, student teacher has a four year 
history of unilateral classical migraine affecting the non-dominant 
hemisphere. She has a visual aura prior to attacks (she loses her right 
field of vision). There is no personal or family psychiatric history.
Her main stresses are college exams and going out on teaching practice as 
part of her course.
(203) A 44 year old, married, housewife with a 26 year history of 
unilateral classical migraine affecting the dominant hemisphere. The 
aura consists of ipsilateral sensory loss and speech disturbance. She 
sometimes experiences depression prior to, and following, migraines.
Prior to attacks she is 'not with it', unable to concentrate and 
overactive. Following the migraine she is sometimes tearful.
(204) This 46 year old, married, teacher has a 16 year history of 
unilateral common migraine affecting the dominant hemisphere. This is 
accompanied by contralateral sensory loss. She has been treated for 
major depression with panic attacks since 1975 and has been on 
antidepressants almost continuously since then. She has had two 
exacerbations of her illness in response to stress at school. She is
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currently depressed, possibly partly due to the death of her aunt a 
month ago. She has numerous life stresses to contend with - her
neighbour is noisy and she has quarrelled with him. Unfortunately this
neighbour is also a colleague at work and this has made her professional 
life difficult. Her husband's elderly relatives require a lot of 
attention and her son, who has Down's syndrome, can be obstinate.
(205) A 25 year old, single, secretary with a 12 year history of 
unilateral common migraine which can affect either hemisphere. There is 
paresis and speech disturbance as part of attacks. She has no complaints 
of mood change related to her headaches. She had one session with a 
psychologist as an outpatient for relaxation training to help her cope 
with her distress after her mother was involved in a road traffic 
accident. She became very overdependent on her boyfriend at that time 
and has remained so since. She has cyclothymic disorder which has been 
present since adolescence.
(206) This 41 year old, divorced, cashier has a 16 year history of common
migraine. She has no complaints of mood change. She feels her migraine
is always triggered by emotional stress. She has had difficulty 
obtaining maintenance payments for herself and her two children since her 
divorce and six months ago her eleven year old son left to stay with his 
father. He had run away on two occasions before he left for good. She 
has been worrying about having a CVA since her boss's wife (who also has 
migraine) had a stroke a few months ago.
(207) A 42 year old, married, cleaner with a 10 year history of 
unilateral classical migraine affecting the dominant hemisphere. The
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aura prior to her headaches includes ipsilateral paresis and sensory loss 
and disturbance of speech and vision. She sometimes has euphoria for a 
few hours prior to the headache. (She feels 'happy and bubbly' and 
without a care in the world.) She feels her migraine is always triggered 
by emotional stress. She had one past episode of major depression which 
was precipitated by the strain of her husband being off work for nine 
months due to a depressive illness. He has now completely recovered.
She meets the criteria for generalised anxiety disorder at present. This 
began eight months ago when her son was made redundant.
(208) This 42 year old, single, office worker has a 20 year history of 
unilateral common migraine. She does not have specific mood changes 
related to her migraines. She has had two past episodes of major 
depression six years and eight months ago. There was no obvious 
precipitating cause for either episode. There is no family history of 
psychiatric illness.
(209) A 40 year old, married, clerical worker with a seven year history 
of bilateral classical migraine. Her aura consists of paraesthesiae 
which can affect either side of the body, difficulty in 'getting the 
words out' and disturbed vision. She has no complaints of mood change 
accompanying her migraines. However she has a six year history of 
depression and has been on antidepressant medication continuously 
throughout this period of time. There is no family history of 
psychiatric illness.
(210) This 49 year old, married, nurse has a 30 year history of common 
migraine. She has no complaints of mood change associated with her
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headaches. There is no personal or family history of psychiatric 
illness.
(211) A 54 year old, married, retired teacher with a 38 year history of 
unilateral classical migraine affecting the dominant hemisphere. Her aura 
is of flashing lights. She has no complaints of mood change related to her 
migraine. There is no personal or family history of psychiatric illness. 
She has just taken early retirement "because she felt under pressure
at work and she also looks after her mother who has senile dementia.
(212) A 40 year old, married, lecturer with a 17 year history of 
unilateral classical migraine usually affecting the dominant hemisphere. 
She has no complaints of mood change related to her migraine. She meets 
DSM-III criteria for current generalised anxiety disorder. She cannot 
date the onset of this condition and describes it as being lifelong. She 
also had an illness 13 years ago, while working abroad, which was 
probably anorexia nervosa. Her sister has been treated by her GP for 
this condition.
(213) This 48 year old, married, catering assistant has a two year 
history of unilateral classical migraine affecting the dominant 
hemisphere. She has no complaints of mood change related to her 
headaches but is just recovering from an episode of depression and is 
still on antidepressant medication. There is a strong family history of 
depressive illness in her.father and two of her sisters. Her own 
depressive illness was precipitated by the suicide of one of these 
sisters two years ago.
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(214) A 27 year old, unmarried, secretary with an 11 year history of 
unilateral migraine affecting the dominant hemisphere. She has no 
complaints of mood change related to her migraine and there is no 
personal or family history of psychiatric illness.
(215) A 39 year old, married, telephonist with a 26 year history of 
unilateral classical migraine affecting the non-dominant hemisphere. Her 
aura consists of disturbance of speech and vision. She has no complaints 
of mood change related to her migraine attacks. There is no personal or 
family history of psychiatric illness.
(216) This 24 year old, married, teacher has a seven month history of 
unilateral classical migraine which can affect either hemisphere. She is 
sometimes irritable and short-tempered prior to migraine attacks. She 
was in bed with 'nerves' till two days before her wedding last July and 
then shortly afterwards she had what she described as a viral illness 
which caused her to take two months off work. This illness meets DSM-III 
criteria for major depression although she is extremely unwilling to 
consider a psychological explanation for her symptoms.
(217) This 39 year old, divorced, housewife has a ten year history of 
unilateral common migraine affecting the non-dominant hemisphere. She . 
has a visual aura with attacks. She says she sometimes feels depressed 
and irritable in association with her migraines. She has a past history 
of a parasuicide attempt five years ago when her husband was having 
extramarital affairs. She meets DSM-III criteria for major depression 
which has been present for the past two weeks. Her main woriy is her 
difficult relationship with her teenage daughter who still lives at home
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with her.
(218) A 42 year old, married, sales assistant with a 17 year history of 
bilateral classical migraine. Her aura involves disturbance of speech 
and vision. She does not report mood change in association with her 
migraine. However she does meet DSM-III criteria for generalised anxiety 
disorder which she says has been present for the last five years. Her 
mother has had a 'nervous breakdown' i.e. she has been treated for 
agoraphobia, low mood and feeling unable to cope. She also has a sister 
who has been treated with antidepressants because of postnatal 
depression. At present she is worried about her daughter, who has given 
up a good job for no apparent reason, and about her father who has 
prostate problems.
(219) This 47 year old, divorced, lecturer has a 25 year history of 
unilateral common migraine which can affect either hemisphere. She has 
no complaints of mood change related to her migraines. She saw a 
psychiatrist as an outpatient prior to the break up of her marriage and 
was treated with tranquillisers and antidepressants. The marriage was a 
very unhappy one. After the divorce she did an Open University degree 
and a postgraduate diploma while bringing up her daughter. She describes 
herself as having to struggle with low self esteem and a poor self image 
during this time. She has now been successful academically and has a 
responsible job. Her daughter has graduated from university and left 
home. This leaves her feeling lonely and 'emotionally empty'.
(220) A 33 year old, separated, assistant bank manageress with a seven 
year history of unilateral classical migraine affecting the dominant
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hemisphere. She sometimes experiences depression when she has a migraine 
(i.e. she feels that her mood is labile and that she is generally slowed 
down). She also meets DSM-III criteria for generalised anxiety disorder 
which has been present for 4-5 years and had a discrete episode of major 
depression following the break up of her marriage three years ago. She 
has difficulty getting on with her male colleagues at work and finds them 
chauvinistic in their attitude towards her.
(221) A 28 year old, divorced, shop assistant with six year history of 
unilateral common migraine affecting the non dominant hemisphere.
Attacks are accompanied by a general feeling of weakness and dizziness. 
She sometimes experiences depression, anxiety and irritability in 
association with her headaches. She meets DSM-III criteria for both 
major depression and alcohol dependence - both of which have been present 
for the last two years. It was impossible to tell from the history which 
was the primary phenomenon. There is a family history of psychiatric 
illness.
(222) This 28 year old, divorced, secretary has a two year history of 
common migraine which can be both bi- and unilateral. She has no 
complaints of mood change in association with her headaches. She was 
brought up by her mother till the age of nine. Her mother then spent a 
year in and out of hospital before dying of cancer. She then stayed with 
her older brother and his new wife and baby and always felt she was 
unwelcome. She broke up her marriage quite abruptly after her husband 
confessed to a brief affair. She could not cope with the breach of trust 
involved even though her husband was penitent and anxious for the 
marriage to continue. She came to the clinic with the expectation that
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she would be found to have something seriously wrong with her although! 
interestingly enough, she was not unduly concerned about her migraine. 
When Dr Price mentioned that she had a benign heart murmur these 
expectations were confirmed and she went on to develop obsessional 
ruminations about her health which her GP, Dr Price, and her family could 
not remove.
(223) A 32 year old, married, housewife with a nine year history of 
unilateral common migraine affecting the dominant hemisphere. She has 
no complaints of mood change associated with her migraines. She has no 
psychiatric history but her mother has seen a psychiatrist as an 
outpatient because of depression. Her only current stresses relate to her 
husband who is wording hard to establish his own business at the same 
time as doing a part-time university degree. As a consequence she has 
recently had to give up her job as a primary school teacher to take on 
more responsibility for the welfare of their two young children.
(224) This 20 year old, unmarried, factory worker has a three year 
history of common migraine which can be bilateral or unilateral. There 
is no family or personal history of psychiatric illness. She had a very 
unhappy childhood - her father frequently physically assaulted her mother 
while intoxicated and they often separated. Her father would then follow 
the family round the country until he had persuaded his wife to take him 
back. Her mother died when she was 14 and her father when she was 16*
She is now engaged and her migraines started after rows with her fiance's 
mother with whom she was staying. She and her fiance now have no contact 
with their families and are dependent solely on each other.
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(225) A 46 year old widow who works as a market researcher. She has a 
ten year history of unilateral common migraine affecting the non-dominant 
hemisphere. She sometimes experiences euphoria for 1-2 days before a 
migraine attack. This euphoria consists of an increase in self 
confidence, increased talkativeness and more enthusiasm for doing things. 
It has only been present in the last year. Her main worries are her 21 
year old son and 19 year old daughter - she has felt totally responsible 
for their welfare since the death of her husband eight years ago. Both 
children have had difficulties related to their jobs in the last year.
She has occasionally required minor tranquillisers which she has obtained 
from her GP but is subthreshold for a diagnosis of generalised anxiety 
disorder at present and is not on any psychotropic medication.
(226) This 52 year old, married, assistant housing manager has a three 
year history of unilateral common migraine which almost always affects 
the non dominant hemisphere. She has no complaints of mood change and no 
personal or family history of psychiatric illness. She feels that the 
onset of her migraine was related to a stressful period of some months 
when her husband's business was failing. These business difficulties 
are now being resolved.
(227) A 58 year old, married, researcher with a 27 year history of 
classical migraine which can be both bi- and unilateral. The aura before 
her attacks involves paresis which can affect either or both sides of her 
body. She has no current or past psychiatric diagnosis and no complaints 
of mood change associated with her headaches.
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(228) A 26 year old housewife with a two year history of unilateral 
common migraine affecting the non-dominant hemisphere. She has no 
complaints of mood change associated with her migraine and no current or 
past psychiatric diagnoses. There are no major stresses in her life at 
the moment.
(229) This 43 year old, divorced, telephonist has a seven year history 
of unilateral classical migraine affecting the dominant hemisphere. She 
has a visual aura to attacks. She has just stopped taking minor 
tranquillisers after being on them continuously for 20 years. She meets 
DSM-III criteria for past barbiturate-sedative dependence (i.e. substance 
abuse disorder) which was present for approximately 17 years. She also 
meets the criteria for current panic disorder with limited phobic 
avoidance over the same period of time. It is possible, but unlikely, 
that her panic attacks were simply withdrawal symptoms from benzo­
diazepines when she occasionally omitted to take the medication. She 
probably has two conditions with abuse of minor tranquillisers being 
secondary to her panic disorder. She is under considerable stress as a 
single parent trying to support herself and her 12 year old daughter on a 
low wage. She finds her job demanding and her father has just had a 
myocardial infarction. Her mother is her major source of emotional 
support.
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